CINXE.COM

Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary - Benzinga

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><title>Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary - Benzinga</title><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "WebPage", "publisher": {"@type":"Organization","logo":{"@type":"ImageObject","url":"/next-assets/images/schema-publisher-logo-benzinga.png"},"name":"Benzinga","url":"https://www.benzinga.com"}, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.benzinga.com/quote/TCNNF" }, "mainEntity": "WebPage", "headline": "Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary", "url": "https://www.benzinga.com/quote/TCNNF", "dateCreated": "2019-01-01T01:01:01", "datePublished": "2019-01-01T01:01:01", "dateModified": "2024-11-29T13:54:24.720-05:00", "creator": { "@type": "Person", "name": "Benzinga" }, "author": { "@type": "Person", "name": "Benzinga" }, "description": "Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile.", "keywords": ["symbol: TCNNF","section: profile"], "mentions": [], "image": "https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&max_width=&width=60&x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&x-bz-exp=1733045090&x-bz-security-isin=CA89788C1041&x-bz-security-symbol=TCNNF&x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9" }</script><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "NewsMediaOrganization", "name": "Benzinga", "email": "info@benzinga.com", "legalName": "Benzinga", "telephone": "877-440-9464", "url": "https://www.benzinga.com/", "logo": "/next-assets/images/schema-publisher-logo-benzinga.png", "image": "/next-assets/images/schema-image-default.png", "address": { "@type": "PostalAddress", "addressLocality": "Detroit", "addressRegion": "MI", "postalCode": "48226", "streetAddress": "1 Campus Martius Suite 200", "addressCountry": "USA" }, "sameAs": [ "https://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109", "https://twitter.com/benzinga", "https://www.linkedin.com/company/benzinga", "https://plus.google.com/108838891574408087738/posts", "https://www.youtube.com/user/BenzingaTV" ], "brand": [ { "@type": "Brand", "name": "Benzinga PreMarket Prep", "url": "https://www.benzinga.com/premarket" }, { "@type": "Brand", "name": "Benzinga Markets", "url": "https://www.benzinga.com/markets/" }, { "@type": "Brand", "name": "Benzinga Pro", "url": "https://pro.benzinga.com/" }, { "@type": "Brand", "name": "Benzinga Cloud: Data & APIs", "url": "https://www.benzinga.com/apis" }, { "@type": "Brand", "name": "Benzinga Events", "url": "https://www.benzinga.com/events" }, { "@type": "Brand", "name": "Benzinga Money", "url": "https://www.benzinga.com/money/" }, { "@type": "Brand", "name": "Benzinga Marketfy", "url": "https://marketfy.com/" } ] }</script><meta content="Copyright Benzinga. All rights reserved." name="copyright"/><link href="https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&amp;max_width=&amp;width=60&amp;x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&amp;x-bz-exp=1733045090&amp;x-bz-security-isin=CA89788C1041&amp;x-bz-security-symbol=TCNNF&amp;x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9" rel="image_src"/><meta content="Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile." name="description"/><link href="https://www.benzinga.com/quote/TCNNF" rel="canonical"/><meta content="Benzinga" name="author"/><link color="#1177BA" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><link href="/next-assets/images/apple-touch-icon.png" rel="apple-touch-icon" sizes="180x180"/><link href="/next-assets/images/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/><link href="/next-assets/images/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/><link href="/next-assets/site.webmanifest" rel="manifest"/><link color="#5bbad5" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><meta content="#2d89ef" name="msapplication-TileColor"/><meta content="#ffffff" name="theme-color"/><meta content="159483118580" property="fb:app_id"/><link href="http://feeds.benzinga.com/benzinga" rel="alternate" title="Benzinga" type="application/rss+xml"/><meta content="https://www.benzinga.com/quote/TCNNF" name="syndication-source"/><meta content="summary" name="twitter:card"/><meta content="@benzinga" name="twitter:site"/><meta content="Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary" name="twitter:title"/><meta content="Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile." name="twitter:description"/><meta content="https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&amp;max_width=&amp;width=60&amp;x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&amp;x-bz-exp=1733045090&amp;x-bz-security-isin=CA89788C1041&amp;x-bz-security-symbol=TCNNF&amp;x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9" name="twitter:image:src"/><meta content="Benzinga" property="og:site_name"/><meta content="https://www.benzinga.com/quote/TCNNF" property="og:url"/><meta content="Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary" property="og:title"/><meta content="website" property="og:type"/><meta content="Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile." property="og:description"/><meta content="/next-assets/images/schema-image-default.png" property="og:image"/><meta content="image/jpeg" property="og:image:type"/><meta content="1200" property="og:image:width"/><meta content="630" property="og:image:height"/><meta content="app-id=688949481, app-argument=https://itunes.apple.com/us/app/id688949481" name="apple-itunes-app" property="Benzinga for iOS"/><meta content="yes" name="apple-mobile-web-app-capable"/><meta content="black" name="apple-mobile-web-app-status-bar-style"/><meta content="max-image-preview:large" name="robots"/><link href="/manifest.json" rel="manifest"/><meta content="648186192" property="fb:admins"/><meta content="B01B3489A33F83DDA4083E88C260097C" name="msvalidate.01"/><meta content="84f3b1552db5dfbe" name="y_key"/><meta content="101a0095-334d-4935-b87e-0e8fc771214e" name="fo-verify"/><meta content="English" name="language"/><script id="voice-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebPage","name":"Benzinga","speakable":{"@type":"SpeakableSpecification","xpath":["/html/head/title","/html/head/meta[@name='description']/@content"]},"url":"https://www.benzinga.com/"}</script><script id="sitelink-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebSite","name":"Benzinga","potentialAction":{"@type":"SearchAction","query-input":"required name=search_term_string","target":"https://www.benzinga.com/search/fast?cx={search_term_string}"},"url":"https://www.benzinga.com/","hasPart":{"@type":"WebPageElement","cssSelector":".paywall-content","isAccessibleForFree":false},"isAccessibleForFree":false}</script><script id="navigation-header-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"SiteNavigationElement","Name":["Our Services","News","Markets","Options","Ratings","Ideas","Money","Crypto","Cannabis"],"Url":["https://www.benzinga.com/services","https://www.benzinga.com/news","https://www.benzinga.com/markets","https://www.benzinga.com/markets/options","https://www.benzinga.com/analyst-stock-ratings","https://www.benzinga.com/trading-ideas","https://www.benzinga.com/money","https://www.benzinga.com/crypto","https://www.benzinga.com/cannabis"]}</script><link href="https://capi.connatix.com" rel="dns-prefetch"/><link href="https://cds.connatix.com" rel="dns-prefetch"/><link as="script" href="https://cd.connatix.com/connatix.player.js?cid=89cc050a-c0fc-4f72-a746-d63fbd3dee72" rel="preload"/><link as="document" href="https://imasdk.googleapis.com/js/core/bridge3.615.0_en.html" rel="preload"/><script id="corporation-schema-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"Corporation","description":"","name":"Trulieve Cannabis Corp","tickerSymbol":"TCNNF","url":"https://www.benzinga.com/quote/TCNNF"}</script><script id="faq-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>You can purchase shares of Trulieve Cannabis (OTCQX:TCNNF) through any online brokerage.</p><p><a href=\"https://www.benzinga.com/money/online-stock-trading/\" rel=\"noreferrer\" target=\"_blank\">View our list of the best stock brokerages</a></p>"},"name":"How do I buy Trulieve Cannabis (TCNNF) stock?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There are no as such competitors for Trulieve Cannabis.</p>"},"name":"Who are Trulieve Cannabis (TCNNF) competitors?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Trulieve Cannabis has a consensus price target of $18.50.</p>"},"name":"What is the forecast, or price target, for Trulieve Cannabis (TCNNF) stock?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>The stock price for Trulieve Cannabis (OTCQX: TCNNF) is $ last updated .</p>"},"name":"What is the current price for Trulieve Cannabis (TCNNF)?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There are no upcoming dividends for Trulieve Cannabis.</p>"},"name":"Does Trulieve Cannabis (TCNNF) pay a dividend?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Trulieve Cannabis’s Q4 earnings are confirmed for Thursday, February 27, 2025.</p>"},"name":"When is Trulieve Cannabis (OTCQX:TCNNF) reporting earnings?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>There is no upcoming split for Trulieve Cannabis.</p>"},"name":"Is Trulieve Cannabis (TCNNF) going to split?"},{"@type":"Question","acceptedAnswer":{"@type":"Answer","text":"<p>Trulieve Cannabis is in the <b>Healthcare</b> sector and <b>Drug Manufacturers—Specialty & Generic</b> industry. They are listed on the OTCQX.</p>"},"name":"What sector and industry does Trulieve Cannabis (TCNNF) operate in?"}]}</script><meta name="next-head-count" content="54"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-300.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-regular.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-500.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-600.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-700.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-800.woff2" rel="preload" type="font/woff2"/><link href="https://cdn.benzinga.com" rel="dns-prefetch"/><link href="https://cdn.segment.com" rel="preconnect"/><link href="https://www.googletagservices.com" rel="preconnect"/><link as="script" href="https://cdn.parsely.com/keys/benzinga.com/p.js" rel="preload"/><link as="script" href="https://www.google-analytics.com/analytics.js" rel="preload"/><style>:root, :host { --fa-font-solid: normal 900 1em/1 &quot;Font Awesome 6 Solid&quot;; --fa-font-regular: normal 400 1em/1 &quot;Font Awesome 6 Regular&quot;; --fa-font-light: normal 300 1em/1 &quot;Font Awesome 6 Light&quot;; --fa-font-thin: normal 100 1em/1 &quot;Font Awesome 6 Thin&quot;; --fa-font-duotone: normal 900 1em/1 &quot;Font Awesome 6 Duotone&quot;; --fa-font-sharp-solid: normal 900 1em/1 &quot;Font Awesome 6 Sharp&quot;; --fa-font-sharp-regular: normal 400 1em/1 &quot;Font Awesome 6 Sharp&quot;; --fa-font-sharp-light: normal 300 1em/1 &quot;Font Awesome 6 Sharp&quot;; --fa-font-sharp-thin: normal 100 1em/1 &quot;Font Awesome 6 Sharp&quot;; --fa-font-brands: normal 400 1em/1 &quot;Font Awesome 6 Brands&quot;; } svg:not(:root).svg-inline--fa, svg:not(:host).svg-inline--fa { overflow: visible; box-sizing: content-box; } .svg-inline--fa { display: var(--fa-display, inline-block); height: 1em; overflow: visible; vertical-align: -0.125em; } .svg-inline--fa.fa-2xs { vertical-align: 0.1em; } .svg-inline--fa.fa-xs { vertical-align: 0em; } .svg-inline--fa.fa-sm { vertical-align: -0.0714285705em; } .svg-inline--fa.fa-lg { vertical-align: -0.2em; } .svg-inline--fa.fa-xl { vertical-align: -0.25em; } .svg-inline--fa.fa-2xl { vertical-align: -0.3125em; } .svg-inline--fa.fa-pull-left { margin-right: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-pull-right { margin-left: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-li { width: var(--fa-li-width, 2em); top: 0.25em; } .svg-inline--fa.fa-fw { width: var(--fa-fw-width, 1.25em); } .fa-layers svg.svg-inline--fa { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; } .fa-layers-counter, .fa-layers-text { display: inline-block; position: absolute; text-align: center; } .fa-layers { display: inline-block; height: 1em; position: relative; text-align: center; vertical-align: -0.125em; width: 1em; } .fa-layers svg.svg-inline--fa { -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-text { left: 50%; top: 50%; -webkit-transform: translate(-50%, -50%); transform: translate(-50%, -50%); -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-counter { background-color: var(--fa-counter-background-color, #ff253a); border-radius: var(--fa-counter-border-radius, 1em); box-sizing: border-box; color: var(--fa-inverse, #fff); line-height: var(--fa-counter-line-height, 1); max-width: var(--fa-counter-max-width, 5em); min-width: var(--fa-counter-min-width, 1.5em); overflow: hidden; padding: var(--fa-counter-padding, 0.25em 0.5em); right: var(--fa-right, 0); text-overflow: ellipsis; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-counter-scale, 0.25)); transform: scale(var(--fa-counter-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-bottom-right { bottom: var(--fa-bottom, 0); right: var(--fa-right, 0); top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom right; transform-origin: bottom right; } .fa-layers-bottom-left { bottom: var(--fa-bottom, 0); left: var(--fa-left, 0); right: auto; top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom left; transform-origin: bottom left; } .fa-layers-top-right { top: var(--fa-top, 0); right: var(--fa-right, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-top-left { left: var(--fa-left, 0); right: auto; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top left; transform-origin: top left; } .fa-1x { font-size: 1em; } .fa-2x { font-size: 2em; } .fa-3x { font-size: 3em; } .fa-4x { font-size: 4em; } .fa-5x { font-size: 5em; } .fa-6x { font-size: 6em; } .fa-7x { font-size: 7em; } .fa-8x { font-size: 8em; } .fa-9x { font-size: 9em; } .fa-10x { font-size: 10em; } .fa-2xs { font-size: 0.625em; line-height: 0.1em; vertical-align: 0.225em; } .fa-xs { font-size: 0.75em; line-height: 0.0833333337em; vertical-align: 0.125em; } .fa-sm { font-size: 0.875em; line-height: 0.0714285718em; vertical-align: 0.0535714295em; } .fa-lg { font-size: 1.25em; line-height: 0.05em; vertical-align: -0.075em; } .fa-xl { font-size: 1.5em; line-height: 0.0416666682em; vertical-align: -0.125em; } .fa-2xl { font-size: 2em; line-height: 0.03125em; vertical-align: -0.1875em; } .fa-fw { text-align: center; width: 1.25em; } .fa-ul { list-style-type: none; margin-left: var(--fa-li-margin, 2.5em); padding-left: 0; } .fa-ul &gt; li { position: relative; } .fa-li { left: calc(var(--fa-li-width, 2em) * -1); position: absolute; text-align: center; width: var(--fa-li-width, 2em); line-height: inherit; } .fa-border { border-color: var(--fa-border-color, #eee); border-radius: var(--fa-border-radius, 0.1em); border-style: var(--fa-border-style, solid); border-width: var(--fa-border-width, 0.08em); padding: var(--fa-border-padding, 0.2em 0.25em 0.15em); } .fa-pull-left { float: left; margin-right: var(--fa-pull-margin, 0.3em); } .fa-pull-right { float: right; margin-left: var(--fa-pull-margin, 0.3em); } .fa-beat { -webkit-animation-name: fa-beat; animation-name: fa-beat; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-bounce { -webkit-animation-name: fa-bounce; animation-name: fa-bounce; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); } .fa-fade { -webkit-animation-name: fa-fade; animation-name: fa-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-beat-fade { -webkit-animation-name: fa-beat-fade; animation-name: fa-beat-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-flip { -webkit-animation-name: fa-flip; animation-name: fa-flip; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-shake { -webkit-animation-name: fa-shake; animation-name: fa-shake; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 2s); animation-duration: var(--fa-animation-duration, 2s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin-reverse { --fa-animation-direction: reverse; } .fa-pulse, .fa-spin-pulse { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, steps(8)); animation-timing-function: var(--fa-animation-timing, steps(8)); } @media (prefers-reduced-motion: reduce) { .fa-beat, .fa-bounce, .fa-fade, .fa-beat-fade, .fa-flip, .fa-pulse, .fa-shake, .fa-spin, .fa-spin-pulse { -webkit-animation-delay: -1ms; animation-delay: -1ms; -webkit-animation-duration: 1ms; animation-duration: 1ms; -webkit-animation-iteration-count: 1; animation-iteration-count: 1; -webkit-transition-delay: 0s; transition-delay: 0s; -webkit-transition-duration: 0s; transition-duration: 0s; } } @-webkit-keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @-webkit-keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @-webkit-keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @-webkit-keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @-webkit-keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @-webkit-keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @-webkit-keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } @keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } .fa-rotate-90 { -webkit-transform: rotate(90deg); transform: rotate(90deg); } .fa-rotate-180 { -webkit-transform: rotate(180deg); transform: rotate(180deg); } .fa-rotate-270 { -webkit-transform: rotate(270deg); transform: rotate(270deg); } .fa-flip-horizontal { -webkit-transform: scale(-1, 1); transform: scale(-1, 1); } .fa-flip-vertical { -webkit-transform: scale(1, -1); transform: scale(1, -1); } .fa-flip-both, .fa-flip-horizontal.fa-flip-vertical { -webkit-transform: scale(-1, -1); transform: scale(-1, -1); } .fa-rotate-by { -webkit-transform: rotate(var(--fa-rotate-angle, none)); transform: rotate(var(--fa-rotate-angle, none)); } .fa-stack { display: inline-block; vertical-align: middle; height: 2em; position: relative; width: 2.5em; } .fa-stack-1x, .fa-stack-2x { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; z-index: var(--fa-stack-z-index, auto); } .svg-inline--fa.fa-stack-1x { height: 1em; width: 1.25em; } .svg-inline--fa.fa-stack-2x { height: 2em; width: 2.5em; } .fa-inverse { color: var(--fa-inverse, #fff); } .sr-only, .fa-sr-only { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .sr-only-focusable:not(:focus), .fa-sr-only-focusable:not(:focus) { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .svg-inline--fa .fa-primary { fill: var(--fa-primary-color, currentColor); opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa .fa-secondary { fill: var(--fa-secondary-color, currentColor); opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-primary { opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-secondary { opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa mask .fa-primary, .svg-inline--fa mask .fa-secondary { fill: black; } .fad.fa-inverse, .fa-duotone.fa-inverse { color: var(--fa-inverse, #fff); }</style><script type="text/javascript">window.OneSignal = window.OneSignal || [];</script><script id="parsely" type="text/javascript" data-nscript="beforeInteractive">window.PARSELY = window.PARSELY || {}; window.PARSELY.use_localstorage = true;</script><link rel="preload" href="/_next/static/css/d6988fecb414318d.css" as="style"/><link rel="stylesheet" href="/_next/static/css/d6988fecb414318d.css" data-n-g=""/><link rel="preload" href="/_next/static/css/3916720a5fae312c.css" as="style"/><link rel="stylesheet" href="/_next/static/css/3916720a5fae312c.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js"></script><script src="/_next/static/chunks/webpack-39186fc1a8e0560b.js" defer=""></script><script src="/_next/static/chunks/framework-e6b7f5edbdf1e600.js" defer=""></script><script src="/_next/static/chunks/main-a8bae8723e38c3f7.js" defer=""></script><script src="/_next/static/chunks/pages/_app-3e23454d7c73b1ef.js" defer=""></script><script src="/_next/static/chunks/93656207-054575cec1993ecf.js" defer=""></script><script src="/_next/static/chunks/4c744e84-475c8634f7d1af26.js" defer=""></script><script src="/_next/static/chunks/ad54e6ef-d46e761f1147ca7a.js" defer=""></script><script src="/_next/static/chunks/aeb74aa0-2bdcc805ac1c6490.js" defer=""></script><script src="/_next/static/chunks/8eec4907-3b52a9e94580c3e0.js" defer=""></script><script src="/_next/static/chunks/a981ec11-57883dfa93c2b67f.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-71dff3b3a37cc29b.js" defer=""></script><script src="/_next/static/chunks/8c469d57-278636cb3035cd4d.js" defer=""></script><script src="/_next/static/chunks/5adc83ef-393b37d1f739f830.js" defer=""></script><script src="/_next/static/chunks/74927-e6eca17cfd52e04d.js" defer=""></script><script src="/_next/static/chunks/25491-a2c0d84c469150a7.js" defer=""></script><script src="/_next/static/chunks/37149-3c57e32bee25fc30.js" defer=""></script><script src="/_next/static/chunks/73737-bc29be1038094f29.js" defer=""></script><script src="/_next/static/chunks/73268-e15b89d697dd4508.js" defer=""></script><script src="/_next/static/chunks/42568-379ea60ff3a1ea4f.js" defer=""></script><script src="/_next/static/chunks/80478-55b510ca744c711f.js" defer=""></script><script src="/_next/static/chunks/97209-33e9c9fa12e49518.js" defer=""></script><script src="/_next/static/chunks/48834-0b3427eb40669fa3.js" defer=""></script><script src="/_next/static/chunks/39097-9e1fd452247607ca.js" defer=""></script><script src="/_next/static/chunks/67326-7eb512377123f4f0.js" defer=""></script><script src="/_next/static/chunks/90162-9baeeb2b96ad8c1c.js" defer=""></script><script src="/_next/static/chunks/6479-3dbc0f000f0bbdc9.js" defer=""></script><script src="/_next/static/chunks/78283-a0f9e26c29b01da4.js" defer=""></script><script src="/_next/static/chunks/62070-ff37c92d4e117f2c.js" defer=""></script><script src="/_next/static/chunks/26212-66b5594b77072bcf.js" defer=""></script><script src="/_next/static/chunks/2052-f87ebf4b92a62c84.js" defer=""></script><script src="/_next/static/chunks/67732-a439f69c1a3ec43f.js" defer=""></script><script src="/_next/static/chunks/10960-bbfebdcf6a53f138.js" defer=""></script><script src="/_next/static/chunks/24609-e6c6f256225974e7.js" defer=""></script><script src="/_next/static/chunks/59392-e5eea99f00426be0.js" defer=""></script><script src="/_next/static/chunks/22055-c20d8ce2383d153b.js" defer=""></script><script src="/_next/static/chunks/87249-43298e6458be0b59.js" defer=""></script><script src="/_next/static/chunks/40570-9afb87c30a807770.js" defer=""></script><script src="/_next/static/chunks/19294-9b6480bc733acc7c.js" defer=""></script><script src="/_next/static/chunks/4471-0f344b0bd32e626c.js" defer=""></script><script src="/_next/static/chunks/50570-d1a9e31fb0450fd1.js" defer=""></script><script src="/_next/static/chunks/62314-9b2028cacd765027.js" defer=""></script><script src="/_next/static/chunks/89859-4cd0f54ecc450f00.js" defer=""></script><script src="/_next/static/chunks/71604-8997cb220734d99c.js" defer=""></script><script src="/_next/static/chunks/44084-667ed8c06e475efb.js" defer=""></script><script src="/_next/static/chunks/97448-60d78b2ba9365e07.js" defer=""></script><script src="/_next/static/chunks/58260-00ccef72f45a2183.js" defer=""></script><script src="/_next/static/chunks/30807-ca57596b5b1ef099.js" defer=""></script><script src="/_next/static/chunks/5677-b2de229f09efba8c.js" defer=""></script><script src="/_next/static/chunks/77039-20e35d04f2791bd6.js" defer=""></script><script src="/_next/static/chunks/13871-c539bda43c147074.js" defer=""></script><script src="/_next/static/chunks/28204-3900958964fba472.js" defer=""></script><script src="/_next/static/chunks/66130-f2836f13855d6249.js" defer=""></script><script src="/_next/static/chunks/43312-ce460bdd5487e7d5.js" defer=""></script><script src="/_next/static/chunks/39129-b242eacefdaa0147.js" defer=""></script><script src="/_next/static/chunks/81120-ba7533545476b514.js" defer=""></script><script src="/_next/static/chunks/80361-673dbc4079b1f8ea.js" defer=""></script><script src="/_next/static/chunks/89268-e6fb27f128c54a8b.js" defer=""></script><script src="/_next/static/chunks/60880-ece185aeb1259b35.js" defer=""></script><script src="/_next/static/chunks/31462-9af6bc0bdb51fa5d.js" defer=""></script><script src="/_next/static/chunks/44791-e305056846e74c64.js" defer=""></script><script src="/_next/static/chunks/pages/quotev2/%5Bticker%5D-edded5b57e677a0d.js" defer=""></script><script src="/_next/static/ai_akWtpvOvhV1YpY4JBy/_buildManifest.js" defer=""></script><script src="/_next/static/ai_akWtpvOvhV1YpY4JBy/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="6.1.8">.bz-featured-ad{position:relative;}/*!sc*/ .bz-featured-ad::after{position:absolute;content:'Featured Ad';padding:1px 10px;vertical-align:super;font-size:12px;display:inline-block;background:#f5f5f5;border-radius:16px;margin-left:3px;border:1px solid #cacaca;bottom:5px;left:inherit;}/*!sc*/ data-styled.g37[id="sc-global-jWNYke1"]{content:"sc-global-jWNYke1,"}/*!sc*/ .iRTtZw{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:capitalize;width:100%;}/*!sc*/ .iRTtZw >h1,.iRTtZw >h2,.iRTtZw >h3,.iRTtZw >h4,.iRTtZw >h5,.iRTtZw >h6,.iRTtZw >span{font-size:inherit;}/*!sc*/ .iRTtZw.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .iRTtZw.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .iRTtZw.border-through >h1,.iRTtZw.border-through >h2,.iRTtZw.border-through >h3,.iRTtZw.border-through >h4,.iRTtZw.border-through >h5,.iRTtZw.border-through >h6,.iRTtZw.border-through >span{position:relative;display:inline-block;}/*!sc*/ .iRTtZw.border-through >h1:before,.iRTtZw.border-through >h2:before,.iRTtZw.border-through >h3:before,.iRTtZw.border-through >h4:before,.iRTtZw.border-through >h5:before,.iRTtZw.border-through >h6:before,.iRTtZw.border-through >span:before,.iRTtZw.border-through >h1:after,.iRTtZw.border-through >h2:after,.iRTtZw.border-through >h3:after,.iRTtZw.border-through >h4:after,.iRTtZw.border-through >h5:after,.iRTtZw.border-through >h6:after,.iRTtZw.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .iRTtZw.border-through >h1:before,.iRTtZw.border-through >h2:before,.iRTtZw.border-through >h3:before,.iRTtZw.border-through >h4:before,.iRTtZw.border-through >h5:before,.iRTtZw.border-through >h6:before,.iRTtZw.border-through >span:before{right:100%;}/*!sc*/ .iRTtZw.border-through >h1:after,.iRTtZw.border-through >h2:after,.iRTtZw.border-through >h3:after,.iRTtZw.border-through >h4:after,.iRTtZw.border-through >h5:after,.iRTtZw.border-through >h6:after,.iRTtZw.border-through >span:after{left:100%;}/*!sc*/ .iRTtZw.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .iRTtZw .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ .kFRmOG{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .kFRmOG >h1,.kFRmOG >h2,.kFRmOG >h3,.kFRmOG >h4,.kFRmOG >h5,.kFRmOG >h6,.kFRmOG >span{font-size:inherit;}/*!sc*/ .kFRmOG.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .kFRmOG.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .kFRmOG.border-through >h1,.kFRmOG.border-through >h2,.kFRmOG.border-through >h3,.kFRmOG.border-through >h4,.kFRmOG.border-through >h5,.kFRmOG.border-through >h6,.kFRmOG.border-through >span{position:relative;display:inline-block;}/*!sc*/ .kFRmOG.border-through >h1:before,.kFRmOG.border-through >h2:before,.kFRmOG.border-through >h3:before,.kFRmOG.border-through >h4:before,.kFRmOG.border-through >h5:before,.kFRmOG.border-through >h6:before,.kFRmOG.border-through >span:before,.kFRmOG.border-through >h1:after,.kFRmOG.border-through >h2:after,.kFRmOG.border-through >h3:after,.kFRmOG.border-through >h4:after,.kFRmOG.border-through >h5:after,.kFRmOG.border-through >h6:after,.kFRmOG.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .kFRmOG.border-through >h1:before,.kFRmOG.border-through >h2:before,.kFRmOG.border-through >h3:before,.kFRmOG.border-through >h4:before,.kFRmOG.border-through >h5:before,.kFRmOG.border-through >h6:before,.kFRmOG.border-through >span:before{right:100%;}/*!sc*/ .kFRmOG.border-through >h1:after,.kFRmOG.border-through >h2:after,.kFRmOG.border-through >h3:after,.kFRmOG.border-through >h4:after,.kFRmOG.border-through >h5:after,.kFRmOG.border-through >h6:after,.kFRmOG.border-through >span:after{left:100%;}/*!sc*/ .kFRmOG.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .kFRmOG .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ .fLScaU{font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .fLScaU >h1,.fLScaU >h2,.fLScaU >h3,.fLScaU >h4,.fLScaU >h5,.fLScaU >h6,.fLScaU >span{font-size:inherit;}/*!sc*/ .fLScaU.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .fLScaU.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .fLScaU.border-through >h1,.fLScaU.border-through >h2,.fLScaU.border-through >h3,.fLScaU.border-through >h4,.fLScaU.border-through >h5,.fLScaU.border-through >h6,.fLScaU.border-through >span{position:relative;display:inline-block;}/*!sc*/ .fLScaU.border-through >h1:before,.fLScaU.border-through >h2:before,.fLScaU.border-through >h3:before,.fLScaU.border-through >h4:before,.fLScaU.border-through >h5:before,.fLScaU.border-through >h6:before,.fLScaU.border-through >span:before,.fLScaU.border-through >h1:after,.fLScaU.border-through >h2:after,.fLScaU.border-through >h3:after,.fLScaU.border-through >h4:after,.fLScaU.border-through >h5:after,.fLScaU.border-through >h6:after,.fLScaU.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .fLScaU.border-through >h1:before,.fLScaU.border-through >h2:before,.fLScaU.border-through >h3:before,.fLScaU.border-through >h4:before,.fLScaU.border-through >h5:before,.fLScaU.border-through >h6:before,.fLScaU.border-through >span:before{right:100%;}/*!sc*/ .fLScaU.border-through >h1:after,.fLScaU.border-through >h2:after,.fLScaU.border-through >h3:after,.fLScaU.border-through >h4:after,.fLScaU.border-through >h5:after,.fLScaU.border-through >h6:after,.fLScaU.border-through >span:after{left:100%;}/*!sc*/ .fLScaU.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .fLScaU .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ data-styled.g38[id="sc-ilxebA"]{content:"iRTtZw,kFRmOG,fLScaU,"}/*!sc*/ .bnTQiZ.spinner{flex:1;display:flex;flex-direction:column;font-size:25px;align-items:center;justify-content:center;}/*!sc*/ .bnTQiZ.spinner .spinner-icon{color:transparent;fill:#1A79FF;-webkit-animation:spin 1s linear infinite;animation:spin 1s linear infinite;width:2rem;height:2rem;}/*!sc*/ .bnTQiZ.spinner .text-text{font-size:14px;color:#1A79FF;margin-top:0.5rem;}/*!sc*/ .bnTQiZ.spinner .sr-only{display:none;}/*!sc*/ @-moz-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-webkit-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-o-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @-ms-keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ @keyframes spin{0%{-moz-transform:rotate(0deg);-o-transform:rotate(0deg);-webkit-transform:rotate(0deg);transform:rotate(0deg);}100%{-moz-transform:rotate(359deg);-o-transform:rotate(359deg);-webkit-transform:rotate(359deg);transform:rotate(359deg);}}/*!sc*/ data-styled.g39[id="sc-jIBlqr"]{content:"bnTQiZ,"}/*!sc*/ .lckOOn{font-size:14px;color:#192940;font-weight:600;display:inline-flex;text-decoration:none;align-items:center;justify-content:center;line-height:1rem;background:#ffffff;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);border:solid 1px #E1EBFA;border-radius:4px;padding-top:0.5rem;padding-bottom:0.5rem;padding-left:0.75rem;padding-right:0.75rem;transition:0.25s background-color ease-in-out,0.25s color ease-in-out,0.25s border-color ease-in-out;}/*!sc*/ .lckOOn >span{display:contents;}/*!sc*/ .lckOOn.sm{padding-left:0.35rem;padding-right:0.35rem;width:auto;height:24px;font-size:0.75rem;border-radius:0.25rem;}/*!sc*/ .lckOOn.lg{height:56px;padding:1rem 2.5rem;font-weight:700;font-size:1rem;line-height:1.25rem;}/*!sc*/ .lckOOn.fusion-md{height:40px;padding:0 1rem;font-weight:700;flex-shrink:0;}/*!sc*/ .lckOOn:focus{outline:none;}/*!sc*/ .lckOOn.danger{color:#c81e1e;border:solid 1px #f98080;background:#fdf2f2;}/*!sc*/ .lckOOn.danger:hover{background:#fde8e8;}/*!sc*/ .lckOOn.flat{color:#395173;border:solid 1px #E1EBFA;background:transparent;}/*!sc*/ .lckOOn.danger-filled{color:#ffffff;border:solid 1px #e02424;background:#e02424;}/*!sc*/ .lckOOn.danger-filled:hover{background:#f05252;}/*!sc*/ .lckOOn.primary{color:#1a56db;border:solid 1px #3f83f8;background:#c3ddfd;}/*!sc*/ .lckOOn.primary:hover{background:#a4cafe;}/*!sc*/ .lckOOn.success-filled{color:#ffffff;border:solid 1px #0e9f6e;background:#0e9f6e;}/*!sc*/ .lckOOn.success-filled:hover{background:#31c48d;}/*!sc*/ .lckOOn.success{color:#046c4e;border:solid 1px #0e9f6e;background:#bcf0da;}/*!sc*/ .lckOOn.success:hover{background:#84e1bc;}/*!sc*/ .lckOOn.warning{color:#b43403;border:solid 1px #ff5a1f;background:#fcd9bd;}/*!sc*/ .lckOOn.warning:hover{background:#fdba8c;}/*!sc*/ .lckOOn.full{width:100%;display:inherit;}/*!sc*/ .lckOOn.full span{width:100%;text-align:center;}/*!sc*/ .lckOOn.cta{background-color:#002d45;color:#ffffff;height:2.5rem;letter-spacing:0.1em;text-transform:uppercase;width:100%;}/*!sc*/ .lckOOn.cta:hover{background-color:rgb(217, 105, 0);box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);position:relative;bottom:2px;}/*!sc*/ .lckOOn.flat-orange{color:#ffffff;border:solid 1px #ff5a1f;background:#ff5a1f;}/*!sc*/ .lckOOn.flat-orange:hover{background:#d03801;}/*!sc*/ .lckOOn.flat-black{color:#ffffff;border:solid 1px #000000;background:#000000;transition:0.2s;}/*!sc*/ .lckOOn.flat-black:hover{background:#ffffff;color:#000000;}/*!sc*/ .lckOOn.flat-gray{color:#ffffff;border:solid 1px #5B7292;background:#5B7292;transition:0.2s;}/*!sc*/ .lckOOn.flat-gray:hover{background:#ffffff;color:#000000;}/*!sc*/ .lckOOn.light-gray{color:#000000;border:solid 1px #CEDDF2;background:#CEDDF2;transition:0.2s;}/*!sc*/ .lckOOn.light-gray:hover{background:#B8CBE6;color:#000000;}/*!sc*/ .lckOOn.flat-blue{color:#ffffff;border:solid 1px #3f83f8;background:#3f83f8;}/*!sc*/ .lckOOn.flat-blue:hover{background:#1c64f2;}/*!sc*/ .lckOOn.dark-blue{color:#ffffff;border:solid 1px #233876;background:#233876;}/*!sc*/ .lckOOn.dark-blue:hover{background:#1e429f;}/*!sc*/ .lckOOn.flat-light-blue{color:#3f83f8;border:solid 1px #e1effe;background:#e1effe;}/*!sc*/ .lckOOn.flat-light-blue:hover{background:#c3ddfd;}/*!sc*/ .lckOOn.flat-light-blue-outlined{color:#3f83f8;border:solid 1px #CEDDF2;background:#e1effe;box-shadow:unset;}/*!sc*/ .lckOOn.flat-light-blue-outlined:hover{background:#c3ddfd;}/*!sc*/ .lckOOn.flat-red{color:#ffffff;border:solid 1px #f05252;background:#f05252;}/*!sc*/ .lckOOn.flat-red:hover{background:#e02424;}/*!sc*/ .lckOOn.flat-ind-blue{color:#ffffff;border:solid 1px #24344F;background:#24344F;}/*!sc*/ .lckOOn.flat-ind-blue:hover{background:#24344F;}/*!sc*/ .lckOOn.white-outline{background:rgba(26, 121, 255, 0.05);border:1px solid #ffffff;color:#ffffff;}/*!sc*/ .lckOOn.white-outline:hover{background:rgba(210, 210, 210, 0.1);}/*!sc*/ .lckOOn.fusion-outline{background:rgba(26, 121, 255, 0.05);border:1px solid rgba(26, 121, 255, 0.75);color:#3f83f8;}/*!sc*/ .lckOOn.fusion-outline:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .lckOOn.fusion-secondary{background:#E1EBFA;border:0;color:#3f83f8;}/*!sc*/ .lckOOn.fusion-secondary:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .lckOOn.fusion-white{background:#ffffff;color:#3f83f8;border:none;}/*!sc*/ .lckOOn.fusion-white:hover{background:#3f83f8;color:#ffffff;}/*!sc*/ data-styled.g40[id="sc-hhyKGa"]{content:"lckOOn,"}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-list-wrapper{overflow-x:auto;overflow-y:hidden;min-width:0;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-list-wrapper{-ms-overflow-style:none;scrollbar-width:none;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-list-wrapper::-webkit-scrollbar{display:none;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-list{display:grid;grid-template-columns:repeat(auto-fit, minmax(160px, 1fr));gap:8px;min-width:max-content;padding-top:14px;padding-bottom:14px;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-listbutton.tab{width:100%;border-radius:4px;background-color:#ffffff;border:1px solid #E1EBFA;color:#5B7292;font-weight:700;font-size:14px;height:36px;padding:0 16px;transition:0.25s color ease-in-out,0.25s box-shadow ease-in-out;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-listbutton.tab:hover{color:#3f83f8;box-shadow:0 2px 16px rgba(25, 68, 128, 0.1);}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-listbutton.tab.active{background-color:#3f83f8;color:#ffffff;}/*!sc*/ .cQRDCg.tabs-container.full-variant.tab-listbutton.tab.active:hover{color:#ffffff;}/*!sc*/ @media screen and (max-width: 800px){.cQRDCg.tabs-container.full-variant.tab-list{overflow-x:auto;}}/*!sc*/ @media screen and (max-width: 959px){.cQRDCg.tabs-container.full-variant.tab-list{grid-auto-flow:column;grid-auto-columns:minmax(160px, 1fr);grid-template-columns:unset;}}/*!sc*/ @media screen and (max-width: 567px){.cQRDCg.tabs-container.full-variant.tab-list{grid-auto-columns:minmax(140px, 1fr);}}/*!sc*/ .cQRDCg.tabs-container .tab-list{gap:0;}/*!sc*/ .cQRDCg.tabs-container .tab-list button.tab.active{color:#1c64f2;}/*!sc*/ .cQRDCg.tabs-container .tab-list button.tab.active:hover{color:#1c64f2;}/*!sc*/ .cQRDCg.tabs-container .ellipsis-icon{color:#1c64f2;}/*!sc*/ .cQRDCg.tabs-container.default-variant .more-items-button,.cQRDCg.tabs-container.lifted-variant .more-items-button{margin-left:auto;}/*!sc*/ .cQRDCg.tabs-container.bordered-variant .tab-list button.tab{border-bottom:2px solid #CEDDF2;}/*!sc*/ .cQRDCg.tabs-container.bordered-variant .tab-list button.tab.active{border-bottom-color:#1c64f2;}/*!sc*/ .cQRDCg.tabs-container.bordered-variant .tab-list button.tab:hover{border-bottom-color:#76a9fa;}/*!sc*/ .cQRDCg.tabs-container.bordered-variant .ellipsis-icon{color:#1c64f2;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .tab-list{background-color:#F2F8FF;border-radius:6px;padding:6px;gap:0.5rem;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .tab-list button.tab{padding:2px 8px;border-radius:6px;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .tab-list button.tab:hover{background-color:#E1EBFA;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .tab-list button.tab.active{background-color:#3f83f8;color:#ffffff;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .tab-list button.tab.active:hover{color:#ffffff;}/*!sc*/ .cQRDCg.tabs-container.pill-variant .more-items-button{margin-left:auto;color:#3f83f8;}/*!sc*/ .cQRDCg.tabs-container.lifted-variant .tab-list-wrapper{border-bottom:1px solid #99AECC;margin-bottom:1rem;}/*!sc*/ .cQRDCg.tabs-container.lifted-variant .tab-list-wrapper::-webkit-scrollbar{display:none;}/*!sc*/ .cQRDCg.tabs-container.lifted-variant .tab-list button.tab{border-bottom:1px solid transparent;background-color:transparent;border-radius:4px 4px 0 0;text-align:center;}/*!sc*/ .cQRDCg.tabs-container.lifted-variant .tab-list button.tab.active{background-color:transparent;border:1px solid #395173;border-bottom-color:#fff;color:#17253A;}/*!sc*/ .cQRDCg.tabs-container.lifted-variant .tab-list button.tab.promo-offer{color:#ff5a1f!important;}/*!sc*/ .cQRDCg.tabs-container:not(.pill-variant) .more-items-button{padding:5px 16px;width:40px;}/*!sc*/ .cQRDCg.tabs-container:not(.pill-variant) .more-items-button .ellipsis-icon{color:#5B7292;}/*!sc*/ .cQRDCg.tabs-container .secondary-tabs-dropdown{position:relative;top:20px;}/*!sc*/ .cQRDCg.tabs-container .secondary-tabs-dropdown button{padding:4px;min-width:70px;text-align:left;font-size:12px;}/*!sc*/ .cQRDCg.tabs-container .secondary-tabs-dropdown button:hover{background-color:#E1EBFA;}/*!sc*/ .cQRDCg.tabs-container .tab-list{white-space:nowrap;display:flex;align-items:center;overflow-x:auto;}/*!sc*/ .cQRDCg.tabs-container .tab-list.overflow-shadow-left{-webkit-mask-image:linear-gradient(270deg, #000 85%, transparent);mask-image:linear-gradient(270deg, #000 85%, transparent);}/*!sc*/ .cQRDCg.tabs-container .tab-list.overflow-shadow-right{-webkit-mask-image:linear-gradient(90deg, #000 85%, transparent);mask-image:linear-gradient(90deg, #000 85%, transparent);}/*!sc*/ .cQRDCg.tabs-container .tab-list.overflow-shadow-both{--scroll-shadow-size:20px;-webkit-mask-image:linear-gradient( to right, #000, #000, transparent 0, #000 var(--scroll-shadow-size), #000 calc(100% - var(--scroll-shadow-size)), transparent );mask-image:linear-gradient( to right, #000, #000, transparent 0, #000 var(--scroll-shadow-size), #000 calc(100% - var(--scroll-shadow-size)), transparent );}/*!sc*/ .cQRDCg.tabs-container .tab-list button.tab{cursor:pointer;padding:8px 16px;border:0;background:none;}/*!sc*/ .cQRDCg.tabs-container .more-items-button{display:flex;align-items:center;justify-content:center;height:100%;width:40px;min-width:40px;color:#395173;border-bottom-color:#395173;}/*!sc*/ .cQRDCg.tabs-container .more-items-button .ellipsis-icon{font-size:1.5rem;}/*!sc*/ .cQRDCg.tabs-container .tab-content{display:none;}/*!sc*/ .cQRDCg.tabs-container .tab-content.selected{display:block;}/*!sc*/ .cQRDCg.tabs-container .select-menu .position-right{right:5px;min-width:12rem;}/*!sc*/ .cQRDCg.tabs-container .select-menu .select-menu-list-item{min-height:35px;font-size:14px;}/*!sc*/ data-styled.g377[id="sc-kOzuoN"]{content:"cQRDCg,"}/*!sc*/ .ljIKRc.tooltip-container{display:inline-flex;position:relative;align-items:center;}/*!sc*/ .ljIKRc.tooltip-container.click{cursor:pointer;}/*!sc*/ data-styled.g379[id="sc-coJLxb"]{content:"ljIKRc,"}/*!sc*/ .ejfjms.qa-container{display:flex;flex-direction:column;width:100%;padding:0.5rem;border-bottom:1px solid #c3ddfd;}/*!sc*/ .ejfjms.qa-container .question{font-size:16px;}/*!sc*/ @media screen and (min-width: 600px){.ejfjms.qa-container .question{font-size:18px;}}/*!sc*/ .ejfjms.qa-container >div{display:flex;align-items:baseline;}/*!sc*/ .ejfjms.qa-container >div .qa-letter-icon{color:#3f83f8;font-weight:700;background-color:#e1effe;border-radius:0.25rem;display:flex;justify-content:center;align-items:center;width:2rem;height:2rem;min-width:2rem;margin-right:1rem;margin-top:0.25rem;margin-bottom:0.25rem;float:left;}/*!sc*/ .ejfjms.qa-container >div .answer-container p{margin-bottom:0!important;}/*!sc*/ @media screen and (max-width: 600px){.ejfjms.qa-container{border:none;border-bottom:1px solid #e1ebfa;max-width:100%;}.ejfjms.qa-container:nth-of-type(odd){padding-left:0.5rem;}}/*!sc*/ data-styled.g388[id="sc-glxhRN"]{content:"ejfjms,"}/*!sc*/ .gjrMOl h2{margin-bottom:6px;}/*!sc*/ data-styled.g389[id="sc-jKsysk"]{content:"gjrMOl,"}/*!sc*/ .cziqXa{border:solid 1px #c3ddfd;border-radius:4px;background:white;}/*!sc*/ .cziqXa .qa-container:last-of-type{border-bottom:none;}/*!sc*/ .cziqXa h2{font-weight:700;font-size:18px;line-height:1.75rem;margin-left:0.5rem;margin-top:0.5rem;text-transform:uppercase;}/*!sc*/ data-styled.g390[id="sc-fDmoKL"]{content:"cziqXa,"}/*!sc*/ .gOUeut.get-report-button button{width:100%;}/*!sc*/ data-styled.g435[id="sc-bfGlA-D"]{content:"gOUeut,"}/*!sc*/ .kyxqzS{display:flex;position:relative;width:100%;padding-left:unset;}/*!sc*/ .kyxqzS .search-icon{align-items:center;color:#378aff;display:flex;height:44px;justify-content:center;width:44px;}/*!sc*/ .kyxqzS .cancel-button{font-size:1.2rem;padding:0 10px;color:#378aff;}/*!sc*/ .kyxqzS .search-button{border-radius:0;width:50px;}/*!sc*/ .kyxqzS input{background-color:transparent;border-width:0;outline:none;width:100%;font-weight:bold;font-size:16px;}/*!sc*/ data-styled.g455[id="sc-izgnRh"]{content:"kyxqzS,"}/*!sc*/ .jOheYi.benzinga-logo{display:inline-block;}/*!sc*/ .jOheYi.benzinga-logo.desktop{width:192px;min-width:192px;max-width:192px;}/*!sc*/ .jOheYi.benzinga-logo img,.jOheYi.benzinga-logo svg{width:100%;height:100%;}/*!sc*/ data-styled.g460[id="sc-hKVfUx"]{content:"jOheYi,"}/*!sc*/ .cATxhb .small-gray{font-size:12px;color:#828282;font-weight:400;}/*!sc*/ .cATxhb .financials-right-spacer{margin-top:56px;position:relative;}/*!sc*/ .cATxhb .divider{height:1px;width:100%;background:#f1f1f1;padding:0px 16px;}/*!sc*/ .cATxhb .body-row{border-bottom:1px solid #f1f1f1;padding:8px 0px;}/*!sc*/ .cATxhb .body-row:last-child{border-bottom:none;}/*!sc*/ .cATxhb .table-row{display:grid;grid-template-columns:1.5fr repeat(4, 1fr);}/*!sc*/ .cATxhb .table-row .table-title{font-size:12px;color:#828282;line-height:15px;font-weight:400;text-align:left;}/*!sc*/ .cATxhb .table-row .table-cell{display:flex;flex-direction:column;padding:2px 4px;}/*!sc*/ .cATxhb .table-row .table-cell .table-cell-title{font-size:14px;font-weight:700;line-height:17px;}/*!sc*/ @media (max-width: 768px){.cATxhb .table-row .table-cell .table-cell-title{font-size:12px;line-height:14px;font-weight:600;}}/*!sc*/ .cATxhb .table-row .table-cell .table-cell-subtitle{font-size:12px;line-height:14px;color:#333333;}/*!sc*/ @media (max-width: 768px){.cATxhb .table-row .table-cell .table-cell-subtitle{font-size:10px;line-height:12px;}}/*!sc*/ data-styled.g498[id="sc-kEXmsn"]{content:"cATxhb,"}/*!sc*/ .gTHsam{align-items:center;background-color:#30BF60;border-radius:4px;display:flex;height:4px;}/*!sc*/ .gTHsam .quote-slider-bar{background-color:#FF4050;border-radius:4px;height:4px;}/*!sc*/ .gTHsam .quote-slider-tick{background-color:#FF4050;border-radius:4px;height:15px;margin-left:-5px;width:4px;}/*!sc*/ .hcCbSS{align-items:center;background-color:#FF4050;border-radius:4px;display:flex;height:4px;}/*!sc*/ .hcCbSS .quote-slider-bar{background-color:#30BF60;border-radius:4px;height:4px;}/*!sc*/ .hcCbSS .quote-slider-tick{background-color:#30BF60;border-radius:4px;height:15px;margin-left:-5px;width:4px;}/*!sc*/ data-styled.g499[id="sc-gMQCKe"]{content:"gTHsam,hcCbSS,"}/*!sc*/ .cWOyzd{width:100%;}/*!sc*/ .cWOyzd .stats-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .cWOyzd .stats-wrapper .stat-column{display:flex;flex-direction:column;}/*!sc*/ .cWOyzd .stats-wrapper .stat-column .label{font-size:0.875rem;line-height:1.25rem;color:rgb(75, 85, 99);}/*!sc*/ .cWOyzd .stats-wrapper .stat-column .value{font-size:1.125rem;line-height:1.5rem;font-weight:500;}/*!sc*/ .cWOyzd .stats-wrapper .stat-column.start{text-align:left;}/*!sc*/ .cWOyzd .stats-wrapper .stat-column.end{text-align:right;}/*!sc*/ .cWOyzd .open-price-wrapper{width:100%;display:flex;}/*!sc*/ .cWOyzd .open-price-wrapper .transparent-box{background-color:transparent;}/*!sc*/ .cWOyzd .open-price-wrapper .open-price-container{display:flex;flex-direction:column;justify-content:flex-start;margin-top:-5px;}/*!sc*/ .cWOyzd .open-price-wrapper .open-price-container span{font-size:0.875rem;line-height:1.25rem;color:rgb(75, 85, 99);line-height:6px;margin-left:2px;}/*!sc*/ data-styled.g500[id="sc-jXIZMl"]{content:"cWOyzd,"}/*!sc*/ .davtfT{height:24px;width:80px;}/*!sc*/ data-styled.g502[id="sc-cVuPSX"]{content:"davtfT,"}/*!sc*/ .ghkflP.company-logo{padding:0.25rem;background-color:#ffffff;border:1px solid #E1EBFA;border-radius:0.25rem;justify-content:center;align-items:center;display:flex;}/*!sc*/ data-styled.g532[id="sc-bNSORF"]{content:"ghkflP,"}/*!sc*/ .eiARcP{color:#ffffff;}/*!sc*/ .eiARcP.missing-data .color-box{background:#e5e5e5;color:#000000;}/*!sc*/ .eiARcP .hold{background:#ffd644;color:#000000;}/*!sc*/ .eiARcP .sell{background:#ff9244;}/*!sc*/ .eiARcP .strong_sell{background:#ff4050;}/*!sc*/ .eiARcP .color-box{display:flex;align-items:center;justify-content:center;height:29px;width:100%;font-weight:600;font-size:14px;gap:8px;}/*!sc*/ data-styled.g533[id="sc-bztcrM"]{content:"eiARcP,"}/*!sc*/ .hlNQqc{background:#f2f8ff;border-radius:4px;}/*!sc*/ .hlNQqc .buy{background:#30bf60;}/*!sc*/ data-styled.g534[id="sc-OQdlP"]{content:"hlNQqc,"}/*!sc*/ .fFpPFY{position:relative;width:100%;}/*!sc*/ data-styled.g546[id="sc-gOHsEJ"]{content:"fFpPFY,"}/*!sc*/ .hqHAYI.searchbar-wrapper{box-shadow:0px 0px 2px 0 rgb(0 0 0 / 15%);background:#ffffff;padding:4px 12px;padding-right:10px;flex-grow:1;max-width:290px;position:relative;max-width:none;}/*!sc*/ @media screen and (max-width: 800px){.hqHAYI.searchbar-wrapper{max-width:none;}}/*!sc*/ .hqHAYI.searchbar-wrapper a{text-decoration:none;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-box,.hqHAYI.searchbar-wrapper.searchbar-inline{padding:0;border:solid 1px #E1EBFA;box-shadow:none;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-box .search-results-wrapper,.hqHAYI.searchbar-wrapper.searchbar-inline .search-results-wrapper{padding:0;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-box .search-result-wrapper,.hqHAYI.searchbar-wrapper.searchbar-inline .search-result-wrapper{padding:0;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-box .search-icon,.hqHAYI.searchbar-wrapper.searchbar-inline .search-icon{height:36px;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-box input ::placeholder,.hqHAYI.searchbar-wrapper.searchbar-inline input ::placeholder{color:#99AECC;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-inline{box-shadow:none;}/*!sc*/ .hqHAYI.searchbar-wrapper.searchbar-inline .search-dropdown{position:relative;box-shadow:none;border:none;}/*!sc*/ .hqHAYI.searchbar-wrapper input:focus{box-shadow:none;}/*!sc*/ .hqHAYI.searchbar-wrapper input ::placeholder{color:#395173;}/*!sc*/ data-styled.g558[id="sc-iAMrAa"]{content:"hqHAYI,"}/*!sc*/ .hFeKYN{display:flex;flex-direction:column;align-items:flex-start;}/*!sc*/ data-styled.g575[id="sc-gSXJRe"]{content:"hFeKYN,"}/*!sc*/ .eSDTgX .analyst-rating-score-circle{color:#ffffff;background-color:#d0d4da;}/*!sc*/ .eSDTgX .analyst-rating-label{background:#e1eaf9;color:#000000;}/*!sc*/ .eSDTgX .strong-buy .analyst-rating-score-circle{background:#30BF60;}/*!sc*/ .eSDTgX .strong-buy .analyst-rating-label{background:#D9F2DF;color:#30BF60;}/*!sc*/ .eSDTgX .buy .analyst-rating-score-circle{background:#84CC16;}/*!sc*/ .eSDTgX .buy .analyst-rating-label{background:#E1F1D2;color:#84CC16;}/*!sc*/ .eSDTgX .hold .analyst-rating-score-circle{background:#FFD644;color:#7e6a22;}/*!sc*/ .eSDTgX .hold .analyst-rating-label{background:#FAF3D8;color:#ac9339;}/*!sc*/ .eSDTgX .sell .analyst-rating-score-circle{background:#F97316;font-weight:600;}/*!sc*/ .eSDTgX .sell .analyst-rating-label{background:#FAE0D1;color:#F97316;}/*!sc*/ .eSDTgX .strong-sell .analyst-rating-score-circle{background:#EF4444;}/*!sc*/ .eSDTgX .strong-sell .analyst-rating-label{background:#F8D8D8;color:#EF4444;}/*!sc*/ data-styled.g605[id="sc-jEZPox"]{content:"eSDTgX,"}/*!sc*/ .hzYGQB .color-key-box{height:6px;width:6px;}/*!sc*/ data-styled.g606[id="sc-fMeROS"]{content:"hzYGQB,"}/*!sc*/ .lZAHV{min-height:375px;}/*!sc*/ data-styled.g627[id="sc-jgFdch"]{content:"lZAHV,"}/*!sc*/ .jcujMk{width:100%;position:relative;}/*!sc*/ .jcujMk .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .jcujMk .newsfeed-card{color:#000000;}/*!sc*/ .jcujMk .newsfeed-card.highlight.fade .post-card-wrapper{animation:fade 5s forwards;}/*!sc*/ @keyframes fade{0%{background-color:#fdf8db;}100%{background-color:transparent;}}/*!sc*/ .jcujMk .newsfeed-card .post-teaser{color:#7c7c7c;font-weight:400;font-size:12px;}/*!sc*/ .jcujMk .news-block{border-bottom:solid 1px #CEDDF2;line-height:1.5;padding:12px 0;}/*!sc*/ .jcujMk .news-block .news-block-headline{color:#000000;}/*!sc*/ .jcujMk .news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ data-styled.g642[id="sc-dCtYgc"]{content:"jcujMk,"}/*!sc*/ .jYmixk.news-block{line-height:1.5;}/*!sc*/ .jYmixk.news-block .news-block-headline a{color:#000000;}/*!sc*/ .jYmixk.news-block .news-block-headline a:hover{color:#69a5ff;}/*!sc*/ .jYmixk.news-block .news-block-headline .news-item-sponsored-tag{display:block;font-size:13px;color:#3f83f8;font-weight:600;}/*!sc*/ .jYmixk.news-block .news-block-image-wrapper{width:90px;height:90px;min-width:90px;margin-right:1rem;border-radius:4px;overflow:hidden;}/*!sc*/ .jYmixk.news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ .jYmixk.news-block .article-teaser{font-size:14px;font-weight:400;}/*!sc*/ .jYmixk.news-block .date-box{min-width:130px;}/*!sc*/ data-styled.g643[id="sc-jWVdrv"]{content:"jYmixk,"}/*!sc*/ .bnxXlT{text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-line-clamp:2;-webkit-box-orient:vertical;}/*!sc*/ @media (max-width: 768px){.bnxXlT{-webkit-line-clamp:4;font-weight:normal;}}/*!sc*/ data-styled.g646[id="sc-bqjyeg"]{content:"bnxXlT,"}/*!sc*/ .emyKxB .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .emyKxB .see-more-button-wrapper .show-more-button{padding:0.5rem 2rem;}/*!sc*/ .emyKxB .content-feed-no-results{height:200px;}/*!sc*/ .emyKxB .quote-news-item{display:flex;}/*!sc*/ .emyKxB .quote-news-item .article-title{-webkit-line-clamp:3;}/*!sc*/ .emyKxB .quote-news-item .article-teaser{color:#395173;text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-line-clamp:1;}/*!sc*/ .emyKxB .quote-news-item .article-author{color:#395173;}/*!sc*/ .emyKxB .quote-news-item .article-datetime{color:#99AECC;}/*!sc*/ .emyKxB .quote-news-item .news-block{all:unset;}/*!sc*/ data-styled.g647[id="sc-PqBve"]{content:"emyKxB,"}/*!sc*/ .bIsfaU{display:flex;height:26px;width:26px;border-radius:4px;justify-content:center;align-items:center;padding:3px;}/*!sc*/ .bIsfaU.up{background-color:#d3efe5;}/*!sc*/ .bIsfaU.down{background-color:#f4dae3;}/*!sc*/ data-styled.g660[id="sc-dNWbAc"]{content:"bIsfaU,"}/*!sc*/ .a-deox .chart-body{border:1px solid #E1EBFA;background:#ffffff;}/*!sc*/ .a-deox .symbol-menu{background:#ffffff;}/*!sc*/ .a-deox .symbol-menu .searchbar{border-bottom:1px solid #E1EBFA;display:flex;align-items:center;gap:0.5rem;padding:0.5rem 1rem;}/*!sc*/ .a-deox .symbol-menu .searchbar .inner-searchbar{border:none;background:transparent;}/*!sc*/ .a-deox .symbol-menu .searchbar .inner-searchbar:focus{outline:none;}/*!sc*/ .a-deox .symbol-menu .symbol-entry{display:flex;align-items:center;gap:0.5rem;margin-left:0.25rem;padding:0.5rem 1rem;}/*!sc*/ .a-deox .symbol-menu .symbol-entry .symbol-pill-dot{width:0.5rem;height:0.5rem;border-radius:50%;}/*!sc*/ .a-deox .symbol-menu .symbol-entry .symbol-pill{display:flex;padding:2px 4px;align-items:flex-start;gap:8px;border-radius:4px;background:#F2F8FF;border:1px solid #CEDDF2;}/*!sc*/ .a-deox .green-chip{background:#d3efe5;}/*!sc*/ .a-deox .green-chip .label-text{color:#30bf60;}/*!sc*/ .a-deox .red-chip{background:#f4dae3;}/*!sc*/ .a-deox .red-chip .label-text{color:#eb5757;}/*!sc*/ .a-deox .compare-tab{cursor:pointer;width:100%;background:#F2F8FF;display:flex;height:72px;padding:12px 12px 9px 12px;flex-direction:column;align-items:center;gap:16px;flex:1 0 0;border-top-left-radius:4px;border-top-right-radius:4px;border:1px solid #CEDDF2;}/*!sc*/ @media (min-width: 768px){.a-deox .compare-tab{max-width:160px;}}/*!sc*/ .a-deox .compare-tab.active{background:#F2F8FF;border-bottom:none;}/*!sc*/ .a-deox .compare-tab .compare-tab__label{font-size:16px;font-weight:700;color:#4f4f4f;line-height:normal;}/*!sc*/ .a-deox .compare-tab .compare-tab__value{font-size:12px;color:#828282;font-weight:700;line-height:normal;}/*!sc*/ .a-deox .tab-content{background:linear-gradient( 180deg, #F2F8FF 100%, #F2F8FF 0% );border:1px solid #CEDDF2;padding:16px;margin-top:-1px;}/*!sc*/ data-styled.g661[id="sc-jSUPYf"]{content:"a-deox,"}/*!sc*/ .fjVA-DK{display:flex;gap:0.5rem;}/*!sc*/ data-styled.g692[id="sc-cuPFEj"]{content:"fjVA-DK,"}/*!sc*/ .kXpGmr{color:#000000;min-height:125px;position:relative;}/*!sc*/ .kXpGmr.quote-header{display:flex;flex-direction:column;justify-content:space-between;position:relative;background:linear-gradient(#f3f9ff, #e1ebfa);border-bottom:none;}/*!sc*/ .kXpGmr.quote-header .header-top-half{padding-top:0.85rem;padding-bottom:0.85rem;}/*!sc*/ .kXpGmr .raptive-header-ad{display:none;margin-top:unset;margin-bottom:unset;}/*!sc*/ @media (min-width: 1100px){.kXpGmr .raptive-header-ad{display:flex;}}/*!sc*/ .kXpGmr .raptive-ben-header-sml #AdThrive_Header_1_desktop{min-width:320px!important;max-width:320px!important;}/*!sc*/ .kXpGmr .quote-actions-desktop{display:none;}/*!sc*/ @media (min-width: 940px){.kXpGmr .quote-actions-desktop{display:block;}}/*!sc*/ .kXpGmr .quote-actions-tablet{display:none;max-width:400px;margin-left:unset;margin-right:unset;}/*!sc*/ @media (min-width: 768px){.kXpGmr .quote-actions-tablet{display:block;}}/*!sc*/ @media (min-width: 940px){.kXpGmr .quote-actions-tablet{display:none;}}/*!sc*/ .kXpGmr .add-to-watchlist-wrapper{width:100%;}/*!sc*/ .kXpGmr .add-to-watchlist-wrapper button{padding:0.35rem 0.75rem;}/*!sc*/ .kXpGmr .comments-count-button button{width:100%;}/*!sc*/ .kXpGmr .get-report-button{white-space:nowrap;width:100%;}/*!sc*/ .kXpGmr .get-report-button button{padding:0.5rem 0.75rem;}/*!sc*/ .kXpGmr .more-quote-actions-button{background:#3f83f81a;box-shadow:unset;}/*!sc*/ .kXpGmr .more-quote-actions-button{height:34px;width:40px;}/*!sc*/ .kXpGmr button.add-to-watchlist-button{box-shadow:unset;}/*!sc*/ .kXpGmr button.add-to-watchlist-button.compact{padding:1rem 0.75rem;}/*!sc*/ .kXpGmr button.more-quote-actions-button{width:40px;background-color:#ffffff;}/*!sc*/ .kXpGmr button.more-quote-actions-button:hover{background-color:#ffffff;}/*!sc*/ .kXpGmr a.perks-button,.kXpGmr a.buy-button,.kXpGmr a.compare-brokers-button{width:100%;background:#3f83f81a;box-shadow:unset;}/*!sc*/ .kXpGmr .quote-actions-container.bottom-buttons{justify-content:center;display:flex;}/*!sc*/ @media (max-width: 600px){.kXpGmr .quote-actions-container.bottom-buttons{flex-direction:column;}}/*!sc*/ .kXpGmr .profile-call-to-action-container .call-to-action-container{margin-top:16px;}/*!sc*/ .kXpGmr .section-title{font-size:24px;font-weight:700;text-transform:uppercase;}/*!sc*/ .kXpGmr .main-quote-tabs-wrapper{display:flex;}/*!sc*/ @media (min-width: 800px){.kXpGmr .main-quote-tabs-wrapper{padding:0 2rem;}}/*!sc*/ .kXpGmr .main-quote-tabs{width:100%;margin:0 auto;max-width:1280px;display:flex;align-items:center;flex-wrap:nowrap;overflow-x:auto;-webkit-overflow-scrolling:touch;}/*!sc*/ .kXpGmr .main-quote-tabs a{color:unset;}/*!sc*/ .kXpGmr .main-quote-tabs .tab{font-size:14px;font-weight:700;border-top-right-radius:4px;border-top-left-radius:4px;cursor:pointer;white-space:nowrap;color:#5b7292;padding:0.8rem 1.3rem;}/*!sc*/ @media (min-width: 800px){.kXpGmr .main-quote-tabs .tab{padding:0.5rem 1.2rem;}}/*!sc*/ .kXpGmr .main-quote-tabs .tab.mobile-tab{padding:12px 16px;height:48px;}/*!sc*/ .kXpGmr .main-quote-tabs .tab:hover{color:#3f83f8;}/*!sc*/ .kXpGmr .main-quote-tabs .tab.active{color:#3f83f8;border-bottom:2px solid #3f83f8;}/*!sc*/ .kXpGmr .company-logo{height:64px;width:64px;min-width:64px;}/*!sc*/ @media (min-width: 768px){.kXpGmr .header-left-text{font-size:20px;line-height:22px;}.kXpGmr .leave-a-comment-wrapper button{padding:0.35rem 0.75rem;}}/*!sc*/ data-styled.g693[id="sc-fjmKZw"]{content:"kXpGmr,"}/*!sc*/ .ihHqQk .section-description{color:#5b7292;}/*!sc*/ .ihHqQk .divider-bottom{border-bottom:1px solid #e1ebfa;}/*!sc*/ .ihHqQk .top-area-and-sidebar-container{display:flex;flex-direction:column;}/*!sc*/ @media screen and (min-width: 1020px){.ihHqQk .top-area-and-sidebar-container{flex-direction:row;}}/*!sc*/ .ihHqQk .metrics-mobile{display:block;}/*!sc*/ .ihHqQk .metrics-desktop{display:none;}/*!sc*/ @media screen and (min-width: 1020px){.ihHqQk .metrics-mobile{display:none;}.ihHqQk .metrics-desktop{display:block;}}/*!sc*/ .ihHqQk .quote-actions-container.bottom-buttons{justify-content:center;}/*!sc*/ .ihHqQk .video-card{cursor:pointer;}/*!sc*/ .ihHqQk .video-card img{width:100%;aspect-ratio:16/9;}/*!sc*/ .ihHqQk .profile-call-to-action-container .call-to-action-container{margin-top:16px;}/*!sc*/ .ihHqQk .inline-image-banner{background-size:contain;background-repeat:no-repeat;background-position:center;}/*!sc*/ .ihHqQk .top-tabs-wrapper{display:flex;flex-direction:row;align-items:center;background:#f2f8ff;border-radius:4px;padding:4px;}/*!sc*/ .ihHqQk .top-tabs-wrapper .top-tabs__tab{cursor:pointer;padding:4px 8px;border-radius:4px;color:#3f83f8;border:none!important;background:#f2f8ff;}/*!sc*/ .ihHqQk .top-tabs-wrapper .top-tabs__tab:hover{color:#ffffff;background:#61a9ff;}/*!sc*/ .ihHqQk .top-tabs-wrapper .top-tabs__tab--active{background:#3f83f8;color:white;}/*!sc*/ .ihHqQk .card{padding:16px;border-radius:4px;border:1px solid #ceddf2;}/*!sc*/ .ihHqQk .card.technical-card{height:164px;}/*!sc*/ .ihHqQk .simple-tab-wrapper{display:flex;flex-direction:row;align-items:center;background:#f2f8ff;border-radius:4px;padding:4px;}/*!sc*/ .ihHqQk .simple-tab-wrapper .simple-tab{cursor:pointer;padding:2px 8px;border-radius:4px;color:#3f83f8;}/*!sc*/ .ihHqQk .simple-tab-wrapper .simple-tab.active{background:#3f83f8;color:white;}/*!sc*/ .ihHqQk .simple-tab-wrapper .simple-tab .simple-tab-text{font-weight:600;}/*!sc*/ .ihHqQk .news-tab-wrapper{flex-direction:row;align-items:center;gap:14px;background:#f2f8ff;border-radius:4px;padding:4px;display:inline-flex;}/*!sc*/ .ihHqQk .news-tab-wrapper .simple-tab{cursor:pointer;padding:2px 4px;border-radius:4px;color:#3f83f8;}/*!sc*/ .ihHqQk .news-tab-wrapper .simple-tab.active{background:#3f83f8;color:white;}/*!sc*/ .ihHqQk .news-tab-wrapper .simple-tab .simple-tab-text{font-weight:600;}/*!sc*/ .ihHqQk .faq-container .faq-block{border:none;}/*!sc*/ .ihHqQk .faq-container .faq-block .qa-container{padding:0rem;margin-bottom:0.5rem;border-radius:0.5rem;border:1px solid #ceddf2;}/*!sc*/ .ihHqQk .faq-container .faq-block .qa-container .qa-header{color:#283d59;padding:0.5rem;border-top-right-radius:0.5rem;border-top-left-radius:0.5rem;}/*!sc*/ .ihHqQk .faq-container .faq-block .qa-container .qa-body{color:#395173;padding:0.5rem;}/*!sc*/ .ihHqQk .bottom-buttons{margin-bottom:12px;}/*!sc*/ .ihHqQk .main-div{margin-left:auto;margin-right:auto;max-width:1280px;width:100%;padding:0 1rem;}/*!sc*/ .ihHqQk .solid-text{font-size:14px;line-height:17px;font-weight:700;}/*!sc*/ .ihHqQk .under-calendar-text{padding:4px;}/*!sc*/ .ihHqQk .quote-calendar{max-width:1280px;}/*!sc*/ .ihHqQk .server-side-calendar-container{display:flex;width:100%;max-width:1280px;overflow-x:auto;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-header-cell{border-left:none!important;border-right:none!important;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-header-cell{padding:4px 6px!important;background:#3f83f8!important;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-header-cell .ag-header-cell-text{color:#ffffff;font-weight:700;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-header-container{background:#e1ebfa!important;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-header-viewport{background:#3f83f8!important;}/*!sc*/ .ihHqQk .ag-root-wrapper .ag-icon-asc,.ihHqQk .ag-root-wrapper .ag-icon-desc{color:#ffffff;}/*!sc*/ .ihHqQk .benzinga-core-table-container .benzinga-core-table-thead tr{background:#3f83f8;border-bottom-color:#3f83f8;}/*!sc*/ .ihHqQk .benzinga-core-table-container .benzinga-core-table-thead tr th{border-left:none;}/*!sc*/ .ihHqQk .benzinga-core-table-container .benzinga-core-table-thead tr th:first-of-type{border-left-color:#3f83f8;}/*!sc*/ .ihHqQk .benzinga-core-table-container .benzinga-core-table-thead tr th:last-of-type{border-right-color:#3f83f8;}/*!sc*/ .ihHqQk .benzinga-core-table-container .benzinga-core-table-wrapper{border-color:rgb(224, 224, 224);}/*!sc*/ data-styled.g696[id="sc-iusedb"]{content:"ihHqQk,"}/*!sc*/ .kTTQZR .tabs-container .tab-list-wrapper{display:flex;flex-direction:column;position:relative;width:100%;}/*!sc*/ .kTTQZR .tabs-container .tab-list-wrapper .recent-news-title{margin-bottom:1rem;}/*!sc*/ @media screen and (min-width: 550px){.kTTQZR .tabs-container .tab-list-wrapper{flex-direction:row;}.kTTQZR .tabs-container .tab-list-wrapper .recent-news-title{margin-bottom:unset;}}/*!sc*/ .kTTQZR .tabs-container .tab-list{font-weight:600;color:#3f83f8;max-width:540px;width:100%;margin-left:auto;}/*!sc*/ .kTTQZR .tabs-container .tab-list .tab{flex:1;max-width:200px;}/*!sc*/ .kTTQZR .tabs-container .tab-content{padding:1rem 0;}/*!sc*/ data-styled.g715[id="sc-dXIwAT"]{content:"kTTQZR,"}/*!sc*/ .jXOnQi{margin-top:0;padding-top:10px;font-size:12px;line-height:21px;text-decoration:none;}/*!sc*/ data-styled.g746[id="sc-cqnWLZ"]{content:"jXOnQi,"}/*!sc*/ .jHYujk{transition:color 0.2s cubic-bezier(0.25, 0.46, 0.45, 0.94),color 0.2s ease;text-decoration:none;}/*!sc*/ data-styled.g747[id="sc-iWHcIr"]{content:"jHYujk,"}/*!sc*/ .gRGBBQ{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .gRGBBQ:hover{color:#3b5998;}/*!sc*/ .gRGBBQ svg{fill:#ffffff;}/*!sc*/ .eMbbze{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .eMbbze:hover{color:#e1306c;}/*!sc*/ .eMbbze svg{fill:#ffffff;}/*!sc*/ .joofhG{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .joofhG:hover{color:#0072b1;}/*!sc*/ .joofhG svg{fill:#ffffff;}/*!sc*/ .kWkEse{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .kWkEse:hover{color:#fe5000;}/*!sc*/ .kWkEse svg{fill:#ffffff;}/*!sc*/ .kWkXwI{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .kWkXwI:hover{color:#000000;}/*!sc*/ .kWkXwI svg{fill:#ffffff;}/*!sc*/ .fflNAI{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .fflNAI:hover{color:red;}/*!sc*/ .fflNAI svg{fill:#ffffff;}/*!sc*/ data-styled.g748[id="sc-bggJJS"]{content:"gRGBBQ,eMbbze,joofhG,kWkEse,kWkXwI,fflNAI,"}/*!sc*/ .iIIBPk.button-wrapper{border-radius:6px;overflow:hidden;background-color:#ffffff;display:flex;align-items:center;justify-content:center;padding:5px;min-width:140px;-webkit-transition:all 200ms ease;transition:all 200ms ease;height:50px;box-sizing:border-box;}/*!sc*/ .iIIBPk.button-wrapper:hover{background-color:#CEDDF2;}/*!sc*/ data-styled.g749[id="sc-iTPigJ"]{content:"iIIBPk,"}/*!sc*/ .lnCMlr.footer-row{display:grid;grid-auto-flow:column;grid-gap:20px;width:100%;padding-top:0.5rem;padding-bottom:2rem;padding-left:1rem;padding-right:1rem;margin-left:auto;margin-right:auto;}/*!sc*/ @media screen and (min-width: 480px){.lnCMlr.footer-row{max-width:480px;}}/*!sc*/ @media screen and (min-width: 768px){.lnCMlr.footer-row{padding-left:4rem;padding-right:4rem;max-width:100%;grid-gap:30px;}}/*!sc*/ @media screen and (max-width: 1000px){.lnCMlr.footer-row{grid-auto-flow:row;grid-template-columns:repeat(auto-fill, minmax(200px, 1fr));}}/*!sc*/ data-styled.g751[id="sc-lgHmWD"]{content:"lnCMlr,"}/*!sc*/ .hXMPNn{display:flex;flex-direction:column;text-align:left;}/*!sc*/ .hXMPNn h3{display:flex;color:#ffffff;font-size:18px;font-weight:600;margin:0;}/*!sc*/ @media screen and (min-width: 480px){.hXMPNn h3{margin-top:0;}}/*!sc*/ @media screen and (min-width: 768px){.hXMPNn h3{font-size:16px;margin-top:2rem;}}/*!sc*/ .hXMPNn ul{list-style:none;padding:0;}/*!sc*/ .hXMPNn ul li{font-size:16px;}/*!sc*/ @media screen and (min-width: 768px){.hXMPNn ul li{font-size:14px;}}/*!sc*/ .hXMPNn ul li >a{color:#CEDDF2;}/*!sc*/ .hXMPNn ul li >a:hover{color:#ffffff;}/*!sc*/ data-styled.g752[id="sc-dqgTYe"]{content:"hXMPNn,"}/*!sc*/ .cWuGai{display:flex;align-items:center;margin:0 4px;padding-right:0px;width:192px;min-width:144px;}/*!sc*/ .cWuGai .benzinga-crypto-logo-wrapper{margin-bottom:-1px;}/*!sc*/ .cWuGai >a{display:inline-flex;}/*!sc*/ data-styled.g757[id="sc-gvEBYa"]{content:"cWuGai,"}/*!sc*/ .iaNPFH{align-items:center;display:flex;justify-content:space-between;}/*!sc*/ data-styled.g762[id="sc-dnxBXz"]{content:"iaNPFH,"}/*!sc*/ .gaynik{color:#CEDDF2;font-weight:600;font-size:14px;line-height:20px;}/*!sc*/ data-styled.g763[id="sc-iPYwOE"]{content:"gaynik,"}/*!sc*/ .gbPlZW{color:#ffffff;font-size:12px;line-height:16px;}/*!sc*/ data-styled.g764[id="sc-dxRmzR"]{content:"gbPlZW,"}/*!sc*/ .djybpZ{color:#99AECC;font-weight:700;display:flex;align-items:center;}/*!sc*/ .djybpZ .quote-icon{margin:0 4px;font-size:12px;}/*!sc*/ data-styled.g765[id="sc-hPnoVK"]{content:"djybpZ,"}/*!sc*/ .kShmtz{display:block;width:100%;max-width:145px;min-width:132px;padding:8px;background:linear-gradient(90deg, #f0525200 0%, #f052520d 100%);}/*!sc*/ .kShmtz .dark{color:#99AECC!important;}/*!sc*/ .kShmtz .light{color:#395173!important;}/*!sc*/ data-styled.g766[id="sc-cxgeGX"]{content:"kShmtz,"}/*!sc*/ .eJENdV{display:flex;flex-grow:1;height:52px;}/*!sc*/ data-styled.g767[id="sc-dTaEtF"]{content:"eJENdV,"}/*!sc*/ .onvr{position:relative;overflow:hidden;white-space:nowrap;}/*!sc*/ .onvr::before{animation:jBCTCY 5s ease-in-out infinite;content:'';position:absolute;top:0;width:100%;height:100%;background:linear-gradient(120deg, transparent, rgba(255, 255, 255, 0.2), transparent);}/*!sc*/ data-styled.g768[id="sc-dEARTM"]{content:"onvr,"}/*!sc*/ .sIZrm{line-height:48px;padding:0 10px;font-family:Manrope,Manrope-fallback,sans-serif;font-weight:bold;font-size:14px;color:#000000;height:100%;display:inline-flex;align-items:center;justify-content:center;}/*!sc*/ .sIZrm:hover{background-color:#e1effe;color:unset;}/*!sc*/ .sIZrm.trading-school{color:#298ccd!important;}/*!sc*/ @media screen and (min-width: 1292px){.sIZrm.trading-school svg{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.sIZrm{color:white;width:100%;text-align:left;display:inline-flex;justify-content:start;}.sIZrm:hover{background-color:inherit;}}/*!sc*/ data-styled.g769[id="sc-gvuZWP"]{content:"sIZrm,"}/*!sc*/ .iDABru{line-height:2em;}/*!sc*/ .iDABru a{color:black;}/*!sc*/ .iDABru a:hover{color:#1a56db;}/*!sc*/ data-styled.g770[id="sc-ggVnwW"]{content:"iDABru,"}/*!sc*/ .bsiliU{line-height:2em;}/*!sc*/ .bsiliU a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .bsiliU:hover{color:#1a79ff;}/*!sc*/ .bsiliU.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .bsiliU.highlight a{color:#ffffff;background-color:unset;font-weight:unset;text-align:center;}/*!sc*/ .bsiliU.highlight:hover{color:unset;}/*!sc*/ .dfFPgo{line-height:2em;}/*!sc*/ .dfFPgo a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .dfFPgo:hover{color:#1a79ff;}/*!sc*/ .dfFPgo.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .dfFPgo.highlight a{color:#ffffff;background-color:#63bc47;font-weight:600;text-align:center;}/*!sc*/ .dfFPgo.highlight:hover{color:#ffffff;}/*!sc*/ data-styled.g771[id="sc-gdaOHR"]{content:"bsiliU,dfFPgo,"}/*!sc*/ .gTOwki{display:grid;gap:8px;grid-template-columns:repeat(2, minmax(0px, 1fr));}/*!sc*/ data-styled.g772[id="sc-fOBchY"]{content:"gTOwki,"}/*!sc*/ .jOJmQw{border-bottom:1px solid #B8CBE6;color:#395173;font-weight:bold;margin-top:4px;margin-bottom:4px;margin-left:16px;margin-right:16px;padding-bottom:4px;}/*!sc*/ data-styled.g773[id="sc-iFvklb"]{content:"jOJmQw,"}/*!sc*/ .cStpHr{display:none;position:absolute;width:max-content;top:48px;z-index:2000;background-color:#ffffff;box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);}/*!sc*/ .cStpHr:hover{display:flex;}/*!sc*/ .cStpHr .subnav{right:0;}/*!sc*/ .cStpHr .menu-wrapper a{width:100%;justify-content:left;}/*!sc*/ @media screen and (min-width: 910px){.cStpHr{min-width:initial;}}/*!sc*/ @media screen and (min-width: 950px){.cStpHr >div:nth-of-type(1){display:none;}}/*!sc*/ @media screen and (min-width: 1000px){.cStpHr >div:nth-of-type(2){display:none;}}/*!sc*/ @media screen and (min-width: 1100px){.cStpHr >div:nth-of-type(3){display:none;}}/*!sc*/ @media screen and (min-width: 1130px){.cStpHr >div:nth-of-type(4){display:none;}}/*!sc*/ @media screen and (min-width: 1190px){.cStpHr >div:nth-of-type(5){display:none;}}/*!sc*/ @media screen and (min-width: 1250px){.cStpHr >div:nth-of-type(6){display:none;}}/*!sc*/ @media screen and (min-width: 1315px){.cStpHr >div:nth-of-type(7){display:none;}}/*!sc*/ data-styled.g774[id="sc-iqVxLi"]{content:"cStpHr,"}/*!sc*/ .bYQLee.sub-group-wrapper{background-color:#ffffff;border-width:1px;border-top-width:1px;border-color:#CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;padding:8px 0;scrollbar-width:thin;max-height:calc(90vh - 100px);}/*!sc*/ .bYQLee.sub-group-wrapper ::-webkit-scrollbar{width:6px!important;}/*!sc*/ .bYQLee.sub-group-wrapper ::-webkit-scrollbar-track{background:#f1f1f1;}/*!sc*/ .bYQLee.sub-group-wrapper ::-webkit-scrollbar-thumb{background:#888;}/*!sc*/ .bYQLee.sub-group-wrapper ::-webkit-scrollbar-thumb:hover{background:#555;}/*!sc*/ data-styled.g775[id="sc-fmJrrp"]{content:"bYQLee,"}/*!sc*/ .jiROLZ.secondary{position:relative;}/*!sc*/ .jiROLZ.secondary .subnav{position:absolute;right:0;top:48px;}/*!sc*/ .jiROLZ .subnav{display:none;position:absolute;z-index:2000;}/*!sc*/ .jiROLZ .subnav .third-level-menu{display:none;position:absolute;left:100%;background:#ffffff;border:1px solid #CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;height:100%;z-index:999999;overflow:auto;top:0;height:auto;min-width:160px;}/*!sc*/ .jiROLZ .subnav .more-nav-menu{position:absolute;top:50%;right:0;transform:translateY(-50%);}/*!sc*/ .jiROLZ:hover .subnav{display:block;}/*!sc*/ .jiROLZ .menu-items{padding:4px;}/*!sc*/ .jiROLZ .menu-items .dropdown-menu-item{position:relative;}/*!sc*/ .jiROLZ .menu-items .dropdown-menu-item:hover .third-level-menu{display:block;}/*!sc*/ @media screen and (max-width: 800px){.jiROLZ .subnav{display:none!important;}}/*!sc*/ data-styled.g776[id="sc-eYjERw"]{content:"jiROLZ,"}/*!sc*/ .jlDfPH{text-align:left;}/*!sc*/ .jlDfPH.has-groups{width:480px;}/*!sc*/ .jlDfPH.has-groups.money-app{max-width:480px;width:auto;min-width:180px;}/*!sc*/ data-styled.g777[id="sc-brYdJo"]{content:"jlDfPH,"}/*!sc*/ .dsEKKn{display:flex;align-items:center;justify-content:center;font-size:12px;font-weight:700;white-space:nowrap;}/*!sc*/ .dsEKKn.others-btn{height:48px;color:#192940;text-transform:capitalize;padding:0 8px;}/*!sc*/ .dsEKKn.others-btn:hover{color:#1a56db;}/*!sc*/ .dsEKKn.research-btn{height:34px;color:white;text-transform:uppercase;border-radius:5px;letter-spacing:1px;padding:0 14px;}/*!sc*/ .dsEKKn.research-btn:hover{opacity:100;color:white;}/*!sc*/ .dsEKKn.invest-in-art-btn{height:34px;color:#000000;border-radius:5px;letter-spacing:1px;padding:0 10px;margin-right:8px;}/*!sc*/ .dsEKKn.invest-in-art-btn:hover{background-color:#a4cafe;}/*!sc*/ data-styled.g778[id="sc-hpmCTx"]{content:"dsEKKn,"}/*!sc*/ .jlUQXq.menu-wrapper{background-color:#033251;position:relative;min-width:65px;}/*!sc*/ .jlUQXq.menu-wrapper:hover .global-menu-dropdown{display:block;}/*!sc*/ @media screen and (max-width: 800px){.jlUQXq.menu-wrapper{background-color:transparent;}}/*!sc*/ .jlUQXq.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .jlUQXq.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.jlUQXq.menu-wrapper .menu-button{padding:0px 6px;}.jlUQXq.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;}.jlUQXq.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .jlUQXq.menu-wrapper .global-menu-dropdown{background-color:#033251;display:none;position:absolute;width:110px;width:max-content;z-index:100;}/*!sc*/ @media screen and (max-width: 800px){.jlUQXq.menu-wrapper .global-menu-dropdown{right:0px;}}/*!sc*/ .jlUQXq.menu-wrapper .global-menu-item{color:white;cursor:pointer;font-size:12px;padding:8px 12px;display:block;margin:0;}/*!sc*/ .jlUQXq.menu-wrapper .global-menu-item a{color:white;display:flex;align-items:center;}/*!sc*/ .jlUQXq.menu-wrapper .global-menu-item span{display:inline-block;vertical-align:middle;line-height:1;margin-right:10px;}/*!sc*/ .jlUQXq.menu-wrapper .global-menu-item img{width:30px;display:inline-block;vertical-align:middle;}/*!sc*/ .jlUQXq.menu-wrapper .global-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.jlUQXq.menu-wrapper .global-text{margin-right:0;}}/*!sc*/ @media screen and (max-width: 800px){.jlUQXq.menu-wrapper{width:3rem;text-align:center;}}/*!sc*/ data-styled.g779[id="sc-ehEeqy"]{content:"jlUQXq,"}/*!sc*/ .inLwBj.menu-wrapper{background-color:#033251;position:relative;width:140px;white-space:nowrap;}/*!sc*/ @media screen and (max-width: 800px){.inLwBj.menu-wrapper{background-color:transparent;}}/*!sc*/ @media screen and (min-width: 800px){.inLwBj.menu-wrapper:hover .account-menu-dropdown{display:block;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);}}/*!sc*/ .inLwBj.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .inLwBj.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.inLwBj.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;margin-right:0;}.inLwBj.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .inLwBj.menu-wrapper .account-menu-dropdown{background-color:#ffffff;border:1px solid #E1EBFA;display:none;position:absolute;width:140px;z-index:104;}/*!sc*/ @media screen and (max-width: 800px){.inLwBj.menu-wrapper .account-menu-dropdown{right:0px;}}/*!sc*/ .inLwBj.menu-wrapper .account-menu-dropdown.open{display:block;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-dropdown .checkbox-container label{display:flex;font-size:12px;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-item{color:#000000;cursor:pointer;font-size:12px;font-weight:700;padding:8px 12px;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-item a{color:#000000;display:inline-flex;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-item.benzinga-plus a{color:#ff5a1f;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-item.benzinga-pro a{color:#1A79FF;}/*!sc*/ .inLwBj.menu-wrapper .account-menu-item.benzinga-edge a{color:#3f83f8;}/*!sc*/ .inLwBj.menu-wrapper .divider{margin:0 auto;width:85%;border-color:#CEDDF2;}/*!sc*/ .inLwBj.menu-wrapper .my-account-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.inLwBj.menu-wrapper .my-account-text{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.inLwBj.menu-wrapper{width:3rem;}}/*!sc*/ data-styled.g780[id="sc-keSDAH"]{content:"inLwBj,"}/*!sc*/ .PUFmK{position:fixed;z-index:100;top:0;left:0;right:0;width:100%;transition:all linear 0.12s;}/*!sc*/ .PUFmK .mobile-header,.PUFmK .mobile-menu-wrapper,.PUFmK .mobile-quote-bar{background-color:#08244d;}/*!sc*/ .PUFmK .mobile-header{border-bottom:1px solid #36537e;margin-top:0;}/*!sc*/ .PUFmK .menu-icon-wrapper{display:flex;align-items:center;justify-content:center;cursor:pointer;flex-shrink:0;width:3rem;height:3rem;color:#CEDDF2;font-size:18px;}/*!sc*/ .PUFmK.fullscreen .account-menu{pointer-events:none;}/*!sc*/ .PUFmK .search-wrapper{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);width:100%;z-index:30;}/*!sc*/ .PUFmK .search-wrapper.fixed{position:fixed;top:181px;}/*!sc*/ .PUFmK .search-wrapper.fullscreen{position:fixed;background:#242424e0;z-index:999;height:100vh;}/*!sc*/ .PUFmK .search-wrapper.fullscreen .searchbar-wrapper{padding:0;}/*!sc*/ .PUFmK .search-wrapper.fullscreen .searchbar-wrapper .search-input-container{border-bottom:1px solid #a4a4a4;padding:8px 12px;background-color:#1d446a;}/*!sc*/ .PUFmK .search-wrapper.fullscreen .searchbar-wrapper .search-input-wrapper{background-color:white;border-radius:4px;}/*!sc*/ .PUFmK .search-wrapper.fullscreen .search-dropdown{border-radius:unset;border:none;box-shadow:none;position:unset;}/*!sc*/ .PUFmK .search-wrapper.fullscreen .search-result-wrapper{border-radius:unset;}/*!sc*/ .PUFmK .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;line-height:15px;}/*!sc*/ .PUFmK .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .PUFmK .search-wrapper .searchbar-wrapper input{font-size:14px;height:45px;}/*!sc*/ .PUFmK .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media screen and (max-width: 800px){.PUFmK .search-wrapper .searchbar-wrapper input{font-size:16px;}}/*!sc*/ .PUFmK .mobile-menu-wrapper{z-index:999999;}/*!sc*/ .PUFmK .mobile-menu-wrapper .premium-button{color:white;line-height:40px;padding:4px 10px;position:fixed;height:min-content;bottom:0px;z-index:10000;background-color:#062b4c;}/*!sc*/ .PUFmK .mobile-menu-wrapper .premium-button div{background-color:#ff5a1f;border-radius:10px;padding:0px 10px;width:100%;border-radius:5px;margin:2px 0px;text-align:center;}/*!sc*/ .PUFmK .mobile-menu-wrapper .premium-button svg{font-size:20px;padding-right:5px;}/*!sc*/ .PUFmK .mobile-menu-wrapper .premium-button:hover div{background-color:#ff8a4c;border-bottom:3px solid #d03801;}/*!sc*/ .PUFmK .bz-pro-logo{height:60px;background:#062b4c;margin-bottom:60px;}/*!sc*/ .PUFmK .bz-pro-logo a{border-top:solid 1px #666;padding:1rem;width:100%;}/*!sc*/ .PUFmK .mobile-logo-wrapper{margin:0;padding:0;width:205px;margin-right:auto;}/*!sc*/ .PUFmK .mobile-logo-wrapper .benzinga-crypto-logo-wrapper{margin-top:5px;}/*!sc*/ .PUFmK .mobile-logo-wrapper .benzinga-logo{height:18.2px;width:134.35px;}/*!sc*/ .PUFmK .mobile-logo-wrapper .benzinga-logo.reactive-holiday-logo{height:30px;}/*!sc*/ data-styled.g785[id="sc-cLGQGY"]{content:"PUFmK,"}/*!sc*/ .cZhpbs{margin-top:242px;width:100%;}/*!sc*/ data-styled.g786[id="sc-iIVpRh"]{content:"cZhpbs,"}/*!sc*/ .hamMjt.top-bar-wrapper{background-color:#072232;height:32px;}/*!sc*/ .hamMjt.top-bar-wrapper .bar-layout-width{max-width:1400px;margin:0 auto;}/*!sc*/ .hamMjt.top-bar-wrapper .top-bar-inner-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .hamMjt.top-bar-wrapper .top-bar-list{list-style:none;display:flex;margin:0;}/*!sc*/ .hamMjt.top-bar-wrapper .auth-buttons{display:flex;height:32px;min-width:234px;}/*!sc*/ .hamMjt.top-bar-wrapper .auth-link-button{color:#ffffff;cursor:pointer;line-height:32px;padding:0 12px;text-transform:uppercase;font-size:14px;font-weight:700;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-pro-btn{display:flex;align-items:center;justify-content:space-between;padding:0 12px;border-radius:3px;height:26px;color:white;font-weight:semi-bold;background-color:#0075cd;margin:3px 3px 0px 0px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item-label{color:white;font-size:12px;line-height:30px;margin:0 8px;white-space:nowrap;}/*!sc*/ .hamMjt.top-bar-wrapper .contributor-link{align-items:center;color:white;display:inline-flex;font-size:12px;height:32px;margin:0 12px;}/*!sc*/ .hamMjt.top-bar-wrapper .contributor-link a{color:white;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item{border-top:2px solid #3f83f8;color:#ffffff;text-transform:uppercase;line-height:28px;font-weight:500;font-size:14px;margin:0;text-align:center;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item.ProLabel{border-top:none;text-transform:none;min-width:140px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(2){border-top-color:#f05252;min-width:84px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(3){border-top-color:#c27803;min-width:66px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(4){border-top-color:#046c4e;min-width:83px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(5){border-top-color:#c81e1e;min-width:93px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(6){border-top-color:#0e9f6e;min-width:59px;}/*!sc*/ .hamMjt.top-bar-wrapper .bz-top-bar-list-item:nth-child(7){min-width:86px;}/*!sc*/ data-styled.g790[id="sc-bUjGoE"]{content:"hamMjt,"}/*!sc*/ .cZwtxE.quote-bar-container{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);}/*!sc*/ .cZwtxE.quote-bar-container .quote-bar-layout-width{max-width:1400px;margin:0 auto;height:52px;}/*!sc*/ .cZwtxE.quote-bar-container .quote-bar-wrapper,.cZwtxE.quote-bar-container .quotes-list{display:flex;flex-grow:1;}/*!sc*/ .cZwtxE.quote-bar-container .quote-list-container{flex-grow:1;overflow-x:auto;scrollbar-width:none;}/*!sc*/ .cZwtxE.quote-bar-container .quote-list-container ::-webkit-scrollbar{display:none;}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper{width:100%;max-width:288px;}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;font-size:16px;line-height:15px;}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper input{font-size:12px;}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media (min-width: 1300px){.cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper{padding-right:0;}.cZwtxE.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:36px;}}/*!sc*/ .cZwtxE.quote-bar-container .search-wrapper .search-icon{height:36px;}/*!sc*/ data-styled.g791[id="sc-cdZxpv"]{content:"cZwtxE,"}/*!sc*/ .beWcfq.quote-switcher-wrapper{overflow-y:auto;height:52px;width:70px;scrollbar-width:none;flex:none;}/*!sc*/ .beWcfq.quote-switcher-wrapper ::-webkit-scrollbar{display:none;}/*!sc*/ .beWcfq.quote-switcher-wrapper .quote-switcher-container{display:flex;flex-direction:column;}/*!sc*/ data-styled.g792[id="sc-fCUNPS"]{content:"beWcfq,"}/*!sc*/ .gprosN.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #99AECC;background:linear-gradient(90deg, #99AECC1a 0%, #99AECC00 100%);text-align:left;color:#99AECC;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .gprosN.quote-switcher-button :focus{outline:none;}/*!sc*/ .cAOwZF.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #E1EBFA;background:linear-gradient(90deg, #1c64f21a 0%, #1c64f200 100%);text-align:left;color:#ffffff;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .cAOwZF.quote-switcher-button :focus{outline:none;}/*!sc*/ data-styled.g793[id="sc-cbhCNN"]{content:"gprosN,cAOwZF,"}/*!sc*/ .eDFIpW{display:flex;overflow-x:scroll;scrollbar-width:none;justify-content:flex-start;}/*!sc*/ .eDFIpW ::-webkit-scrollbar{display:none;}/*!sc*/ .eDFIpW li{flex-shrink:0;}/*!sc*/ .eDFIpW li:nth-of-type(3),.eDFIpW li:nth-of-type(4),.eDFIpW li:nth-of-type(5),.eDFIpW li:nth-of-type(6),.eDFIpW li:nth-of-type(7),.eDFIpW li:nth-of-type(8),.eDFIpW li:nth-of-type(9),.eDFIpW li:nth-of-type(10),.eDFIpW li:nth-of-type(11),.eDFIpW li:nth-of-type(12){display:none;}/*!sc*/ @media screen and (min-width: 850px){.eDFIpW li:nth-of-type(3){display:initial;}}/*!sc*/ @media screen and (min-width: 900px){.eDFIpW li:nth-of-type(4){display:initial;}}/*!sc*/ @media screen and (min-width: 950px){.eDFIpW li:nth-of-type(5){display:initial;}}/*!sc*/ @media screen and (min-width: 1000px){.eDFIpW li:nth-of-type(6){display:initial;}}/*!sc*/ @media screen and (min-width: 1100px){.eDFIpW li:nth-of-type(7){display:initial;}}/*!sc*/ @media screen and (min-width: 1130px){.eDFIpW li:nth-of-type(8){display:initial;}}/*!sc*/ @media screen and (min-width: 1190px){.eDFIpW li:nth-of-type(9){display:initial;}}/*!sc*/ @media screen and (min-width: 1250px){.eDFIpW li:nth-of-type(10){display:initial;}}/*!sc*/ @media screen and (min-width: 1315px){.eDFIpW li:nth-of-type(11){display:initial;}}/*!sc*/ @media screen and (min-width: 1360px){.eDFIpW li:nth-of-type(12){display:initial;}}/*!sc*/ data-styled.g796[id="sc-nbCPO"]{content:"eDFIpW,"}/*!sc*/ .gyEjVP{display:block;position:unset;top:unset;width:unset;z-index:999;box-shadow:unset;}/*!sc*/ @media (max-width: 800px){.gyEjVP{display:none;}}/*!sc*/ .gyEjVP .breaking-news-banner{position:absolute;top:-50px;transition:all ease-in 0.5s;z-index:-1;}/*!sc*/ .gyEjVP .breaking-news-wrapper{position:relative;}/*!sc*/ .gyEjVP .breaking-news-wrapper--visible .breaking-news-banner{position:unset;top:0;}/*!sc*/ .gyEjVP .more-nav-tabs-icon-container{position:relative;display:flex;align-items:center;justify-content:center;margin-left:5px;margin-right:5px;cursor:pointer;}/*!sc*/ .gyEjVP .more-nav-tabs-icon-container:hover >div{display:flex;}/*!sc*/ @media screen and (min-width: 1315px){.gyEjVP .more-nav-tabs-icon-container{display:none!important;}}/*!sc*/ data-styled.g797[id="sc-hmzteu"]{content:"gyEjVP,"}/*!sc*/ .kvgWDr{background-color:#ffffff;border-bottom:0px solid #B8CBE6;width:100%;padding:0;}/*!sc*/ data-styled.g798[id="sc-bUsiPH"]{content:"kvgWDr,"}/*!sc*/ .hGAYdc{height:48px;max-width:1400px;margin:0 auto;}/*!sc*/ data-styled.g799[id="sc-hwTdGM"]{content:"hGAYdc,"}/*!sc*/ .hIMOyK{display:flex;position:relative;height:100%;justify-content:center;}/*!sc*/ data-styled.g802[id="sc-fAlvPn"]{content:"hIMOyK,"}/*!sc*/ .ifHtbk{flex-grow:1;margin-left:20px;}/*!sc*/ data-styled.g803[id="sc-lcMqGs"]{content:"ifHtbk,"}/*!sc*/ .BJLkT{display:inline-flex;align-items:center;justify-content:flex-end;height:48px;min-width:244px;}/*!sc*/ data-styled.g804[id="sc-fKFgrF"]{content:"BJLkT,"}/*!sc*/ .hOsksO.header-container .navbar-placeholder{height:132px;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar{background-color:#192940;border:none;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar .main-menu-wrapper{max-width:1300px;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar .main-menu-wrapper .menu-wrapper:hover{background-color:#151f2e;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar .logo-wrapper{width:260px;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar .menu-item-link{color:#ceddf2;}/*!sc*/ .hOsksO.header-container.money-app .main-menu-bar .menu-item-link:hover{background-color:transparent;}/*!sc*/ data-styled.g817[id="sc-lmVGTp"]{content:"hOsksO,"}/*!sc*/ .gnTyRF{display:block;margin-bottom:0;}/*!sc*/ @media screen and (min-width: 800px){.gnTyRF{display:none;}}/*!sc*/ data-styled.g819[id="sc-ekHxab"]{content:"gnTyRF,"}/*!sc*/ @keyframes jBCTCY{0%{left:-100%;transition-property:left;}11.504424778761061%,100%{left:100%;transition-property:left;}}/*!sc*/ data-styled.g820[id="sc-keyframes-jBCTCY"]{content:"jBCTCY,"}/*!sc*/ </style></head><body><div id="__next"><div class="sc-lmVGTp hOsksO header-container "><div class="sc-ekHxab gnTyRF mobile-header-wrapper"><div class="sc-iIVpRh cZhpbs"><div id="navigation-header" class="sc-cLGQGY PUFmK"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="left-0 right-0 top-0 z-[9999999]" id="mobile-main-block"><div class="mobile-header flex items-center justify-between relative" style="transition:all linear 0.3s;z-index:20"><div class="menu-icon-wrapper"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M0 80c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16C7.2 96 0 88.8 0 80zM0 240c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16c-8.8 0-16-7.2-16-16zM448 400c0 8.8-7.2 16-16 16H16c-8.8 0-16-7.2-16-16s7.2-16 16-16H432c8.8 0 16 7.2 16 16z" fill="currentColor"></path></svg></div></div><div class="sc-gvEBYa cWuGai logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-hKVfUx jOheYi benzinga-logo light mobile"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span></a></div><div class="flex h-12 items-center text-blue-300"><div class="sc-ehEeqy jlUQXq global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><div class="sc-keSDAH inLwBj account-menu menu-wrapper"><button class="menu-button"><span role="img" aria-label="user" class="anticon anticon-user"><svg viewBox="64 64 896 896" focusable="false" data-icon="user" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.5 763.6a374 374 0 00-80.6-119.5 375.63 375.63 0 00-119.5-80.6c-.4-.2-.8-.3-1.2-.5C719.5 518 760 444.7 760 362c0-137-111-248-248-248S264 225 264 362c0 82.7 40.5 156 102.8 201.1-.4.2-.8.3-1.2.5-44.8 18.9-85 46-119.5 80.6a375.63 375.63 0 00-80.6 119.5A371.7 371.7 0 00136 901.8a8 8 0 008 8.2h60c4.4 0 7.9-3.5 8-7.8 2-77.2 33-149.5 87.8-204.3 56.7-56.7 132-87.9 212.2-87.9s155.5 31.2 212.2 87.9C779 752.7 810 825 812 902.2c.1 4.4 3.6 7.8 8 7.8h60a8 8 0 008-8.2c-1-47.8-10.9-94.3-29.5-138.2zM512 534c-45.9 0-89.1-17.9-121.6-50.4S340 407.9 340 362c0-45.9 17.9-89.1 50.4-121.6S466.1 190 512 190s89.1 17.9 121.6 50.4S684 316.1 684 362c0 45.9-17.9 89.1-50.4 121.6S557.9 534 512 534z"></path></svg></span><span class="my-account-text">My Account</span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></button><div class="account-menu-dropdown"><div class="account-menu-item"><span><a href="/account">My Account</a></span></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=notifications">Notifications</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio">Overview</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=new_watchlist">+ New Watchlist</a></div><hr class="divider"/><div class="account-menu-item benzinga-edge"><a href="https://www.benzinga.com/profile/portfolio">Benzinga Edge</a></div><div class="account-menu-item benzinga-plus"><a href="https://www.benzinga.com/research">Benzinga Research</a></div><div class="account-menu-item benzinga-pro"><a href="https://pro.benzinga.com">Benzinga Pro</a></div><hr class="divider"/><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=login">Log In</a></div></div></div></div></div></div><div class="mobile-quote-bar overflow-x-scroll" id="mobile-quote-bar"><div class="sc-dTaEtF eJENdV quote-list-wrapper"><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper transition" id="mobile-search-bar" style="transition:all linear 0.3s"><div class="sc-iAMrAa hqHAYI searchbar-wrapper searchbar-default"><div class="sc-gOHsEJ fFpPFY searchbar-container"><div class="sc-ZEpg fzPRhZ search-input-container"><div class="sc-izgnRh kyxqzS search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div><div class="sc-hmzteu gyEjVP desktop-menu-wrapper" id="navigation-header"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="sc-bUjGoE hamMjt top-bar-wrapper"><div class="bar-layout-width"><div class="top-bar-inner-wrapper"><ul class="top-bar-list"><li class="bz-top-bar-list-item ProLabel"><a aria-label="Get Benzinga Pro" class="sc-dEARTM onvr shine-effect text-white bz-pro-btn" href="https://www.benzinga.com/pro/register?utm_source=homepage-blue-button">Get Benzinga Pro<!-- --> </a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/apis"><div class="bz-top-bar-list-item-label">Data &amp; APIs</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/events"><div class="bz-top-bar-list-item-label">Events</div></a></li><li class="bz-top-bar-list-item"><a href="https://marketfy.com/?__hstc=258999573.1ab86f21505b156c04ee556f3ea4a8de.1617281961141.1623244531459.1623314433592.60&amp;__hssc=258999573.1.1623314433592&amp;__hsfp=58102761"><div class="bz-top-bar-list-item-label">Marketfy</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/premarket"><div class="bz-top-bar-list-item-label">Premarket</div></a></li><li class="bz-top-bar-list-item"><a href="https://boost.benzinga.com"><div class="bz-top-bar-list-item-label">Boost</div></a></li><li class="bz-top-bar-list-item"><a href="https://advertise.benzinga.com"><div class="bz-top-bar-list-item-label">Advertise</div></a></li></ul><div class="auth-buttons"><div class="contributor-link"><a href="https://contributor.benzinga.com/contributor-onboarding">Contribute</a></div><div class="sc-ehEeqy jlUQXq global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><button class="auth-link-button">Login</button><button class="auth-link-button bg-orange-600">Register</button></div></div></div></div><div class="sc-bUsiPH kvgWDr main-menu-bar"><div class="sc-hwTdGM hGAYdc main-menu-wrapper"><div class="sc-fAlvPn hIMOyK bar-content-layout"><div class="sc-gvEBYa cWuGai logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-hKVfUx jOheYi benzinga-logo dark desktop"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#093451"></path></svg></span></a></div><div class="sc-lcMqGs ifHtbk primary-menu-wrapper"><ul class="sc-nbCPO eDFIpW menu-item-container"><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/services" style="min-width:108px" title="Our Services">Our Services<!-- --> </a></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/news" style="min-width:57px" title="News">News<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings">Earnings</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance">Guidance</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividends">Dividends</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&amp;amp;A">M&amp;A</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/buybacks" title="Buybacks">Buybacks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/legal" title="Legal">Legal</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/interview" title="Interviews">Interviews</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/management" title="Management">Management</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/offerings" title="Offerings">Offerings</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPOs">IPOs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/insider-trades" title="Insider Trades">Insider Trades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="Biotech/FDA">Biotech/FDA</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/general/politics" title="Politics">Politics</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/healthcare" title="Healthcare">Healthcare</a></div></div></div></div></div></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options<!-- --> </a></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav has-groups"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="sc-fOBchY gTOwki group-list"><div><div class="sc-iFvklb jOJmQw group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iFvklb jOJmQw group-list-item-label">Best Stocks &amp; ETFs</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&amp;P 500 ETFs">Best S&amp;P 500 ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto<!-- --> </a></div></li><li><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR dfFPgo highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></li></ul></div><button aria-label="Click to open more navbar items" class="more-nav-tabs-icon-container"><div class="text-2xl text-black"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M432 256a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zm-160 0a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zM64 304a48 48 0 1 1 0-96 48 48 0 1 1 0 96z" fill="currentColor"></path></svg></div><div class="sc-iqVxLi cStpHr more-menu-items-dropdown-container"><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options<!-- --> </a></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav has-groups"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="sc-fOBchY gTOwki group-list"><div><div class="sc-iFvklb jOJmQw group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iFvklb jOJmQw group-list-item-label">Best Stocks &amp; ETFs</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&amp;P 500 ETFs">Best S&amp;P 500 ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto<!-- --> </a></div><div class="sc-eYjERw jiROLZ menu-wrapper primary"><a class="sc-gvuZWP sIZrm menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis<!-- --> </a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR dfFPgo highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></div></button><div class="sc-fKFgrF BJLkT secondary-menu-wrapper"><div class="sc-eYjERw jiROLZ menu-wrapper secondary"><a aria-label="This opens Research in a new tab" class="sc-hpmCTx dsEKKn others-btn primary-toolbar-button" href="https://www.benzinga.com/research" style="min-width:110px" target="_blank" title="Research"><div class="text-xl pr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M96 32C60.7 32 32 60.7 32 96V384H96V96l384 0V384h64V96c0-35.3-28.7-64-64-64H96zM224 384v32H32c-17.7 0-32 14.3-32 32s14.3 32 32 32H544c17.7 0 32-14.3 32-32s-14.3-32-32-32H416V384c0-17.7-14.3-32-32-32H256c-17.7 0-32 14.3-32 32z" fill="currentColor"></path></svg></div>Research</a></div><div class="sc-eYjERw jiROLZ menu-wrapper secondary"><a aria-label="This opens My Stocks in a new tab" class="sc-hpmCTx dsEKKn others-btn primary-toolbar-button" href="https://www.benzinga.com/login?action=register&amp;next=https://www.benzinga.com/profile/portfolio" style="min-width:105px" target="_blank" title="My Stocks"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M500 89c13.8-11 16-31.2 5-45s-31.2-16-45-5L319.4 151.5 211.2 70.4c-11.7-8.8-27.8-8.5-39.2 .6L12 199c-13.8 11-16 31.2-5 45s31.2 16 45 5L192.6 136.5l108.2 81.1c11.7 8.8 27.8 8.5 39.2-.6L500 89zM160 256V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32zM32 352v96c0 17.7 14.3 32 32 32s32-14.3 32-32V352c0-17.7-14.3-32-32-32s-32 14.3-32 32zm288-64c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V320c0-17.7-14.3-32-32-32zm96-32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32z" fill="currentColor"></path></svg></div>My Stocks</a></div><div class="sc-eYjERw jiROLZ menu-wrapper secondary"><a aria-label="This opens Tools in a new tab" class="sc-hpmCTx dsEKKn others-btn primary-toolbar-button" href="https://www.benzinga.com/tools" style="min-width:100px" target="_blank" title="Tools"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M352 320c88.4 0 160-71.6 160-160c0-15.3-2.2-30.1-6.2-44.2c-3.1-10.8-16.4-13.2-24.3-5.3l-76.8 76.8c-3 3-7.1 4.7-11.3 4.7H336c-8.8 0-16-7.2-16-16V118.6c0-4.2 1.7-8.3 4.7-11.3l76.8-76.8c7.9-7.9 5.4-21.2-5.3-24.3C382.1 2.2 367.3 0 352 0C263.6 0 192 71.6 192 160c0 19.1 3.4 37.5 9.5 54.5L19.9 396.1C7.2 408.8 0 426.1 0 444.1C0 481.6 30.4 512 67.9 512c18 0 35.3-7.2 48-19.9L297.5 310.5c17 6.2 35.4 9.5 54.5 9.5zM80 408a24 24 0 1 1 0 48 24 24 0 1 1 0-48z" fill="currentColor"></path></svg></div>Tools</a><div class="sc-brYdJo jlDfPH sub-nav-wrapper subnav has-groups"><div class="sc-fmJrrp bYQLee sub-group-wrapper"><a aria-label="Free Benzinga Pro Trial" class="sc-dEARTM onvr shine-effect text-white block py-2 rounded-sm bg-bzblue-600 text-center mx-2 md:mx-4 my-2" href="https://pro.benzinga.com/register/?utm_source=tools-bz-pro-free-trial">Free Benzinga Pro Trial<!-- --> </a><div class="sc-fOBchY gTOwki group-list"><div><div class="sc-iFvklb jOJmQw group-list-item-label">Calendars</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings Calendar">Analyst Ratings Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/conference-calls" title="Conference Call Calendar">Conference Call Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividend Calendar">Dividend Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings Calendar">Earnings Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Economic Calendar">Economic Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="FDA Calendar">FDA Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance Calendar">Guidance Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPO Calendar">IPO Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&amp;A Calendar">M&amp;A Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/spac" title="SPAC Calendar">SPAC Calendar</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/stock-splits" title="Stock Split Calendar">Stock Split Calendar</a></div></div></div></div></div><div><div class="sc-iFvklb jOJmQw group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/reports" title="Free Stock Reports">Free Stock Reports</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/sec/insider-trades/" title="Insider Trades">Insider Trades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas" title="Trade Idea Feed">Trade Idea Feed</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings">Analyst Ratings</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/unusual-options-activity" title="Unusual Options Activity">Unusual Options Activity</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/heatmap" title="Heatmaps">Heatmaps</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/free-newsletters" title="Free Newsletter">Free Newsletter</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/gov-trades" title="Government Trades">Government Trades</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/perfect-stock-portfolio" title="Perfect Stock Portfolio">Perfect Stock Portfolio</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/easy-income-portfolio" title="Easy Income Portfolio">Easy Income Portfolio</a></div></div></div></div></div><div><div class="sc-iFvklb jOJmQw group-list-item-label">Short Interest</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/most-shorted" title="Most Shorted">Most Shorted</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-increase" title="Largest Increase">Largest Increase</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-decrease" title="Largest Decrease">Largest Decrease</a></div></div></div></div></div><div><div class="sc-iFvklb jOJmQw group-list-item-label">Calculators</div><div><div class="menu-items"><div class="sc-ggVnwW iDABru menu-item-wrapper"><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/margin-calculator" title="Margin Calculator">Margin Calculator</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/forex-profit-calculator" title="Forex Profit Calculator">Forex Profit Calculator</a></div><div class="sc-gdaOHR bsiliU dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/100x-options-profit-calculator" title="100x Options Profit Calculator">100x Options Profit Calculator</a></div></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-cdZxpv cZwtxE quote-bar-container"><div class="quote-bar-layout-width"><div class="quote-bar-wrapper"><div class="sc-fCUNPS beWcfq quote-switcher-wrapper"><div class="quote-switcher-container"><button class="sc-cbhCNN gprosN quote-switcher-button">Recent</button><button class="sc-cbhCNN cAOwZF quote-switcher-button">Markets</button></div></div><div class="quote-list-container"><div class="sc-dTaEtF eJENdV quote-list-wrapper"><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a><a class="sc-cxgeGX kShmtz quote-block " href="/quote/null"><h5 class="sc-iPYwOE gaynik quotebox-quote-name"></h5><div class="sc-dnxBXz iaNPFH quotebox-quote-data"><span class="sc-dxRmzR gbPlZW quotebox-quote-price"></span><span class="sc-dxRmzR sc-hPnoVK gbPlZW djybpZ quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper"><div class="sc-iAMrAa hqHAYI searchbar-wrapper searchbar-default"><div class="sc-gOHsEJ fFpPFY searchbar-container"><div class="sc-ZEpg fzPRhZ search-input-container"><div class="sc-izgnRh kyxqzS search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div></div></div><!--$--><div class="sc-iusedb ihHqQk quote-page-container profile"><div class="sc-fjmKZw kXpGmr quote-header"><div class="flex"><div aria-labelledby="comments-drawer" class="fixed top-0 right-0 z-40 h-screen p-4 overflow-y-auto transition-transform bg-white w-full max-w-[700px] z-[9999999] translate-x-full" tabindex="-1"><div class="flex items-center justify-between mb-4"><div class="flex items-center"><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div><h5 class="inline-flex items-center text-base font-bold text-gray-700" id="comments-drawer">Comments</h5></div><button class="text-gray-400 bg-transparent hover:bg-gray-200 hover:text-gray-900 rounded-lg text-sm w-8 h-8 flex items-center justify-center" type="button"><div class="w-3.5 h-3.5"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 384 512" xmlns="http://www.w3.org/2000/svg"><path d="M345 137c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-119 119L73 103c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9l119 119L39 375c-9.4 9.4-9.4 24.6 0 33.9s24.6 9.4 33.9 0l119-119L311 409c9.4 9.4 24.6 9.4 33.9 0s9.4-24.6 0-33.9l-119-119L345 137z" fill="currentColor"></path></svg></div><span class="sr-only">Close menu</span></button></div><div id="coral_thread"><div class="sc-jIBlqr bnTQiZ spinner"><div role="status"><svg aria-hidden="true" class="spinner-icon" fill="none" viewBox="0 0 100 101" xmlns="http://www.w3.org/2000/svg"><path d="M100 50.5908C100 78.2051 77.6142 100.591 50 100.591C22.3858 100.591 0 78.2051 0 50.5908C0 22.9766 22.3858 0.59082 50 0.59082C77.6142 0.59082 100 22.9766 100 50.5908ZM9.08144 50.5908C9.08144 73.1895 27.4013 91.5094 50 91.5094C72.5987 91.5094 90.9186 73.1895 90.9186 50.5908C90.9186 27.9921 72.5987 9.67226 50 9.67226C27.4013 9.67226 9.08144 27.9921 9.08144 50.5908Z" fill="currentColor"></path><path d="M93.9676 39.0409C96.393 38.4038 97.8624 35.9116 97.0079 33.5539C95.2932 28.8227 92.871 24.3692 89.8167 20.348C85.8452 15.1192 80.8826 10.7238 75.2124 7.41289C69.5422 4.10194 63.2754 1.94025 56.7698 1.05124C51.7666 0.367541 46.6976 0.446843 41.7345 1.27873C39.2613 1.69328 37.813 4.19778 38.4501 6.62326C39.0873 9.04874 41.5694 10.4717 44.0505 10.1071C47.8511 9.54855 51.7191 9.52689 55.5402 10.0491C60.8642 10.7766 65.9928 12.5457 70.6331 15.2552C75.2735 17.9648 79.3347 21.5619 82.5849 25.841C84.9175 28.9121 86.7997 32.2913 88.1811 35.8758C89.083 38.2158 91.5421 39.6781 93.9676 39.0409Z" fill="currentFill"></path></svg><span class="sr-only">Loading...</span></div></div></div></div><div class="bg-black/40 w-screen h-screen fixed z-[998] top-0 left-0 hidden"></div></div><div class="header-top-half flex items-center justify-between w-full main-div"><div class="flex flex-col"><div class="lg:text-lg flex items-center"><div class="sc-bNSORF ghkflP company-logo"><span class="ticker-logo" style="background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%"><img alt="" aria-hidden="true" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNTAiIGhlaWdodD0iNTAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+" style="background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial"/></span><img alt="Trulieve Cannabis" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/><noscript><img alt="Trulieve Cannabis" src="https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&amp;max_width=&amp;width=60&amp;x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&amp;x-bz-exp=1733045090&amp;x-bz-security-isin=CA89788C1041&amp;x-bz-security-symbol=TCNNF&amp;x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9" srcSet="https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&amp;max_width=&amp;width=60&amp;x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&amp;x-bz-exp=1733045090&amp;x-bz-security-isin=CA89788C1041&amp;x-bz-security-symbol=TCNNF&amp;x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9 1x, https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60&amp;max_width=&amp;width=60&amp;x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu&amp;x-bz-exp=1733045090&amp;x-bz-security-isin=CA89788C1041&amp;x-bz-security-symbol=TCNNF&amp;x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9 2x" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/></noscript></span></div><div class="flex gap-2 header-left-text items-center"><div class="flex items-center gap-2"><div class="flex flex-col items-start ml-2"><h1 class="quote-name text-bzblue-1000 text-3xl">Trulieve Cannabis</h1><div class="flex items-center gap-3 mt-1"><div class="quote-exchange-information flex items-center font-semibold sm:text-sm text-grey-darker"><span class="text-bzgray-900 py-0.5 px-2.5 rounded-full border border-bzblue-400 mr-2">TCNNF</span><span class="text-bzgray-600">OTCQX</span></div><div class="hidden md:flex gap-3 mr-2"><div class="md:ml-1 items-center w-full add-to-watchlist-wrapper"><div class="relative w-fit"><div class="inline-flex relative truncate w-full"><button aria-label="Add to watchlist" class="sc-hhyKGa lckOOn flat-blue md add-to-watchlist-button whitespace-nowrap default" type="button"><span><div class="watchlist-dropdown-icon mr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M287.9 0c9.2 0 17.6 5.2 21.6 13.5l68.6 141.3 153.2 22.6c9 1.3 16.5 7.6 19.3 16.3s.5 18.1-5.9 24.5L433.6 328.4l26.2 155.6c1.5 9-2.2 18.1-9.7 23.5s-17.3 6-25.3 1.7l-137-73.2L151 509.1c-8.1 4.3-17.9 3.7-25.3-1.7s-11.2-14.5-9.7-23.5l26.2-155.6L31.1 218.2c-6.5-6.4-8.7-15.9-5.9-24.5s10.3-14.9 19.3-16.3l153.2-22.6L266.3 13.5C270.4 5.2 278.7 0 287.9 0zm0 79L235.4 187.2c-3.5 7.1-10.2 12.1-18.1 13.3L99 217.9 184.9 303c5.5 5.5 8.1 13.3 6.8 21L171.4 443.7l105.2-56.2c7.1-3.8 15.6-3.8 22.6 0l105.2 56.2L384.2 324.1c-1.3-7.7 1.2-15.5 6.8-21l85.9-85.1L358.6 200.5c-7.8-1.2-14.6-6.1-18.1-13.3L287.9 79z" fill="currentColor"></path></svg></div>Watchlist</span></button></div></div></div><div class="leave-a-comment-wrapper whitespace-nowrap"><div class="flex comments-count-button"><button class="sc-hhyKGa lckOOn flat-blue md" type="button"><span><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div>Leave a Comment</span></button></div></div></div></div></div></div></div></div><a class="benzinga-logo-copy text-sm text-blue-500 mt-2" href="https://www.benzinga.com/apis/cloud-product/company-logo-api/" rel="noreferrer noopener" target="_blank">Logo brought to you by Benzinga Data</a></div><span class="md:hidden"><div class="relative w-fit"><div class="inline-flex relative truncate w-full"><button aria-label="Add to watchlist" class="sc-hhyKGa lckOOn flat-blue sm add-to-watchlist-button whitespace-nowrap compact" type="button"><span><div class="watchlist-dropdown-icon"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M287.9 0c9.2 0 17.6 5.2 21.6 13.5l68.6 141.3 153.2 22.6c9 1.3 16.5 7.6 19.3 16.3s.5 18.1-5.9 24.5L433.6 328.4l26.2 155.6c1.5 9-2.2 18.1-9.7 23.5s-17.3 6-25.3 1.7l-137-73.2L151 509.1c-8.1 4.3-17.9 3.7-25.3-1.7s-11.2-14.5-9.7-23.5l26.2-155.6L31.1 218.2c-6.5-6.4-8.7-15.9-5.9-24.5s10.3-14.9 19.3-16.3l153.2-22.6L266.3 13.5C270.4 5.2 278.7 0 287.9 0zm0 79L235.4 187.2c-3.5 7.1-10.2 12.1-18.1 13.3L99 217.9 184.9 303c5.5 5.5 8.1 13.3 6.8 21L171.4 443.7l105.2-56.2c7.1-3.8 15.6-3.8 22.6 0l105.2 56.2L384.2 324.1c-1.3-7.7 1.2-15.5 6.8-21l85.9-85.1L358.6 200.5c-7.8-1.2-14.6-6.1-18.1-13.3L287.9 79z" fill="currentColor"></path></svg></div></span></button></div></div></span><div class="quote-actions-desktop"><div class="sc-cuPFEj fjVA-DK quote-actions-container bottom-buttons"><div class="sc-bfGlA-D gOUeut get-report-button flex"><button class="sc-hhyKGa lckOOn flat-blue md" type="button"><span>Get Report</span></button></div><a data-action="Click Perks" href="https://www.tiicker.com/brand/TCNNF/perks?utm_campaign=benzinga-perks-button&amp;utm_medium=benzinga-tiicker-pages&amp;utm_source=benzinga-perks" rel="noreferrer nofollow" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md perks-button w-full" type="button"><span>Perks</span></a><a href="https://www.benzinga.com/go/start-investing/?pl=buy&amp;utm_source=/quote/TCNNF" rel="noreferrer" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md buy-button block full" type="button"><span>Buy</span></a><a data-action="Compare Brokers Button Click" href="https://www.benzinga.com/money/compare-online-brokers" rel="noreferrer" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md compare-brokers-button flex justify-center w-full whitespace-nowrap" type="button"><span>Compare Brokers</span></a></div></div></div><div class="quote-actions-tablet main-div"><div class="sc-cuPFEj fjVA-DK quote-actions-container bottom-buttons"><div class="sc-bfGlA-D gOUeut get-report-button flex"><button class="sc-hhyKGa lckOOn flat-blue md" type="button"><span>Get Report</span></button></div><a data-action="Click Perks" href="https://www.tiicker.com/brand/TCNNF/perks?utm_campaign=benzinga-perks-button&amp;utm_medium=benzinga-tiicker-pages&amp;utm_source=benzinga-perks" rel="noreferrer nofollow" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md perks-button w-full" type="button"><span>Perks</span></a><a href="https://www.benzinga.com/go/start-investing/?pl=buy&amp;utm_source=/quote/TCNNF" rel="noreferrer" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md buy-button block full" type="button"><span>Buy</span></a><a data-action="Compare Brokers Button Click" href="https://www.benzinga.com/money/compare-online-brokers" rel="noreferrer" target="_blank" class="sc-hhyKGa lckOOn flat-light-blue md compare-brokers-button flex justify-center w-full whitespace-nowrap" type="button"><span>Compare Brokers</span></a></div></div><div class="main-div flex"><div class="w-full md:w-auto flex flex-col items-center justify-center"><div class="flex flex-wrap gap-2 w-full"><div class="quote-price-data flex items-center gap-x-4 p-4 rounded-md w-full md:w-auto min-h-[84px] bg-bzred-500/10"><div class="text-3xl md:text-5xl text-bzgray-900 leading-none">$6.03</div><div><div class="quote-change-data flex items-center gap-2 text-bzgray-900 text-base min-h-[26px]"><div class="flex items-center justify-center p-3 rounded w-5 h-5 bg-bzred-500/10 text-bzred-500"><span><svg class="feather feather-arrow-up-right" fill="none" height="20" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="3" viewBox="0 0 24 24" width="20" xmlns="http://www.w3.org/2000/svg"><path d="M7 7L17 17"></path><path d="M17 7L17 17 7 17"></path></svg></span></div><span class="font-bold quote-change text-red-500">-0.1</span><span class="px-1 py-[1px] rounded bg-bzred-500/10"><span class="font-bold quote-change-percent text-red-500">-1.62%</span></span></div><div class="text-bzgray-600 text-sm font-semibold uppercase mt-1">At close: -</div></div></div><div class="quote-price-data flex items-center gap-x-4 p-4 rounded-md w-full md:w-auto min-h-[84px] bg-bzgray-200 text-bzgray-900 border border-bzgray-400"><div class="text-3xl md:text-5xl text-bzgray-900 leading-none">$5.94</div><div><div class="quote-change-data flex items-center gap-2 text-base min-h-[26px]"><div class="flex items-center justify-center p-3 rounded w-5 h-5 bg-bzred-500/10 text-bzred-500"><span><svg class="feather feather-arrow-up-right" fill="none" height="20" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="3" viewBox="0 0 24 24" width="20" xmlns="http://www.w3.org/2000/svg"><path d="M7 7L17 17"></path><path d="M17 7L17 17 7 17"></path></svg></span></div><span class="font-bold quote-change text-red-500">-0.09</span><span class="px-1 py-[1px] rounded bg-bzred-500/10"><span class="font-bold quote-change-percent text-red-500">-1.51%</span></span></div><div class="text-bzgray-600 text-sm font-semibold uppercase mt-1">After Hours: Nov 22, 8:05 AM EDT</div></div></div></div></div></div><div class="main-div"><div class="w-full my-4"></div></div><div class="main-div md:hidden w-full flex flex-col gap-2 mb-2"><div class="flex gap-2 items-center w-full"><div class="sc-bfGlA-D gOUeut get-report-button flex"><button class="sc-hhyKGa lckOOn flat-blue md" type="button"><span>Get Report</span></button></div><div class="flex items-center w-full"><div class="leave-a-comment-wrapper whitespace-nowrap w-full"><div class="flex comments-count-button"><button class="sc-hhyKGa lckOOn flat-blue md" type="button"><span><div class="mr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M512 240c0 114.9-114.6 208-256 208c-37.1 0-72.3-6.4-104.1-17.9c-11.9 8.7-31.3 20.6-54.3 30.6C73.6 471.1 44.7 480 16 480c-6.5 0-12.3-3.9-14.8-9.9c-2.5-6-1.1-12.8 3.4-17.4l0 0 0 0 0 0 0 0 .3-.3c.3-.3 .7-.7 1.3-1.4c1.1-1.2 2.8-3.1 4.9-5.7c4.1-5 9.6-12.4 15.2-21.6c10-16.6 19.5-38.4 21.4-62.9C17.7 326.8 0 285.1 0 240C0 125.1 114.6 32 256 32s256 93.1 256 208z" fill="currentColor"></path></svg></div>Comment</span></button></div></div></div><button aria-label="Toggle more quote actions" class="sc-hhyKGa lckOOn flat-light-blue md more-quote-actions-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></span></button></div></div><div class="main-div"><div class="sc-gSXJRe hFeKYN"></div></div><div class="mx-2"><div class="main-quote-tabs-wrapper"><div class="main-quote-tabs"><h2 class="tab active" id="active-tab-item">Trulieve Cannabis (TCNNF) Forecast</h2><a class="tab" href="/quote/TCNNF/news">News</a><a class="tab" href="/quote/TCNNF/earnings">Earnings</a><a class="tab" href="/quote/TCNNF/option-chain">Trulieve Cannabis (TCNNF) Options</a><a class="tab" href="/quote/TCNNF/guidance">Guidance</a><a class="tab" href="/quote/TCNNF/dividends">Dividends</a><a class="tab" href="/quote/TCNNF/analyst-ratings">Analyst Ratings</a><a class="tab" href="/quote/TCNNF/insider-trades">Insider Trades</a><a class="tab" href="/quote/TCNNF/short-interest">Short Interest</a></div></div></div></div><div class="quote-page-above-layout-ads"><!--$--><!--/$--></div><div class="sc-llHdZW fFHvaw flex flex-col gap-y-8 w-full ml-auto py-4"><!--$--><div class="main-dev w-full flex gap-4 px-4"><div class="w-full flex flex-col gap-8 md:gap-4"><div class="main-div"></div><div class="main-div flex flex-col gap-2"><div class="sc-ilxebA iRTtZw section-title"><h1>Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary</h1></div><p class="section-description">Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile.</p></div><div class="top-area-and-sidebar-container w-full flex mx-auto max-w-[1280px] gap-8 md:gap-4"><div class="w-full lg:w-8/12 flex flex-col gap-8 md:gap-4"><div class=""><div class="w-full flex flex-col gap-8"><div class="w-full flex flex-col lg:flex-row gap-8 md:gap-4"><div class="w-full flex flex-col"><div class="flex flex-col gap-8 md:gap-4"><div class="card flex-grow flex flex-col justify-center min-h-[400px] md:min-h-[500px]"><!--$--><div class="tradingview-widget-container"><div id="tradingview_f52f1"></div></div><!--/$--></div><div class="metrics-mobile w-full"><table class="w-full h-full"><tbody class="flex flex-col h-full divide-y divide-bzblue-300 px-4 py-2 rounded border border-bzblue-400"><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Open</td><td class="value font-bold">$6.20</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Close</td><td class="value font-bold">$6.03</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Volume / Avg.</td><td class="value font-bold">262.65K / 554.39K</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Day Range</td><td class="value font-bold">$5.94 - $6.21</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">52 Wk Range</td><td class="value font-bold">4.75 - 14.50</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Market Cap</td><td class="value font-bold">$1.12B</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">P/E Ratio</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Dividend Yield</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Exchange</td><td class="value font-bold">OTC</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">RSI</td><td class="value font-bold"><div class="flex items-center gap-4">0<div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Short Interest</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Days to Cover</td><td class="value font-bold">1</td></tr></tbody></table></div></div></div></div><div class="w-full"><div class="flex flex-col"><div class="sc-jFWsBE hjHUa news-tab-and-ads-wrapper w-full flex flex-col lg:flex-row gap-8 md:gap-4"><div class="sc-dXIwAT kTTQZR w-full"><div class="sc-kOzuoN cQRDCg tabs-container pill-variant"><div class="tab-list-wrapper"><div class="flex items-center whitespace-nowrap mr-4 recent-news-title"><div class="sc-ilxebA kFRmOG section-title leading-none"><h3>Recent News</h3></div></div><div class="tab-list"><button class="tab active" name="News">News</button><button class="tab" name="Partners">Partners</button><button class="tab" name="Press Releases">Press Releases</button></div></div><div class="tabs-content"><div class="tab-content selected"><div class="sc-PqBve emyKxB flex flex-col"><div class="quote-news-list"><div class="sc-dCtYgc jcujMk content-feed "><div class="content-feed-container"><div class="content-feed-list"><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-jWVdrv jYmixk news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/government/regulations/24/11/42235292/pharma-grade-cannabis-could-hit-walgreens-cvs-but-can-the-industry-survive-the-fda"><div class="sc-bqjyeg bnxXlT article-title"><span>Pharma-Grade Cannabis Could Hit Walgreens &amp; CVS—But Can The Industry Survive The FDA?</span></div><div class="sc-bqjyeg bnxXlT article-teaser"><span>As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.</span></div></a><div><span class="article-author text-sm font-semibold mr-2">Nicolás Jose Rodriguez</span><div class="flex items-center"><div class="sc-cVuPSX davtfT"></div></div></div></div></div></div><!--$--><!--/$--></div><div class="absolute" style="height:1px;width:1px"></div></div><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-jWVdrv jYmixk news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42226503/florida-awards-22-new-cannabis-licenses-after-18-month-waitlegal-battles-ahead"><div class="sc-bqjyeg bnxXlT article-title"><span>Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?</span></div><div class="sc-bqjyeg bnxXlT article-teaser"><span>Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000.</span></div></a><div><span class="article-author text-sm font-semibold mr-2">Franca Quarneti</span><div class="flex items-center"><div class="sc-cVuPSX davtfT"></div></div></div></div></div></div><!--$--><!--/$--></div><div class="absolute" style="height:1px;width:1px"></div></div><div class="quote-news-item bg-[#F2F8FF66] border border-bzblue-400 rounded p-4"><div class="sc-jWVdrv jYmixk news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030"><div class="sc-bqjyeg bnxXlT article-title"><span>Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030</span></div><div class="sc-bqjyeg bnxXlT article-teaser"><span>According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.</span></div></a><div><span class="article-author text-sm font-semibold mr-2">Nicolás Jose Rodriguez</span><div class="flex items-center"><div class="sc-cVuPSX davtfT"></div></div></div></div></div></div><!--$--><!--/$--></div><div class="absolute" style="height:1px;width:1px"></div></div></div><div class="mt-8"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div></div></div></div><div class="tab-content"><div class="lazyload-wrapper "><div style="height:400px" class="lazyload-placeholder"></div></div></div><div class="tab-content"><div class="lazyload-wrapper "><div style="height:400px" class="lazyload-placeholder"></div></div></div></div></div></div></div></div></div></div></div><div class="main-div"><div class="flex gap-2 items-center mb-3"><div class="sc-ilxebA kFRmOG section-title"><h3>Financials</h3></div></div><div class="flex flex-col gap-8 md:gap-4 lg:flex-row"><div class="w-full flex flex-col gap-8 md:gap-4"><div class="sc-kEXmsn cATxhb"><div class="card"><div class="flex justify-between items-center"><div class="simple-tab-wrapper"></div><div class="simple-tab-wrapper"><div class="simple-tab active"><div class="simple-tab-text">Quarterly</div></div><div class="simple-tab "><div class="simple-tab-text">Annual</div></div></div></div><div style="height:325px;overflow:hidden;width:100%" class="echarts-for-react chart-body mt-4 z-[1]"></div><div class="divider my-4"></div><table class="w-full"><thead><tr class="table-row"><th class="table-title">Name</th></tr></thead><tbody class="mt-2"><tr><td><div class="mt-2 divider"></div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Revenue</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Gross</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">EBITDA</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">EBIT</div><div class="table-cell-subtitle">Change</div></td></tr><tr class="table-row body-row"><td class="table-cell"><div class="table-cell-title">Earnings</div><div class="table-cell-subtitle">Change</div></td></tr></tbody></table></div></div><div class="flex flex-col md:flex-row gap-8 md:gap-4 w-full"><div class="analyst-rating-bar-chart card flex flex-col flex-1"><h6 class="font-bold mb-4">Analyst Trends and Forecast</h6><div class="flex gap-5 md:gap-8 mt-auto mx-auto"><div class="flex h-[200px]"><div class="sc-bztcrM sc-OQdlP eiARcP hlNQqc flex flex-col items-center h-full w-full w-[48px] md:w-[50px] rounded overflow-hidden"><div class="color-box buy" style="height:100%"><span class="leading-none">1</span></div><div class="color-box hold" style="height:0"><span class="leading-none"> </span></div><div class="color-box sell" style="height:0"><span class="leading-none"> </span></div><div class="color-box strong_sell" style="height:0"><span class="leading-none"> </span></div><div class="font-normal whitespace-nowrap text-center text-sm p-2 text-gray-700 mt-auto">Aug</div></div></div></div><div class="mt-2 lg:ml-0"><div class="sc-fMeROS hzYGQB flex items-center justify-center gap-4 lg:gap-2 p-1 flex-wrap"><div class="flex items-center gap-2"><div class="color-key-box" style="background:#30BF60"></div><div class="text-sm">Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FFD644"></div><div class="text-sm">Hold</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF9244"></div><div class="text-sm">Sell</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF4050"></div><div class="text-sm">Strong Sell</div></div></div></div></div><div class="sc-jEZPox eSDTgX analyst-rating-semi-circle-chart card flex-1"><div class="flex items-center gap-2 mb-4"><h6 class="font-bold">Analyst Rating and Forecast</h6><div class="sc-coJLxb ljIKRc tooltip-container hover" id="tooltip-container"><div class="info-circle-icon text-sm flex items-center justify-center"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M256 512A256 256 0 1 0 256 0a256 256 0 1 0 0 512zM216 336h24V272H216c-13.3 0-24-10.7-24-24s10.7-24 24-24h48c13.3 0 24 10.7 24 24v88h8c13.3 0 24 10.7 24 24s-10.7 24-24 24H216c-13.3 0-24-10.7-24-24s10.7-24 24-24zm40-208a32 32 0 1 1 0 64 32 32 0 1 1 0-64z" fill="currentColor"></path></svg></div></div></div><div class="w-full mx-auto"><div class="box gauge--3 relative"><div class="container gauge-background"><div><svg viewBox="0 0 100 55" xmlns="http://www.w3.org/2000/svg"><defs><linearGradient id="linear" x1="0%" x2="100%" y1="0%" y2="0%"><stop offset="0%" stop-color="#EF4444"></stop><stop offset="25%" stop-color="#F97316"></stop><stop offset="50%" stop-color="#FFD644"></stop><stop offset="75%" stop-color="#84CC16"></stop><stop offset="100%" stop-color="#30BF60"></stop></linearGradient></defs><path d="M10,50 A40,40 0 1,1 90,50" fill="none" stroke="#E1EAF9" stroke-dasharray="0" stroke-dashoffset="0" stroke-linecap="round" stroke-width="8"></path><path d="M10,50 A40,40 0 1,1 90,50" fill="none" stroke="url(#linear)" stroke-dasharray="128.4911395318225" stroke-linecap="round" stroke-width="8" style="stroke-dashoffset:24.413316511046272"></path><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="10" cy="50" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="10" y="50.25">1</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="20.25" cy="23" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="20.25" y="23.25">2</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="50" cy="10" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="50" y="10.25">3</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="80" cy="23" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="80" y="23.25">4</text></g><g class="number-circle" fill="white" stroke="green" stroke-width="0"><circle cx="90" cy="50" fill="#00000054" r="3"></circle><text alignment-baseline="middle" fill="#FFFFFF" font-size="4px" font-weight="600" text-anchor="middle" x="90" y="50.25">5</text></g></svg></div></div><div class="analyst-rating-score buy flex flex-col items-center justify-center absolute bottom-[-30px] left-1/2 -translate-y-2/4 -translate-x-2/4 z-[2]"><div class="analyst-rating-score-circle text-white font-bold rounded-full w-12 h-12 text-center flex items-center justify-center">4.2</div><span class="analyst-rating-label rounded-full font-bold text-sm z-[2] -mt-2 py-0.5 px-2 min-w-[60px] text-center">Buy</span></div></div></div><div class="mt-2 lg:ml-0"><div class="sc-fMeROS hzYGQB flex items-center justify-center gap-4 lg:gap-2 p-1 flex-wrap"><div class="flex items-center gap-2"><div class="color-key-box" style="background:#30BF60"></div><div class="text-sm">Strong Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#91DBB0"></div><div class="text-sm">Buy</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FFD644"></div><div class="text-sm">Hold</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF9244"></div><div class="text-sm">Sell</div></div><div class="flex items-center gap-2"><div class="color-key-box" style="background:#FF4050"></div><div class="text-sm">Strong Sell</div></div></div></div></div></div></div></div></div></div><div class="w-full lg:w-4/12 flex flex-col items-center gap-8 md:gap-4"><div class="metrics-desktop w-full"><table class="w-full h-full"><tbody class="flex flex-col h-full divide-y divide-bzblue-300 px-4 py-2 rounded border border-bzblue-400"><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Open</td><td class="value font-bold">$6.20</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Close</td><td class="value font-bold">$6.03</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Volume / Avg.</td><td class="value font-bold">262.65K / 554.39K</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Day Range</td><td class="value font-bold">$5.94 - $6.21</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">52 Wk Range</td><td class="value font-bold">4.75 - 14.50</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Market Cap</td><td class="value font-bold">$1.12B</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">P/E Ratio</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Dividend Yield</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Exchange</td><td class="value font-bold">OTC</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">RSI</td><td class="value font-bold"><div class="flex items-center gap-4">0<div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Short Interest</td><td class="value font-bold">-</td></tr><tr class="flex items-center justify-between w-full py-[0.4rem]"><td class="label text-gray-500">Days to Cover</td><td class="value font-bold">1</td></tr></tbody></table></div><div class="flex flex-col gap-8 md:gap-4 px-4 md:mt-4"><div class="min-h-[220px] w-full"></div></div></div></div><div class="main-div"><div class="flex gap-2 items-center mb-4"><div class="sc-ilxebA kFRmOG section-title"><h3>Compare</h3></div></div><div class="sc-jSUPYf a-deox"><div class="flex flex-col gap-8 md:gap-4 w-full md:hidden"><div><button class="compare-tab active"><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div><div class="compare-tab__label font-bold">EPS</div><div class="compare-tab__value inverse">$-0.33</div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 111c9.4-9.4 24.6-9.4 33.9 0L465 303c9.4 9.4 9.4 24.6 0 33.9s-24.6 9.4-33.9 0l-175-175L81 337c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9L239 111z" fill="currentColor"></path></svg></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe gTHsam"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><div class="tab-content w-full"><div class="flex flex-col items-start w-full gap-2"><div class="flex items-center gap-2"><div class="rounded-lg p-2 red-chip"><div class="text-xs whitespace-nowrap label-text">EPS<!-- --> <!-- -->worse<!-- --> <!-- -->than industry</div></div><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div><div><div class="font-bold text-lg text-gray-600 mb-2 tab-title">Earnings Per Share</div><div class="text-gray-600 text-md tab-description">EPS is the portion of a company&#x27;s profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company&#x27;s profitability.</div></div></div><div class="sc-jgFdch lZAHV flex flex-col-reverse md:flex-row w-full mt-4"><div class="w-full lg:w-9/12 z-[1]"><div style="height:375px;width:100%" class="echarts-for-react chart-body"></div></div><div class="w-full lg:w-3/12"><div class="symbol-menu h-full border border-b-0 md:border-b-1 md:border-l-0"><div class="searchbar border-b"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M248 72c0-13.3-10.7-24-24-24s-24 10.7-24 24V232H40c-13.3 0-24 10.7-24 24s10.7 24 24 24H200V440c0 13.3 10.7 24 24 24s24-10.7 24-24V280H408c13.3 0 24-10.7 24-24s-10.7-24-24-24H248V72z" fill="currentColor"></path></svg></div><div class="sc-iAMrAa hqHAYI searchbar-wrapper searchbar-box"><div class="sc-gOHsEJ fFpPFY searchbar-container"><div class="sc-ZEpg fzPRhZ search-input-container"><div class="sc-izgnRh kyxqzS search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Compare" role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div><div class="flex flex-col overflow-y-auto max-h-[310px]"><div class="symbol-entry justify-between"><div class="flex items-center gap-2"><div class="symbol-pill-dot" style="background-color:#1060FF"></div><div class="symbol-pill">TCNNF</div></div></div></div></div></div></div></div></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/E</div><div class="compare-tab__value "></div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="sc-dNWbAc bIsfaU up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div><div class="compare-tab__label font-bold">P/B</div><div class="compare-tab__value ">0.9x</div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div><div class="compare-tab__label font-bold">ROE</div><div class="compare-tab__value inverse">-4.5%</div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe gTHsam"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button></div><div><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="sc-dNWbAc bIsfaU up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div><div class="compare-tab__label font-bold">D/E</div><div class="compare-tab__value ">0.6x</div></div><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M239 401c9.4 9.4 24.6 9.4 33.9 0L465 209c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0l-175 175L81 175c-9.4-9.4-24.6-9.4-33.9 0s-9.4 24.6 0 33.9L239 401z" fill="currentColor"></path></svg></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button></div></div><div class="hidden md:block"><div class="tabs-row flex items-center gap-4 wrap"><button class="compare-tab active"><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">EPS</div><div class="compare-tab__value inverse">$-0.33</div></div><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe gTHsam"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/E</div><div class="compare-tab__value "></div></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">P/B</div><div class="compare-tab__value ">0.9x</div></div><div class="sc-dNWbAc bIsfaU up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">ROE</div><div class="compare-tab__value inverse">-4.5%</div></div><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe gTHsam"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button><button class="compare-tab "><div class="flex items-center w-full justify-between"><div class="flex items-center gap-1"><div class="compare-tab__label font-bold">D/E</div><div class="compare-tab__value ">0.6x</div></div><div class="sc-dNWbAc bIsfaU up"><div style="color:#30bf60"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 34.8c-38.2-10.9-78.1 11.2-89 49.4l-5.7 20c-3.7 13-10.4 25-19.5 35l-51.3 56.4c-8.9 9.8-8.2 25 1.6 33.9s25 8.2 33.9-1.6l51.3-56.4c14.1-15.5 24.4-34 30.1-54.1l5.7-20c3.6-12.7 16.9-20.1 29.7-16.5s20.1 16.9 16.5 29.7l-5.7 20c-5.7 19.9-14.7 38.7-26.6 55.5c-5.2 7.3-5.8 16.9-1.7 24.9s12.3 13 21.3 13L448 224c8.8 0 16 7.2 16 16c0 6.8-4.3 12.7-10.4 15c-7.4 2.8-13 9-14.9 16.7s.1 15.8 5.3 21.7c2.5 2.8 4 6.5 4 10.6c0 7.8-5.6 14.3-13 15.7c-8.2 1.6-15.1 7.3-18 15.2s-1.6 16.7 3.6 23.3c2.1 2.7 3.4 6.1 3.4 9.9c0 6.7-4.2 12.6-10.2 14.9c-11.5 4.5-17.7 16.9-14.4 28.8c.4 1.3 .6 2.8 .6 4.3c0 8.8-7.2 16-16 16H286.5c-12.6 0-25-3.7-35.5-10.7l-61.7-41.1c-11-7.4-25.9-4.4-33.3 6.7s-4.4 25.9 6.7 33.3l61.7 41.1c18.4 12.3 40 18.8 62.1 18.8H384c34.7 0 62.9-27.6 64-62c14.6-11.7 24-29.7 24-50c0-4.5-.5-8.8-1.3-13c15.4-11.7 25.3-30.2 25.3-51c0-6.5-1-12.8-2.8-18.7C504.8 273.7 512 257.7 512 240c0-35.3-28.6-64-64-64l-92.3 0c4.7-10.4 8.7-21.2 11.8-32.2l5.7-20c10.9-38.2-11.2-78.1-49.4-89zM32 192c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32H96c17.7 0 32-14.3 32-32V224c0-17.7-14.3-32-32-32H32z" fill="currentColor"></path></svg></div></div></div><div class="sc-jXIZMl cWOyzd"><div class="sc-gMQCKe hcCbSS"><div class="quote-slider-bar" style="width:0%"></div><div class="quote-slider-tick"></div></div><div class="open-price-wrapper"><div class="transparent-box" style="width:0%"></div><div class="open-price-container"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M182.6 137.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-9.2 9.2-11.9 22.9-6.9 34.9s16.6 19.8 29.6 19.8H288c12.9 0 24.6-7.8 29.6-19.8s2.2-25.7-6.9-34.9l-128-128z" fill="currentColor"></path></svg></div></div></div></div></button></div><div class="tab-content w-full"><div class="flex items-center justify-between w-full"><div><div class="font-bold text-lg text-gray-600 mb-2 tab-title">Earnings Per Share</div><div class="text-gray-600 text-md tab-description">EPS is the portion of a company&#x27;s profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company&#x27;s profitability.</div></div><div class="flex items-center gap-2"><div class="rounded p-2 red-chip"><div class="text-xs whitespace-nowrap label-text">EPS<!-- --> <!-- -->worse<!-- --> <!-- -->than industry</div></div><div class="sc-dNWbAc bIsfaU down"><div style="color:#ff4050"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M323.8 477.2c-38.2 10.9-78.1-11.2-89-49.4l-5.7-20c-3.7-13-10.4-25-19.5-35l-51.3-56.4c-8.9-9.8-8.2-25 1.6-33.9s25-8.2 33.9 1.6l51.3 56.4c14.1 15.5 24.4 34 30.1 54.1l5.7 20c3.6 12.7 16.9 20.1 29.7 16.5s20.1-16.9 16.5-29.7l-5.7-20c-5.7-19.9-14.7-38.7-26.6-55.5c-5.2-7.3-5.8-16.9-1.7-24.9s12.3-13 21.3-13L448 288c8.8 0 16-7.2 16-16c0-6.8-4.3-12.7-10.4-15c-7.4-2.8-13-9-14.9-16.7s.1-15.8 5.3-21.7c2.5-2.8 4-6.5 4-10.6c0-7.8-5.6-14.3-13-15.7c-8.2-1.6-15.1-7.3-18-15.2s-1.6-16.7 3.6-23.3c2.1-2.7 3.4-6.1 3.4-9.9c0-6.7-4.2-12.6-10.2-14.9c-11.5-4.5-17.7-16.9-14.4-28.8c.4-1.3 .6-2.8 .6-4.3c0-8.8-7.2-16-16-16H286.5c-12.6 0-25 3.7-35.5 10.7l-61.7 41.1c-11 7.4-25.9 4.4-33.3-6.7s-4.4-25.9 6.7-33.3l61.7-41.1c18.4-12.3 40-18.8 62.1-18.8H384c34.7 0 62.9 27.6 64 62c14.6 11.7 24 29.7 24 50c0 4.5-.5 8.8-1.3 13c15.4 11.7 25.3 30.2 25.3 51c0 6.5-1 12.8-2.8 18.7C504.8 238.3 512 254.3 512 272c0 35.3-28.6 64-64 64l-92.3 0c4.7 10.4 8.7 21.2 11.8 32.2l5.7 20c10.9 38.2-11.2 78.1-49.4 89zM32 384c-17.7 0-32-14.3-32-32V128c0-17.7 14.3-32 32-32H96c17.7 0 32 14.3 32 32V352c0 17.7-14.3 32-32 32H32z" fill="currentColor"></path></svg></div></div></div></div><div class="sc-jgFdch lZAHV flex flex-col-reverse md:flex-row w-full mt-4"><div class="w-full lg:w-9/12 z-[1]"><div style="height:375px;width:100%" class="echarts-for-react chart-body"></div></div><div class="w-full lg:w-3/12"><div class="symbol-menu h-full border border-b-0 md:border-b-1 md:border-l-0"><div class="searchbar border-b"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M248 72c0-13.3-10.7-24-24-24s-24 10.7-24 24V232H40c-13.3 0-24 10.7-24 24s10.7 24 24 24H200V440c0 13.3 10.7 24 24 24s24-10.7 24-24V280H408c13.3 0 24-10.7 24-24s-10.7-24-24-24H248V72z" fill="currentColor"></path></svg></div><div class="sc-iAMrAa hqHAYI searchbar-wrapper searchbar-box"><div class="sc-gOHsEJ fFpPFY searchbar-container"><div class="sc-ZEpg fzPRhZ search-input-container"><div class="sc-izgnRh kyxqzS search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Compare" role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div><div class="flex flex-col overflow-y-auto max-h-[310px]"><div class="symbol-entry justify-between"><div class="flex items-center gap-2"><div class="symbol-pill-dot" style="background-color:#1060FF"></div><div class="symbol-pill">TCNNF</div></div></div></div></div></div></div></div></div></div></div><div class="main-div"><div class="flex flex-col gap-8 md:gap-4 lg:flex-row"><div class="w-full lg:w-9/12"><div class="sc-ilxebA fLScaU section-title text-2xl"><h3>FAQ</h3></div><div class="mt-6 mb-1"><div class="sc-jKsysk gjrMOl faq-container"><div class="sc-fDmoKL cziqXa faq-block"><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">How do I buy Trulieve Cannabis (TCNNF) stock?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>You can purchase shares of Trulieve Cannabis (OTCQX:TCNNF) through any online brokerage.</p><p><a href="https://www.benzinga.com/money/online-stock-trading/" rel="noreferrer" target="_blank">View our list of the best stock brokerages</a></p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Who are Trulieve Cannabis (TCNNF) competitors?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There are no as such competitors for Trulieve Cannabis.</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What is the forecast, or price target, for Trulieve Cannabis (TCNNF) stock?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Trulieve Cannabis has a consensus price target of $18.50.</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What is the current price for Trulieve Cannabis (TCNNF)?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>The stock price for Trulieve Cannabis (OTCQX: TCNNF) is $ last updated .</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Does Trulieve Cannabis (TCNNF) pay a dividend?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There are no upcoming dividends for Trulieve Cannabis.</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">When is Trulieve Cannabis (OTCQX:TCNNF) reporting earnings?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Trulieve Cannabis’s Q4 earnings are confirmed for Thursday, February 27, 2025.</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">Is Trulieve Cannabis (TCNNF) going to split?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>There is no upcoming split for Trulieve Cannabis.</p></div></div></div><div class="sc-glxhRN ejfjms qa-container"><div class="qa-header"><div class="qa-letter-icon">Q</div><h3 class="font-bold question">What sector and industry does Trulieve Cannabis (TCNNF) operate in?</h3></div><div class="qa-body"><div class="qa-letter-icon">A</div><div class="answer-container"><p>Trulieve Cannabis is in the <b>Healthcare</b> sector and <b>Drug Manufacturers—Specialty & Generic</b> industry. They are listed on the OTCQX.</p></div></div></div></div></div></div></div></div></div><div class="main-div px-50"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div><!--/$--></div></div><!--/$--><div class="footer"><div class="footer-top-section"><div class="benzinga-links-section"><div class="logo-and-socials-wrapper"><span class="sc-hKVfUx jOheYi benzinga-logo light presentation"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span><div class="social-sites-list"><a aria-label="Click to check out Benzinga&#x27;s facebook" class="sc-bggJJS gRGBBQ facebook" color="#3b5998" href="https://web.facebook.com/Benzinga/?_rdc=1&amp;_rdr" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64h98.2V334.2H109.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H255V480H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga&#x27;s instagram" class="sc-bggJJS eMbbze instagram" color="#e1306c" href="https://www.instagram.com/benzinga/?hl=en" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga&#x27;s linkedin" class="sc-bggJJS joofhG linkedin" color="#0072b1" href="https://www.linkedin.com/company/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga&#x27;s soundcloud" class="sc-bggJJS kWkEse soundcloud" color="#fe5000" href="https://soundcloud.com/bztv" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 640 512" xmlns="http://www.w3.org/2000/svg"><path d="M111.4 256.3l5.8 65-5.8 68.3c-.3 2.5-2.2 4.4-4.4 4.4s-4.2-1.9-4.2-4.4l-5.6-68.3 5.6-65c0-2.2 1.9-4.2 4.2-4.2 2.2 0 4.1 2 4.4 4.2zm21.4-45.6c-2.8 0-4.7 2.2-5 5l-5 105.6 5 68.3c.3 2.8 2.2 5 5 5 2.5 0 4.7-2.2 4.7-5l5.8-68.3-5.8-105.6c0-2.8-2.2-5-4.7-5zm25.5-24.1c-3.1 0-5.3 2.2-5.6 5.3l-4.4 130 4.4 67.8c.3 3.1 2.5 5.3 5.6 5.3 2.8 0 5.3-2.2 5.3-5.3l5.3-67.8-5.3-130c0-3.1-2.5-5.3-5.3-5.3zM7.2 283.2c-1.4 0-2.2 1.1-2.5 2.5L0 321.3l4.7 35c.3 1.4 1.1 2.5 2.5 2.5s2.2-1.1 2.5-2.5l5.6-35-5.6-35.6c-.3-1.4-1.1-2.5-2.5-2.5zm23.6-21.9c-1.4 0-2.5 1.1-2.5 2.5l-6.4 57.5 6.4 56.1c0 1.7 1.1 2.8 2.5 2.8s2.5-1.1 2.8-2.5l7.2-56.4-7.2-57.5c-.3-1.4-1.4-2.5-2.8-2.5zm25.3-11.4c-1.7 0-3.1 1.4-3.3 3.3L47 321.3l5.8 65.8c.3 1.7 1.7 3.1 3.3 3.1 1.7 0 3.1-1.4 3.1-3.1l6.9-65.8-6.9-68.1c0-1.9-1.4-3.3-3.1-3.3zm25.3-2.2c-1.9 0-3.6 1.4-3.6 3.6l-5.8 70 5.8 67.8c0 2.2 1.7 3.6 3.6 3.6s3.6-1.4 3.9-3.6l6.4-67.8-6.4-70c-.3-2.2-2-3.6-3.9-3.6zm241.4-110.9c-1.1-.8-2.8-1.4-4.2-1.4-2.2 0-4.2.8-5.6 1.9-1.9 1.7-3.1 4.2-3.3 6.7v.8l-3.3 176.7 1.7 32.5 1.7 31.7c.3 4.7 4.2 8.6 8.9 8.6s8.6-3.9 8.6-8.6l3.9-64.2-3.9-177.5c-.4-3-2-5.8-4.5-7.2zm-26.7 15.3c-1.4-.8-2.8-1.4-4.4-1.4s-3.1.6-4.4 1.4c-2.2 1.4-3.6 3.9-3.6 6.7l-.3 1.7-2.8 160.8s0 .3 3.1 65.6v.3c0 1.7.6 3.3 1.7 4.7 1.7 1.9 3.9 3.1 6.4 3.1 2.2 0 4.2-1.1 5.6-2.5 1.7-1.4 2.5-3.3 2.5-5.6l.3-6.7 3.1-58.6-3.3-162.8c-.3-2.8-1.7-5.3-3.9-6.7zm-111.4 22.5c-3.1 0-5.8 2.8-5.8 6.1l-4.4 140.6 4.4 67.2c.3 3.3 2.8 5.8 5.8 5.8 3.3 0 5.8-2.5 6.1-5.8l5-67.2-5-140.6c-.2-3.3-2.7-6.1-6.1-6.1zm376.7 62.8c-10.8 0-21.1 2.2-30.6 6.1-6.4-70.8-65.8-126.4-138.3-126.4-17.8 0-35 3.3-50.3 9.4-6.1 2.2-7.8 4.4-7.8 9.2v249.7c0 5 3.9 8.6 8.6 9.2h218.3c43.3 0 78.6-35 78.6-78.3.1-43.6-35.2-78.9-78.5-78.9zm-296.7-60.3c-4.2 0-7.5 3.3-7.8 7.8l-3.3 136.7 3.3 65.6c.3 4.2 3.6 7.5 7.8 7.5 4.2 0 7.5-3.3 7.5-7.5l3.9-65.6-3.9-136.7c-.3-4.5-3.3-7.8-7.5-7.8zm-53.6-7.8c-3.3 0-6.4 3.1-6.4 6.7l-3.9 145.3 3.9 66.9c.3 3.6 3.1 6.4 6.4 6.4 3.6 0 6.4-2.8 6.7-6.4l4.4-66.9-4.4-145.3c-.3-3.6-3.1-6.7-6.7-6.7zm26.7 3.4c-3.9 0-6.9 3.1-6.9 6.9L227 321.3l3.9 66.4c.3 3.9 3.1 6.9 6.9 6.9s6.9-3.1 6.9-6.9l4.2-66.4-4.2-141.7c0-3.9-3-6.9-6.9-6.9z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga&#x27;s twitter" class="sc-bggJJS kWkXwI twitter" color="#000000" href="https://twitter.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zm297.1 84L257.3 234.6 379.4 396H283.8L209 298.1 123.3 396H75.8l111-126.9L69.7 116h98l67.7 89.5L313.6 116h47.5zM323.3 367.6L153.4 142.9H125.1L296.9 367.6h26.3z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga&#x27;s youtube" class="sc-bggJJS fflNAI youtube" color="red" href="https://www.youtube.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z" fill="currentColor"></path></svg></div></a></div></div><div class="app-store-wrapper"><a aria-label="Click to download the Benzinga app" class="sc-iTPigJ iIIBPk google-play-store-button-wrapper button-wrapper" data-action="Download on Google Play Store Click" href="https://play.google.com/store/apps/details?id=com.benzinga.app&amp;hl=en_NZ&amp;gl=US"><svg clip-rule="evenodd" fill-rule="evenodd" height="39px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 36" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M2863.6 530.6c-36.3 0-66.9-12.7-91.1-37.7-24-24.3-37.4-57.8-36.8-92 0-36.5 12.4-67.4 36.8-91.9 24.1-25 54.7-37.7 91-37.7 35.9 0 66.5 12.7 91.1 37.7 24.4 25.3 36.8 56.2 36.8 91.9-.4 36.6-12.8 67.5-36.8 91.9-24.1 25.2-54.7 37.8-91 37.8zm-1080.1 0c-35.5 0-66.3-12.5-91.5-37.2-25-24.6-37.7-55.7-37.7-92.4s12.7-67.8 37.7-92.4c24.7-24.7 55.5-37.2 91.5-37.2a127.533 127.533 0 0151.1 10.6c16.1 6.9 29.2 16.3 38.9 27.8l2.4 2.9-27.1 26.6-2.8-3.3c-15.3-18.2-35.8-27.1-62.9-27.1-24.2 0-45.3 8.6-62.7 25.6-17.5 17.1-26.4 39.5-26.4 66.6 0 27.1 8.9 49.5 26.4 66.6 17.4 17 38.5 25.6 62.7 25.6 25.8 0 47.5-8.6 64.4-25.6 10-10 16.2-24 18.4-41.7H1779v-37.4h124.2l.5 3.4c.9 6.3 1.8 12.8 1.8 18.8 0 34.5-10.4 62.4-31 83-23.4 24.4-54 36.8-91 36.8zm1436.1-5.3h-38.3L3064 337.6l1 33.8v153.8h-38.3V276.7h43.7l1.2 1.9 110.3 176.8-1-33.7v-145h38.7v248.6zm-643.8 0H2537V314.1h-67.3v-37.4H2643v37.4h-67.3v211.2h.1zm-137.7 0h-38.7V276.7h38.7v248.6zm-217.5 0h-38.7V314.1h-67.3v-37.4h173.3v37.4h-67.3v211.2zm-130.5-.4h-148.4V276.7h148.4v37.4h-109.6v68.2h98.9v37h-98.9v68.2h109.6v37.4zm710.8-57.7c17.3 17.3 38.3 26 62.7 26 25.1 0 45.6-8.5 62.7-26 17-17 25.6-39.3 25.6-66.2 0-26.9-8.6-49.3-25.5-66.2-17.3-17.3-38.4-26-62.7-26-25.1 0-45.6 8.5-62.6 26-17 17-25.6 39.3-25.6 66.2 0 26.9 8.5 49.3 25.4 66.2zM2732.1 872.4c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.6-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4.1 61-44.5 103.4-96.2 103.4zm-373.3-273.6c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.7-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4 0 61-44.5 103.4-96.2 103.4zm-444.2-221.5v72.2h173.3c-5.3 40.5-18.7 70.4-39.2 90.9-25.4 25.4-64.6 53-133.7 53-106.5 0-189.8-86-189.8-192.5s83.3-192.5 189.8-192.5c57.5 0 99.4 22.7 130.5 51.7l51.2-51.2c-43.2-41.4-100.7-73.1-181.3-73.1-146.1 0-268.7 119-268.7 264.7 0 146.1 122.5 264.7 268.7 264.7 78.9 0 138.1-25.8 184.9-74.4 47.7-47.7 62.8-115 62.8-169.3 0-16.9-1.3-32.1-4-45h-244.6c.1-.1.1.8.1.8zm1816.9 56.2C3717.2 942.4 3674 872 3585.4 872c-87.8 0-160.8 69.1-160.8 170.6 0 95.8 72.2 170.6 169.3 170.6 78 0 123.4-47.7 142.1-75.7l-57.9-38.8c-19.2 28.5-45.9 47.2-83.8 47.2-38.3 0-65.1-17.4-82.9-51.7l228.1-94.5c0 .1-8-19-8-19zm-232.6 57c-1.8-65.9 51.2-99.4 89.1-99.4 29.9 0 54.8 14.7 63.3 36.1l-152.4 63.3zM3313.6 1203h74.9V701.8h-74.9V1203zm-123-292.7h-2.7c-16.9-20.1-49-38.3-90-38.3-85.1 0-163.5 74.9-163.5 171.1 0 95.8 78 169.8 163.5 169.8 40.5 0 73.1-18.3 90-38.8h2.7v24.5c0 65.1-34.8 100.2-90.9 100.2-45.9 0-74.4-33-86-60.6l-65.1 27.2c18.7 45 68.6 100.7 151 100.7 87.8 0 162.2-51.7 162.2-177.8V882.2H3191v28.1h-.4zm-86 235.7c-51.7 0-94.9-43.2-94.9-102.9 0-60.2 43.2-103.8 94.9-103.8 51.2 0 90.9 44.1 90.9 103.8.5 59.7-39.6 102.9-90.9 102.9zm977.6-444.2h-179.1V1203h74.9v-189.8h104.3c82.9 0 164.4-60.1 164.4-155.5s-81.2-155.9-164.5-155.9zm2.2 241.4h-106.5v-172h106.5c56.1 0 87.8 46.3 87.8 86 0 39.3-32.1 86-87.8 86zm462.5-71.7c-54.4 0-110.5 24.1-133.7 76.6l66.4 27.6c14.3-27.6 40.5-37 68.2-37 38.8 0 78 23.2 78.9 64.6v5.3c-13.4-7.6-42.8-19.2-78-19.2-71.7 0-144.4 39.2-144.4 112.7 0 67.3 58.8 110.5 124.3 110.5 50.3 0 78-22.7 95.3-49h2.7v38.8h72.2v-192c0-89.4-66.4-138.9-151.9-138.9zm-9.4 274.5c-24.5 0-58.8-12-58.8-42.8 0-38.8 42.8-53.5 79.3-53.5 33 0 48.6 7.1 68.2 16.9-5.4 45-43.4 79-88.7 79.4zm424.7-263.8l-86 217.4h-2.7l-89.1-217.4h-80.6l133.7 303.9-76.2 168.9h78L5045 882.2h-82.8zM4288 1203h74.9V701.8H4288V1203zM418.4 302.1c-11.6 12.5-18.3 31.6-18.3 56.6v886.7c0 25 6.7 44.1 18.7 56.1l3.1 2.7 496.8-496.8v-11.1L421.5 299.4l-3.1 2.7z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1084 973.5L918.3 807.8v-11.6L1084 630.5l3.6 2.2 196 111.4c56.1 31.6 56.1 83.8 0 115.8l-196 111.4-3.6 2.2z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1087.6 971.3L918.3 802l-499.9 499.9c18.3 19.6 49 21.8 83.3 2.7l585.9-333.3M1087.6 632.7L501.7 299.9c-34.3-19.6-65.1-16.9-83.3 2.7L918.3 802l169.3-169.3z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path></svg></a><a aria-label="Click to download the Benzinga app" class="sc-iTPigJ iIIBPk apple-app-store-button-wrapper button-wrapper" data-action="Download on Apple App Store Click" href="https://apps.apple.com/us/app/benzinga-stock-news-tracker/id688949481"><svg fill="#0c2140" height="43.3px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 40" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M24.997 19.889a5.15 5.15 0 012.45-4.317 5.27 5.27 0 00-4.15-2.244c-1.746-.183-3.439 1.045-4.329 1.045-.907 0-2.277-1.027-3.753-.997a5.534 5.534 0 00-4.651 2.837c-2.011 3.482-.511 8.6 1.416 11.414.963 1.378 2.09 2.918 3.564 2.863 1.442-.06 1.981-.919 3.722-.919 1.725 0 2.231.919 3.734.885 1.548-.026 2.523-1.385 3.453-2.776a11.366 11.366 0 001.579-3.216 4.98 4.98 0 01-3.035-4.575zm-2.841-8.412a5.066 5.066 0 001.159-3.63 5.153 5.153 0 00-3.335 1.726 4.82 4.82 0 00-1.19 3.495 4.265 4.265 0 003.366-1.591zM42.302 27.14h-4.734l-1.136 3.356h-2.005l4.483-12.418h2.083l4.484 12.418h-2.039l-1.136-3.356zm-4.243-1.549h3.752l-1.85-5.447h-.052l-1.85 5.447zm17.1.379c0 2.813-1.506 4.621-3.778 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.298 0 3.812 1.816 3.812 4.622zm-1.91 0c0-1.833-.947-3.038-2.393-3.038-1.419 0-2.375 1.23-2.375 3.038 0 1.824.956 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm11.876 0c0 2.813-1.507 4.621-3.779 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.297 0 3.813 1.816 3.813 4.622zm-1.911 0c0-1.833-.947-3.038-2.393-3.038-1.42 0-2.375 1.23-2.375 3.038 0 1.824.955 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm8.495 1.066c.138 1.232 1.334 2.04 2.969 2.04 1.567 0 2.694-.808 2.694-1.919 0-.964-.68-1.541-2.289-1.936l-1.61-.388c-2.28-.551-3.339-1.617-3.339-3.348 0-2.142 1.867-3.614 4.518-3.614 2.625 0 4.424 1.472 4.484 3.614H77.26c-.112-1.239-1.136-1.987-2.634-1.987s-2.521.757-2.521 1.858c0 .878.654 1.395 2.255 1.79l1.368.336c2.548.603 3.605 1.626 3.605 3.443 0 2.323-1.849 3.778-4.793 3.778-2.753 0-4.613-1.421-4.733-3.667h1.902zM83.346 19.3v2.142h1.722v1.472h-1.722v4.991c0 .776.345 1.137 1.102 1.137.204-.004.408-.018.611-.043v1.463c-.34.063-.686.092-1.032.086-1.833 0-2.548-.689-2.548-2.445v-5.189h-1.316v-1.472h1.316V19.3h1.867zm2.718 6.67c0-2.849 1.678-4.639 4.294-4.639 2.625 0 4.295 1.79 4.295 4.639 0 2.856-1.661 4.638-4.295 4.638s-4.294-1.782-4.294-4.638zm6.695 0c0-1.954-.895-3.108-2.401-3.108s-2.401 1.162-2.401 3.108c0 1.962.895 3.106 2.401 3.106s2.401-1.144 2.401-3.106zm3.426-4.528h1.773v1.541h.043a2.164 2.164 0 012.177-1.635c.214-.001.428.022.637.069v1.738a2.62 2.62 0 00-.835-.112l-.076-.002a1.883 1.883 0 00-1.873 1.873 1.87 1.87 0 00.012.212v5.37h-1.858v-9.054zm13.198 6.395c-.25 1.643-1.85 2.771-3.898 2.771-2.634 0-4.269-1.764-4.269-4.595 0-2.84 1.644-4.682 4.191-4.682 2.505 0 4.08 1.721 4.08 4.466v.637h-6.395v.112l-.009.208a2.37 2.37 0 002.358 2.358l.087-.002a2.05 2.05 0 002.091-1.273h1.764zm-6.282-2.702h4.526l.004-.121a2.19 2.19 0 00-2.177-2.178l-.047.001a2.306 2.306 0 00-2.306 2.292v.006zM37.826 8.731l.189-.007a2.653 2.653 0 012.64 2.64 2.63 2.63 0 01-.021.332c0 1.906-1.03 3.002-2.808 3.002h-2.155V8.731h2.155zm-1.228 5.123h1.125l.112.003a1.884 1.884 0 001.875-1.876 1.79 1.79 0 00-.02-.273c.012-.085.018-.17.018-.256a1.89 1.89 0 00-1.881-1.881l-.104.003h-1.125v4.28zm5.083-1.41a2.143 2.143 0 012.123-2.336c1.17 0 2.133.963 2.133 2.133l-.009.203.01.207c0 1.171-.963 2.134-2.134 2.134s-2.133-.963-2.133-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm6.559 2.254h-.922l-.93-3.317h-.071l-.926 3.317h-.913l-1.242-4.503h.902l.806 3.436h.067l.926-3.436h.852l.926 3.436h.07l.803-3.436h.889l-1.237 4.503zm2.281-4.503h.855v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.472 1.472 0 011.449 1.679v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.888v-4.503zm5.24-1.758h.889v6.261h-.889zm2.124 4.007a2.144 2.144 0 012.124-2.336c1.171 0 2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.17-.963 2.134-2.133 2.134s-2.134-.964-2.134-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm1.85.98c0-.81.603-1.278 1.675-1.344l1.219-.07v-.389c0-.475-.314-.744-.921-.744-.497 0-.84.182-.939.5h-.86c.091-.773.818-1.269 1.84-1.269 1.128 0 1.765.562 1.765 1.513v3.077h-.855v-.633h-.071a1.52 1.52 0 01-1.352.707 1.33 1.33 0 01-.141.007c-.744 0-1.357-.61-1.36-1.355zm2.894-.384v-.377l-1.099.07c-.62.042-.902.253-.902.65 0 .405.352.641.835.641a.97.97 0 00.107.005c.556 0 1.022-.435 1.059-.989zm2.053-.596c0-1.423.732-2.324 1.869-2.324a1.486 1.486 0 011.381.79h.067V8.437h.888v6.261h-.851v-.712h-.071a1.565 1.565 0 01-1.414.786c-1.145 0-1.869-.901-1.869-2.328zm.918 0c0 .955.45 1.53 1.203 1.53s1.212-.583 1.212-1.526-.468-1.53-1.212-1.53-1.203.579-1.203 1.526zm6.964 0l-.01-.203c0-1.17.963-2.133 2.134-2.133s2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.171-.963 2.134-2.133 2.134s-2.134-.963-2.134-2.134l.01-.207zm3.333 0c0-.976-.438-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.435 1.551 1.207 1.551s1.208-.571 1.208-1.551zm2.106-2.249h.856v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.47 1.47 0 011.464 1.464c0 .072-.005.144-.015.215v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.889v-4.503zm8.846-1.121v1.141h.976v.749h-.976v2.315c0 .472.194.679.637.679.113-.001.226-.008.339-.021v.74c-.16.029-.322.044-.484.046-.988 0-1.381-.348-1.381-1.216v-2.543h-.715v-.749h.715V9.074h.889zm2.19-.637h.88v2.481h.071c.241-.53.792-.853 1.373-.806l.08-.002a1.49 1.49 0 011.484 1.483c0 .066-.005.132-.013.198v2.907h-.89V12.01c0-.719-.335-1.084-.963-1.084l-.086-.003a1.06 1.06 0 00-1.052 1.052l.004.093v2.63h-.888V8.437zm9.056 5.045a1.833 1.833 0 01-1.951 1.303h-.054a2.055 2.055 0 01-2.026-2.325 2.086 2.086 0 012.058-2.352c1.271 0 2.027.856 2.027 2.27v.31h-3.18v.05a1.1 1.1 0 00-.004.1c0 .653.537 1.19 1.19 1.19a1.09 1.09 0 001.085-.546h.855zm-3.126-1.451h2.275l.003-.081c0-.596-.491-1.086-1.087-1.086h-.025a1.16 1.16 0 00-1.166 1.152v.015z"></path></svg></a></div></div><div class="sc-lgHmWD lnCMlr footer-row"><div class="sc-dqgTYe hXMPNn"><h3>Popular Channels</h3><ul><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/premarket-prep/" class="sc-iWHcIr jHYujk">PreMarket Prep</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/pressreleases" class="sc-iWHcIr jHYujk">Press Releases</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/analyst-stock-ratings" class="sc-iWHcIr jHYujk">Analyst Ratings</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/news" class="sc-iWHcIr jHYujk">News</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/markets/options" class="sc-iWHcIr jHYujk">Options</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/etfs" class="sc-iWHcIr jHYujk">ETFs</a></li></ul></div><div class="sc-dqgTYe hXMPNn"><h3>Tools &amp; Features</h3><ul><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://pro.benzinga.com/" class="sc-iWHcIr jHYujk">Real Time Feed</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/feeds/list" class="sc-iWHcIr jHYujk">Public RSS Feeds</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/contact" class="sc-iWHcIr jHYujk">Submit News Tips</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://pro.benzinga.com/blog/" class="sc-iWHcIr jHYujk">Blog</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/widgets" class="sc-iWHcIr jHYujk">Embeddable Finance Widgets &amp; Tools</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/catalyst" class="sc-iWHcIr jHYujk">Benzinga Catalyst</a></li></ul></div><div class="sc-dqgTYe hXMPNn"><h3>Partners &amp; Contributors</h3><ul><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://app.impact.com/campaign-promo-signup/Benzinga1659111587301.brand?execution=e1s1" class="sc-iWHcIr jHYujk">Affiliate Program</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://contributor.benzinga.com/contributor-onboarding" class="sc-iWHcIr jHYujk">Contributor Portal</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/apis/" class="sc-iWHcIr jHYujk">Licensing &amp; Syndication</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/reach/" class="sc-iWHcIr jHYujk">Sponsored Content</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://advertise.benzinga.com/" class="sc-iWHcIr jHYujk">Advertise With Us</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/contact/" class="sc-iWHcIr jHYujk">Lead Generation &amp; SEO</a></li></ul></div><div class="sc-dqgTYe hXMPNn"><h3>About Benzinga</h3><ul><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/about" class="sc-iWHcIr jHYujk">About Us</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://jobs.benzinga.com/" class="sc-iWHcIr jHYujk">Careers</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/inthenews" class="sc-iWHcIr jHYujk">In The News</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/events/" class="sc-iWHcIr jHYujk">Events</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/contact" class="sc-iWHcIr jHYujk">Contact Us</a></li></ul></div></div></div><div class="footer-bottom-section"><ul><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/terms-and-conditions" class="sc-iWHcIr jHYujk">Terms &amp; Conditions </a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/page/privacy" class="sc-iWHcIr jHYujk"> Do Not Sell My Personal Data/Privacy Policy</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/disclaimer" class="sc-iWHcIr jHYujk">Disclaimer </a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="http://www.benzingastatus.com" class="sc-iWHcIr jHYujk">Service Status</a></li><li class="sc-cqnWLZ jXOnQi footer-link"><a href="https://www.benzinga.com/sitemap" class="sc-iWHcIr jHYujk">Sitemap</a></li></ul><div class="copyright-section text-center w-full whitespace-nowrap mt-2">© <!-- -->2024<!-- --> Benzinga | All Rights Reserved</div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"activeTab":"profile","advertiserProfile":null,"headerProps":{},"includeAGGridStyles":false,"isAdvertiser":false,"isETF":false,"metaProps":{"author":"Benzinga","canonical":"https://www.benzinga.com/quote/TCNNF","dateCreated":"2019-01-01T01:01:01","dateUpdated":"2024-11-29T13:54:24.720-05:00","description":"Trulieve Cannabis Stock (OTC: TCNNF) stock price, news, charts, stock research, profile.","image":"https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60\u0026max_width=\u0026width=60\u0026x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu\u0026x-bz-exp=1733045090\u0026x-bz-security-isin=CA89788C1041\u0026x-bz-security-symbol=TCNNF\u0026x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9","language":"en","pageType":"ticker","structuredData":{"keywords":["\"symbol: TCNNF\"","\"section: profile\""]},"title":"Trulieve Cannabis (OTC:TCNNF) Stock Quotes, Forecast and News Summary","translations":{"auth":{"Auth":{"AuthModal":{"login":{"join-over":"Join over \u003cstrong\u003e6000 investors\u003c/strong\u003e who joined this week!","login-label":"Welcome Back","toggle-box":{"text1":"New to Benzinga?","text2":"Create Account"},"forgot-text":"Forgot Password?","get-unlimited-access":"Get Unlimited Access","come-see":"Come see why nearly \u003cspan class=\"font-black\"\u003e10,000 INVESTORS\u003c/span\u003e joined us THIS WEEK ALONE! Also get the Benzinga Research bonus report \u003cspan class=\"font-black\"\u003eBuy These 3 Stocks Before the Election\u003c/span\u003e emailed to you free when you create a new account with a valid email."},"register":{"auth-action-text":"Account Creation","toggle-box":{"text1":"Already have an account?","text2":"Login"}},"cta-label":"Please enter your email \u0026 password","continue-row":"or continue with","Benefits":{"institutional-research-reports":"Institutional Research Reports","actionable-trading-ideas":"Actionable Trading Ideas","professional-level-stock":"Professional Level Stock \u0026 Options Data","comment-on-articles":"Comment on Articles \u0026 Engage with Community Boards","in-depth-reports":"In Depth Reports","analyst-ratings":"Analyst Ratings","earnings":"Earnings","trade-ideas-more":"Trade Ideas, and more!","or-return-to":"Or return to"}},"Login":{"button":"Login","email":"Email","password":"Password","logged-in-success":"Logged in successfully"},"Register":{"button":"Register","email":"Email","password":"Password","thank-you":"Thank you for choosing Benzinga","completed":"Your registration process has been successfully completed","return-to-app":"Return to App"},"Meta":{"login-to-benzinga":"Login to Benzinga","login-to-access-features":"Login to Benzinga to access advanced features","logout-from-benzinga":"Logout from Benzinga","register-to-benzinga":"Register to Benzinga","register-to-access-features":"Register to Benzinga to access advanced features"},"Logout":{"logout-successful":"Logout Successful","returning-to-prev-page":"Returning to previous page..."}}},"common":{"Sidebars":{"Widgets":{"WatchlistSidebarWidget":{"title":"Your Watchlist","watchListBox":{"actionText":"Get Alerts","subtitle":"Create a Benzinga.com account for news on the stocks and cryptocurrencies you care about!","title":"Get News and Alerts"},"signUpBox":{"action":"Click to Get Started","subtitle":"FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.","title":"Create a Watchlist"}},"WatchListMovers":{"button":"Customize Watchlists"}}},"CompanyWatchlist":{"addToWatchlist":"Add To Watchlist +"},"AddToWatchlist":{"manageWatchListsLink":"Manage watchlists"},"Navigation":{"AccountMenu":{"my-account-text":"My Account","login":"Log In","logout":"Logout","reset-password":"Reset Password","forgot-password":"Forgot Password"},"TopBar":{"contributor":"Contribute","sign-in":"Sign in","login":"Login","register":"Register","DataAndAPIs":"Data \u0026 APIs","Events":"Events","Marketfy":"Marketfy","Premarket":"Premarket","Boost":"Boost"}},"Buttons":{"get-report":"Get Report","perks":"Perks","buy":"Buy","sell":"Sell","compare-brokers":"Compare Brokers","watchlist":"Watchlist","show-more":"Show More","see-more":"See More","show-less":"Show Less","browse":"Browse","skip":"Skip","back":"Back","close-window":"Close Window","allow":"Allow","deny":"Deny"},"Inputs":{"phone-number":"Phone Number","first-name":"First Name","email":"Email","password":"Password","Error":{"is-required":"{{field}} is required"}},"Date":{"Days":{"tomorrow":"tomorrow","today":"today","today-at":"Today at {{time}}"},"Periods":{"quarterly":"Quarterly","annual":"Annual","monthly":"Monthly","semi-annually":"Semi-Annually","other-regular":"Other Regular"}},"Table":{"name":"Name"},"Market":{"Actions":{"buy":"Buy","hold":"Hold","sell":"Sell","strong-sell":"Strong Sell","strong-buy":"Strong Buy"},"Direction":{"higher":"higher","lower":"lower","stagnant":"stagnant","positive":"positive","negative":"negative"}},"Fields":{"n-a":"N/A"},"Helpers":{"and":"and","as-of":"as of","the":"The","but":"but","yes":"Yes","no":"No","a-good":"a good","not-a-good":"not a good","above":"above","below":"below","is":"is","not":"not","is-not":"is not"},"Channels":{"general":"General","contracts":"Contracts","dividends":"Dividends","events":"Events","fda":"FDA","m-a":"M\u0026A","offerings":"Offerings","stock-split":"Stock Split","media":"Media","buybacks":"Buybacks","insider-trades":"Insider Trades","earnings":"Earnings","guidance":"Guidance","analyst-ratings":"Analyst Ratings","trading-ideas":"Trading Ideas"},"Sponsored":{"sponsored":"Sponsored"},"Watchlist":{"my-first-watchlist":"My First Watchlist","what-stocks-you-interested":"Which Stocks are you interested in?","select-stocks-you-are-interested":"Select stocks you are interested in below or in the search bar","search-stocks-to-add":"Search stocks to add","recommended-tickers":"Recommended Tickers","watchlist-tickers":"Watchlist Tickers"},"Notifications":{"dont-miss-alerts":"Don't miss out on alerts!","get-email-notifications":"Get Email Notifications","get-the-most-out-of-benzinga":"Get the most out of Benzinga by staying up to date with what's happening. Get Emails with updates on the the news you want.","get-sms-notifications":"Get SMS Notifications","allow-us-to-send-news":"Allow us to send you the news that matters most to you.","i-agree-to-receive-alerts":"I agree to receive alerts, educational, and promotional messages sent via an autodialer, and this agreement isn't a condition of any purchase. I also agree to the","data-rates-may-apply":"9 Msgs/Week. Msg \u0026 Data rates may apply.","get-push-notifications-prompt":"Would you like to be notified of the latest news and updates on the stock market?","disable-notifications-through-browser":"You can disable these notifications through your browser settings.","disabled-settings-alert":"Notifications are not enabled. Please reset your browser settings to allow notifications.","unable-to-subscribe-alert":"Unable to subscribe to notifications. Please try again later."},"Policy":{"terms-of-service":"Terms of Service","privacy-policy":"Privacy Policy"},"Comments":{"leave-a-comment":"Leave a Comment"}},"welcome":{"Welcome":{"meta":{"title":"Get started with your account","description":"Welcome to Benzinga"},"welcome-to":"Welcome to Benzinga!","choose-type-of-profile":"Choose the type of profile that suits you best","trader":"Trader","trader-description":"I actively buy and sell securities in financial markets to make short-term profits.","investor":"Investor","investor-description":"I seek long-term wealth accumulation by allocating capital to assets I believe will grow over time.","steps":{"profile-info":"Profile Info","watchlist":"Watchlist","alerts":"Alerts"},"before-you-leave":"Before you leave! Please answer the type of profile that suits you. This will help us create content you want.","view-dashboard":"View Dashboard","continue":"Continue","return-to-benzinga":"Return to Benzinga.com","before-you-go":"Before you go...","we-would-love-know-you-better":"We would love to know you better. What should we call you?"}},"quote":{"Quote":{"Nav":{"overview":"Overview","news":"News","holdings":"Holdings","dividends":"Dividends","short-interest":"Short Interest","guidance":"Guidance","earnings":"Earnings","option":"{{company}} ({{symbol}}) Options","analyst-ratings":"Analyst Ratings","insider-trades":"Insider Trades","government-trades":"Government Trades","forecast":"{{company}} ({{symbol}}) Forecast"},"Market":{"minutes-delayed":"{{minutes}} minutes delayed","after-hours":"After Hours","pre-market":"Pre-Market","intraday":"Intraday","high":"high","low":"low"},"WIIM":{"why-is-it-moving":"Why is it moving?"},"Headers":{"stock":"Stock","quotes-and-news-summary":"Quotes, Forecast and News Summary","analyst-ratings-rice-predictions":"Analyst Ratings, Price Targets, Forecasts","crypto":"{{name}} ({{symbol}}) Crypto Price, News and Market Data","earnings-estimates-eps-revenue":"Earnings Estimates, EPS, And Revenue","dividends":"Dividends","insider-trading-activity":"Insider Trading Activity","short-interest-report":"Short Interest Report","guidance-and-forecast":"Guidance And Forecast","latest-news-for":"Latest news for","holdings":"Top Holdings","option-chain":"Option Chain"},"Descriptions":{"profile":"stock price, news, charts, stock research, profile","dividend":"{{companyName}} issues dividends to shareholders from excess cash {{companyName}} generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals","crypto-description":"{{name}} crypto price, news, charts, data, profile.","earnings":"{{companyName}} reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results","insider-trades":"{{companyName}}: Insider buying and selling updated today.","short-interest":"Short interest for {{companyName}} gives investors a sense of the degree to which investors are betting on the decline of {{companyName}}'s stock. Short interest data is updated every two weeks.","guidance":"Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period","option-chain":"Option chain shows key data for {{companyName}}'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for {{companyName}}"},"Metrics":{"open":"Open","close":"Close","high":"High","low":"Low","volume":"Volume","beta":"Beta","volume-avg":"Volume / Avg.","day-range":"Day Range","52wkrange":"52 Wk Range","52wklow":"52 Wk Low","52wkhigh":"52 Wk High","market-cap":"Market Cap","pe-ratio":"P/E Ratio","pb-ratio":"P/B Ratio","previous-close":"Prev. Close","dividend-yield":"Dividend Yield","dividend":"Dividend","ex-div-date":"Ex-Div Date","rsi":"RSI","short-interest":"Short Interest","days-to-cover":"Days to Cover","shares-out":"Shares Out","yield":"Yield","div-freq":"Div. Freq","price":"Price","24hr-price-change":"24 Hr Price Change","24hr-change":"24 Hr Change %","fully-diluted-valuation":"Fully Diluted Valuation","total-volume":"Total Volume","all-time-high":"All Time High (ATH)","ath-change":"ATH Change %","24-hr-high-low":"24 Hr High/Low","circulating-supply":"Circulating Supply","total-supply":"Total Supply","max-supply":"Max Supply","assets-under-management":"AUM","management-fee":"Mgmt Fee","average-daily-volume":"Avg. Volume Daily","average-expense-ratio":"Avg. Expense Ratio","implied-volatility":"Implied Volatility","put-call-volume-ratio":"Put/Call Vol Ratio","exchange":"Exchange"},"Reports":{"the-dividend-ex-date-was":"The dividend Ex-Date was {{date}}","the-dividend-ex-date-is":"The dividend Ex-Date is {{date}}","DuringPeriod":{"after-market":"after the market close","pre-market":"before the market open","regular":"during market hours"},"Earnings":{"earnings-were-released-today":"{{period}} earnings were released today {{duringPeriod}}","earnings-announcement":"{{period}} earnings announcement {{duringPeriod}} today","earnings-tomorrow-on":"{{period}} earnings tomorrow on {{formattedDate}} {{duringPeriod}}","earnings-from-now-on":"{{period}} Earnings {{timeFromNow}} from now on {{formattedDate}}, {{duringPeriod}}","earnings-were-released-on":"{{period}} Earnings were released on {{formattedDate}}, {{duringPeriod}}"},"ConferenceCall":{"scheduled-at-today":"Conference call scheduled today at {{callTime}}","in-progress":"Conference call in progress","ended-over":"Today's conference call ended over {{hoursAgo}}","scheduled-at-tomorrow":"Conference call scheduled tomorrow at {{callTime}}","recent":"The most recent conference call was at {{callTime}}, {{timeFromNow}}","scheduled-at":"Conference call scheduled {{timeFromNow}} at {{callTime}}","click-to-view-past-webcast":"Click to view past webcast","click-to-view-the-webcast":"Click to view the webcast"},"StockSplits":{"is-expected-to-split":"{{companyName}} is expected to split","recently-split-on":"{{companyName}} is expected to split","with-a-ratio-of":"with a ratio of"}},"News":{"all-news":"All News","recent-news":"Recent News","news":"News","partners":"Partners","press-release":"Press Releases","press-release-full-archive":"Full archive of press releases available on Benzinga Pro","no-news-found":"No news found"},"Financials":{"title":"Financials","revenue":"Revenue","change":"Change","gross":"Gross","earnings":"Earnings","profit-margin":"Profit Margin","analyst-trend":"Analyst Trends and Forecast","analyst-rating":"Analyst Rating and Forecast","analyst-rating-score":"This score is based on {{ratingsLength}} analyst{{s}} from the past {{timeBetween}}","no-rating":"No rating"},"About":{"about":"About {{company}}","sector":"Sector","industry":"Industry","team":"Team","executives":"Executives","board":"Board","other-members":"Other Members","contact-info":"Contact Info","address":"Address","logo-brought":"Logo brought to you by Benzinga Data"},"Compare":{"compare":"Compare","earnings-per-share":"Earnings Per Share","earnings-per-share-description":"EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.","price-to-earnings":"Price to Earnings","price-to-earnings-description":"The price-to-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings (EPS).","price-to-book":"Price to Book","price-to-book-description":"The price-to-book ratio (P/B ratio) is a financial ratio used to compare a company's current market price to its book value.","return-on-equity":"Return on Equity","return-on-equity-description":"Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.","debt-to-equity":"Debt to Equity","debt-to-equity-description":"The debt-to-equity (D/E) ratio is calculated by dividing a company’s total liabilities by its shareholder equity.","better":"better","worse":"worse","than-industry":"than industry"},"Peers":{"people-also-watch":"People Also Watch","show-all-related-companies":"Show all {{companiesLength}} related companies"},"FAQ":{"faq":"FAQ","Questions":{"how-do-i-buy-stock":"How do I buy {{quoteName}} ({{symbol}}) stock?","who-are-competitors":"Who are {{quoteName}} ({{symbol}}) competitors?","what-is-the-target-price-for":"What is the target price for {{quoteName}} ({{symbol}}) stock?","current-stock-price":"What is the current price for {{quoteName}} ({{symbol}})?","what-is-the-forecast-or-price-target-for":"What is the forecast, or price target, for {{quoteName}} ({{symbol}}) stock?","does-pay-dividend":"Does {{quoteName}} ({{symbol}}) pay a dividend?","when-is-reporting-earnings":"When is {{quoteName}} ({{exchange}}:{{symbol}}) reporting earnings?","is-going-to-split":"Is {{quoteName}} ({{symbol}}) going to split?","what-sector-industry-does-operate-in":"What sector and industry does {{quoteName}} ({{symbol}}) operate in?","what-were-the-latest-earnings":"What were the latest earnings per share (EPS) for {{quoteName}} ({{exchange}}:{{symbol}})?","what-were-revenues":"What were {{quoteName}}’s ({{exchange}}:{{symbol}}) revenues?","Dividends":{"when-does-pay-its-next-dividend":"When does {{quoteName}} ({{quoteSymbol}}) pay its next dividend?","what-date-did-i-need-to-own":"What date did I need to own {{quoteName}} ({{quoteSymbol}}) stock to get the latest dividend?","how-much-per-share-is-the-next":"How much per share is the next {{quoteName}} ({{quoteSymbol}}) dividend?","what-is-the-dividend-yield-for":"What is the dividend yield for {{quoteName}} ({{exchange}}:{{quoteSymbol}})?","what-was-the-announcement-date":"What was the announcement date for the next {{quoteName}} ({{quoteSymbol}}) dividend?","why-is-dividend-considered":"Why is {{quoteName}} ({{quoteSymbol}}) dividend considered {{status}}?","is-a-good-dividend":"Is {{quoteName}} ({{quoteSymbol}}) a good dividend?","is-the-dividend-sustainable":"Is the {{quoteName}} ({{quoteSymbol}}) dividend sustainable?"},"AnalystRatings":{"what-is-the-most-recent":"What is the most recent analyst rating for {{quoteName}} ({{quoteSymbol}})?","when-was-the-last-upgrade":"When was the last upgrade for {{quoteName}} ({{quoteSymbol}})?","when-was-the-last-downgrade":"When was the last downgrade for {{quoteName}} ({{quoteSymbol}})?","when-is-the-next-analyst-rating-update":"When is the next analyst rating going to be posted or updated for {{quoteName}} ({{quoteSymbol}})?","is-the-analyst-rating-correct":"Is the Analyst Rating {{quoteName}} ({{quoteSymbol}}) correct?"},"InsiderTrades":{"is-insider-trading-legal":"Is insider trading legal?","what-market-manipulation":"What are some examples of market manipulation?"},"Guidance":{"what-is-the-most-recent-guidance":"What is the most recent guidance for {{quoteName}} ({{quoteSymbol}})?"},"ETFs":{"how-has-etf-performed":"How has {{symbol}} ETF performed?","what-is-the-expense-ratio":"What is the expense ratio for {{symbol}}?","what-is-aum":"What is the Assets Under Management (AUM) for {{symbol}}?","what-is-investment-style":"What is the investment style for {{symbol}}?","what-are-top-holdings":"What are the top holdings for {{symbol}}?","what-is-the-avg-daily-volume":"What is the average daily trading volume for {{symbol}}?"}},"Answers":{"no-upcoming-slits-for":"There is no upcoming split for {{quoteName}}.","stock-slits-today":"The stock split for {{quoteSymbol}} was announced on {{date}}. The important ex-date for split is today. Holding the stock on the end of this date will include the value of the split.","stock-splits":"The stock split for {{quoteSymbol}} was announced on {{date}}. The date this stock split will start trading, also known as the ex-date, will be on {{dateEx}}.","stock-splits-date":"{{date}} with a ratio of","recently-split":"{{quoteName}} ({{symbol}}) recently split on {{date}} {{ratio}}","you-can-purchase-shares":"You can purchase shares of {{quoteName}} ({{exchange}}:{{symbol}}) through any online brokerage.","view-our-list-best-stock-brokerages":"View our list of the best stock brokerages","there-are-no-as-such-competitors":"There are no as such competitors for {{quoteName}}.","other-companies-in-space-includes":"Other companies in {{quoteName}}’s space includes","there-is-no-analysis-for":"There is no analysis for {{quoteName}}.","analyst-choice-answer":"The latest price target for {{quoteName}} ({{exchange}}:{{symbol}}) was reported by {{analyst}} on {{date}}. The analyst firm set a price target for {{ptCurrent}} expecting {{symbol}} to {{tickerTrend}} to within 12 months (a possible {{priceChange}}% {{tickerDirection}}). {{ratingsLength}} analyst firms have reported ratings in the last year.","the-stock-price-is":"The stock price for {{quoteName}} ({{exchange}}: {{symbol}}) is ${{lastTradePrice}} last updated {{lastUpdatedDate}}.","there-are-no-upcoming-dividends-for":"There are no upcoming dividends for {{quoteName}}.","there-is-no-dividend-information-for":"There is no dividend information for {{quoteName}}.","quarterly-cash-dividend":"A quarterly cash dividend of {{dividend}} per share of Class A Common Stock. The quarterly cash dividend was payable on {{payDate}} to stockholders of record on {{exDate}}.","the-next-dividend-date-is":"The next {{quoteName}} ({{symbol}}) dividend date is projected to be {{exDividendDate}}.","we-are-an-FPI-and-not-obliged":"We are an FPI and not obliged to release the earnings quarterly for the first two years. Thus, our interim earnings release for FY2021 is planned to be released in the end of October.","does-not-have-any":"{{quoteName}} does not have any upcoming earnings scheduled.","period-earnings-are-confirmed":"{{quoteName}}’s {{nextEarningPeriod}} earnings are confirmed for {{date}}.","industry-info":"{{quoteName}} is in the \u003cb\u003e{{sector}}\u003c/b\u003e sector and \u003cb\u003e{{industry}}\u003c/b\u003e industry. They are listed on the {{exchange}}.","there-are-no-earnings-for":"There are no earnings for {{quoteName}}","future-earning":"{{quoteName}} ({{quoteSymbol}}) is scheduled to report earnings on {{futureDate}}. The last reported earnings were for reported on {{pastDate}} for {{period}}.","earnings-not-scheduled":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{pastDate}} for {{period}}.","the-actual-eps-was":"The Actual EPS was {{actualEPS}}, which {{type}} the estimate of {{estEPS}}.","does-not-have-any-upcoming-earnings":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{date}} for {{period}} and the Actual EPS was {{actualEPS}}, which {{type}} the estimate of {{estEPS}}.","will-be-reporting-earnings-on":"{{quoteName}} ({{quoteSymbol}}) will be reporting earnings on {{date}}.","the-actual-revenue-was":"The Actual Revenue was {{actualREV}}, which {{type}} the estimate of {{estREV}}.","does-not-have-any-upcoming-earnings-revenue":"{{quoteName}} ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on {{date}} for {{period}} and the Actual Revenue was {{actualREV}}, which {{type}} the estimate of {{estREV}}.","the-last-reported-revenue":"The last reported revenues were from {{period}} and were {{actualREV}}.","no-analysis-for-consensus-price-target":"There is no analysis for {{quoteName}} to provide a consensus price target.","consensus-price-target":"{{quoteName}} has a consensus price target of ${{consensusPriceTarget}}.","has-a-consensus-price-target-of":"{{quoteName}} has a consensus price target of ${{consensusPriceTarget}}.","Dividends":{"the-out-to-investors-was":"out to investors was {{formattedDividendYield}} on {{date}}","next-dividend-was-announced-on":"{{quoteName}} next dividend was announced on {{announcedDate}} and will have an ex-dividend date of {{futureDate}}.","last-dividend-payout":"last dividend payout","and-was":"{{date}} and was {{formattedDividend}}.","the-next-dividend-payout-for":"The next dividend payout for {{quoteName}} ({{quoteSymbol}}) will be on {{payableDate}}. Investors need to be owners of {{quoteName}} ({{quoteSymbol}}) shares by {{recordDate}}.","the-next-dividend-for":"The next dividend for {{quoteName}} ({{quoteSymbol}}) will be on {{payableDate}} and will be {{formattedDividend}}.","was-paid-out":"was paid out","will-be-paid-out-next":"will be paid out next","has-no-upcoming-dividends-reported":"{{quoteName}} has no upcoming dividends reported. The last reported dividend for {{quoteName}} ({{quoteSymbol}}) was {{formattedDividendYield}} and {{hasDividendBeenPaid}} on {{payableDate}}.","the-most-current-yield-for":"The most current yield for {{quoteName}} ({{quoteSymbol}}) is {{futureFormattedYield}} and is payable next on {{futurePayableDate}}.","there-are-no-upcoming-dividends-announced-for":"There are no upcoming dividends announced for {{quoteName}}","the-last-dividend-was-announced-on":"$t(Quote.FAQ.Answers.Dividends.there-are-no-upcoming-dividends-announced-for, {\"quoteName\": {{quoteName}}). The last dividend was announced on {{announcedDate}}","the-next-dividend-was-announced-on":"The next dividend for {{quoteName}} ({{quoteSymbol}}) was announced on {{announcedDate}}.","not-enough-data-to-provide-evaluation":"There is not enough data to provide an evaluation.","dividend-decisions":"Dividend decisions can be influenced by what other companies in the same industry are doing. {{quoteName}}'s dividend yield is {{direction}} than the average dividend yield of its peers.","dividend-considered":"{{positive}} {{quoteName}} is considered {{good}} dividend. The dividend is {{position}} their peers {{conjunction}}, based on the TTM, the year-over-year dividend growth is {{marketDirection}}","based-on-historical":"{{positive}}. Based on historical data, {{quoteName}} dividend {{good}} considered sustainable. The company is {{dividendConsistency}} paying dividends consistently {{conjunction}} is {{earningsAvg}} make a profit."},"AnalystRatings":{"no-price-target":"There is no price target for {{quoteName}}","no-analyst-for":"There is no analyst for {{quoteName}}","no-last-upgrade":"There is no last upgrade for {{quoteName}}","the-latest-analyst-rating-for":"The latest analyst rating for {{quoteName}} ({{exchange}}:{{symbol}}) was provided by {{analyst}}, and {{quoteName}} {{actionCompany}} their {{currentRating}} rating.","no-next-analyst":"There is no next analyst rating for {{quoteName}}.","analysis-arrive":"Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of {{companyName}}, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for {{companyName}} was filed on {{lastRatingDate}} so you should expect the next rating to be made available sometime around {{nextRatingDateFormatted}}.","subjective":"While ratings are subjective and will change, the latest {{companyName}} ({{symbol}}) rating was a {{actionCompany}} with a price target of {{priceTargetPrior}} to {{priceTargetCurrent}}. The current price {{companyName}} ({{symbol}}) is trading at is {{lastTradePriceValue}}, which is {{typeValue}} the analyst’s predicted range.","last-upgrade-happened":"The last upgrade for {{companyName}} happened on {{upgradeDate}} when {{analyst}} raised their price target to {{priceTargetCurrent}}. {{analyst}} previously had {{ratingPrior}} for {{companyName}}.","no-last-downgrade":"There is no last downgrade for {{quoteName}}.","last-downgrade":"The last downgrade for {{companyName}} happened on {{downgradeDate}} when {{analyst}} changed their price target from {{priceTargetPrior}} to {{priceTargetCurrent}} for {{companyName}}.","initiated":"initiated","upgraded":"upgraded","downgraded":"downgraded","maintained":"maintained","reiterated":"reiterated"},"InsiderTrades":{"insider-trading-legal":"Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.","insider-trading-pump":"Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward."},"Guidance":{"no-specific-guidance":"There have been no specific sales or earnings guidance reported for {{quoteName}} in recent months.","there-have-been-no-specific-sales":"There have been no specific sales or earnings guidance reported for {{quoteName}} in recent months.","the-full-year":"the full year","the-last-reported":"The most recent guidance for {{name}} ({{ticker}}) was reported on {{date}} for {{period}} {{periodYear}}. The company provided earnings per share guidance in the range of {{formattedMin}} to {{formattedMax}}, compared to the estimated EPS of {{formattedEst}}. Additionally, {{name}} forecasted revenue between {{formattedRevenueMin}} and {{formattedRevenueMax}} for the quarter."},"ETFs":{"etf-performance":"The {{symbol}} ETF is currently trading at ${{currentPrice}}, which represents a {{changePercent}}% change. Over the past 52 weeks, the ETF has traded as high as ${{fiftyTwoWeekHigh}} and as low as ${{fiftyTwoWeekLow}}.","expense-ratio":"The expense ratio of {{symbol}} is {{expenseRatio}}. This represents the annual fee that all funds or ETFs charge their shareholders.","aum":"The total Assets Under Management (AUM) for {{symbol}} is {{aum}}. This represents the total market value of the assets managed by the ETF.","investment-style":"{{symbol}} follows a {{style}} investment style.","top-holdings":"The top holdings of {{symbol}} include: {{holdings}}. These represent the largest positions in the ETF's portfolio.","avg-daily-volume":"The average daily trading volume for {{symbol}} is {{volume}} shares.","no-performance-data-available":"Performance data for {{symbol}} is currently not available.","no-expense-ratio-data":"Expense ratio data for {{symbol}} is currently not available.","no-aum-data":"Assets Under Management (AUM) data for {{symbol}} is currently not available.","no-investment-style-data":"Investment style data for {{symbol}} is currently not available.","no-top-holdings-data":"Top holdings data for {{symbol}} is currently not available.","no-avg-daily-volume-data":"Average daily volume data for {{symbol}} is currently not available."}}},"Earnings":{"analyze-earnings":"Analyze the earnings history of {{companyName}} using advanced sorting and filters.","earnings-estimates-eps":"earnings estimates, EPS, and revenue","earnings-date":"Earnings Date","eps-estimate":"EPS Estimate","quarterly-revenue-estimate":"Quarterly Revenue Estimate","eps":"EPS","quarterly-revenue":"Quarterly Revenue","annual-revenue":"Annual Revenue","revenue":"Revenue","Charts":{"company-earnings-per-share":"{{companyName}} ({{symbol}}) Earnings Per Share","company-revenue":"{{companyName}} ({{symbol}}) Revenue","quarterly-eps-surprise":"Quarterly Earnings Surprise Amount","quarterly-revenue-surprise":"Quarterly Revenue Surprise Amount","legend":{"reported-eps":"Reported Earnings","estimated-eps":"Estimated Earnings","reported-revenue":"Reported Revenue","estimated-revenue":"Estimated Revenue","eps-surprise":"EPS Surprise %","revenue-surprise":"Revenue Surprise %"},"table":{"fiscal-quarter-end":"Fiscal Quarter End","date-reported":"Date Reported","actual-eps":"Actual EPS","estimate-eps":"Estimated EPS","actual-revenue":"Actual Revenue","estimate-revenue":"Estimated Revenue","surprise-percent":"Surprise %","no-data-available":"no data available to display"}}},"EPS":{"Type":{"beat":"beat","missed":"missed","hit":"hit"}},"Dividend":{"dividend-yield":"Dividend Yield","forward":"Forward","annual-dividend":"Annual Dividend","last-dividend":"Last Dividend","next-dividend":"Next Dividend","dividends-for":"Dividends for {{companyName}}","dividend-overview-title":"{{companyName}} Dividend Overview","dividend-overview-description":"{{companyName}} currently pays a {{dividendFrequency}} dividend of \u003cb\u003e{{annualDividend}}\u003c/b\u003e per year for a yield of \u003cb\u003e{{dividendYield}}%\u003c/b\u003e.","dividend-overview-description-no-dividend":"{{companyName}} does not currently pay a dividend or dividend information is unavailable.","dividend-overview-description-2":"{{companyName}} last traded ex-dividend on \u003cb\u003e{{lastDividendDate}}\u003c/b\u003e and the next ex-dividend date is scheduled for \u003cb\u003e{{nextDividendDate}}\u003c/b\u003e.","dividend-overview-description-2-next-date-unknown":"{{companyName}} last traded ex-dividend on \u003cb\u003e{{lastDividendDate}}\u003c/b\u003e and the next ex-dividend date is unknown.","dividend-overview-description-2-last-date-unknown":"{{companyName}} last traded ex-dividend is unknown and the next ex-dividend date is \u003cb\u003e{{nextDividendDate}}\u003c/b\u003e.","dividend-overview-description-2-both-dates-unknown":"{{companyName}}'s last ex-dividend date and next ex-dividend date are both unknown.","key-highlights-title":"Key Highlights","KeyHighlights":{"annual-payout":"Annual Payout","current-yield":"Current Yield","next-ex-dividend-date":"Next Ex-Dividend Date","last-ex-dividend-date":"Last Ex-Dividend Date","payments-per-year":"Payments per Year"}},"AnalystRatings":{"description":"{{companyName}} has a consensus price target of \u003cb\u003e{{consensusPriceTarget}}\u003c/b\u003e based on the ratings of \u003cb\u003e{{numRatings}}\u003c/b\u003e analysts. The high is \u003cb\u003e{{highestPriceTarget}}\u003c/b\u003e issued by \u003cb\u003e{{highestPriceTargetFirm}}\u003c/b\u003e on \u003cb\u003e{{highestPriceTargetDate}}\u003c/b\u003e. The low is \u003cb\u003e{{lowestPriceTarget}}\u003c/b\u003e issued by \u003cb\u003e{{lowestPriceTargetFirm}}\u003c/b\u003e on \u003cb\u003e{{lowestPriceTargetDate}}\u003c/b\u003e. The \u003cb\u003e{{numLastThreeRatings}}\u003c/b\u003e most-recent analyst ratings were released by \u003cb\u003e{{ratingsCompanies}}\u003c/b\u003e on \u003cb\u003e{{ratingsDate}}\u003c/b\u003e, respectively. With an average price target of \u003cb\u003e{{averagePriceTarget}}\u003c/b\u003e between \u003cb\u003e{{ratingsCompanies}}\u003c/b\u003e, there's an implied \u003cb\u003e{{averagePercentageChange}}%\u003c/b\u003e {{tickerDirection}} for {{companyName}} from these most-recent analyst ratings.","analyst-ratings-for":"Analyst Ratings for {{name}}","analyst-firms-making-recommendations":"Analyst Firms Making Recommendations","calculated-from-analyst-ratings":"calculated from analyst ratings","consensus-rating":"Consensus Rating","highest-price":"Highest Price Target","lowest-price-target":"Lowest Price Target","consensus-price-target":"Consensus Price Target","analyst-ratings-and-price-targets":"analyst ratings and price targets"},"InsiderTrades":{"what-is-insider-activity":"What is Insider Activity?","what-is-insider-activity-description":"Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.","what-are-company-insiders-doing":"What are {{companyName}} Insiders Doing?","what-are-company-insiders-doing-description":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of \u003cb\u003e{{totalSharesSold}}\u003c/b\u003e shares worth \u003cb\u003e{{totalSharesSoldValue}}\u003c/b\u003e, meanwhile, insiders have reported buying a total of \u003cb\u003e{{totalSharesPurchased}}\u003c/b\u003e shares for a total value of \u003cb\u003e{{totalSharesPurchasedValue}}\u003c/b\u003e.","what-are-company-insiders-doing-description-no-sold":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of \u003cb\u003e{{totalSharesPurchased}}\u003c/b\u003e shares for a total value of \u003cb\u003e{{totalSharesPurchasedValue}}\u003c/b\u003e.","what-are-company-insiders-doing-description-no-purchases":"At {{companyName}}, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of \u003cb\u003e{{totalSharesSold}}\u003c/b\u003e shares worth \u003cb\u003e{{totalSharesSoldValue}}\u003c/b\u003e, meanwhile, insiders have report no purchases in the last 30 days.","what-are-company-insiders-doing-no-data":"Insiders have report no purchases/sales in the last 30 days.","notable-recent-insider-trades-no-data":"There has been no Insider buying or selling in the last 90 days.","notable-recent-insider-trades-title":"Notable Recent Insider Buys and Sales","notable-recent-insider-trades-item":"On \u003cb\u003e{{date}}\u003c/b\u003e, {{name}}, the company's \u003cb\u003e{{title}}\u003c/b\u003e {{tradeType}} \u003cb\u003e{{shareCount}}\u003c/b\u003e shares for \u003cb\u003e{{shareValue}}\u003c/b\u003e each.","insider-summary-box-title":"Ownership Statistics for {{companyName}}","shares-outstanding":"Shares Outstanding","shares-float":"Shares Float","insider-shares-owned":"Insider Shares Owned","insider-percentage-owned":"Insider Percentage Owned","institutional-shared-held":"Institutional Shares Held","institutional-percentage-held":"Institutional Percentage Held","insider-trading-news":"{{symbol}} Insider Trading News","insider-trades":"insider trades"},"ShortInterest":{"short-interest":"Short Interest","days-to-cover":"Days to Cover","looking-for-the":"Looking for the","most-shorted-stocks":"most shorted stocks","short-interest-volume":"Based on the recent average volume of \u003cb\u003e{{volume}}\u003c/b\u003e shares traded per day, it would take \u003cb\u003e{{daysToCover}}\u003c/b\u003e day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.","short-interest-performance":"Short interest in {{companyName}} ({{ticker}}) {{trend}} during the last reporting period, {{rise}} from \u003cb\u003e{{shortInterestPriorMonth}}\u003c/b\u003e to \u003cb\u003e{{shortInterest}}\u003c/b\u003e. This put \u003cb\u003e{{shortPercentOfFloat}}%\u003c/b\u003e of the company's publicly available shares short.","increased":"increased","decreased":"decreased","rising":"rising","falling":"falling"},"Guidance":{"guidance-and-forecast":"guidance and forecast"},"Holdings":{"number-of-bond-holding-net":"Number of Bond Holdings","number-of-stock-holding-net":"Number of Stock Holdings","number-of-other-holding-net":"Number of Other Holdings","number-of-etfs":"Number of ETFs","total-number-of-holdings":"Total Holdings"},"Helpers":{"on-all-stocks":"on all stocks."},"Analysis":{"overview-rating":"Overview Rating","technicals-analysis":"Technicals Analysis","technicals-analysis-content":"Scores stock's market momentum out of 100, using buy/sell ratings, RSI, and price trends.","financials-analysis":"Financials Analysis","financials-analysis-content":"Rates stock's financial health out of 100, based on EPS, PE, PB ratios, ROE, and debt equity ratio.","status":{"good":"Good","promising":"Promising","speculative":"Speculative","very-promising":"Very Promising"}},"Price":{"last-update":"Last update","at-close":"At close"},"OptionChain":{"all":"All","expiration-date":"Expiration Date","moneyness":"Moneyness","strike-range":"Strike Range","in-the-money":"In The Money","near-the-money":"Near The Money","last-price":"Last price","change":"Change","bid":"Bid","ask":"Ask","volume":"Volume","open-interest":"Open Interest","options-news-education":" Options News and Education","unusual-options-activity":"Unusual Options Activity for {{companyStandardName}} ({{symbol}})"}}},"profile":{"Profile":{"profile-information":"Personal Information","profile-info":"Profile Info","first-name":"First Name","last-name":"Last Name","email-address":"Email Address","phone-no":"Phone No.","password":"Password","verified":"Verify Now","change-your-password":"Change your password","add-first-name":"Add First Name","add-last-name":"Add Last Name","add-email-address":"Add Email Address","add-phone-number":"Add Phone Number","unverified":"Unverified -","edit":"Edit","save":"Save","cancel":"Cancel","verification-email-sent":"Verification Email Sent!"},"Billing":{"label":"Billing","invalid-card":"Invalid card","subscription-info":"Subscription Info","noactive-subscription":"You have no active subscriptions.","billing-info":"Billing Info","click-or-drag":" Click or drag and drop image to change your avatar. Accepted file formats:{' '}","format":"JPG, PNG, GIF"},"Chat":{"label":"Chat","chat-username":"Chat Username","name":"JohnSmith1990","update":"Update","muted-users":"Muted User","muted":"You have no muted users","success":"Nickname updated successfully","error":"Nickname update failed. Please contact admin to change the name.'"},"NewsAlerts":{"label":"News Alerts"}}}},"overviewValues":{"bullSayBearSay":{"bear_case":"Trulieve Cannabis Corp experienced a challenging financial year in 2023, with a reported revenue decline of 7% and EBITDA down 19%, indicating weakening operational performance. The company's projections suggest a further decrease in EBITDA by over 20%, a stark contrast to the modest growth achieved in the previous year, highlighting ongoing pressures in the market. Additionally, anticipated changes in gross margin and a flat revenue outlook for 1Q exacerbate concerns about the sustainability of Trulieve's financial health amidst unpredictable market conditions.","bull_case":"Trulieve Cannabis Corp has demonstrated a robust financial position with a 35% year-over-year growth in adjusted EBITDA, reaching $105.8 million, well above consensus estimates. The company has shown consistent revenue growth, achieving $297.6 million in sales for the latest quarter, surpassing guidance and driven by increased customer traffic. Additionally, operational improvements and expense control have bolstered cash flow, with expectations for over $100 million in operating cash flow and a significant reduction in outstanding debt, aligning with a long-term positive outlook for the company's financial health.","id":"6746a26cf7752a1091d1c21c","securities":[{"cik":"1754195","exchange":"OTC","isin":"CA89788C1041","name":"Trulieve Cannabis","symbol":"TCNNF"}],"ticker":"TCNNF","updated":1732682348},"financials":{"down":0,"up":0},"ratingsByMonthWithCounts":[{"date":"Aug/2024","ratingBuyCount":1,"ratingCountTotal":1,"ratingHoldCount":0,"ratingSellCount":0,"ratingStrongBuyCount":0,"ratingStrongSellCount":0}],"technicals":{"down":0,"up":0}},"pageTargeting":{"BZ_PTYPE":"ticker","BZ_TICKER":"TCNNF"},"peersChartData":{},"profile":{"conferenceCallsSummary":{"conferenceCalls":[{"access_code":"3735709","date":"2024-11-05","exchange":"OTC","id":"6718f3b247411f0001badae1","importance":2,"international_num":"1-412-542-4136","isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","phone_num":"1-844-824-3830","reservation_num":"","start_time":"08:30:00","ticker":"TCNNF","time":"09:01:38","updated":1729688551,"webcast_url":"https://app.webinar.net/lp5RXEQXNeJ"}],"last":{"access_code":"3735709","date":"2024-11-05","exchange":"OTC","id":"6718f3b247411f0001badae1","importance":2,"international_num":"1-412-542-4136","isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","phone_num":"1-844-824-3830","reservation_num":"","start_time":"08:30:00","ticker":"TCNNF","time":"09:01:38","updated":1729688551,"webcast_url":"https://app.webinar.net/lp5RXEQXNeJ"},"next":null},"dividendSummary":{"avgAnnualizedDividendGrowth":null,"dividends":[],"largestDividendYield":null,"last":null,"next":null,"yearOverYearGrowth":null},"fundamentals":{"valuationRatios":[{"id":{"shareClassId":"0P0001EP2I","date":"2024-11-27"},"payoutRatio":0,"sustainableGrowthRate":-0.1676,"cashReturn":0.1864,"salesPerShare":6.178,"bookValuePerShare":6.9348,"cfoPerShare":1.9618,"fcfPerShare":1.3447,"earningYield":-0.1158,"salesYield":1.0078,"psRatio":0.992234,"bookValueYield":1.1313,"pbRatio":0.883944,"cfYield":0.32,"pcfRatio":3.12463,"fcfYield":0.2194,"fcfRatio":4.558625,"forwardEarningYield":-0.0408,"tangibleBookValuePerShare":-0.239,"tangibleBvPerShare3YrAvg":1.4068,"tangibleBvPerShare5YrAvg":1.8417,"workingCapitalPerShare":2.4648,"workingCapitalPerShare3YrAvg":1.5719,"workingCapitalPerShare5YrAvg":1.8815,"evToEbitda":5.3573,"ratioPe5YearAverage":41.6164,"priceChange1M":0.533,"pricetoEbitda":3.759098}],"company":{"primarySymbol":"TRUL","primaryExchange":"CNQ","cik":"1754195","isin":"CA89788C1041","standardName":"Trulieve Cannabis","countryId":"USA","isReit":false,"industryTemplateCode":"N","businessCountryId":"USA","isLimitedPartnership":false,"yearofEstablishment":1940,"isLimitedLiabilityCompany":false},"companyProfile":{"companyStatus":"U","countryId":"USA","fiscalYearEnd":"12","shortName":"Trulieve Cannabis","standardName":"Trulieve Cannabis Corp","address1":"6749 Ben Bostic Road","city":"Quincy","country":"USA","homepage":"https://www.trulieve.com","phone":"+1 850 480-7955","postalCode":"32351","province":"FL","totalEmployees":5400,"legalName":"Trulieve Cannabis Corp","longDescription":"Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis."},"shareClass":{"shareClassId":"0P0001EP2I","companyId":"0C0000BIMI","symbol":"TCNNF","exchangeId":"PINX","currencyId":"USD","ipoDate":"2018-09-26","isDepositaryReceipt":false,"securityType":"ST00000001","shareClassDescription":"Ordinary Shares (Sub Voting)","shareClassStatus":"A","isPrimaryShare":false,"isDividendReinvest":false,"isDirectInvest":false,"investmentId":"F0000118VS","mic":"OOTC"},"earningReports":[{"id":{"shareClassId":"0P0001EP2I","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","periodEndingDate":"2024-09-30","fileDate":"2024-11-05","accessionNumber":"0001628280-24-045099","formType":"10-Q","basicContinuousOperations":-0.32,"basicDiscontinuousOperations":-0.01,"basicEps":-0.33,"dilutedContinuousOperations":-0.32,"dilutedDiscontinuousOperations":-0.01,"dilutedEps":-0.33,"basicAverageShares":190190923,"dilutedAverageShares":190190923,"continuingAndDiscontinuedBasicEps":-0.33,"continuingAndDiscontinuedDilutedEps":-0.33,"normalizedBasicEps":-0.337844,"normalizedDilutedEps":-0.337844}],"earningRatios":[{"id":{"shareClassId":"0P0001EP2I","asOf":"2024-09-30","reportType":"A","period":"3M","aorOrRestate":"AOR"},"fiscalYearEnd":12,"equityPerShareGrowth":-0.058691}],"financials":[{"asOf":"2024-09-30","period":"3M","reportType":"R","aorOrRestate":"RESTATE","balanceSheet":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-05","accessionNumber":"0001628280-24-045099","formType":"10-Q","accountsPayable":96051000,"accountsReceivable":9031000,"totalLiabilitiesAsReported":1565780000,"totalEquityAsReported":1301344000,"additionalPaidInCapital":2047963000,"capitalStock":0,"cashAndCashEquivalents":237666000,"cashCashEquivalentsAndMarketableSecurities":317845000,"commonStock":0,"currentAssets":603011000,"currentDebt":3342000,"currentDebtAndCapitalLeaseObligation":25889000,"currentLiabilities":136693000,"currentCapitalLeaseObligation":22547000,"nonCurrentDeferredLiabilities":204242000,"currentDeferredLiabilities":6663000,"currentDeferredRevenue":6663000,"nonCurrentDeferredTaxesLiabilities":204242000,"goodwill":483905000,"goodwillAndOtherIntangibleAssets":1357222000,"grossPpe":883246000,"inventory":220916000,"longTermDebt":477176000,"longTermDebtAndCapitalLeaseObligation":794818000,"longTermCapitalLeaseObligation":317642000,"minorityInterest":-3541000,"netPpe":883246000,"notesReceivable":1770000,"nonCurrentNoteReceivables":5773000,"otherCurrentLiabilities":8090000,"otherIntangibleAssets":873317000,"otherShortTermInvestments":80179000,"payables":96051000,"payablesAndAccruedExpenses":96051000,"prepaidAssets":19154000,"receivables":16645000,"retainedEarnings":-735959000,"stockholdersEquity":1312004000,"totalAssets":2874243000,"totalLiabilities":1565780000,"totalNonCurrentAssets":2271232000,"investedCapital":1792522000,"totalLiabilitiesNetMinorityInterest":1565780000,"totalNonCurrentLiabilitiesNetMinorityInterest":1429087000,"totalEquityGrossMinorityInterest":1308463000,"commonStockEquity":1312004000,"finishedGoods":48731000,"otherCurrentAssets":26620000,"otherCurrentBorrowings":3342000,"otherNonCurrentAssets":24991000,"otherProperties":883246000,"rawMaterials":52643000,"restrictedCash":907000,"taxesReceivable":5844000,"totalCapitalization":1789180000,"workInProcess":119542000,"otherNonCurrentLiabilities":390641000,"capitalLeaseObligations":340189000,"tangibleBookValue":-45218000,"totalEquity":1312004000,"workingCapital":466318000,"totalDebt":820707000,"ordinarySharesNumber":189154228,"netTangibleAssets":-45218000,"liabilitiesHeldforSaleNonCurrent":39386000,"netDebt":242852000,"shareIssued":189154228},"cashFlowStatement":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-05","accessionNumber":"0001628280-24-045099","formType":"10-Q","changeinCashSupplementalAsReported":-117518000,"capitalExpenditure":-50209000,"cashFlowFromContinuingFinancingActivities":-16361000,"cashFlowFromContinuingInvestingActivities":-131494000,"cashFlowFromContinuingOperatingActivities":30337000,"cashFlowFromDiscontinuedOperation":0,"financingCashFlow":-16361000,"investingCashFlow":-131494000,"operatingCashFlow":30337000,"beginningCashPosition":356091000,"endCashPosition":238573000,"changeInAccountPayable":4876000,"changesInCash":-117518000,"changeInInventory":-13291000,"changeInPayable":4876000,"changeInPayablesAndAccruedExpense":4876000,"changeInPrepaidAssets":4898000,"changeInReceivables":-1459000,"changeInWorkingCapital":47971000,"deferredIncomeTax":-6194000,"deferredTax":-6194000,"depreciation":44615000,"depreciationAndAmortization":44615000,"depreciationAmortizationDepletion":44615000,"netIssuancePaymentsOfDebt":-4197000,"netLongTermDebtIssuance":-4197000,"netIncomeFromContinuingOperations":-61856000,"longTermDebtPayments":-4197000,"proceedsFromStockOptionExercised":0,"purchaseOfIntangibles":-13277000,"purchaseOfPpe":-36932000,"netBusinessPurchaseAndSale":255000,"netIntangiblesPurchaseAndSale":-13277000,"netPpePurchaseAndSale":-36932000,"saleOfBusiness":255000,"changesInAccountReceivables":-1459000,"assetImpairmentCharge":-4296000,"changeInOtherCurrentAssets":-1067000,"changeInOtherCurrentLiabilities":-152614000,"changeInOtherWorkingCapital":206628000,"netOtherFinancingCharges":-12164000,"netOtherInvestingChanges":-356000,"otherNonCashItems":4151000,"stockBasedCompensation":5469000,"interestPaidSupplementalData":9052000,"repaymentOfDebt":-4197000,"freeCashFlow":-19872000,"interestReceivedCfi":-1184000,"provisionandWriteOffofAssets":477000},"incomeStatement":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","fileDate":"2024-11-05","accessionNumber":"0001628280-24-045099","formType":"10-Q","costOfRevenue":111006000,"depreciationAndAmortization":28332000,"depreciationAmortizationDepletion":28332000,"netIncomeDiscontinuousOperations":-1636000,"generalAndAdministrativeExpense":81897000,"grossProfit":173278000,"interestExpense":17459000,"interestExpenseNonOperating":17459000,"interestIncomeNonOperating":4202000,"netNonOperatingInterestIncomeExpense":-13257000,"minorityInterests":1643000,"netIncome":-60213000,"netIncomeCommonStockholders":-60642000,"netIncomeContinuousOperations":-60220000,"netInterestIncome":-13257000,"totalRevenue":284284000,"operatingExpense":176956000,"operatingIncome":-3678000,"operatingRevenue":284284000,"otherIncomeExpense":4098000,"pretaxIncome":-12837000,"taxProvision":47383000,"sellingAndMarketingExpense":66727000,"sellingGeneralAndAdministration":148624000,"specialIncomeCharges":4296000,"totalExpenses":287962000,"interestIncome":4202000,"ebit":4622000,"ebitda":49237000,"impairmentOfCapitalAssets":-4296000,"netIncomeFromContinuingAndDiscontinuedOperation":-60213000,"reconciledCostOfRevenue":94723000,"reconciledDepreciation":44615000,"normalizedIncome":-61970840,"netIncomeFromContinuingOperationNetMinorityInterest":-58577000,"netIncomeIncludingNoncontrollingInterests":-61856000,"otherunderPreferredStockDividend":429000,"otherNonOperatingIncomeExpenses":-198000,"totalUnusualItems":4296000,"totalUnusualItemsExcludingGoodwill":4296000,"taxRateForCalcs":0.21,"taxEffectOfUnusualItems":902160,"normalizedEbitda":44941000,"totalOperatingIncomeAsReported":618000,"totalRevenueAsReported":284284000,"normalizedEbitdaAsReported":96086000,"effectiveTaxRateAsReported":-3.69}}],"operationRatios":[{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"3M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"isCalculated":false,"revenueGrowth":0.032971,"operationRevenueGrowth3MonthAvg":0.032971,"grossMargin":0.609524,"operationMargin":-0.012938,"pretaxMargin":-0.045156,"netMargin":-0.213315,"ebitMargin":0.016258,"ebitdaMargin":0.173197,"salesPerEmployee":52645.185185,"currentRatio":4.411426,"quickRatio":2.447016,"longTermDebtTotalCapitalRatio":0.377259,"interestCoverage":0.264735,"longTermDebtEquityRatio":0.605805,"financialLeverage":2.190727,"totalDebtEquityRatio":0.625537,"normalizedNetProfitMargin":-0.217989,"daysInSales":2.658532,"daysInInventory":176.139972,"daysInPayment":75.324448,"cashConversionCycle":103.474057,"receivableTurnover":34.323453,"inventoryTurnover":0.518054,"paymentTurnover":1.211426,"fixAssetsTuronver":0.330095,"assetsTurnover":0.099069,"roe":-0.045048,"roa":-0.021133,"roic":-0.023263,"debttoAssets":0.285538,"commonEquityToAssets":0.456469,"normalizedRoic":-0.02234}],"alphaBeta":[],"ownership":[{"id":{"shareClassId":"0P0001EP2I","asOf":"2024-10-31"},"period":"","sharesOutstanding":189190590,"institutionHolderNumber":20,"institutionPercentHeld":0.0097132315,"institutionPercentHeld13f":0.0002554303,"institutionSharesHeld":1837652,"institutionSharesBought":114952,"institutionSharesSold":21205876,"shareFloat":159756764,"shareClassLevelSharesOutstandingBalanceSheet":164027024,"shareClassLevelSharesOutstandingInterim":165964290,"sharesOutstandingWithBalanceSheetEndingDate":187253324}],"assetClassification":{"sic":"2834","sicName":"Pharmaceutical Preparations","naics":"325412","naicsName":"Pharmaceutical Preparation Manufacturing","msSuperSectorCode":2,"msSuperSectorName":"Defensive","msSectorCode":206,"msSectorName":"Healthcare","msGroupCode":20620,"msGroupName":"Drug Manufacturers","msIndustryCode":20620020,"msIndustryName":"Drug Manufacturers—Specialty \u0026 Generic"},"shareClassProfile":{"asOf":"2024-10-31","marketCap":1159738316,"enterpriseValue":1646702781,"sharesOutstanding":189190590},"symbol":"TCNNF","idType":"SYMBOL","id":"TCNNF"},"fundamentalsAnnual":{"valuationRatios":[{"id":{"shareClassId":"0P0001EP2I","date":"2024-11-27"},"payoutRatio":0,"sustainableGrowthRate":-0.1676,"cashReturn":0.1864,"salesPerShare":6.178,"bookValuePerShare":6.9348,"cfoPerShare":1.9618,"fcfPerShare":1.3447,"earningYield":-0.1158,"salesYield":1.0078,"psRatio":0.992234,"bookValueYield":1.1313,"pbRatio":0.883944,"cfYield":0.32,"pcfRatio":3.12463,"fcfYield":0.2194,"fcfRatio":4.558625,"forwardEarningYield":-0.0408,"tangibleBookValuePerShare":-0.239,"tangibleBvPerShare3YrAvg":1.4068,"tangibleBvPerShare5YrAvg":1.8417,"workingCapitalPerShare":2.4648,"workingCapitalPerShare3YrAvg":1.5719,"workingCapitalPerShare5YrAvg":1.8815,"evToEbitda":5.3573,"ratioPe5YearAverage":41.6164,"priceChange1M":0.533,"pricetoEbitda":3.759098}],"company":{"primarySymbol":"TRUL","primaryExchange":"CNQ","cik":"1754195","isin":"CA89788C1041","standardName":"Trulieve Cannabis","countryId":"USA","isReit":false,"industryTemplateCode":"N","businessCountryId":"USA","isLimitedPartnership":false,"yearofEstablishment":1940,"isLimitedLiabilityCompany":false},"companyProfile":{"companyStatus":"U","countryId":"USA","fiscalYearEnd":"12","shortName":"Trulieve Cannabis","standardName":"Trulieve Cannabis Corp","address1":"6749 Ben Bostic Road","city":"Quincy","country":"USA","homepage":"https://www.trulieve.com","phone":"+1 850 480-7955","postalCode":"32351","province":"FL","totalEmployees":5400,"legalName":"Trulieve Cannabis Corp","longDescription":"Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis."},"shareClass":{"shareClassId":"0P0001EP2I","companyId":"0C0000BIMI","symbol":"TCNNF","exchangeId":"PINX","currencyId":"USD","ipoDate":"2018-09-26","isDepositaryReceipt":false,"securityType":"ST00000001","shareClassDescription":"Ordinary Shares (Sub Voting)","shareClassStatus":"A","isPrimaryShare":false,"isDividendReinvest":false,"isDirectInvest":false,"investmentId":"F0000118VS","mic":"OOTC"},"earningReports":[{"id":{"shareClassId":"0P0001EP2I","asOf":"2024-09-30","reportType":"TTM","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","periodEndingDate":"2024-09-30","basicContinuousOperations":-0.71,"basicDiscontinuousOperations":-0.01,"basicEps":-0.72,"dilutedContinuousOperations":-0.71,"dilutedDiscontinuousOperations":-0.01,"dilutedEps":-0.72,"basicAverageShares":189757781,"dilutedAverageShares":189757781,"continuingAndDiscontinuedBasicEps":-0.72,"continuingAndDiscontinuedDilutedEps":-0.72,"normalizedBasicEps":-0.714226,"normalizedDilutedEps":-0.714226}],"earningRatios":[],"financials":[{"asOf":"2024-09-30","period":"12M","reportType":"R","aorOrRestate":"RESTATE","balanceSheet":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30"},"cashFlowStatement":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","changeinCashSupplementalAsReported":39609000,"capitalExpenditure":-117105000,"cashFlowFromContinuingFinancingActivities":-142068000,"cashFlowFromContinuingInvestingActivities":-190596000,"cashFlowFromContinuingOperatingActivities":372273000,"cashFlowFromDiscontinuedOperation":94000,"financingCashFlow":-142068000,"investingCashFlow":-190596000,"operatingCashFlow":372273000,"beginningCashPosition":198870000,"endCashPosition":238573000,"changeInAccountPayable":1748000,"changesInCash":39703000,"changeInInventory":8496000,"changeInPayable":113817000,"changeInPayablesAndAccruedExpense":113817000,"changeInPrepaidAssets":-3391000,"changeInReceivables":-568000,"changeInWorkingCapital":298593000,"deferredIncomeTax":-1153000,"deferredTax":-1153000,"depreciation":176781000,"depreciationAndAmortization":176781000,"depreciationAmortizationDepletion":176781000,"netIssuancePaymentsOfDebt":-126050000,"netLongTermDebtIssuance":-126050000,"netIncomeFromContinuingOperations":-133805000,"longTermDebtPayments":-150768000,"proceedsFromStockOptionExercised":210000,"purchaseOfIntangibles":-18215000,"purchaseOfPpe":-88423000,"netBusinessPurchaseAndSale":-9743000,"netIntangiblesPurchaseAndSale":-18215000,"netPpePurchaseAndSale":-83396000,"saleOfBusiness":-9743000,"changesInAccountReceivables":-568000,"assetImpairmentCharge":-9903000,"changeInOtherCurrentAssets":-5194000,"changeInOtherCurrentLiabilities":-5142000,"changeInOtherWorkingCapital":190575000,"netOtherFinancingCharges":-16178000,"netOtherInvestingChanges":12205000,"otherNonCashItems":7591000,"stockBasedCompensation":18739000,"interestPaidSupplementalData":70781000,"repaymentOfDebt":-150768000,"freeCashFlow":255168000,"provisionandWriteOffofAssets":6794000},"incomeStatement":{"id":{"companyId":"0C0000BIMI","asOf":"2024-09-30","reportType":"R","period":"12M","aorOrRestate":"RESTATE"},"fiscalYearEnd":12,"currencyId":"USD","isCalculated":false,"periodEndingDate":"2024-09-30","costOfRevenue":489738000,"depreciationAndAmortization":111364000,"depreciationAmortizationDepletion":111364000,"netIncomeDiscontinuousOperations":-2800000,"generalAndAdministrativeExpense":198829000,"grossProfit":682581000,"interestExpense":68221000,"interestExpenseNonOperating":68221000,"interestIncomeNonOperating":13340000,"netNonOperatingInterestIncomeExpense":-54881000,"minorityInterests":5054000,"netIncome":-128751000,"netIncomeCommonStockholders":-231009000,"netIncomeContinuousOperations":-131005000,"netInterestIncome":-54881000,"totalRevenue":1172319000,"operatingExpense":560168000,"operatingIncome":122413000,"operatingRevenue":1172319000,"otherIncomeExpense":-3094000,"pretaxIncome":64438000,"taxProvision":195443000,"sellingAndMarketingExpense":249975000,"sellingGeneralAndAdministration":448804000,"specialIncomeCharges":1015000,"totalExpenses":1049906000,"interestIncome":13340000,"ebit":132659000,"ebitda":309440000,"impairmentOfCapitalAssets":-3239000,"netIncomeFromContinuingAndDiscontinuedOperation":-128751000,"reconciledCostOfRevenue":424321000,"reconciledDepreciation":176781000,"normalizedIncome":-126752850,"netIncomeFromContinuingOperationNetMinorityInterest":-125951000,"netIncomeIncludingNoncontrollingInterests":-133805000,"otherNonOperatingIncomeExpenses":-4109000,"totalUnusualItems":1015000,"totalUnusualItemsExcludingGoodwill":1015000,"taxRateForCalcs":0.21,"taxEffectOfUnusualItems":213150,"normalizedEbitda":308425000,"totalOperatingIncomeAsReported":125652000,"totalRevenueAsReported":1172319000,"normalizedEbitdaAsReported":396667000}}],"operationRatios":[],"alphaBeta":[],"ownership":[{"id":{"shareClassId":"0P0001EP2I","asOf":"2024-10-31"},"period":"","sharesOutstanding":189190590,"institutionHolderNumber":20,"institutionPercentHeld":0.0097132315,"institutionPercentHeld13f":0.0002554303,"institutionSharesHeld":1837652,"institutionSharesBought":114952,"institutionSharesSold":21205876,"shareFloat":159756764,"shareClassLevelSharesOutstandingBalanceSheet":164027024,"shareClassLevelSharesOutstandingInterim":165964290,"sharesOutstandingWithBalanceSheetEndingDate":187253324}],"assetClassification":{"sic":"2834","sicName":"Pharmaceutical Preparations","naics":"325412","naicsName":"Pharmaceutical Preparation Manufacturing","msSuperSectorCode":2,"msSuperSectorName":"Defensive","msSectorCode":206,"msSectorName":"Healthcare","msGroupCode":20620,"msGroupName":"Drug Manufacturers","msIndustryCode":20620020,"msIndustryName":"Drug Manufacturers—Specialty \u0026 Generic"},"shareClassProfile":{"asOf":"2024-10-31","marketCap":1159738316,"enterpriseValue":1646702781,"sharesOutstanding":189190590},"symbol":"TCNNF","idType":"SYMBOL","id":"TCNNF"},"isStockReportSupported":false,"logoUrl":"https://image-util.benzinga.com/api/v2/logos/file/image/1754195/mark_composite_light__b0c60ea960e58a42b5a4a25599eeb06c.png?height=60\u0026max_width=\u0026width=60\u0026x-bz-cred=sb~JvrqtV2eSeV5KdkqKw9ZcXAPd8NlSEL7FUJDDLa_pw7PPdFoo6d5Om71NmlF-mIOklUfPfYaYVqwGU5cm7f38qu1_qdFvE2ySvxn6oKMijduOf31Qxp50ZWmtpLNiOaLaaAtk4GOizJHrKKpc4HtH1SuPDyu\u0026x-bz-exp=1733045090\u0026x-bz-security-isin=CA89788C1041\u0026x-bz-security-symbol=TCNNF\u0026x-bz-signature=92c112a1b8a589b560df3fb4a68c2c010774c85e3dcd885b76dfed974feee5d9","maSummary":{"last":null,"ma":[],"next":null},"quotes":{"TCNNF":{"symbol":"TCNNF","dxSymbol":"TCNNF","exchange":"OOTC","isoExchange":"OOTC","bzExchange":"OTC","otcMarket":"OP","otcTier":"QX","type":"STOCK","name":"Trulieve Cannabis","companyStandardName":"Trulieve Cannabis Corp","description":"TRULIEVE CANNABIS CORP by Trulieve Cannabis Corporation","open":6.2,"high":6.21,"low":5.94,"close":6.031,"bidPrice":5.97,"askPrice":6.1,"askSize":0,"bidSize":0,"size":1000,"bidTime":1732906802000,"askTime":1732906802000,"volume":262649,"previousClosePrice":6.13,"previousCloseDate":"2024-11-27T16:00:00.000-05:00","fiftyDayAveragePrice":10.3,"hundredDayAveragePrice":10.16,"twoHundredDayAveragePrice":10.33,"averageVolume":554392,"fiftyTwoWeekHigh":14.5,"fiftyTwoWeekLow":4.75,"marketCap":1159738317,"sharesOutstanding":189190590,"sharesFloat":159756764,"currency":"USD","primary":false,"issuerShortName":"Trulieve Cannabis"}},"richQuoteData":{"symbol":"TCNNF","dxSymbol":"TCNNF","exchange":"OOTC","isoExchange":"OOTC","bzExchange":"OTC","otcMarket":"OP","otcTier":"QX","type":"STOCK","name":"Trulieve Cannabis","companyStandardName":"Trulieve Cannabis Corp","description":"TRULIEVE CANNABIS CORP by Trulieve Cannabis Corporation","open":6.2,"high":6.21,"low":5.94,"close":6.031,"bidPrice":5.97,"askPrice":6.1,"askSize":0,"bidSize":0,"size":1000,"bidTime":1732906802000,"askTime":1732906802000,"lastTradePrice":5.94,"lastTradeTime":1732280705045,"volume":262649,"change":-0.19,"changePercent":-3.1,"previousClosePrice":6.13,"previousCloseDate":"2024-11-27T16:00:00.000-05:00","fiftyDayAveragePrice":10.3,"hundredDayAveragePrice":10.16,"twoHundredDayAveragePrice":10.33,"averageVolume":554392,"fiftyTwoWeekHigh":14.5,"fiftyTwoWeekLow":4.75,"marketCap":1123792104,"sharesOutstanding":189190590,"sharesFloat":159756764,"ethPrice":5.94,"ethVolume":4500,"ethTime":1732280705045,"currency":"USD","primary":false,"issuerShortName":"Trulieve Cannabis"},"schedule":{"schedule":{"trading":false,"shortDay":false,"resetTime":1732953600000,"localResetDate":"2024-11-30T03:00:00.000-05:00","dayId":20057,"startTime":1732942800000,"endTime":1733029200000,"timeZoneId":"America/New_York","sessions":[{"startTime":1732942800000,"endTime":1733029200000,"type":"NO_TRADING","localStartDate":"2024-11-30T00:00:00.000-05:00","localEndDate":"2024-12-01T00:00:00.000-05:00"}]},"type":"NO_TRADING"},"shortInterest":[{"recordDate":"2024-11-26","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"572034","daysToCover":1,"shortPercentOfFloat":0.36,"shortPriorMo":"457598","percentChangeMoMo":25.01,"sharesFloat":"159756764","averageDailyVolume":"2591978","sharesOutstanding":"189190590","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-11-19","settlementDate":"2024-11-15"},{"recordDate":"2024-11-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"457598","daysToCover":1,"shortPercentOfFloat":0.29,"shortPriorMo":"482030","percentChangeMoMo":-5.07,"sharesFloat":"159756764","averageDailyVolume":"902370","sharesOutstanding":"189190590","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-11-04","settlementDate":"2024-10-31"},{"recordDate":"2024-10-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"482030","daysToCover":1.01,"shortPercentOfFloat":0.31,"shortPriorMo":"493202","percentChangeMoMo":-2.27,"sharesFloat":"157855934","averageDailyVolume":"479073","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-10-17","settlementDate":"2024-10-15"},{"recordDate":"2024-10-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"493202","daysToCover":1,"shortPercentOfFloat":0.31,"shortPriorMo":"496092","percentChangeMoMo":-0.58,"sharesFloat":"157855934","averageDailyVolume":"636268","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-10-02","settlementDate":"2024-09-30"},{"recordDate":"2024-09-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"496092","daysToCover":1,"shortPercentOfFloat":0.31,"shortPriorMo":"677042","percentChangeMoMo":-26.73,"sharesFloat":"157855934","averageDailyVolume":"753045","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-09-17","settlementDate":"2024-09-13"},{"recordDate":"2024-09-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"677042","daysToCover":1,"shortPercentOfFloat":0.43,"shortPriorMo":"509845","percentChangeMoMo":32.79,"sharesFloat":"157855934","averageDailyVolume":"734268","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-09-04","settlementDate":"2024-08-30"},{"recordDate":"2024-08-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"475950","daysToCover":1,"shortPercentOfFloat":0.3,"shortPriorMo":"739042","percentChangeMoMo":-35.6,"sharesFloat":"157855934","averageDailyVolume":"575468","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-08-02","settlementDate":"2024-07-31"},{"recordDate":"2024-07-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"739042","daysToCover":1.34,"shortPercentOfFloat":0.47,"shortPriorMo":"631842","percentChangeMoMo":16.97,"sharesFloat":"157855934","averageDailyVolume":"550804","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-07-17","settlementDate":"2024-07-15"},{"recordDate":"2024-07-10","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"631842","daysToCover":1,"shortPercentOfFloat":0.4,"shortPriorMo":"644414","percentChangeMoMo":-1.95,"sharesFloat":"157855934","averageDailyVolume":"762266","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-07-02","settlementDate":"2024-06-28"},{"recordDate":"2024-06-26","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"644414","daysToCover":1,"shortPercentOfFloat":0.41,"shortPriorMo":"746598","percentChangeMoMo":-13.69,"sharesFloat":"157855934","averageDailyVolume":"781624","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-06-18","settlementDate":"2024-06-14"},{"recordDate":"2024-06-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"746598","daysToCover":1,"shortPercentOfFloat":0.47,"shortPriorMo":"744919","percentChangeMoMo":0.23,"sharesFloat":"157855934","averageDailyVolume":"1141575","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-06-04","settlementDate":"2024-05-31"},{"recordDate":"2024-05-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"744919","daysToCover":1,"shortPercentOfFloat":0.47,"shortPriorMo":"755868","percentChangeMoMo":-1.45,"sharesFloat":"157855934","averageDailyVolume":"1258103","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-05-17","settlementDate":"2024-05-15"},{"recordDate":"2024-05-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"755868","daysToCover":1,"shortPercentOfFloat":0.48,"shortPriorMo":"671695","percentChangeMoMo":12.53,"sharesFloat":"157855934","averageDailyVolume":"1337274","sharesOutstanding":"187289760","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-05-02","settlementDate":"2024-04-30"},{"recordDate":"2024-04-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"671695","daysToCover":1,"shortPercentOfFloat":0.45,"shortPriorMo":"373646","percentChangeMoMo":79.77,"sharesFloat":"149422415","averageDailyVolume":"1183239","sharesOutstanding":"186278394","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-04-17","settlementDate":"2024-04-15"},{"recordDate":"2024-04-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"373646","daysToCover":1,"shortPercentOfFloat":0.25,"shortPriorMo":"461460","percentChangeMoMo":-19.03,"sharesFloat":"149422415","averageDailyVolume":"857644","sharesOutstanding":"186278394","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-04-02","settlementDate":"2024-03-28"},{"recordDate":"2024-03-26","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"461460","daysToCover":1,"shortPercentOfFloat":0.31,"shortPriorMo":"444366","percentChangeMoMo":3.85,"sharesFloat":"149422415","averageDailyVolume":"776508","sharesOutstanding":"186278394","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-03-19","settlementDate":"2024-03-15"},{"recordDate":"2024-03-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"444366","daysToCover":1,"shortPercentOfFloat":0.3,"shortPriorMo":"495386","percentChangeMoMo":-10.3,"sharesFloat":"149422415","averageDailyVolume":"896416","sharesOutstanding":"186278394","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-03-04","settlementDate":"2024-02-29"},{"recordDate":"2024-02-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"381735","daysToCover":1,"shortPercentOfFloat":0.26,"shortPriorMo":"383168","percentChangeMoMo":-0.37,"sharesFloat":"149131447","averageDailyVolume":"1368899","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-02-02","settlementDate":"2024-01-31"},{"recordDate":"2024-01-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"383168","daysToCover":1,"shortPercentOfFloat":0.26,"shortPriorMo":"374953","percentChangeMoMo":2.19,"sharesFloat":"149131447","averageDailyVolume":"759268","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-01-17","settlementDate":"2024-01-12"},{"recordDate":"2024-01-10","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"374953","daysToCover":1,"shortPercentOfFloat":0.25,"shortPriorMo":"413299","percentChangeMoMo":-9.28,"sharesFloat":"149131447","averageDailyVolume":"844892","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2024-01-03","settlementDate":"2023-12-29"},{"recordDate":"2023-12-27","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"413299","daysToCover":1,"shortPercentOfFloat":0.28,"shortPriorMo":"456406","percentChangeMoMo":-9.44,"sharesFloat":"149131447","averageDailyVolume":"844025","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-12-19","settlementDate":"2023-12-15"},{"recordDate":"2023-12-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"456406","daysToCover":1.06,"shortPercentOfFloat":0.31,"shortPriorMo":"470515","percentChangeMoMo":-3,"sharesFloat":"149131447","averageDailyVolume":"431812","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-12-04","settlementDate":"2023-11-30"},{"recordDate":"2023-11-27","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"470515","daysToCover":1,"shortPercentOfFloat":0.32,"shortPriorMo":"703924","percentChangeMoMo":-33.16,"sharesFloat":"149131447","averageDailyVolume":"579162","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-11-17","settlementDate":"2023-11-15"},{"recordDate":"2023-11-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"703924","daysToCover":1,"shortPercentOfFloat":0.47,"shortPriorMo":"865073","percentChangeMoMo":-18.63,"sharesFloat":"149131447","averageDailyVolume":"894357","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-11-02","settlementDate":"2023-10-31"},{"recordDate":"2023-10-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"865073","daysToCover":1.13,"shortPercentOfFloat":0.58,"shortPriorMo":"676096","percentChangeMoMo":27.95,"sharesFloat":"149131447","averageDailyVolume":"765121","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-10-17","settlementDate":"2023-10-13"},{"recordDate":"2023-10-10","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"676096","daysToCover":1,"shortPercentOfFloat":0.45,"shortPriorMo":"522848","percentChangeMoMo":29.31,"sharesFloat":"149131447","averageDailyVolume":"742531","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-10-03","settlementDate":"2023-09-29"},{"recordDate":"2023-09-26","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"522848","daysToCover":1,"shortPercentOfFloat":0.35,"shortPriorMo":"1067902","percentChangeMoMo":-51.04,"sharesFloat":"149131447","averageDailyVolume":"1550250","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-09-19","settlementDate":"2023-09-15"},{"recordDate":"2023-09-12","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1067902","daysToCover":1.07,"shortPercentOfFloat":0.72,"shortPriorMo":"1076986","percentChangeMoMo":-0.84,"sharesFloat":"149131447","averageDailyVolume":"1001274","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-09-05","settlementDate":"2023-08-31"},{"recordDate":"2023-08-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1076986","daysToCover":2.5,"shortPercentOfFloat":0.72,"shortPriorMo":"1025746","percentChangeMoMo":5,"sharesFloat":"149131447","averageDailyVolume":"430620","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-08-17","settlementDate":"2023-08-15"},{"recordDate":"2023-08-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1025746","daysToCover":1.88,"shortPercentOfFloat":0.69,"shortPriorMo":"1038578","percentChangeMoMo":-1.24,"sharesFloat":"149131447","averageDailyVolume":"544299","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-08-02","settlementDate":"2023-07-31"},{"recordDate":"2023-07-25","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1038578","daysToCover":1.27,"shortPercentOfFloat":0.7,"shortPriorMo":"1060655","percentChangeMoMo":-2.08,"sharesFloat":"149131447","averageDailyVolume":"816817","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-07-18","settlementDate":"2023-07-14"},{"recordDate":"2023-07-12","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1060655","daysToCover":1.9,"shortPercentOfFloat":0.71,"shortPriorMo":"1031584","percentChangeMoMo":2.82,"sharesFloat":"149131447","averageDailyVolume":"557087","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-07-05","settlementDate":"2023-06-30"},{"recordDate":"2023-06-27","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1031584","daysToCover":1.63,"shortPercentOfFloat":0.69,"shortPriorMo":"1013311","percentChangeMoMo":1.8,"sharesFloat":"149131447","averageDailyVolume":"632436","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-06-20","settlementDate":"2023-06-15"},{"recordDate":"2023-06-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1013311","daysToCover":1.84,"shortPercentOfFloat":0.68,"shortPriorMo":"1062091","percentChangeMoMo":-4.59,"sharesFloat":"149131447","averageDailyVolume":"549847","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-06-02","settlementDate":"2023-05-31"},{"recordDate":"2023-05-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1062091","daysToCover":1.01,"shortPercentOfFloat":0.71,"shortPriorMo":"1067141","percentChangeMoMo":-0.47,"sharesFloat":"149131447","averageDailyVolume":"1048974","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-05-17","settlementDate":"2023-05-15"},{"recordDate":"2023-05-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1067141","daysToCover":2.6,"shortPercentOfFloat":0.72,"shortPriorMo":"1014860","percentChangeMoMo":5.15,"sharesFloat":"149131447","averageDailyVolume":"410694","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-05-02","settlementDate":"2023-04-28"},{"recordDate":"2023-04-25","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"1014860","daysToCover":1.9,"shortPercentOfFloat":0.68,"shortPriorMo":"693518","percentChangeMoMo":46.34,"sharesFloat":"149131447","averageDailyVolume":"533956","sharesOutstanding":"185987426","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-04-18","settlementDate":"2023-04-14"},{"recordDate":"2023-04-12","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"693518","daysToCover":1,"shortPercentOfFloat":0.55,"shortPriorMo":"532194","percentChangeMoMo":30.31,"sharesFloat":"125480147","averageDailyVolume":"1470194","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-04-04","settlementDate":"2023-03-31"},{"recordDate":"2023-03-24","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"532194","daysToCover":1,"shortPercentOfFloat":0.42,"shortPriorMo":"582882","percentChangeMoMo":-8.7,"sharesFloat":"125480147","averageDailyVolume":"831350","sharesOutstanding":"184184143","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-03-17","settlementDate":"2023-03-15"},{"recordDate":"2023-03-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"582882","daysToCover":1.21,"shortPercentOfFloat":0.34,"shortPriorMo":"587121","percentChangeMoMo":-0.72,"sharesFloat":"171018076","averageDailyVolume":"480190","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-03-02","settlementDate":"2023-02-28"},{"recordDate":"2023-02-27","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"587121","daysToCover":1.14,"shortPercentOfFloat":0.34,"shortPriorMo":"649050","percentChangeMoMo":-9.54,"sharesFloat":"171018076","averageDailyVolume":"513229","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-02-17","settlementDate":"2023-02-15"},{"recordDate":"2023-02-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"649050","daysToCover":1,"shortPercentOfFloat":0.38,"shortPriorMo":"583076","percentChangeMoMo":11.31,"sharesFloat":"171018076","averageDailyVolume":"1031345","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-02-02","settlementDate":"2023-01-31"},{"recordDate":"2023-01-25","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"583076","daysToCover":1.29,"shortPercentOfFloat":0.34,"shortPriorMo":"671234","percentChangeMoMo":-13.13,"sharesFloat":"171018076","averageDailyVolume":"450724","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-01-18","settlementDate":"2023-01-13"},{"recordDate":"2023-01-11","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"671234","daysToCover":1,"shortPercentOfFloat":0.39,"shortPriorMo":"398353","percentChangeMoMo":68.5,"sharesFloat":"171018076","averageDailyVolume":"1660243","sharesOutstanding":"185987512","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2023-01-04","settlementDate":"2022-12-30"},{"recordDate":"2022-12-27","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"398353","daysToCover":1,"shortPercentOfFloat":0.27,"shortPriorMo":"411719","percentChangeMoMo":-3.25,"sharesFloat":"150159059","averageDailyVolume":"998827","sharesOutstanding":"185880255","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2022-12-19","settlementDate":"2022-12-15"},{"recordDate":"2022-12-09","symbol":"TCNNF","company":"Trulieve Cannabis Corporation","totalShortInterest":"411719","daysToCover":1,"shortPercentOfFloat":0.27,"shortPriorMo":"398732","percentChangeMoMo":3.26,"sharesFloat":"150159059","averageDailyVolume":"474016","sharesOutstanding":"185880255","exchange":"OTC","sector":"Healthcare","industry":"Drug Manufacturers—Specialty \u0026 Generic","exchangeReceiptDate":"2022-12-02","settlementDate":"2022-11-30"}],"splitsSummary":{"last":null,"next":null,"splits":[]},"symbol":"TCNNF","tickerDetails":{"symbol":"TCNNF","financialStats":{"operationRatiosAsOf1Y":"2023-12-31","revenueGrowth1Y":-0.073086},"company":{"exists":true,"fiscalYearEnd":12,"longDescription":"Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis."},"keyStatistics":{"revenueGrowth":0.032971,"grossMargin":0.521282,"cashAndCashEquivalents":237666000,"totalAssets":2874243000,"longTermDebt":477176000,"currentDebt":3342000,"totalDebtEquityRatio":0.625537,"currentRatio":4.411426,"ebitdaMargin":-0.019463,"psRatio":0.992234,"evToEbitda":5.3573,"pcfRatio":3.12463,"tangibleBookValuePerShare":-0.239},"peers":[],"percentiles":[]},"wiim":null,"earningsSummary":{"earnings":[{"currency":"USD","cusip":"89788C104","date":"2025-02-27","date_confirmed":0,"eps":"","eps_est":"-0.090","eps_prior":"-0.120","eps_surprise":"","eps_surprise_percent":"","eps_type":"","exchange":"OTC","id":"65e07540ea8d4900019d537e","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2024,"revenue":"","revenue_est":"301390000.000","revenue_prior":"287000000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"","ticker":"TCNNF","time":"06:00:00","updated":1729779525},{"currency":"USD","cusip":"89788C104","date":"2024-11-05","date_confirmed":1,"eps":"-0.060","eps_est":"-0.130","eps_prior":"-0.080","eps_surprise":"0.0700","eps_surprise_percent":"0.5385","eps_type":"Adj","exchange":"OTC","id":"654ca64a336d940001b2209a","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2024,"revenue":"284300000.000","revenue_est":"291550000.000","revenue_prior":"275200000.000","revenue_surprise":"-7250000.0000","revenue_surprise_percent":"-0.0249","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1730804771},{"currency":"USD","cusip":"89788C104","date":"2024-08-06","date_confirmed":1,"eps":"0.000","eps_est":"-0.090","eps_prior":"-0.080","eps_surprise":"0.0900","eps_surprise_percent":"1.0000","eps_type":"Adj","exchange":"OTC","id":"64d364dde42a0b0001100d9c","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q2","period_year":2024,"revenue":"303400000.000","revenue_est":"293400000.000","revenue_prior":"281800000.000","revenue_surprise":"10000000.0000","revenue_surprise_percent":"0.0341","revenue_type":"GAAP","ticker":"TCNNF","time":"07:30:00","updated":1722944092},{"currency":"USD","cusip":"89788C104","date":"2024-05-09","date_confirmed":1,"eps":"-0.050","eps_est":"-0.110","eps_prior":"-0.110","eps_surprise":"0.0600","eps_surprise_percent":"0.5455","eps_type":"Adj","exchange":"OTC","id":"645b66114951d30001064eda","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q1","period_year":2024,"revenue":"297600000.000","revenue_est":"286360000.000","revenue_prior":"289100000.000","revenue_surprise":"11240000.0000","revenue_surprise_percent":"0.0393","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1715249293},{"currency":"USD","cusip":"89788C104","date":"2024-02-29","date_confirmed":1,"eps":"-0.120","eps_est":"-0.160","eps_prior":"-0.180","eps_surprise":"0.0400","eps_surprise_percent":"0.2500","eps_type":"Adj","exchange":"OTC","id":"6422921a4a876f0001e73b14","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2023,"revenue":"287000000.000","revenue_est":"267950000.000","revenue_prior":"298500000.000","revenue_surprise":"19050000.0000","revenue_surprise_percent":"0.0711","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1709205022},{"currency":"USD","cusip":"89788C104","date":"2023-11-09","date_confirmed":1,"eps":"-0.080","eps_est":"-0.170","eps_prior":"0.020","eps_surprise":"0.0900","eps_surprise_percent":"0.5294","eps_type":"Adj","exchange":"OTC","id":"636b50691d263400015fe93f","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2023,"revenue":"275200000.000","revenue_est":"269470000.000","revenue_prior":"300793000.000","revenue_surprise":"5730000.0000","revenue_surprise_percent":"0.0213","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1699528539},{"currency":"USD","cusip":"89788C104","date":"2023-08-09","date_confirmed":1,"eps":"-0.080","eps_est":"-0.190","eps_prior":"-0.010","eps_surprise":"0.1100","eps_surprise_percent":"0.5789","eps_type":"Adj","exchange":"OTC","id":"62f358645558230001161477","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q2","period_year":2023,"revenue":"281800000.000","revenue_est":"280670000.000","revenue_prior":"320300000.000","revenue_surprise":"1130000.0000","revenue_surprise_percent":"0.0040","revenue_type":"GAAP","ticker":"TCNNF","time":"07:00:00","updated":1691579867},{"currency":"USD","cusip":"89788C104","date":"2023-05-10","date_confirmed":1,"eps":"-0.110","eps_est":"-0.160","eps_prior":"0.010","eps_surprise":"0.0500","eps_surprise_percent":"0.3125","eps_type":"Adj","exchange":"OTC","id":"627cb14b4a3c0b000180d557","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q1","period_year":2023,"revenue":"289100000.000","revenue_est":"292910000.000","revenue_prior":"318300000.000","revenue_surprise":"-3810000.0000","revenue_surprise_percent":"-0.0130","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1683712900},{"currency":"USD","cusip":"89788C104","date":"2023-03-08","date_confirmed":1,"eps":"-0.180","eps_est":"-0.110","eps_prior":"0.010","eps_surprise":"-0.0700","eps_surprise_percent":"-0.6364","eps_type":"Adj","exchange":"OTC","id":"624400a93ed058000183a82a","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2022,"revenue":"302000000.000","revenue_est":"304810000.000","revenue_prior":"305300000.000","revenue_surprise":"-2810000.0000","revenue_surprise_percent":"-0.0092","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1678273470},{"currency":"USD","cusip":"89788C104","date":"2022-11-09","date_confirmed":1,"eps":"0.020","eps_est":"-0.050","eps_prior":"0.140","eps_surprise":"0.0700","eps_surprise_percent":"1.4000","eps_type":"Adj","exchange":"OTC","id":"6192059cda975a00014fbcb6","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2022,"revenue":"300793000.000","revenue_est":"308420000.000","revenue_prior":"224092000.000","revenue_surprise":"-7627000.0000","revenue_surprise_percent":"-0.0247","revenue_type":"GAAP","ticker":"TCNNF","time":"16:15:00","updated":1668036620},{"currency":"USD","cusip":"89788C104","date":"2022-08-10","date_confirmed":1,"eps":"-0.010","eps_est":"0.070","eps_prior":"0.310","eps_surprise":"-0.0800","eps_surprise_percent":"-1.1429","eps_type":"Adj","exchange":"OTC","id":"6114c76afb18e800018cc651","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q2","period_year":2022,"revenue":"320300000.000","revenue_est":"320520000.000","revenue_prior":"215122000.000","revenue_surprise":"-220000.0000","revenue_surprise_percent":"-0.0007","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1660832499},{"currency":"USD","cusip":"89788C104","date":"2022-05-12","date_confirmed":1,"eps":"0.010","eps_est":"0.030","eps_prior":"0.240","eps_surprise":"-0.0200","eps_surprise_percent":"-0.6667","eps_type":"Adj","exchange":"OTC","id":"609ccebf02f2590001ab31f4","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q1","period_year":2022,"revenue":"318300000.000","revenue_est":"307080000.000","revenue_prior":"193823000.000","revenue_surprise":"11220000.0000","revenue_surprise_percent":"0.0365","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1652352920},{"currency":"USD","cusip":"89788C104","date":"2022-03-30","date_confirmed":1,"eps":"0.010","eps_est":"0.180","eps_prior":"0.310","eps_surprise":"-0.1700","eps_surprise_percent":"-0.9444","eps_type":"Adj","exchange":"OTC","id":"60599240b0ce0700013d1401","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2021,"revenue":"305300000.000","revenue_est":"","revenue_prior":"168437000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1648634714},{"currency":"USD","cusip":"89788C104","date":"2021-11-15","date_confirmed":1,"eps":"0.140","eps_est":"0.240","eps_prior":"0.040","eps_surprise":"-0.1000","eps_surprise_percent":"-0.4167","eps_type":"GAAP","exchange":"OTC","id":"5fbf52b395505d0001cd2932","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2021,"revenue":"224092000.000","revenue_est":"","revenue_prior":"136274000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"TCNNF","time":"06:30:00","updated":1636986633},{"currency":"USD","cusip":"89788C104","date":"2021-08-12","date_confirmed":1,"eps":"0.310","eps_est":"0.260","eps_prior":"0.060","eps_surprise":"0.0500","eps_surprise_percent":"0.1923","eps_type":"GAAP","exchange":"OTC","id":"5f34e5491ef0a0000183c3a0","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q2","period_year":2021,"revenue":"215122000.000","revenue_est":"207500000.000","revenue_prior":"120765000.000","revenue_surprise":"7622000.0000","revenue_surprise_percent":"0.0367","revenue_type":"GAAP","ticker":"TCNNF","time":"06:30:00","updated":1628774524},{"currency":"USD","cusip":"89788C104","date":"2021-05-13","date_confirmed":1,"eps":"0.240","eps_est":"0.240","eps_prior":"0.120","eps_surprise":"0.0000","eps_surprise_percent":"0.0000","eps_type":"GAAP","exchange":"OTC","id":"5ec6274d908ed5000184d164","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q1","period_year":2021,"revenue":"193823000.000","revenue_est":"188290000.000","revenue_prior":"96057000.000","revenue_surprise":"5533000.0000","revenue_surprise_percent":"0.0294","revenue_type":"GAAP","ticker":"TCNNF","time":"06:30:00","updated":1620943197},{"currency":"USD","cusip":"89788C104","date":"2021-03-23","date_confirmed":1,"eps":"0.310","eps_est":"0.220","eps_prior":"0.410","eps_surprise":"0.0900","eps_surprise_percent":"0.4091","eps_type":"GAAP","exchange":"OTC","id":"5e8d76c72225520001166a93","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2020,"revenue":"168437000.000","revenue_est":"162040000.000","revenue_prior":"79700000.000","revenue_surprise":"6397000.0000","revenue_surprise_percent":"0.0395","revenue_type":"GAAP","ticker":"TCNNF","time":"06:30:00","updated":1616536871},{"currency":"USD","cusip":"89788C104","date":"2020-11-17","date_confirmed":1,"eps":"0.040","eps_est":"0.220","eps_prior":"0.550","eps_surprise":"-0.1800","eps_surprise_percent":"-0.8182","eps_type":"GAAP","exchange":"OTC","id":"5e27f3187076fe0001ac582b","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2020,"revenue":"136274000.000","revenue_est":"131890000.000","revenue_prior":"70700000.000","revenue_surprise":"4384000.0000","revenue_surprise_percent":"0.0332","revenue_type":"GAAP","ticker":"TCNNF","time":"08:00:00","updated":1605618415},{"currency":"USD","cusip":"89788C104","date":"2020-08-12","date_confirmed":1,"eps":"0.060","eps_est":"","eps_prior":"0.520","eps_surprise":"","eps_surprise_percent":"","eps_type":"GAAP","exchange":"OTC","id":"5e27e05c430dee0001c786f0","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q2","period_year":2020,"revenue":"120765000.000","revenue_est":"","revenue_prior":"57900000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"TCNNF","time":"06:30:00","updated":1597269126},{"currency":"USD","cusip":"89788C104","date":"2020-05-20","date_confirmed":1,"eps":"0.120","eps_est":"","eps_prior":"0.130","eps_surprise":"","eps_surprise_percent":"","eps_type":"GAAP","exchange":"OTC","id":"5e27e05e430dee0001c786f2","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q1","period_year":2020,"revenue":"96057000.000","revenue_est":"","revenue_prior":"44500000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"GAAP","ticker":"TCNNF","time":"08:00:00","updated":1594356470},{"currency":"USD","cusip":"89788C104","date":"2020-04-08","date_confirmed":1,"eps":"0.410","eps_est":"0.120","eps_prior":"","eps_surprise":"0.2900","eps_surprise_percent":"2.4167","eps_type":"","exchange":"OTC","id":"5e27e05f430dee0001c786f4","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2019,"revenue":"79700000.000","revenue_est":"78610000.000","revenue_prior":"","revenue_surprise":"1090000.0000","revenue_surprise_percent":"0.0139","revenue_type":"","ticker":"TCNNF","time":"08:00:00","updated":1586342040}],"last":{"currency":"USD","cusip":"89788C104","date":"2024-11-05","date_confirmed":1,"eps":"-0.060","eps_est":"-0.130","eps_prior":"-0.080","eps_surprise":"0.0700","eps_surprise_percent":"0.5385","eps_type":"Adj","exchange":"OTC","id":"654ca64a336d940001b2209a","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q3","period_year":2024,"revenue":"284300000.000","revenue_est":"291550000.000","revenue_prior":"275200000.000","revenue_surprise":"-7250000.0000","revenue_surprise_percent":"-0.0249","revenue_type":"GAAP","ticker":"TCNNF","time":"06:00:00","updated":1730804771},"next":{"currency":"USD","cusip":"89788C104","date":"2025-02-27","date_confirmed":0,"eps":"","eps_est":"-0.090","eps_prior":"-0.120","eps_surprise":"","eps_surprise_percent":"","eps_type":"","exchange":"OTC","id":"65e07540ea8d4900019d537e","importance":2,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","period":"Q4","period_year":2024,"revenue":"","revenue_est":"301390000.000","revenue_prior":"287000000.000","revenue_surprise":"","revenue_surprise_percent":"","revenue_type":"","ticker":"TCNNF","time":"06:00:00","updated":1729779525},"year":null},"etfFund":null,"guidance":[{"currency":"USD","cusip":"89788C104","date":"2022-11-09","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"636c36f62cec4c00019f76e7","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"Targeting the low end of 2022 guidance of $1.25 billion to $1.3 billion","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1260000000.000","revenue_guidance_max":"1250000000.000","revenue_guidance_min":"1250000000.000","revenue_guidance_prior_max":"1300000000.000","revenue_guidance_prior_min":"1250000000.000","revenue_type":"GAAP","ticker":"TCNNF","time":"18:25:42","updated":1668036390},{"currency":"USD","cusip":"89788C104","date":"2022-08-10","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"62f38dfe2127030001d3f923","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1340000000.000","revenue_guidance_max":"1300000000.000","revenue_guidance_min":"1250000000.000","revenue_guidance_prior_max":"1400000000.000","revenue_guidance_prior_min":"1300000000.000","revenue_type":"GAAP","ticker":"TCNNF","time":"06:52:46","updated":1660128906},{"currency":"USD","cusip":"89788C104","date":"2022-05-12","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"627cde04766cb1000166cdae","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1350000000.000","revenue_guidance_max":"1400000000.000","revenue_guidance_min":"1300000000.000","revenue_guidance_prior_max":"","revenue_guidance_prior_min":"","revenue_type":"GAAP","ticker":"TCNNF","time":"06:14:28","updated":1652350513},{"currency":"USD","cusip":"89788C104","date":"2021-03-23","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"605b1c428b500900011df0c8","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2021,"prelim":"N","revenue_guidance_est":"826160000.000","revenue_guidance_max":"850000000.000","revenue_guidance_min":"815000000.000","revenue_guidance_prior_max":"","revenue_guidance_prior_min":"","revenue_type":"GAAP","ticker":"TCNNF","time":"07:02:26","updated":1616583837}],"guidanceSummary":{"guidance":[{"currency":"USD","cusip":"89788C104","date":"2022-11-09","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"636c36f62cec4c00019f76e7","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"Targeting the low end of 2022 guidance of $1.25 billion to $1.3 billion","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1260000000.000","revenue_guidance_max":"1250000000.000","revenue_guidance_min":"1250000000.000","revenue_guidance_prior_max":"1300000000.000","revenue_guidance_prior_min":"1250000000.000","revenue_type":"GAAP","ticker":"TCNNF","time":"18:25:42","updated":1668036390},{"currency":"USD","cusip":"89788C104","date":"2022-08-10","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"62f38dfe2127030001d3f923","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1340000000.000","revenue_guidance_max":"1300000000.000","revenue_guidance_min":"1250000000.000","revenue_guidance_prior_max":"1400000000.000","revenue_guidance_prior_min":"1300000000.000","revenue_type":"GAAP","ticker":"TCNNF","time":"06:52:46","updated":1660128906},{"currency":"USD","cusip":"89788C104","date":"2022-05-12","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"627cde04766cb1000166cdae","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1350000000.000","revenue_guidance_max":"1400000000.000","revenue_guidance_min":"1300000000.000","revenue_guidance_prior_max":"","revenue_guidance_prior_min":"","revenue_type":"GAAP","ticker":"TCNNF","time":"06:14:28","updated":1652350513},{"currency":"USD","cusip":"89788C104","date":"2021-03-23","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"605b1c428b500900011df0c8","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"","period":"FY","period_year":2021,"prelim":"N","revenue_guidance_est":"826160000.000","revenue_guidance_max":"850000000.000","revenue_guidance_min":"815000000.000","revenue_guidance_prior_max":"","revenue_guidance_prior_min":"","revenue_type":"GAAP","ticker":"TCNNF","time":"07:02:26","updated":1616583837}],"last":{"currency":"USD","cusip":"89788C104","date":"2022-11-09","eps_guidance_est":"","eps_guidance_max":"","eps_guidance_min":"","eps_guidance_prior_max":"","eps_guidance_prior_min":"","eps_type":"","exchange":"OTC","id":"636c36f62cec4c00019f76e7","importance":0,"is_primary":"Y","name":"Trulieve Cannabis","notes":"Targeting the low end of 2022 guidance of $1.25 billion to $1.3 billion","period":"FY","period_year":2022,"prelim":"N","revenue_guidance_est":"1260000000.000","revenue_guidance_max":"1250000000.000","revenue_guidance_min":"1250000000.000","revenue_guidance_prior_max":"1300000000.000","revenue_guidance_prior_min":"1250000000.000","revenue_type":"GAAP","ticker":"TCNNF","time":"18:25:42","updated":1668036390},"next":null},"initialRecentNews":[{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis rescheduling pharma walgreens cvs","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"902319","filename":"AI-Generated-Image.jpeg","filepath":"files/images/story/2024/11/28/AI-Generated-Image.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":64,"vid":1,"name":"M\u0026A"},{"tid":927212,"vid":1,"name":"Market Summary"},{"tid":57,"vid":1,"name":"News"},{"tid":144213,"vid":1,"name":"Regulations"},{"tid":140295,"vid":1,"name":"Health Care"},{"tid":30777,"vid":1,"name":"Retail Sales"},{"tid":59,"vid":1,"name":"FDA"},{"tid":29619,"vid":1,"name":"Legal"},{"tid":60,"vid":1,"name":"Management"},{"tid":145889,"vid":1,"name":"Exclusives"},{"tid":2,"vid":1,"name":"Markets"},{"tid":22,"vid":1,"name":"Trading Ideas"},{"tid":125566,"vid":1,"name":"Interview"}],"created":"2024-11-28T17:30:25Z","createdAt":"2024-11-28T17:30:25Z","id":42235292,"image":"https://www.benzinga.com/files/images/story/2024/11/28/AI-Generated-Image.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":8099,"Industry":"Health \u0026 Allied Services, N.E.C.","IndustryGroup":809,"MajorGroup":80,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""},{"IndustryCode":5912,"Industry":"Drug Stores \u0026 Proprietary Stores","IndustryGroup":591,"MajorGroup":59,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":621399,"NationalIndustry":"Offices of All Other Miscellaneous Health Practitioners ","IndustryCode":62139,"Industry":"Offices of All Other Health Practitioners","IndustryGroupCode":6213,"IndustryGroup":"Offices of Other Health Practitioners","SubSectorCode":621,"SubSector":"Ambulatory Health Care Services","SectorCode":62,"Sector":"Health Care and Social Assistance"},{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":446110,"NationalIndustry":"Pharmacies and Drug Stores ","IndustryCode":44611,"Industry":"Pharmacies and Drug Stores ","IndustryGroupCode":4461,"IndustryGroup":"Health and Personal Care Stores ","SubSectorCode":446,"SubSector":"Health and Personal Care Stores ","SectorCode":44,"Sector":"Retail Trade"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":20630010,"Industry":"Healthcare Plans","IndustryGroupCode":20630,"IndustryGroup":"Healthcare Plans","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"},{"IndustryCode":20645020,"Industry":"Pharmaceutical Retailers","IndustryGroupCode":20645,"IndustryGroup":"Healthcare Providers \u0026 Services","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":668299,"post_path":"government/regulations/24/11/42235292/pharma-grade-cannabis-could-hit-walgreens-cvs-but-can-the-industry-survive-the-fda","post_type":"post"}},"nodeId":42235292,"stocks":[{"tid":786348,"vid":2,"name":"AYRWF"},{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":14215,"vid":2,"name":"CVS","description":"Cvs Corp."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":714097,"vid":2,"name":"TRSSF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"},{"tid":147996,"vid":2,"name":"WBA","description":"Walgreens Boots Alliance Inc."}],"storyId":"6748a8a5b6cb720001aba510","tags":[{"tid":744472,"vid":3,"name":"Cannabis Legislation"},{"tid":733528,"vid":3,"name":"Cannabis M\u0026A"},{"tid":775074,"vid":3,"name":"Cannabis Markets"},{"tid":753067,"vid":3,"name":"Cannabis Regulation"},{"tid":793737,"vid":3,"name":"cannabis regulatory update"},{"tid":907579,"vid":3,"name":"cannabis rescheduling"},{"tid":148171,"vid":3,"name":"cannabis stocks"},{"tid":856059,"vid":3,"name":"Controlled Substance Act"},{"tid":144282,"vid":3,"name":"CVS Corporation"},{"tid":39013,"vid":3,"name":"DEA"},{"tid":886459,"vid":3,"name":"Denise Pollicella"},{"tid":18656,"vid":3,"name":"Donald Trump"},{"tid":684909,"vid":3,"name":"FDA"},{"tid":717114,"vid":3,"name":"Florida Cannabis"},{"tid":664672,"vid":3,"name":"Michigan cannabis"},{"tid":945813,"vid":3,"name":"Omnus Law"},{"tid":797787,"vid":3,"name":"Pennsylvania cannabis"},{"tid":37433,"vid":3,"name":"Walgreens"},{"tid":152456,"vid":3,"name":"Walgreens Boots Alliance"}],"teaser":"As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.","teaserText":"As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.","tickers":[{"tid":786348,"vid":2,"name":"AYRWF"},{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":14215,"vid":2,"name":"CVS","description":"Cvs Corp."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":714097,"vid":2,"name":"TRSSF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"},{"tid":147996,"vid":2,"name":"WBA","description":"Walgreens Boots Alliance Inc."}],"title":"Pharma-Grade Cannabis Could Hit Walgreens \u0026amp; CVS—But Can The Industry Survive The FDA?","updated":"2024-11-28T17:30:25Z","updatedAt":"2024-11-28T17:30:25Z","url":"https://www.benzinga.com/government/regulations/24/11/42235292/pharma-grade-cannabis-could-hit-walgreens-cvs-but-can-the-industry-survive-the-fda"},{"assets":[{"type":"image","title":"DALL·E-2024-11-27-19.03","alt":"cannabis license florida","source":"","mime":"","primary":true,"attributes":{"fid":"902213","filename":"DALLE-2024-11-27-19-03.jpeg","filepath":"files/images/story/2024/11/27/DALLE-2024-11-27-19-03.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Franca Quarneti","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-27T22:32:25Z","createdAt":"2024-11-27T22:32:25Z","id":42226503,"image":"https://www.benzinga.com/files/images/story/2024/11/27/DALLE-2024-11-27-19-03.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":668288,"post_path":"24/11/42226503/florida-awards-22-new-cannabis-licenses-after-18-month-waitlegal-battles-ahead","post_type":"post"}},"nodeId":42226503,"stocks":[{"tid":731053,"vid":2,"name":"TCNNF","primary":true}],"storyId":"67479dedb6cb720001ab8321","tags":[{"tid":698880,"vid":3,"name":"cannabis license"},{"tid":717114,"vid":3,"name":"Florida Cannabis"},{"tid":945780,"vid":3,"name":"Florida's Department of Health"},{"tid":802491,"vid":3,"name":"Gov. Ron DeSantis"},{"tid":721801,"vid":3,"name":"Jim Belushi"},{"tid":698879,"vid":3,"name":"marijuana license"},{"tid":631239,"vid":3,"name":"medical cannabis"},{"tid":41047,"vid":3,"name":"medical marijuana"},{"tid":519269,"vid":3,"name":"Ron DeSantis"}],"teaser":"Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000.","teaserText":"Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000.","tickers":[{"tid":731053,"vid":2,"name":"TCNNF","primary":true}],"title":"Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?","updated":"2024-11-27T22:32:25Z","updatedAt":"2024-11-27T22:32:25Z","url":"https://www.benzinga.com/24/11/42226503/florida-awards-22-new-cannabis-licenses-after-18-month-waitlegal-battles-ahead"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis market usa","source":"AI-Generated Image ","mime":"image/jpeg","primary":true,"attributes":{"fid":"901801","filename":"AI-Generated-Image_0.jpeg","filepath":"files/images/story/2024/11/26/AI-Generated-Image_0.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-26T15:45:19Z","createdAt":"2024-11-26T15:45:19Z","id":42193387,"image":"https://www.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_0.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665137,"post_path":"news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030","post_type":"post"}},"nodeId":42193387,"stocks":[{"tid":786348,"vid":2,"name":"AYRWF"},{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":801974,"vid":2,"name":"CSE:AAWH"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":761043,"vid":2,"name":"VEXTF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"},{"vid":2,"name":"AAWHF"},{"vid":2,"name":"TGODF"},{"vid":2,"name":"HRVSF"}],"storyId":"6745ed0bb6cb720001aaf181","tags":[{"tid":902888,"vid":3,"name":"cannabis retail sales"}],"teaser":"According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.","teaserText":"According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.","tickers":[{"tid":786348,"vid":2,"name":"AYRWF"},{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":801974,"vid":2,"name":"CSE:AAWH"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":761043,"vid":2,"name":"VEXTF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"},{"vid":2,"name":"AAWHF"},{"vid":2,"name":"TGODF"},{"vid":2,"name":"HRVSF"}],"title":"Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030","updated":"2024-11-26T15:45:19Z","updatedAt":"2024-11-26T15:45:19Z","url":"https://www.benzinga.com/news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030"}],"isPublicComSupported":false,"listings":[{"symbol":"TCNNF","type":"STOCK","cik":1754195,"name":"Trulieve Cannabis Corp","exchange":"OTC","shortName":"Trulieve Cannabis Corp","description":"TRULIEVE CANNABIS CORP by Trulieve Cannabis Corporation","currency":"USD"}],"newsAll":[{"id":42235292,"author":"Nicolás Jose Rodriguez","created":"Thu, 28 Nov 2024 12:30:25 -0500","updated":"Thu, 28 Nov 2024 12:30:25 -0500","title":"Pharma-Grade Cannabis Could Hit Walgreens \u0026 CVS—But Can The Industry Survive The FDA?","teaser":"As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.","body":"\u003cp\u003eAs the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. With the \u003cstrong\u003eDEA\u003c/strong\u003e hearing delayed until early 2025 and a possible \u003cstrong\u003eTrump\u003c/strong\u003e presidency adding uncertainty, cannabis businesses are preparing for what rescheduling to Schedule III could mean.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eFrom \u003cstrong\u003eFDA\u003c/strong\u003e oversight to interstate commerce and pharmaceutical-grade standards, these changes could fundamentally reshape the landscape—and investors and businesses need to be ready.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch2 class=\"wp-block-heading\"\u003eRescheduling: A Door To Big-Box Pharmacies?\u003c/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDenise Pollicella\u003c/strong\u003e, a cannabis attorney and head of \u003cstrong\u003eOmnus Law\u003c/strong\u003e\u0026#8216;s cannabis practice, points out that rescheduling cannabis isn't just about new retail partnerships but about overhauling how cannabis businesses operate.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\"It's about transforming how cannabis businesses operate—adapting to FDA oversight, meeting pharmaceutical-grade standards, and navigating stricter compliance requirements,\" she told Benzinga Cannabis in an exclusive interview.\u003c/p\u003e\n\u003cp\u003eRescheduling to Schedule III could allow major pharmaceutical retailers like \u003cstrong\u003eCVS\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CVS#NYSE\"\u003eCVS\u003c/a\u003e) and \u003cstrong\u003eWalgreens\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/WBA#NASDAQ\"\u003eWBA\u003c/a\u003e) to carry cannabis. But is the pathway straightforward? \u003c/p\u003e\n\u003cp\u003ePollicella anticipates a system similar to the \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42068539/billion-dollar-strike-farm-bill-amendment-could-change-the-hemp-industry\"\u003e2018 hemp legalization framework\u003c/a\u003e, where states submit regulatory schemes to meet federal guidelines. \"Most states prefer to regulate these things themselves, particularly from a financial and tax point of view,\" she said, noting states' interest in retaining control of fees and fines.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28053734/Denise-Pollicella-Square-Website-Image.png\" alt=\"\" class=\"wp-image-668972\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28053734/Denise-Pollicella-Square-Website-Image.png 500w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28053734/Denise-Pollicella-Square-Website-Image-300x300.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28053734/Denise-Pollicella-Square-Website-Image-150x150.png 150w\" sizes=\"(max-width: 500px) 100vw, 500px\" /\u003e\u003cfigcaption class=\"wp-element-caption\"\u003e\u003cem\u003eDenise Pollicella \u003c/em\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eFDA Oversight: Stricter Standards Ahead\u003c/h3\u003e\n\u003cp\u003eIf cannabis becomes a pharmaceutical-grade product, compliance with\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33482140/rescheduling-cannabis-what-are-the-implications-for-msos-tax-rule-280e-fda-and-phar\"\u003e FDA standards will significantly change how businesses operate\u003c/a\u003e. Pollicella explained that the cannabis industry has historically focused on ensuring safety and avoiding contaminants, with minimal emphasis on seed traceability. \"Most of the testing and analysis has revolved around making sure that it's safe and doesn't have contaminants, and then around THC and CBD levels,\" she noted.\u003c/p\u003e\n\u003cp\u003ePollicella added that transitioning to pharmaceutical-grade products would require stricter production standards and significantly more testing, which could drive up costs in an already expensive industry. Pollicella noted the likely challenges: \"When it goes to a more pharmaceutical-grade product, not only will the production standards have to become more strict, but you'll also have significantly more testing.\"\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39720968/is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions\"\u003e Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eInterstate Commerce\u003c/h3\u003e\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41502695/exclusive-tilray-ceo-irwin-simon-on-why-us-cannabis-rescheduling-wont-change-a-billion-dollar-pl\"\u003eRescheduling cannabis from Schedule I to Schedule III \u003c/a\u003ecould pave the way for interstate trade, a shift that would fundamentally reshape supply chains and market dynamics. By lowering cannabis\u0026#8217;s federal regulatory classification, rescheduling would enable cannabis to be treated more like other pharmaceutical products, potentially allowing producers in one state to sell to buyers in another. However, this transition would introduce new regulatory complexities.\u003c/p\u003e\n\u003cp\u003ePollicella thinks that cannabis crossing state lines will require permissions, excise taxes, and strict identification as medical marijuana, and noted that states with mature medical markets, such as \u003ca href=\"https://www.benzinga.com/topic/michigan-cannabis\"\u003eMichigan\u003c/a\u003e, \u003ca href=\"https://www.benzinga.com/topic/pennsylvania-cannabis\"\u003ePennsylvania\u003c/a\u003e, and \u003ca href=\"https://www.benzinga.com/topic/florida-cannabis\"\u003eFlorida\u003c/a\u003e, could dominate the wholesale market. \u003c/p\u003e\n\u003cp\u003eMSOs operating in these states include \u003cstrong\u003eTerrAscend\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TRSSF#OTC\"\u003eTRSSF\u003c/a\u003e), \u003cstrong\u003eCresco Labs Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e) in Michigan; \u003cstrong\u003eGreen Thumb Industries Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e), \u003cstrong\u003eCuraleaf\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), and \u003cstrong\u003eVerano Holdings Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e) in Pennsylvania; and \u003cstrong\u003eTrulieve Cannabis Corp. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) and \u003cstrong\u003eAyr Wellness Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AYRWF#OTC\"\u003eAYRWF\u003c/a\u003e) in Florida.\u003c/p\u003e\n\u003cp\u003eThese companies have heavily invested in CapEx for pharmaceutical-grade cannabis to meet stringent standards aligned with FDA requirements, positioning them to \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39609582/europe-is-turning-cash-flow-positive-well-see-what-happens-in-the-u-s-largest-canna\"\u003esupply pharmacies and other large-scale buyers\u003c/a\u003e. \"Michigan has tried to position itself as being nearly equal to FDA standards,\" Pollicella explained, highlighting the state's competitive advantage.\u0026nbsp;\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eM\u0026amp;A Activity: A Rescheduled Catalyst? \u003c/h3\u003e\n\u003cp\u003eThe prospect of federal rescheduling is already sparking discussions about mergers and acquisitions. Pollicella foresees significant consolidation as businesses struggle to meet pharmaceutical-grade compliance. \"Companies that have grown thoughtfully and in a measured way are going to knock it out of the park,\" she said, emphasizing the Darwinian nature of the cannabis business.\u003c/p\u003e\n\u003cp\u003eMidwest markets, like Michigan and Illinois, are expected to play pivotal roles in\u003ca href=\"https://www.benzinga.com/cannabis/deals\"\u003e M\u0026amp;A activity\u003c/a\u003e. Pollicella highlighted Michigan's readiness, citing its strict testing standards and proactive lobbying efforts. \u0026#8220;Michigan has tried to position itself as being nearly equal to FDA standards,\u0026#8221; she explained, adding that the state could become a major producer for the Midwest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38881456/bidens-greenlight-what-to-know-about-fed-regulated-marijuana-markets-legal-circuits-and-complian\"\u003e Biden\u0026#8217;s Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003eWill A Trump Presidency Delay Progress?\u003c/h2\u003e\n\u003cp\u003ePollicella warns that\u003ca href=\"https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform\"\u003e rescheduling is far from guaranteed.\u003c/a\u003e \"Anybody counting on the rescheduling of marijuana down to Schedule III in the new administration is making an assumption that's not necessarily based on anything we've seen yet,\" she cautioned.\u003c/p\u003e\n\u003cp\u003eWhile some industry advocates hope the promise of tax revenue and economic growth will sway federal policymakers, Pollicella remains skeptical. \"It's not a priority for this administration,\" she said, adding that substantial lobbying will likely be needed to make progress.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e2025\u003c/h3\u003e\n\u003cp\u003eDespite the challenges, Pollicella is optimistic about the industry's potential under a rescheduled framework. She believes businesses with scalable production capabilities and strategic foresight will thrive. However, she also underscores the need for readiness.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDespite the significant political and economic discussions surrounding cannabis rescheduling, the process itself is more straightforward than many assume. Pollicella explains that the \u003cstrong\u003eControlled Substances Act\u003c/strong\u003e of 1970 placed cannabis on Schedule I through political and legislative decisions, rather than medical consensus. \"None of the criteria for Schedule I—no known medical use, no known safe use, and a high probability of addictiveness—really apply to marijuana,\" she said. As with its initial classification, rescheduling will require bipartisan consensus and can follow one of two paths.\u003c/p\u003e\n\u003cp\u003eCongress could pass legislation to amend the Controlled Substances Act, or the \u003cstrong\u003eAttorney General \u003c/strong\u003ecould direct the FDA and \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003e\u003cstrong\u003eDEA\u003c/strong\u003e to conduct a review\u003c/a\u003e and implement rescheduling through administrative rule-making.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42220254/dea-sets-stage-for-marijuana-rescheduling-with-december-2-hearing\"\u003eDEA Sets Stage For Marijuana Rescheduling With December 2 Hearing\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003ePolitical Will \u003c/h3\u003e\n\u003cp\u003e\"Once there's political will, it can happen like this,\" Pollicella said, snapping her fingers metaphorically to illustrate how quickly the process could move once initiated.\u003c/p\u003e\n\u003cp\u003eThis swift \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40632193/marijuana-rescheduling-is-not-solution-to-industrys-banking-issues-congressional-researchers-say\"\u003erescheduling would require states to align their regulatory schemes with federal guidelines\u003c/a\u003e. Pollicella anticipates that it might follow a model similar to the 2018 hemp rollout:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\"The \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/41936736/fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen\"\u003eFDA\u003c/a\u003e could give states with existing regulatory structures a timeline, say six to nine months, to refine their programs\u003ca href=\"https://www.benzinga.com/general/biotech/24/09/40820581/want-organic-cannabis-operators-are-turning-to-this-tech-to-save-millions-and-get-certified\"\u003e to meet federal standards\u003c/a\u003e. States that comply could maintain control, while those that don't might see federal intervention.\"\u003c/p\u003e\n\u003cp\u003eHowever, the question remains whether the upcoming administration will prioritize this process. \"The real challenge isn't the steps—it's the political will to move forward,\" she noted.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030\"\u003eFederal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/government/regulations/24/11/42235292/pharma-grade-cannabis-could-hit-walgreens-cvs-but-can-the-industry-survive-the-fda","image":"https://cdn.benzinga.com/files/images/story/2024/11/28/AI-Generated-Image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/28/AI-Generated-Image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/28/AI-Generated-Image.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":64,"name":"M\u0026A","description":""},{"tid":927212,"name":"Market Summary","description":""},{"tid":57,"name":"News","description":""},{"tid":144213,"name":"Regulations","description":""},{"tid":140295,"name":"Health Care","description":""},{"tid":30777,"name":"Retail Sales","description":""},{"tid":59,"name":"FDA","description":""},{"tid":29619,"name":"Legal","description":""},{"tid":60,"name":"Management","description":""},{"tid":145889,"name":"Exclusives","description":""},{"tid":2,"name":"Markets","description":""},{"tid":22,"name":"Trading Ideas","description":""},{"tid":125566,"name":"Interview","description":""}],"stocks":[{"tid":786348,"name":"AYRWF","description":null},{"tid":735580,"name":"CRLBF","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":14215,"name":"CVS","description":"Cvs Corp."},{"tid":724072,"name":"GTBIF","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":714097,"name":"TRSSF","description":""},{"tid":797063,"name":"VRNOF","description":"Verano Holdings"},{"tid":147996,"name":"WBA","description":"Walgreens Boots Alliance Inc."}],"tags":[{"tid":744472,"name":"Cannabis Legislation","description":""},{"tid":733528,"name":"Cannabis M\u0026A","description":""},{"tid":775074,"name":"Cannabis Markets","description":""},{"tid":753067,"name":"Cannabis Regulation","description":""},{"tid":793737,"name":"cannabis regulatory update","description":""},{"tid":907579,"name":"cannabis rescheduling","description":""},{"tid":148171,"name":"cannabis stocks","description":""},{"tid":856059,"name":"Controlled Substance Act","description":""},{"tid":144282,"name":"CVS Corporation","description":""},{"tid":39013,"name":"DEA","description":""},{"tid":886459,"name":"Denise Pollicella","description":""},{"tid":18656,"name":"Donald Trump","description":""},{"tid":684909,"name":"FDA","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":664672,"name":"Michigan cannabis","description":""},{"tid":945813,"name":"Omnus Law","description":""},{"tid":797787,"name":"Pennsylvania cannabis","description":""},{"tid":37433,"name":"Walgreens","description":""},{"tid":152456,"name":"Walgreens Boots Alliance","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42235292\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42235292\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42235292\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42226503,"author":"Franca Quarneti","created":"Wed, 27 Nov 2024 17:32:25 -0500","updated":"Wed, 27 Nov 2024 17:32:25 -0500","title":"Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?","teaser":"Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000.","body":"\u003cp\u003e\u003cstrong\u003eFlorida's Department of Health\u003c/strong\u003e announced plans to award 22 new medical cannabis licenses, a decision that could reshape the state's cannabis industry but is likely to face legal challenges. \u003c/p\u003e\n\u003cp\u003eThe announcement, posted Tuesday on the agency's website (\u003ca href=\"https://www.tallahassee.com/story/news/local/state/2024/11/27/florida-picks-22-applicants-to-get-next-medical-marijuana-licenses/76623095007/\"\u003evia\u003c/a\u003e Tallahassee Democrat), comes more than 18 months after applications closed in April 2023.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSee Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42225423/mexico-president-claudia-sheinbaum-to-trump-neither-threats-nor-tariffs-will-solve-your-fentanyl-crisis\"\u003eMexico President Claudia Sheinbaum To Trump: \u0026#8216;Neither Threats Nor Tariffs\u0026#8217; Will Solve Your Fentanyl Crisis\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe new licenses are a result of a 2017 law mandating an increase in licenses as the number of medical marijuana patients grows, which now surpasses 880,000. This process has attracted significant attention since it marks the first chance for new businesses to enter Florida\u0026#8217;s medical cannabis market since the law\u0026#8217;s enactment.\u003c/p\u003e\n\u003cp\u003eThe department's letters of intent signal approval for 22 businesses out of the 74 that applied last year, each paying a $143,000 application fee. The evaluation process, carried out by consulting firm \u003cstrong\u003eKPMG,\u003c/strong\u003e cost the state nearly $1.79 million. However, the letters do not grant immediate operating licenses, leaving room for legal action from applicants who were not selected.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eAnticipated Legal Battles\u003c/h3\u003e\n\u003cp\u003eLegal disputes are expected to delay the process, possibly for years, given the competitive nature of \u003ca href=\"https://www.benzinga.com/24/11/42017405/medical-marijuana-footprint-grows-in-florida-as-legalization-push-fizzles-and-other-new-cannabis-stores-that-launched-sales\"\u003eFlorida's cannabis market. \u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\"Historically, when these sorts of things happen, litigation does occur. You have 22 people that are very happy and 50 people that are not very happy at all,\" Department of Health spokesperson \u003cstrong\u003eJae Williams\u003c/strong\u003e said in dialogue with The News Service of Florida. \u003c/p\u003e\n\u003cp\u003eHe also noted the substantial investments made by applicants and the department's responsibility to ensure that approved operators meet high standards for quality.\u003c/p\u003e\n\u003cp\u003eApplicants have called for legislative intervention to prevent prolonged delays. Attorney \u003cstrong\u003ePaula Savchenko\u003c/strong\u003e, who worked with Florida Sports Consultants, Inc.—operating as Belushi's Farm Florida—said the process could stall for months or even years without action.\u003c/p\u003e\n\u003cp\u003e\"If we don't have a legislative fix, we're going to see these licenses held up for anywhere between six months to two years,\" Savchenko said.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eIndustry Shifts And New Players\u003c/h3\u003e\n\u003cp\u003eNotable applicants receiving letters include Florida Sports Consultants, Inc., led by actor\u003cstrong\u003e Jim Belushi\u003c/strong\u003e, who also operates a cannabis farm in Oregon. Other approved businesses include \u003cstrong\u003eSTIIIZY Florida, LLC, A Good Decision, LLC\u003c/strong\u003e and \u003cstrong\u003eTheory Wellness of Florida, LLC. \u003c/strong\u003eThe additions bring Florida closer to doubling its licensed operators, which currently stand at 25, managing over 690 dispensaries statewide.\u003c/p\u003e\n\u003cp\u003eQuincy-based \u003cstrong\u003eTrulieve Cannabis Corp. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), the state's largest medical marijuana operator, welcomed the expansion. \u003c/p\u003e\n\u003cp\u003e\"We are pleased that the licenses are finally issued, bringing the number of licensees to 47. We continue to look forward to working with the governor and legislature to expand access to safe, lab-tested cannabis for Floridians,\" the company said in a statement.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003c/em\u003e\u003c/strong\u003e\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003cstrong\u003e\u003cem\u003ehere\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e\u003cem\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eBroader Context\u003c/h3\u003e\n\u003cp\u003eThe decision to award licenses coincides with \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res\"\u003ethe defeat of a proposed constitutional amendment \u003c/a\u003ethat sought to legalize recreational marijuana. \u003c/p\u003e\n\u003cp\u003eThe measure received 56% voter approval but fell short of the 60% threshold needed for passage. Governor\u003cstrong\u003e Ron DeSanti\u003c/strong\u003es played a significant role in opposing the amendment, which had been heavily supported by industry leaders, including Trulieve.\u003c/p\u003e\n\u003cp\u003e\"The majority of people in the industry would rather have had recreational pass, but we all are pretty confident that it's going to pass sometime in the next two to four years,\" Savchenko said.\u003c/p\u003e\n\u003cp\u003eFor now, Florida's medical marijuana industry is bracing for the next phase, with new players poised to enter the market and potential legal hurdles still ahead.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42222815/cannabis-on-thanksgiving-10-science-backed-benefits-for-a-happier-holiday\"\u003eCannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover image made with AI.\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/24/11/42226503/florida-awards-22-new-cannabis-licenses-after-18-month-waitlegal-battles-ahead","image":"https://cdn.benzinga.com/files/images/story/2024/11/27/DALLE-2024-11-27-19-03.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/27/DALLE-2024-11-27-19-03.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/27/DALLE-2024-11-27-19-03.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":698880,"name":"cannabis license","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":945780,"name":"Florida's Department of Health","description":""},{"tid":802491,"name":"Gov. Ron DeSantis","description":""},{"tid":721801,"name":"Jim Belushi","description":""},{"tid":698879,"name":"marijuana license","description":""},{"tid":631239,"name":"medical cannabis","description":""},{"tid":41047,"name":"medical marijuana","description":""},{"tid":519269,"name":"Ron DeSantis","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42226503\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42226503\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42193387,"author":"Nicolás Jose Rodriguez","created":"Tue, 26 Nov 2024 10:45:19 -0500","updated":"Tue, 26 Nov 2024 10:45:19 -0500","title":"Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030","teaser":"According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.","body":"\u003cp\u003eThe U.S. cannabis industry continues its impressive growth, generating over $32 billion in annual retail sales as of 2024, according to data from \u003cstrong\u003eLeafLink\u003c/strong\u003e. This marks a 10.8% year-over-year increase, with $2.8 billion in sales recorded in October 2024 alone. From its humble beginnings, cannabis now operates in 41 states, with over 80% of Americans having access to it. \u003c/p\u003e\n\u003cp\u003eDespite challenges like price declines, margin pressures and operational inefficiencies, the industry is on track to reach $55 billion by 2030, driven by regional growth and federal policy changes.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eKey Growth Drivers \u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eNear-term growth will be fueled by rapid licensing and retail expansion in emerging markets such as New York, New Jersey and Ohio. Over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.\u003c/p\u003e\n\u003cp\u003eFederal policy reform, notably the potential reclassification of cannabis to Schedule III in 2025, could relieve the current 280E tax burden and inject $2-3 billion annually into the industry, boosting profitability.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42068539/billion-dollar-strike-farm-bill-amendment-could-change-the-hemp-industry\"\u003eBillion-Dollar Strike: Farm Bill Amendment Could Change The Hemp Industry\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eState-Specific Insights: Strong Performers and Untapped Potential\u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eThe cannabis market shows significant variance across states.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eTop Performers\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAlaska leads in sales per resident, driven by tourism, followed by Michigan and Nevada, with the latter benefiting from \u003ca href=\"https://www.benzinga.com/24/11/42148169/formula-1-drivers-react-to-cannabis-smell-at-las-vegas-grand-prix-everyone-would-test-positive\"\u003eLas Vegas tourism\u003c/a\u003e, achieving the highest sales per dispensary.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eRoom For Growth\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCalifornia leads in overall sales but lags in per capita sales. \u003ca href=\"https://www.benzinga.com/topic/illinois-cannabis\"\u003eIllinois\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/florida-cannabis\"\u003eFlorida\u003c/a\u003e show strong sales but lower per capita, signaling opportunities for deeper market penetration. Florida is poised for growth once recreational cannabis is legalized.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eEmerging Markets\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/topic/new-york-cannabis\"\u003eNew York\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio\u003c/a\u003e show lower sales per resident but have large population bases and expanding retail infrastructures, making them prime candidates for long-term growth.\u003c/li\u003e\n\u003cli\u003eCannabis companies operating in New York include\u003cstrong\u003e Curaleaf Holdings, Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), \u003cstrong\u003eAyr Wellness Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AYRWF#OTC\"\u003eAYRWF\u003c/a\u003e), \u003cstrong\u003eGreen Thumb Industries\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e), \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), \u003cstrong\u003eVerano Holdings Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e), and \u003cstrong\u003eAscend Wellness Holdings\u003c/strong\u003e (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AAWH#CSE\"\u003eAAWH\u003c/a\u003e, OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AAWHF#OTC\"\u003eAAWHF\u003c/a\u003e). In Ohio, key players include\u003cstrong\u003e Vext Science \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXTF#OTC\"\u003eVEXTF\u003c/a\u003e), \u003cstrong\u003eThe Green Organic Dutchman\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TGODF#OTC\"\u003eTGODF\u003c/a\u003e), \u003cstrong\u003eCresco Labs Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e), and \u003cstrong\u003eHarvest Health \u0026amp; Recreation\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/HRVSF#OTC\"\u003eHRVSF\u003c/a\u003e), which is now part of Trulieve.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales\"\u003e Green Wednesday\u0026#8217;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStrategic Opportunities\u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eWholesale cannabis sales are projected to reach $11.7 billion in 2024, an 11% increase from 2023. However, monthly fluctuations require strategic planning for both sellers and buyers. In October 2024, wholesale sales dipped 2% from the previous month but rose 9.6% year-over-year.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSeller Impact\u003c/strong\u003e\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSellers in \u003ca href=\"https://www.benzinga.com/topic/massachusetts-cannabis\"\u003eMassachusetts\u003c/a\u003e, \u003ca href=\"https://www.benzinga.com/topic/michigan-cannabis\"\u003eMichigan\u003c/a\u003e, and Illinois see robust demand, while those in Maryland and Michigan face pricing pressure, with Maryland\u0026#8217;s prices falling 23.2% and Michigan\u0026#8217;s dropping 14.1%.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBuyer Impact\u003c/strong\u003e\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003eBuyers can capitalize on price dips, particularly as some states, such as\u003ca href=\"https://www.benzinga.com/topic/arkansas-cannabis\"\u003e Arkansas\u003c/a\u003e and Washington, saw price increases of 20.7% and 17.9%, respectively, while\u003ca href=\"https://www.benzinga.com/topic/maryland-cannabis\"\u003e Maryland\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/arizona-cannabis\"\u003eArizona\u003c/a\u003e saw declines.\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003ePricing\u0026nbsp;\u003c/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIn October 2024, the average flower price was $1,065 per pound, down $100 from the summer peak of $1,152. The price drop reflects typical seasonal oversupply from outdoor harvests in states like Michigan and Arizona. At the same time, reduced cultivation in mature markets like \u003ca href=\"https://www.benzinga.com/topic/california-cannabis\"\u003eCalifornia\u003c/a\u003e, Oregon, and \u003ca href=\"https://www.benzinga.com/topic/colorado-cannabis\"\u003eColorado\u003c/a\u003e should help stabilize prices.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cul\u003e\n\u003cli\u003eMaryland experienced a 23.2% price drop, while Arkansas saw a 20.7% price increase year-over-year. States like California and Arizona, facing oversupply issues, may see stabilization as cultivation is reduced.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42086135/pre-rolls-the-avocado-toast-of-cannabis-why-millennials-are-spending-100m-a-month\"\u003e Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eEmerging Hotspots\u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eMarkets like\u003ca href=\"https://www.benzinga.com/topic/missouri-cannabis\"\u003e Missouri\u003c/a\u003e and Maryland are showing strong growth. Missouri generated $6.5 million in sales per dispensary in 2024, while Maryland reached $11.6 million per retail license. Arkansas, with its limited number of permits, is generating $7.6 million per license, signaling robust demand in a limited-license environment.\u003c/p\u003e\n\u003cp\u003eBy contrast, Oklahoma has the lowest sales per license, at just $0.4 million, due to oversaturation with over 1,800 licenses, presenting opportunities for consolidation or increased operational efficiency.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eLong-Term Outlook: A $55 Billion Industry by 2030\u003c/h3\u003e\n\u003cp\u003eThe U.S. cannabis industry is projected to reach $55 billion by 2030, driven by retail expansion in states like New York, \u003ca href=\"https://www.benzinga.com/topic/new-jersey-cannabis\"\u003eNew Jersey\u003c/a\u003e, and Ohio, as well as continued growth in mature markets like Illinois and Florida.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003eCan Trump\u0026#8217;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSource Acknowledgment\u003c/strong\u003e: This article is based on insights from \u003ca href=\"https://www.leaflink.com/\"\u003e\u003cstrong\u003eLeafLink\u0026#8217;s Fall 2024 U.S. Cannabis Industry Report\u003c/strong\u003e \u003c/a\u003eand other relevant industry data. All projections and trends discussed are sourced directly from the report, which includes sales figures, state-specific insights, pricing trends, and wholesale dynamics for the cannabis sector.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eDisclaimer\u003c/strong\u003e: The projections and data shared in this article are based on the most current information available as of the Fall 2024 report. Results may vary, and the cannabis industry is subject to ongoing regulatory changes, market fluctuations, and shifts in federal policy.\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030","image":"https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_0.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_0.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_0.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":30777,"name":"Retail Sales","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":945671,"name":"AAWHF","description":null},{"tid":786348,"name":"AYRWF","description":null},{"tid":735580,"name":"CRLBF","description":""},{"tid":801974,"name":"CSE:AAWH","description":null},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":739370,"name":"HRVSF","description":null},{"tid":731053,"name":"TCNNF","description":""},{"tid":720473,"name":"TGODF","description":"GREEN ORGANIC DUTCHMAN by Green Organic Dutchman Hlgds."},{"tid":761043,"name":"VEXTF","description":null},{"tid":797063,"name":"VRNOF","description":"Verano Holdings"}],"tags":[{"tid":902888,"name":"cannabis retail sales","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42193387\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42193387\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42193387\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42147417,"author":"Nicolás Jose Rodriguez","created":"Fri, 22 Nov 2024 16:00:20 -0500","updated":"Fri, 22 Nov 2024 16:00:21 -0500","title":"80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?","teaser":"According to Z\u0026A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.","body":"\u003cp\u003eDespite flat earnings and challenging market conditions, \u003cstrong\u003eCresco Labs Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e) remains an \u0026#8220;Overweight\u0026#8221; stock, according to analysis firm \u003cstrong\u003eZuanic \u0026amp; Associates\u003c/strong\u003e. In his latest report, Zuanic underscores Cresco\u0026#8217;s strong positioning in emerging adult-use markets such as Pennsylvania and Ohio while identifying valuation advantages that set the company apart. \u003c/p\u003e\n\u003cp\u003eCresco trades at 5.5x forward EBITDA, below \u003cstrong\u003eGreen Thumb Industries Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e) at 7x and \u003cstrong\u003eCuraleaf Holdings Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e) at 10x. \u003c/p\u003e\n\u003cp\u003e\u0026#8220;This discount presents an appealing entry point for investors looking beyond short-term volatility,\u0026#8221; Zuanic writes.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMarket Dynamics: Cresco In The Tier 1 Landscape\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eZuanic's report benchmarks Cresco against other Tier 1 multi-state operators (MSOs), including Green Thumb, \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), \u003cstrong\u003eVerano Holdings Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e), and Curaleaf.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eWhile Cresco\u0026#8217;s third-quarter revenue of $180 million fell 2% sequentially, the decline aligns with broader industry trends, with peers like Curaleaf and Verano posting declines of 3% and 5%, respectively. By contrast, Green Thumb achieved a 2% increase, reaching $287 million.\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/cannabis/earnings\"\u003eAdjusted EBITDA margins \u003c/a\u003efurther illustrate Cresco's position: the company held steady at 29% in Q3, compared to Green Thumb at 31% (-200 basis points) and Trulieve at 34% (-100 basis points). However, \u003ca href=\"https://www.benzinga.com/quote/CRLBF\"\u003eCresco lags in adjusted cash flow.\u003c/a\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIts negative $3 million adjusted figure for the first nine months of 2024, factoring in tax liabilities, contrasts sharply with Green Thumb's $139 million (17% of sales) and Trulieve's $37 million (4% of sales). \u003ca href=\"https://www.benzinga.com/topic/pablo-zuanic\"\u003eZuanic highlights\u003c/a\u003e cash flow conversion as a critical area where Cresco \u0026#8216;lags\u0026#8217; its competitors.\u0026#8221;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42145406/nebraskas-cannabis-legalization-faces-courtroom-showdown-over-alleged-fraud\"\u003eNebraska\u0026#8217;s Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eValuation Analysis: Digging Into The Numbers\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eCresco's \u003ca href=\"https://www.benzinga.com/cannabis/earnings\"\u003evaluation metrics reveal potential upside\u003c/a\u003e. Its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. This discount extends to EV-to-EBITDA multiples, with Cresco trading at 5.5x compared to Green Thumb at 7x and Curaleaf at 10x.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThese figures include tax liabilities, financial net debt, and other obligations. \"Cresco's lower EV multiples, alongside its gross cash holdings of $157 million, make it a compelling value play among Tier 1 operators,\" Zuanic explains.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStrategic Hurdles And Growth Catalysts\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eDespite these advantages, Zuanic identifies several hurdles. Cresco\u0026#8217;s total leverage, including financial and tax liabilities, amounts to 80% of trailing sales, the highest among Tier 1 MSOs. In contrast, Green Thumb's leverage is just 9%. Moreover, while Cresco holds promising positions in \u003ca href=\"https://www.benzinga.com/topic/pennsylvania-cannabis\"\u003ePennsylvania\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio\u003c/a\u003e, Zuanic emphasizes the need for a strategic partner to close the scale gap with peers like Green Thumb and Curaleaf. \u0026#8220;A partnership would help Cresco achieve operational efficiencies and capitalize on upcoming recreational markets,\u0026#8221; he notes.\u003c/p\u003e\n\u003cp\u003eZuanic\u0026#8217;s projections account for regulatory uncertainty, including delays in Pennsylvania's adult-use legalization timeline to mid-2026 and the potential impact of federal rescheduling challenges. Nonetheless, he remains optimistic about Cresco's long-term prospects. \u0026#8220;We see Cresco as a buy for investors with a one-to-two-year horizon, particularly given its discounted valuation,\u0026#8221; he concludes. \u003c/p\u003e\n\u003cp\u003eFor a deeper dive into his methodology and projections, \u003ca href=\"https://zuanicgroup.com/\"\u003evisit Zuanic \u0026amp; Associates' research portal\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eDEA Slammed For Unlawful Talks With Cannabis Opponents \u0026#8211; The Plot Thickens\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":68,"name":"Analyst Color","description":""},{"tid":123430,"name":"Cannabis","description":""},{"tid":927212,"name":"Market Summary","description":""},{"tid":57,"name":"News","description":""},{"tid":30777,"name":"Retail Sales","description":""},{"tid":46411,"name":"Small Cap","description":""},{"tid":145889,"name":"Exclusives","description":""},{"tid":2,"name":"Markets","description":""},{"tid":67,"name":"Analyst Ratings","description":""},{"tid":22,"name":"Trading Ideas","description":""}],"stocks":[{"tid":735580,"name":"CRLBF","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":797063,"name":"VRNOF","description":"Verano Holdings"}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42147417\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42147417\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42143770,"author":"Maureen Meehan","created":"Fri, 22 Nov 2024 12:37:16 -0500","updated":"Fri, 22 Nov 2024 12:37:17 -0500","title":"Trump's Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform","teaser":"Trump picks Pam Bondi as new attorney general nominee, shifting focus to her record. Bondi's tough stance on cannabis contrasts with the pro-reform views of former choice, Matt Gaetz.","body":"\u003cp\u003eJust hours after former Rep. \u003cstrong\u003eMatt Gaetz\u003c/strong\u003e (R-Fla.) \u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\"\u003ewithdrew\u003c/a\u003e from consideration for attorney general, President-elect \u003cstrong\u003eDonald Trump\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/news/24/11/42130207/trump-picks-former-florida-ag-pam-bondi-for-justice-department-after-matt-gaetz-withdraws\"\u003eannounced his new nominee\u003c/a\u003e: former Florida Attorney General \u003cstrong\u003ePam Bondi\u003c/strong\u003e. \u003c/p\u003e\n\u003cp\u003eThe selection shifts the spotlight to Bondi's record, especially her stance on cannabis reform, which contrasts starkly with Gaetz's pro-legalization views.\u003c/p\u003e\n\u003cp\u003eDespite the \u003ca href=\"https://www.benzinga.com/news/24/11/42026047/gaetz-nomination-in-peril-due-to-gop-resistance\"\u003eunsavory allegations\u003c/a\u003e\u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\"\u003e \u003c/a\u003eagainst Gaetz's personal behavior, he\u0026#8217;s been an \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/07/33127611/rep-matt-gaetz-wants-to-end-cannabis-testing-for-us-military-citing-recruitment-crisis\"\u003eadvocate for cannabis reform\u003c/a\u003e and was expected to adopt a lenient approach toward legalization if appointed. In contrast, Bondi had a tougher stance on medical marijuana during her tenure as Florida's Attorney General (2011-2019).\u003c/p\u003e\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBondi While Florida\u0026#8217;s AG\u003c/strong\u003e\u003c/h1\u003e\n\u003cp\u003eFor example, in 2013, Bondi\u0026#8217;s office \u003ca href=\"https://www.huffpost.com/entry/florida-medical-marijuana_n_4159849\"\u003efiled a 57-page challenge\u003c/a\u003e to the proposed ballot initiative that was seeking to put medical marijuana (MMJ) on the ballot the following year. Once medical marijuana was approved, she defended state laws restricting cannabis use, including a ban on publicly smoking it. Bondi argued at the time that the ban was justified due to concerns over secondhand smoke exposure. \u003c/p\u003e\n\u003cp\u003eA state judge later ruled the ban to be inconsistent with Florida's constitutional amendment that legalized medical cannabis in 2014. The restriction was eventually overturned under Gov. Ron DeSantis who \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna\"\u003ewent on the warpath\u003c/a\u003e against smoking in public.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus\"\u003eCannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump\u0026#8217;s Attorney General Nominee\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eTrump's Drug Addiction Commission\u003c/strong\u003e\u003c/h1\u003e\n\u003cp\u003eBondi's role on Trump's Commission on Combating Drug Addiction and the Opioid Crisis during his first term in the White House could further complicate her position on cannabis. \u003c/p\u003e\n\u003cp\u003eThe commission, which was chaired by former New Jersey Gov. \u003ca href=\"https://www.benzinga.com/topic/chris-christie\"\u003eChris Christie\u003c/a\u003e, was skeptical about cannabis as a treatment for chronic pain or opioid addiction, citing studies suggesting a potential link between marijuana use and opioid abuse. Authoritative \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/01/36578723/huge-study-reveals-cannabis-provides-similar-pain-relief-benefits-as-opioids-without-negative-co\"\u003estudies\u003c/a\u003e have since shown the contrary to be the case.\u003c/p\u003e\n\u003cp\u003eThough Bondi's track record has raised concerns among some cannabis reform advocates, industry leader \u003cstrong\u003eKim Rivers\u003c/strong\u003e, CEO of \u003cstrong\u003eTrulieve Cannabis Corp\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), described Bondi on X as \"straightforward and very fair,\" \u003ca href=\"https://www.marijuanamoment.net/trumps-new-attorney-general-pick-opposed-legalizing-medical-marijuana-in-florida/\"\u003ereported\u003c/a\u003e Marijuana Moment.\u003c/p\u003e\n\u003cp\u003e\"She is passionate about ending the opioid crisis and did great work shutting down pill mills in Florida. She is an advocate for safe, regulated markets and I believe she will bring the same energy to end the fentanyl issues our country is facing,\" Rivers said.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1\"\u003e \u003c/a\u003e\u003cbr /\u003e • \u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1\"\u003eKentucky Gov. Beshear: \u0026#8216;Go Online And Find\u0026#8217; Your Medical Marijuana Practitioner On Dec. 1\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003ePhoto: Shutterstock\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform","image":"https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":29619,"name":"Legal","description":""}],"stocks":[{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":18656,"name":"Donald Trump","description":""},{"tid":24883,"name":"Florida","description":""},{"tid":741723,"name":"Kim Rivers","description":""},{"tid":828877,"name":"Matt Gaetz","description":""},{"tid":515055,"name":"Pam Bondi","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42143770\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42143770\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42143770\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42130221,"author":"Nicolás Jose Rodriguez","created":"Thu, 21 Nov 2024 22:25:47 -0500","updated":"Thu, 21 Nov 2024 22:25:48 -0500","title":"Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners \u0026 Losers","teaser":"BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%.","body":"\u003cp\u003e\u003cstrong\u003eBDSA\u003c/strong\u003e\u0026#8216;s October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date (YTD) increase of 57.8%, totaling $942.2 million.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/maryland-cannabis\"\u003eMaryland\u0026#8217;s impressive performance\u003c/a\u003e within BDSA\u0026#8217;s tracked markets cements its place as a key emerging state in the cannabis industry.\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio \u003c/a\u003efollowed with a 30.9% growth, reaching $522.6 million, while New Jersey achieved a 24.6% increase, amounting to $805.7 million in YTD sales.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGreen Thumb Industries\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e), \u003cstrong\u003eCuraleaf Holdings\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), \u003cstrong\u003eCresco Labs \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e), and \u003cstrong\u003eVerano Holdings\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e) are publicly traded multi-state operators with active operations in both Ohio and Maryland, supporting the cannabis industry\u0026#8217;s growth in these states.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eStruggling Markets\u003c/h3\u003e\n\u003cp\u003eStates with established cannabis markets are grappling with significant downturns. Arizona saw a 12.9% decrease in YTD sales, generating $989.8 million, while \u003ca href=\"https://www.benzinga.com/topic/colorado-cannabis\"\u003eColorado\u003c/a\u003e, another mature market, reported a 9.5% drop, totaling $1.18 billion.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eEven \u003ca href=\"https://www.benzinga.com/topic/california-cannabis\"\u003eCalifornia\u003c/a\u003e, the leader in total sales with $4.16 billion YTD, experienced a 3.6% decline, underscoring challenges faced by long-established markets.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/41959233/yougov-poll-reveals-what-women-want-with-weed-relax-mindfulness-and-great-deals\"\u003e YouGov Poll Reveals What Women Want With Weed: Relax, Mindfulness And Great Deals\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eMonthly Shifts\u003c/h3\u003e\n\u003cp\u003eWhile year-to-date trends provide long-term insights, monthly data reveals shorter-term momentum shifts. \u003ca href=\"https://bdsa.com/\"\u003eAccording to BDSA\u003c/a\u003e, Missouri leads recent growth with a 4.9% month-over-month (MoM) increase, totaling $123.3 million.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eArizona, despite its YTD struggles, achieved a 4.4% MoM rise to $93.1 million. Conversely, \u003ca href=\"https://www.benzinga.com/topic/michigan-cannabis\"\u003eMichigan\u003c/a\u003e recorded the steepest monthly decline, dropping 7.7% to $246.3 million, followed by New York with a 7.3% decrease, ending at $11.1 million.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42086135/pre-rolls-the-avocado-toast-of-cannabis-why-millennials-are-spending-100m-a-month\"\u003e Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/24/11/42130221/the-best-and-worst-performing-states-for-cannabis-sales-in-2024-ytd-winners-and-losers","image":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":68,"name":"Analyst Color","description":""},{"tid":123430,"name":"Cannabis","description":""},{"tid":927212,"name":"Market Summary","description":""},{"tid":57,"name":"News","description":""},{"tid":16889,"name":"Guidance","description":""},{"tid":125558,"name":"Emerging Markets","description":""},{"tid":17412,"name":"Entrepreneurship","description":""},{"tid":30777,"name":"Retail Sales","description":""},{"tid":145889,"name":"Exclusives","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":735580,"name":"CRLBF","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":797063,"name":"VRNOF","description":"Verano Holdings"}],"tags":[{"tid":664676,"name":"Arizona cannabis","description":""},{"tid":664761,"name":"California cannabis","description":""},{"tid":718003,"name":"Colorado Cannabis","description":""},{"tid":734987,"name":"Maryland Cannabis","description":""},{"tid":733780,"name":"Ohio Cannabis","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42130221\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42130221\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42130221\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42125955,"author":"Nicolás Jose Rodriguez","created":"Thu, 21 Nov 2024 17:18:34 -0500","updated":"Thu, 21 Nov 2024 17:18:34 -0500","title":"Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee","teaser":"The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.","body":"\u003cp\u003eCannabis stocks reacted with mixed results on Thursday after \u003cstrong\u003eMatt Gaetz\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\"\u003ewithdrew his nomination\u003c/a\u003e for U.S. Attorney General amid \u003ca href=\"https://www.benzinga.com/news/legal/24/11/42078192/trumps-attorney-general-pick-matt-gaetz-resigned-from-congress-ethics-committee-to-decide-if-report-will-be-released\"\u003eallegations\u003c/a\u003e of sexual misconduct, drug use, lack of legal experience and more. Last week, President-elect \u003cstrong\u003eDonald Trump\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general\"\u003enominated\u003c/a\u003e Gaetz who is a long-time supporter of cannabis legalization. \u003c/p\u003e\n\u003cp\u003eWhile Gaetz's exit may not be directly tied to the sector's performance, multi-state operators (MSOs) and cannabis ETFs recorded notable declines, reflecting ongoing investor jitters in a politically sensitive market.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eMSOs Slides, Sector Faces Pressure\u003c/h3\u003e\n\u003cp\u003eThe\u003cstrong\u003e AdvisorShares Pure US Cannabis ETF \u003c/strong\u003e(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOS#NYSE\"\u003eMSOS\u003c/a\u003e), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. This decline highlights the continued uncertainty in the cannabis space, as investors reassess the implications of a reshuffling political landscape.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCuraleaf Holdings Inc. \u003c/strong\u003e(OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTCQX\"\u003eCURLF\u003c/a\u003e), one of the largest MSOs in the U.S., shed -4.10%, finishing the day at $1.99.\u003cstrong\u003e Trulieve Cannabis Corp. \u003c/strong\u003e(OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e) was not far behind, falling -1.93% to $6.11. Meanwhile, \u003cstrong\u003eCresco Labs Inc. \u003c/strong\u003e(OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTCQX\"\u003eCRLBF\u003c/a\u003e) dropped -5.74%, closing at $1.15.While some MSOs struggled, \u003cstrong\u003eGreen Thumb Industries\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTCQX\"\u003eGTBIF\u003c/a\u003e) managed to stay in positive territory closing at $9.30.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eSundial Stands Out\u003c/h3\u003e\n\u003cp\u003e\u003cstrong\u003eSundial Growers Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SNDL#NASDAQ\"\u003eSNDL\u003c/a\u003e) defied the broader sector trends, climbing 1.79% to end the day at $1.995. Other gainers included \u003cstrong\u003eTilray Brands Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e), which rose 1.94% to $1.315, and\u003cstrong\u003e Canopy Growth Corporation \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e), up 2.53% to $3.855.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eDeep Declines\u0026nbsp;\u003c/h3\u003e\n\u003cp\u003eThursday saw significant losses among smaller players, with\u003cstrong\u003e Cansortium Inc.\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CNTMF#OTCQX\"\u003eCNTMF\u003c/a\u003e) plunging -22.72%, closing at $0.0711. \u003cstrong\u003eiAnthus Capital Holdings Inc.\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ITHUF#OTCQX\"\u003eITHUF\u003c/a\u003e) also struggled, dropping -11.43% to $0.00558.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42122634/gop-bathroom-battle-cannabis-advocate-nancy-mace-will-stand-in-the-way-of-any-man-who-tries-to-get-into-womens-room\"\u003eGOP Bathroom Battle: Cannabis Advocate Nancy Mace Will \u0026#8216;Stand In The Way Of Any Man\u0026#8217; Who Tries To Get Into Women\u0026#8217;s Room\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus","image":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_1.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":138079,"name":"Top Stories","description":""},{"tid":2,"name":"Markets","description":""},{"tid":47,"name":"ETFs","description":""}],"stocks":[{"tid":22438,"name":"CGC","description":"Canopy Growth Corp"},{"tid":744423,"name":"CNTMF","description":"Cansortium"},{"tid":735580,"name":"CRLBF","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":94170,"name":"ITHUF","description":"ITALIAN THAI DEV "},{"tid":774329,"name":"MSOS","description":null},{"tid":753165,"name":"SNDL","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":723743,"name":"TLRY","description":""}],"tags":[{"tid":775074,"name":"Cannabis Markets","description":""},{"tid":148171,"name":"cannabis stocks","description":""},{"tid":18656,"name":"Donald Trump","description":""},{"tid":828877,"name":"Matt Gaetz","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42125955\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42125955\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42125955\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42072196,"author":"Rolando García","created":"Tue, 19 Nov 2024 14:21:45 -0500","updated":"Tue, 19 Nov 2024 14:21:46 -0500","title":"Trulieve Cannabis Execs Buy 26K Company Shares: What Does This Mean For Investors?","teaser":"Trulieve execs purchase 26,000 shares amid stock drop. Insider buys spark speculation of undervaluation despite Florida setbacks.","body":"\u003cp\u003e\u003cstrong\u003eTrulieve Cannabis Corp\u003c/strong\u003e. (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e, CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TRUL#CSE\"\u003eTRUL\u003c/a\u003e) executives recently purchased 26,000 shares, signaling potential confidence in the company's future. Between November 8 and 13, COO \u003cstrong\u003eMarie Zhang\u003c/strong\u003e, CPO \u003cstrong\u003eKyle Landrum\u003c/strong\u003e, and CLO \u003cstrong\u003eEric Powers \u003c/strong\u003eincreased their holdings, according to a report by Beacon Securities. \u003c/p\u003e\n\u003cp\u003eZhang made the largest move, acquiring 21,300 shares at \u003cstrong\u003ean average price of $7.19,\u003c/strong\u003e adding $153,147 of an estimated total of around $186.000. What does this mean for investors? Is the stock undervalued?\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStock Decline\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eTrulieve's stock has dropped sharply in recent weeks, trading at around $6.34 after peaking at $14 in mid-October. The decline follows two major setbacks: the failure of Florida's cannabis legalization ballot and heightened political uncertainty tied to Donald Trump's election victory.\u003c/p\u003e\n\u003cp\u003eThese setbacks created an election gapt hat the stock has yet to close.\u003c/p\u003e\n\u003cp\u003eThere\u0026#8217;s a reason why those events had a significant impact on the company. \u003ca href=\"https://www.benzinga.com/topic/florida-cannabis\"\u003eFlorida\u003c/a\u003e is the company's largest market, and the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res\"\u003eballot's failure\u003c/a\u003e denied an opportunity to double the size of the state's legal cannabis market. A Trump presidency also \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003eraises concerns\u003c/a\u003e about the future of federal cannabis reform, further complicating Trulieve's growth outlook.\u003c/p\u003e\n\u003cp\u003eThe ballot's defeat was particularly damaging. If approved, it would have allowed Trulieve to expand its 156 Florida stores into the recreational market, dramatically boosting revenue potential.\u003c/p\u003e\n\u003cp\u003eAdding to these challenges, Trulieve's third-quarter 2024 earnings showed \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41743807/trulieves-q3-revenue-up-slightly-year-over-year-net-loss-grows-amid-48m-in-cannabis-legalization\"\u003emixed results\u003c/a\u003e. The company reported $284 million in revenue, a modest 3% increase from the previous year, with a strong gross margin of 61% and adjusted EBITDA of $96 million (up 24% year-over-year). However, a $60 million net loss, significantly higher than the $25.4 million loss in Q3 2023 highlighted the financial strain of $48 million in non-recurring expenses tied to the Florida ballot campaign.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003eCan Trump\u0026#8217;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eIs Trulieve Undervalued?\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/22/05/27419808/trulieve-executives-buying-their-company-shares-heres-what-we-know\"\u003eInsider stock purchases\u003c/a\u003e often indicate that management views the stock as undervalued. These moves could also be intended to restore investor confidence after a significant drop. However, determining undervaluation is complex and subjective, often requiring a mix of financial analyses and market sentiment.\u003c/p\u003e\n\u003cp\u003eFrom a technical perspective, Trulieve appears oversold, with an RSI of 31.94, suggesting the possibility of a rebound. Key resistance levels are $9.58 (SMA) and $14 (the October high), while support hovers at $6.00, with a critical floor near $3.71 (lower Bollinger Band). Recent high volumes during the selloff suggest heavy selling pressure, but the current lower volumes indicate stabilization. \u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"630\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19123625/Captura-de-pantalla-2024-11-19-a-las-14.36.18-1024x630.png\" alt=\"\" class=\"wp-image-655536\" style=\"width:613px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19123625/Captura-de-pantalla-2024-11-19-a-las-14.36.18-1024x630.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19123625/Captura-de-pantalla-2024-11-19-a-las-14.36.18-300x185.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19123625/Captura-de-pantalla-2024-11-19-a-las-14.36.18-768x473.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19123625/Captura-de-pantalla-2024-11-19-a-las-14.36.18.png 1071w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eAt a glance, it seems the market has not bought yet on the promising future this cannabis company has to offer, with or without legal recreational cannabis in Florida. But, with small-cap cannabis stocks prone to volatility, this is a situation investors should monitor closely.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41743807/trulieves-q3-revenue-up-slightly-year-over-year-net-loss-grows-amid-48m-in-cannabis-legalization\"\u003eTrulieve\u0026#8217;s Q3 Revenue Up Slightly Year-Over-Year, Net Loss Grows Amid $48M In Cannabis Legalization Support\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/buybacks/24/11/42072196/trulieve-cannabis-execs-buy-26k-company-shares-what-does-this-mean-for-investors","image":"https://cdn.benzinga.com/files/images/story/2024/11/19/Trulieve.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/19/Trulieve.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/19/Trulieve.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":63,"name":"Buybacks","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":738732,"name":"CSE:TRUL","description":null},{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":148171,"name":"cannabis stocks","description":""},{"tid":19664,"name":"technical analysis","description":""},{"tid":945275,"name":"Trulieve stocks","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42072196\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42072196\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":42017405,"author":"Jelena Martinovic","created":"Fri, 15 Nov 2024 14:42:21 -0500","updated":"Fri, 15 Nov 2024 14:42:22 -0500","title":"Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores","teaser":"RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new West Orlando location expanded RISE Dispensaries' retail footprint in Florida to 21 locations and 99 nationwide. Cannabis giant Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) opened a new medical dispensary in Miami, Florida in October. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd. in Miami, brought the company's Florida store count to 66 locations, with 151 dispensaries total nationwide.Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), one of the biggest supporters of Amendment 3 which was rejected by Florida voters earlier this month and would have legalized recreational cannabis in the Sunshine State, additionally expanded its already substantial retail footprint statewide.","body":"\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWeed Is Not Legal In Florida But Medical Cannabis Retail Footprint Grows Nonetheless\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003e\u003cstrong\u003eRISE Dispensaries, \u003c/strong\u003ea cannabis retail chain owned by \u003cstrong\u003eGreen Thumb Industries Inc\u003c/strong\u003e. (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTII#CSE\"\u003eGTII\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTCQX\"\u003eGTBIF\u003c/a\u003e), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new West Orlando location expanded RISE Dispensaries' retail footprint in Florida to 21 locations and 99 nationwide.\u003c/p\u003e\n\u003cp\u003eCannabis giant \u003cstrong\u003eCuraleaf Holdings, Inc.\u003c/strong\u003e (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURA#TSX\"\u003eCURA\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTCQX\"\u003eCURLF\u003c/a\u003e) opened a new medical dispensary in Miami in October. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd. in Miami, brought the company's Florida store count to 66 locations, with 151 dispensaries total nationwide.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TRUL#CSE\"\u003eTRUL\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e), one of the biggest supporters of Amendment 3 which was rejected by Florida voters earlier this month and would have legalized recreational cannabis in the Sunshine State, additionally expanded its already substantial retail footprint statewide.\u003c/p\u003e\n\u003cp\u003eOctober store opening celebrations were held at:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eTrulieve Bonita Springs South Tamiami, located at 28811 South Tamiami Trail, Unit 12, and Trulieve St. Augustine A1A, located at 3945 A1A South on Oct. 18;\u003c/li\u003e\n\u003cli\u003eTrulieve Orlando West Colonial, located at 7225 West Colonial Drive, Unit 100 on Oct. 25; and\u003c/li\u003e\n\u003cli\u003eTrulieve Lake Placid, located at 413 U.S. Highway 27, on Nov. 1.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eNew Cannabis Stores In Six States And Canada\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eIllinois cannabis sales reached a major milestone in July, with sales surpassing $1 billion, as announced by Governor\u003cstrong\u003e JB Pritzker\u003c/strong\u003e‘s office. The burgeoning industry continues to grow by the day with new stores launching cannabis sales and events celebrating the plant. \u003cstrong\u003eStash Dispensaries\u003c/strong\u003e recently announced the return of\u0026nbsp;Sesh Haunted City, a special haunted house event to commemorate Sesh\u0026#8217;s third anniversary.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eC3 Industries, \u003c/strong\u003ea multi-state cannabis company dedicated to crafting premium consumer experiences, recently opened High Profile Cannabis Shop Pineville at 35 Macadoodle Lane, its 9th retail location in Missouri and 29th nationwide.\u003c/p\u003e\n\u003cp\u003eCannabis concept store\u003cstrong\u003e Gotham \u003c/strong\u003eheld a grand opening event in October for its new Brooklyn, New York City location. The expansive 4,000-square-foot storefront is located in the heart of Williamsburg on Kent Avenue and South 2nd Street in The Refinery at Domino.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSweetspot Farms, \u003c/strong\u003ea new premium cannabis dispensary, is officially open at 111 High Ridge Rd. in Stamford, Connecticut, offering medical and recreational customers a modern and welcoming retail experience. Founded by two Stamford natives, Sweetspot aims to improve access to legal and regulated cannabis for qualified locals who depend on plant-based products for an improved quality of life.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSLO CAL Roots\u003c/strong\u003e celebrated the grand opening of its third dispensary, Root One, in Guadalupe, California in October. Root One is the latest location from SLO CAL Roots, a Central Coast cannabis company founded in 2003 by local growers \u003cstrong\u003eAusten Connella\u003c/strong\u003e and \u003cstrong\u003eKristin Kordich.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHashstoria,\u003c/strong\u003e a cannabis dispensary co-founded by hip-hop icon \u003cstrong\u003eRaekwon the Chef\u003c/strong\u003e of \u003cstrong\u003eWu-Tang Clan \u003c/strong\u003efame, media personality\u003cstrong\u003e Charlamagne Tha God,\u003c/strong\u003e civil rights attorney\u003cstrong\u003e Bakari Sellers\u003c/strong\u003e and entrepreneur\u003cstrong\u003e Jedd Canty \u003c/strong\u003ehosted the official grand opening celebration in downtown Newark, New Jersey on Wednesday, Nov. 13. It's located at 799-805 Broad Street in the historic Four Corners district.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHigh Tide Inc\u003c/strong\u003e.'s (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/HITI#NASDAQ\"\u003eHITI\u003c/a\u003e) (TSXV:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/HITI#TSXV\"\u003eHITI\u003c/a\u003e) (FSE: 2LYA) Canna Cabana retail cannabis store, located at 97 Bath Road, Kingston, Ontario, began selling recreational cannabis products and consumption accessories for adult use on Oct. 31. This opening marked the 186th \u003cstrong\u003eCanna Cabana\u003c/strong\u003e branded retail cannabis location in Canada, the 72nd in the province of Ontario, and the first in Kingston for the Canadian retail cannabis giant.\u003c/p\u003e\n\n","url":"https://www.benzinga.com/24/11/42017405/medical-marijuana-footprint-grows-in-florida-as-legalization-push-fizzles-and-other-new-cannabis-stores-that-launched-sales","image":"https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":17412,"name":"Entrepreneurship","description":""},{"tid":30777,"name":"Retail Sales","description":""}],"stocks":[{"tid":738831,"name":"CSE:GTII","description":null},{"tid":738732,"name":"CSE:TRUL","description":null},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":604007,"name":"GTII","description":"Global Tech Industries"},{"tid":734667,"name":"HITI","description":null},{"tid":731053,"name":"TCNNF","description":""},{"tid":96325,"name":"TRUL","description":"TRULITE, INC."},{"tid":747685,"name":"TSX:CURA","description":null},{"tid":785468,"name":"TSXV:HITI","description":null}],"tags":[{"tid":712759,"name":"Canada Cannabis","description":""},{"tid":815244,"name":"Cannabis Dispensary Roundup","description":""},{"tid":137271,"name":"cannabis sales","description":""},{"tid":943647,"name":"cannabis shop","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":805171,"name":"JB Pritzker","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 42017405\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 42017405\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 42017405\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41997206,"author":"Nina Zdinjak","created":"Thu, 14 Nov 2024 19:19:52 -0500","updated":"Mon, 18 Nov 2024 03:44:42 -0500","title":"Ground Cannabis Dust Is A Hazardous Chemical, Confirms Massachusetts Regulator","teaser":" ","body":"\u003cp\u003e\u003cstrong\u003eThe Massachusetts Cannabis Control Commission \u003c/strong\u003eissued new recommendations Wednesday through a bulletin designed to improve workplace health and safety at marijuana processing facilities and broadly across the legal industry.\u003c/p\u003e\n\u003cp\u003eThe announcement represents the Commission's formal recognition of ground cannabis dust as a hazardous chemical that can irritate the respiratory system\u003cstrong\u003e \u003c/strong\u003eand exposed skin and marks a major step towards updating Massachusetts' workplace safety expectations following the \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/10/29130552/cannabis-employee-dies-from-inhaling-cannabis-dust-osha-report\"\u003e2022 occupational asthma death of a Holyoke processing facility employee\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003e\"Today's bulletin is intended to bring increased awareness of an identified health risk in the marijuana industry and will support Commission and industry efforts to enhance safety standards across Massachusetts,\" stated commission acting executive director/chief people officer \u003cstrong\u003eDebbie Hilton-Creek\u003c/strong\u003e. \"We will continue to partner with licensees to appropriately and effectively communicate this message and depend on them to implement protocols that will protect the overall well-being of our workforce.\"\u003c/p\u003e\n\u003cp\u003eUnder the new bulletin, the Commission recommends that all licensees engaged in marijuana processing follow Occupational Safety and Health Administration (OSHA) guidelines around hazardous chemicals in the workplace.\u003cstrong\u003e \u003c/strong\u003eThe Commission also reminds licensees of its obligation to have a hazard communication program which includes the evaluation of hazardous chemicals in its facility and develop Safety Data Sheets to inform its employees.\u003c/p\u003e\n\u003cp\u003eGoing forward, the Commission is advising licensees engaged in marijuana processing to protect employees from hazards associated with cannabis dust exposure by using\u003cstrong\u003e \u003c/strong\u003eengineering controls like local exhaust ventilation, plus administrative controls like limiting employee exposure during the workday.\u003cstrong\u003e \u003c/strong\u003eThe Commission recommends that licensees provide personal protective equipment, and appropriately manage medical situations when they arise.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat Happened\u003c/strong\u003e: On Jan. 4, 2022, \u003cstrong\u003eLorna McMurrey\u003c/strong\u003e (27) complained she could not breathe, presumably due to cannabis kief (cannabis dust) in the air where she was grinding and packaging pre-rolls. She was taken to a local hospital\u0026nbsp;where she died on Jan. 7. According to the \u003ca href=\"https://www.cdc.gov/mmwr/volumes/72/wr/mm7246a2.htm\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ereport from\u003c/a\u003e the Centers for Disease Control and Prevention (CDC), this was the first\u003ca href=\"https://www.benzinga.com/markets/cannabis/23/11/35844553/cannabis-employee-died-from-occupational-asthma-fed-report-confirms-first-such-case-in-us\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e known case of an occupational asthma death\u003c/a\u003e in the U.S. cannabis industry. The report confirmed that the occupational asthma was triggered by ground cannabis dust, and revealed that cannabis giant Trulieve (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e) committed three \u0026#8220;serious\u0026#8221; violations assessed by OSHA for which it paid fines totaling $35,219.\u003c/p\u003e\n\u003cp\u003eIn June, the Commission fined medical marijuana giant \u003cstrong\u003eTrulieve\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e) in relation to the death of a company\u0026#8217;s employee in 2022. A company representative signed a tentative settlement with Commission, agreeing to a fine in the amount of \u003cstrong\u003e$350,000.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/11/35915235/mother-of-deceased-cannabis-worker-sues-marijuana-giant-claiming-wrongful-death-and-negligence\"\u003eMother Of Deceased Cannabis Worker Sues Marijuana Giant Claiming Wrongful Death And Negligence\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSafety And Sanitary Standards\u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eToday's update follows a state Department of Public Health (DPH) Fatality Assessment and Control Evaluation (FACE) report and Occupational Lung Disease Bulletin that were issued following McMurrey's death.\u003c/p\u003e\n\u003cp\u003eAs the first confirmed case of\u0026nbsp;occupational asthma in a cannabis facility, the CDC report said the incident\u0026nbsp;\"illustrates missed opportunities for prevention, including control of workplace exposures, medical surveillance, and treatment according to current asthma guidelines.\"\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThe previous DPH report also included recommendations for marijuana cannabis processors, including training all employees about how to work safely around hazardous materials, developing comprehensive health and safety programs, and monitoring employees for health symptoms.\u003c/p\u003e\n\u003cp\u003eThe Commission's latest announcement relative to cannabis dust follows a February bulletin that advised licensees about new safety and sanitary standards for processing the leaves and flowers of female marijuana plants in a way that is:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eWell cured and free from seeds and stems;\u003c/li\u003e\n\u003cli\u003eFree of dirt, sand, debris, and other foreign matter;\u003c/li\u003e\n\u003cli\u003eFree of contamination by mold, rot, other fungus, pests and bacterial diseases and satisfying the sanitation requirements in 105 CMR 500.000, and if applicable, 105 CMR 590.000: State Sanitary Code Chapter X – Minimum Sanitation Standards for Food Establishments;\u003c/li\u003e\n\u003cli\u003ePrepared and handled on food-grade stainless steel tables with no contact with Licensees' or Marijuana Establishment Agents' bare hands; and\u003c/li\u003e\n\u003cli\u003ePackaged in a secure area.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eCommission's new bulletin clarifies that all licensees engaged in the processing of marijuana have a separate obligation to ensure the safety of workers, and all marijuana establishments and medical marijuana treatment centers in Massachusetts are required to follow Commission regulations that require written workplace safety and health standard operating procedures.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41958902/hemp-co-wins-8-4m-grant-from-us-energy-dept-to-develop-carbon-negative-building-materials\"\u003e\u003cstrong\u003eHemp Co. Wins $8.4M Grant From US Energy Dept. To Develop Carbon-Negative Building Materials\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of CRYSTALWEED cannabis on Unsplash\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41997206/ground-cannabis-dust-is-a-hazardous-chemical-confirms-massachusetts-regulator","image":"https://cdn.benzinga.com/files/images/story/2024/11/18/crystalweed-cannabis-Wl-Xv2MRRZw-unsplas.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/18/crystalweed-cannabis-Wl-Xv2MRRZw-unsplas.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/18/crystalweed-cannabis-Wl-Xv2MRRZw-unsplas.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""}],"stocks":[{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":932870,"name":"Debbie Hilton-Creek","description":""},{"tid":859101,"name":"Lorna McMurrey","description":""},{"tid":724951,"name":"Massachusetts Cannabis","description":""},{"tid":810150,"name":"Massachusetts Cannabis Control Commission","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41997206\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41997206\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 41997206\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41959036,"author":"Maureen Meehan","created":"Wed, 13 Nov 2024 18:28:30 -0500","updated":"Wed, 13 Nov 2024 19:26:03 -0500","title":"Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General","teaser":"Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.","body":"\u003cp\u003ePresident-elect \u003cstrong\u003eDonald Trump\u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation\"\u003e nominated\u003c/a\u003e another cannabis legalization supporter to his cabinet. Rep. \u003ca href=\"https://www.benzinga.com/topic/matt-gaetz\"\u003eMatt Gaetz\u003c/a\u003e (R) of Florida is being tapped to serve as U.S. attorney general.\u003c/p\u003e\n\u003cp\u003eTrump wrote on Truth Social that Gaetz \"has distinguished himself in Congress through his focus on achieving desperately needed reform at the Department of Justice.\"\u003c/p\u003e\n\u003cp\u003eGaetz replied on X, \"It will be an honor to serve as President Trump's Attorney General!\"\u003c/p\u003e\n\u003cp\u003eIn July 2023, Gaetz \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/07/33127611/rep-matt-gaetz-wants-to-end-cannabis-testing-for-us-military-citing-recruitment-crisis\"\u003eproposed an amendment\u003c/a\u003e that would eliminate cannabis testing for individuals wanting to enlist as a member or commissioned officer in the U.S. armed forces. He said at the time that eliminating cannabis testing could help the military meet its\u0026nbsp;recruitment goals.\u003c/p\u003e\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eInvestigation By House Ethics Committee\u003c/strong\u003e\u003c/h1\u003e\n\u003cp\u003eMeanwhile, Gaetz was being investigated by the House Ethics Committee as to whether he engaged in sexual misconduct or illicit drug use. If confirmed for the position, Gaetz will take over for current Attorney General \u003cstrong\u003eMerrick Garland\u003c/strong\u003e, who led the U.S. Department of Justice that undertook the sex-trafficking investigation though it did not end up charging the 42-year congressman whose reputation for partying precedes him.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41951578/trump-taps-cannabis-supporters-elon-musk-vivek-ramaswamy-to-slash-government-spending\"\u003eTrump Taps Cannabis Supporters Elon Musk, Vivek Ramaswamy To Slash Government Spending\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eGaetz also has a reputation for being a fawning Trump loyalist. Who can forget the chaos in the House in October 2023 when he \u003ca href=\"https://www.benzinga.com/news/23/10/35342612/kevin-mccarthy-reportedly-tells-matt-gaetz-to-sit-your-a-down-in-heated-gop-meeting-amid-speakership\"\u003eled a group of Republicans\u003c/a\u003e to kick then-House Speaker \u003cstrong\u003eKevin McCarthy \u003c/strong\u003eto the curb? Trump\u0026#8217;s disdain for McCarthy was no secret. The situation got so testy that Gaetz\u0026#8217;s own colleagues \u003ca href=\"https://www.benzinga.com/news/23/10/35104506/gop-lawmakers-express-frustration-with-matt-gaetz-make-him-stand-near-democrats-amid-house-speaker-c\"\u003edisallowed him to debate\u003c/a\u003e within their caucus, relegating him to sit on the\u0026nbsp;Democratic side of the chamber. \u003c/p\u003e\n\u003cp\u003eNow, Gaetz's fortunes have changed, though the jury is still out on whether his behavior has, which apparently doesn't matter.\u003c/p\u003e\n\u003cp\u003eNBC News \u003ca href=\"https://www.cnbc.com/2024/11/13/trump-taps-rep-matt-gaetz-as-attorney-general.html\"\u003ereported\u003c/a\u003e Gaetz traveled with Trump, \u003cstrong\u003eElon Musk\u003c/strong\u003e and others on Wednesday to Washington, D.C., where they were received by President \u003cstrong\u003eJoe Biden \u003c/strong\u003eas part of the formal beginning\u0026nbsp;\u003ca href=\"https://www.benzinga.com/topic/donald-trump\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eof the handover process.\u003c/a\u003e\u003c/p\u003e\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCannabis Stocks Enjoying The Ride\u003c/strong\u003e\u003c/h1\u003e\n\u003cp\u003eMeanwhile, cannabis stocks seem to be enjoying the news, beginning on Tuesday with a \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41910180/exclusive-chris-christie-says-trump-will-remove-federal-restrictions-on-marijuana-find-sweet-spot-for-crypto-regulation\"\u003eBenzinga exclusive\u003c/a\u003e in which former New Jersey Gov. \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/chris-christie\"\u003eChris Christie\u003c/a\u003e, \u003c/strong\u003esuggested that President-elect \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/donald-trump\"\u003eTrump\u003c/a\u003e\u003c/strong\u003e will likely deschedule cannabis.\u003c/p\u003e\n\u003cp\u003eThe cannabis stock market reacted positively for the most part with several companies experiencing notable gains Wednesday:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e)\u003cstrong\u003e:\u003c/strong\u003e\u0026nbsp;Increased by 8.18% to $7.01.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCresco Labs Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e)\u003cstrong\u003e:\u003c/strong\u003e\u0026nbsp;Rose by 14.29% to $1.44.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCuraleaf Holdings, Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e):\u0026nbsp;Climbed 9.80% to $2.24.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eGreen Thumb Industries Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e)\u003cstrong\u003e:\u003c/strong\u003e\u0026nbsp;Advanced 8.38% to $9.70.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eThe \u003cstrong\u003eAdvisorShares Pure US Cannabis ETF\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOS#NYSE\"\u003eMSOS\u003c/a\u003e), which tracks U.S. cannabis companies, gained 9.96%, reflecting investor optimism about potential federal policy changes under Gaetz\u0026#8217;s influence. These movements underscore the market\u0026#8217;s sensitivity to political developments affecting the cannabis industry.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eNow Read: \u003c/strong\u003e\u003cbr /\u003e • \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/41950826/kristi-noems-appointment-as-homeland-security-secretary-raises-questions-about-federal-cannabis-policy\"\u003eTrump\u0026#8217;s Appointment Of Kristi Noem To Homeland Security Chief Raises Questions About Fed Cannabis Policy\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\n\u003ch1 class=\"sc-dUHDFv dLLBJn layout-title \" style=\"box-sizing: border-box; border: 0px solid rgb(229, 231, 235); --tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-pan-x: ; --tw-pan-y: ; --tw-pinch-zoom: ; --tw-scroll-snap-strictness: proximity; --tw-gradient-from-position: ; --tw-gradient-via-position: ; --tw-gradient-to-position: ; --tw-ordinal: ; --tw-slashed-zero: ; --tw-numeric-figure: ; --tw-numeric-spacing: ; --tw-numeric-fraction: ; --tw-ring-inset: ; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgba(59,130,246,.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; --tw-blur: ; --tw-brightness: ; --tw-contrast: ; --tw-grayscale: ; --tw-hue-rotate: ; --tw-invert: ; --tw-saturate: ; --tw-sepia: ; --tw-drop-shadow: ; --tw-backdrop-blur: ; --tw-backdrop-brightness: ; --tw-backdrop-contrast: ; --tw-backdrop-grayscale: ; --tw-backdrop-hue-rotate: ; --tw-backdrop-invert: ; --tw-backdrop-opacity: ; --tw-backdrop-saturate: ; --tw-backdrop-sepia: ; --tw-contain-size: ; --tw-contain-layout: ; --tw-contain-paint: ; --tw-contain-style: ; font-size: 2.6rem; font-weight: bold; margin: 0px; font-family: sans-serif; color: rgb(17, 17, 17); padding: 0px; line-height: 3.25rem; white-space-collapse: collapse;\"\u003e\u003c/h1\u003e\n\u003c/p\u003e\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of The Fresh Toast\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general","image":"https://cdn.benzinga.com/files/images/story/2024/11/13/matt-gaetz-51772587794-1-copy.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/13/matt-gaetz-51772587794-1-copy.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/13/matt-gaetz-51772587794-1-copy.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":29619,"name":"Legal","description":""},{"tid":138079,"name":"Top Stories","description":""}],"stocks":[{"tid":735580,"name":"CRLBF","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":774329,"name":"MSOS","description":null},{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":24238,"name":"attorney general","description":""},{"tid":148171,"name":"cannabis stocks","description":""},{"tid":18656,"name":"Donald Trump","description":""},{"tid":828877,"name":"Matt Gaetz","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41959036\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41959036\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41855573,"author":"Rolando García","created":"Fri, 08 Nov 2024 14:35:00 -0500","updated":"Fri, 08 Nov 2024 14:35:00 -0500","title":"Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?","teaser":"Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.","body":"\u003cp\u003eThe cannabis market is facing heightened volatility \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003epost-election\u003c/a\u003e as investor concerns mount over political uncertainty and the fallout from Florida's \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775201/cannabis-reform-stumbles-in-2024-elections-a-state-by-state-breakdown-as-stocks-take-a-hit\"\u003efailed legalization vote\u003c/a\u003e, leading to significant selloffs in top U.S. and Canadian cannabis stocks. Adult-use legalization was also \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775201/cannabis-reform-stumbles-in-2024-elections-a-state-by-state-breakdown-as-stocks-take-a-hit\"\u003erejected\u003c/a\u003e in North Dakota and South Dakota.\u003c/p\u003e\n\u003cp\u003eGiven this setup, investors might be asking: was the post-elections selloff an overreaction or a rational market adjustment?\u003c/p\u003e\n\u003cp\u003eExperts analysts from \u003cstrong\u003eViridian Capital Advisors\u003c/strong\u003e weighed in on the debate.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eMarket Meltdown: Was The Sell-Off Justified?\u003c/h3\u003e\n\u003cp\u003eIn the wake of Florida\u0026#8217;s failed ballot vote for adult-use cannabis, the market cap of 31 publicly traded cannabis companies fell by $2.6 billion from Friday, November 1 to Wednesday, November 6.\u003c/p\u003e\n\u003cp\u003eFlorida\u0026#8217;s medical cannabis market alone is projected to reach $2.1 billion in sales by 2024. \u003c/p\u003e\n\u003cp\u003eIf adult-use legalization had passed, it could have effectively doubled sales, adding another $2.1 billion. \u003c/p\u003e\n\u003cp\u003eApplying a conservative 30% EBITDA margin to these potential sales would yield an EBITDA loss of $630 million. \u003c/p\u003e\n\u003cp\u003eUsing a 5x multiple, also considered conservative, the projected decline in market cap would be around $3.15 billion — suggesting that the $2.6 billion markdown might\u003cstrong\u003e \u003c/strong\u003enot have been as exaggerated as it seems.\u003c/p\u003e\n\u003cp\u003eHowever, there's a caveat: not all companies on the list have operations in Florida, though 81% of the market cap is held by firms actively operating there. \u003c/p\u003e\n\u003cp\u003eA greater concern is the broader impact on the industry's growth narrative.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775201/cannabis-reform-stumbles-in-2024-elections-a-state-by-state-breakdown-as-stocks-take-a-hit\"\u003eCannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSome Earnings Added Pessimism\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eFor \u003ca href=\"https://www.benzinga.com/author/viridian-capital-advisors\"\u003eViridian Capital Advisors\u003c/a\u003e, in addition to the disappointing ballot results, earnings reports from major players including Trulieve (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e), TerrAscend (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TRSSF#OTC\"\u003eTRSSF\u003c/a\u003e), Curaleaf (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41808095/the-cannabist-co-q3-revenue-declines-8-completes-5m-asset-sale-exits-florida-market-amid-restruc\"\u003eCannabist\u003c/a\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CBSTF#OTCQX\"\u003eCBSTF\u003c/a\u003e) and GTI (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e)\u003cem\u003e \u003c/em\u003ehave compounded concerns.\u003c/p\u003e\n\u003cp\u003eThe results revealed significant misses, even against lowered expectations. \u003c/p\u003e\n\u003cp\u003eAggregate revenues for these companies are projected to be down 0.4% year-over-year and 1.1% sequentially. The\u003cstrong\u003e \u003c/strong\u003edecline in EBITDA is 2.2% year-over-year and 4.2% sequentially.\u003c/p\u003e\n\u003cp\u003eThe failed vote has undeniably stretched the industry's growth timeline, leaving investors to weigh \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41823267/cannabis-stocks-is-it-time-to-buy-the-dip-after-elections-and-legalization-setbacks\"\u003epotential catalysts \u003c/a\u003eagainst a stark present reality.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/41851368/hemp-market-surge-how-new-regulations-could-impact-growth\"\u003eHemp Market Surge: How New Regulations Could Impact Growth\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41855573/cannabis-stocks-plunged-after-florida-legalization-failed-rational-reaction-or-market-overreach","image":"https://cdn.benzinga.com/files/images/story/2024/11/08/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/08/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/08/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":17375,"name":"Economics","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":910020,"name":"CBSTF","description":"THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC."},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":714097,"name":"TRSSF","description":""}],"tags":[{"tid":775074,"name":"Cannabis Markets","description":""},{"tid":148171,"name":"cannabis stocks","description":""},{"tid":614083,"name":"Viridian Capital Advisors","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41855573\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41855573\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41851368,"author":"Patricio Liddle","created":"Fri, 08 Nov 2024 12:10:22 -0500","updated":"Fri, 08 Nov 2024 12:10:22 -0500","title":"Hemp Market Surge: How New Regulations Could Impact Growth","teaser":"Hemp industry regulatory changes in 2024 may impact delta-8 THC sales, spark market shifts, and intensify hemp vs. marijuana sector conflicts.","body":"\u003cp\u003eThe hemp industry is at a crossroads as \u003cstrong\u003eproposed changes in the 2024 Farm Bill\u003c/strong\u003e threaten to reshape its regulatory landscape. Lawmakers are considering amendments that could ban products like delta-8 THC, a hemp-derived compound that has \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/01/30442687/controversial-delta-8-thc-products-garner-2b-in-sales-over-2-years-so-whats-the-problem\"\u003esurged in popularity\u003c/a\u003e, especially in states where marijuana remains illegal.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eProposed Hemp Redefinition Could Threaten Hemp\u0026#8217;s Growth\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eAccording to a recent \u003ca href=\"https://businesslawtoday.org/month-in-brief/october-in-brief-business-regulation-and-regulated-industries-2024/#Cannabis_Law\"\u003ereport\u003c/a\u003e by the \u003cstrong\u003eAmerican Bar Association (ABA)\u003c/strong\u003e, the House Agriculture Committee\u0026#8217;s draft of the 2024 Farm Bill includes language aimed at closing loopholes that allow the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40286086/anti-drug-groups-urge-congress-to-ban-hemp-derived-cannabinoids-as-debate-grows\"\u003eproduction and sale of intoxicating hemp-derived cannabinoids\u003c/a\u003e. If enacted, these changes would redefine hemp, excluding products containing cannabinoids not naturally produced by the cannabis plant or synthesized outside of it. This move could significantly impact \u003ca href=\"http://benzinga.com/topic/hemp\"\u003ehemp\u003c/a\u003e businesses that rely on the burgeoning market for delta-8 THC products.\u003c/p\u003e\n\u003cp\u003ePsychoactive hemp-derived products such as delta-8 THC have surged in the market. According to Cannabis Business Times figures cited by the ABA, delta-8 THC products generated $1.2 billion in sales in 2023. The compound has found a niche market due to its \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained\"\u003esimilar effects to delta-9 THC but with less potency\u003c/a\u003e.\u0026nbsp;Companies like \u003cstrong\u003eCuraleaf Holdings Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e) have \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39820619/strategy-shift-in-the-works-are-cannabis-giants-getting-into-the-hemp-derived-thc-market\"\u003eentered the delta-8 THC market\u003c/a\u003e, capitalizing on consumer demand for these alternative cannabinoids.\u003c/p\u003e\n\u003cp\u003eHowever, the potential ban has raised concerns among hemp industry advocates who fear it could \u0026#8220;destroy the hemp cannabinoid market,\u0026#8221; as the ABA briefing noted. \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40833963/expert-calls-for-a-united-hemp-and-cannabis-front-industries-should-collaborate-and-push-for-fed\"\u003eMany are calling for regulatory oversight\u003c/a\u003e rather than an outright ban. States like \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41297880/california-judge-rules-gov-newsoms-hemp-ban-stands-despite-industry-pushback\"\u003eCalifornia\u003c/a\u003e, South Dakota, Louisiana, Iowa and Nebraska have already \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39610764/intoxicating-hemp-products-face-regulatory-crackdown-across-multiple-states\"\u003eimplemented bans on hemp THC products\u003c/a\u003e, adding pressure to the national debate.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eGlobal Hemp Market Growth Projections Soar\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eWhile regulatory pressures mount, the global industrial hemp market is experiencing significant growth. A \u003ca href=\"https://www.globenewswire.com/news-release/2024/11/06/2975897/0/en/Industrial-Hemp-Strategic-Industry-Research-Report-2024-2030-Rising-Legalization-of-Hemp-Cultivation-and-Growing-Use-in-Bioplastics-and-Bio-Composites-Expands-Market-Opportunities.html\"\u003ereport\u003c/a\u003e by \u003cstrong\u003eResearch and Markets \u003c/strong\u003eprojects the market to reach $23.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.7% from 2023. Factors driving this expansion include increasing demand for sustainable and biodegradable materials, favorable regulatory changes and \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40418137/industrial-hemps-14b-projected-growth-an-investment-opportunity-too-good-to-miss\"\u003ethe rising popularity\u003c/a\u003e of hemp-derived products.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"400\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08091432/industrial-hemp-market.png\" alt=\"\" class=\"wp-image-637723\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08091432/industrial-hemp-market.png 600w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08091432/industrial-hemp-market-300x200.png 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" /\u003e\u003cfigcaption class=\"wp-element-caption\"\u003e\u003cem\u003eIndustrial Hemp Market \u0026#x7C; Courtesy of Research and Markets\u003c/em\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eLegal Ambiguities Fuel Cannabis Industry Divide\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eNevertheless, despite the market\u0026#8217;s positive trajectory, internal tensions within the industry are intensifying. Conflicts between hemp companies and large marijuana operators have come to the forefront, particularly within the \u003cstrong\u003eU.S. Cannabis Council (USCC)\u003c/strong\u003e. Hemp businesses, benefiting from legal ambiguities to sell \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/03/37853470/e-commerce-giants-exposed-hemp-gummies-on-amazon-mask-unsafe-delta-8-thc-levels-new-report-revea\"\u003eoften unregulated psychoactive products\u003c/a\u003e, are clashing with multi-state operators (MSOs) over market influence and regulatory approaches.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/40027836/hempcrete-project-gets-6-2m-epa-grant-to-develop-eco-friendly-construction-materials\"\u003e\u003cstrong\u003eHempcrete Project Gets $6.2M EPA Grant To Develop Eco-Friendly Construction Materials\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRobert Hoban\u003c/strong\u003e, a prominent figure in the cannabis sector, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775784/hemp-vs-marijuana-industry-tensions-rise-amid-rejection-of-cannabis-legalization-in-florida-the-\"\u003erecently described the situation\u003c/a\u003e as an industry \u0026#8220;civil war.\u0026#8221; He questioned whether the market will be \u0026#8220;controlled by a small group of publicly-traded, multi-billion-dollar vertically integrated marijuana companies\u0026#8230; or produced and distributed by farmers and small businesses.\u0026#8221;\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp THC Products Challenge Marijuana Markets\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eMeanwhile, these internal disputes are further complicated by recent events in states like Florida, where \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003evoters there rejected Amendment 3\u003c/a\u003e, a measure to legalize recreational cannabis. Hemp businesses contributed \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726320/hemp-donations-fuel-desantis-and-florida-gops-charge-against-weed-legalization-new-findings\"\u003eover $500,000 to Gov. DeSantis\u0026#8217; bid to defeat the amendment\u003c/a\u003e, fearing legalization would harm businesses involved in hemp cultivation and sales. Conversely, major cannabis company \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) supported the initiative, which underscores the ongoing tensions within the industry. It should be noted that the Florida cannabis initiative garnered 56% of the vote but to be adopted as a constitutional amendment, it needed 60%.\u003c/p\u003e\n\u003cp\u003eThe rejection of cannabis legalization in \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res\"\u003eFlorida\u003c/a\u003e and the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41765421/south-dakota-rejects-measure-29-cannabis-legalization-fails-again\"\u003eDakotas\u003c/a\u003e underscores the complex dynamics at play. Hemp-derived THC products continue to challenge traditional cannabis markets, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40561082/delta-8-thc-exposure-is-lower-in-states-where-recreational-marijuana-is-legal-say-researchers-ba\"\u003eespecially in regions where adult-use cannabis remains illegal\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003eAs the hemp sector grapples with potential regulatory changes and internal conflicts, its future remains uncertain. The industry needs to find a balance between growth, safety and fair market practices.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41776510/cannabis-industry-leaders-react-to-trump-victory-expect-changes\"\u003e\u003cstrong\u003eCannabis Industry Leaders React To Trump Victory: Expect Changes\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003ePhoto by Nicky via Pixabay.\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/government/regulations/24/11/41851368/hemp-market-surge-how-new-regulations-could-impact-growth","image":"https://cdn.benzinga.com/files/images/story/2024/11/08/Hemp.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/08/Hemp.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/08/Hemp.jpeg?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":144213,"name":"Regulations","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":29619,"name":"Legal","description":""}],"stocks":[{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":181416,"name":"American Bar Association","description":""},{"tid":715484,"name":"Delta-8 THC","description":""},{"tid":155693,"name":"Hemp","description":""},{"tid":938983,"name":"Hemp Vs Cannabis","description":""},{"tid":614496,"name":"Research and Markets","description":""},{"tid":792594,"name":"U.S. Cannabis Council","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41851368\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41851368\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41823267,"author":"Rolando García","created":"Thu, 07 Nov 2024 15:57:47 -0500","updated":"Thu, 07 Nov 2024 15:57:47 -0500","title":"Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?","teaser":"After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?","body":"\u003cp\u003eThe cannabis sector is showing signs of stabilization following a harsh post-election sell-off triggered by \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003eelection results.\u003c/a\u003e \u003c/p\u003e\n\u003cp\u003eWith \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41787490/donald-trumps-evolving-stance-on-marijuana-is-cannabis-legalization-finally-on-his-agenda\"\u003eDonald Trump's return\u003c/a\u003e to the presidency, a GOP-controlled Senate, and Florida's \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003erejection of Amendment 3\u003c/a\u003e, which would have legalized cannabis, investor sentiment turned cautious, leading to widespread panic selling. \u003c/p\u003e\n\u003cp\u003eYet, as of Thursday, some stocks are making a modest comeback, suggesting that Wednesday\u0026#8217;s declines may have been oversold.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"605\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03-1024x605.png\" alt=\"\" class=\"wp-image-636069\" style=\"width:510px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03-1024x605.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03-768x454.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03-1536x908.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133826/Captura20de20pantalla202024-11-0720a20la28s292015.27.03.png 1732w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eCannabis Watchist \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eTilray Brands (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e): A Tentative Recovery\u003c/h3\u003e\n\u003cp\u003eTilray experienced a sharp drop yesterday, trading down to $1.51 amid panic selling, but has recovered slightly to $1.56, marking a 1.3% gain. \u003c/p\u003e\n\u003cp\u003eThe RSI stands near 41.85, indicating that the stock \u003cstrong\u003eis approaching oversold\u003c/strong\u003e. \u003c/p\u003e\n\u003cp\u003eThis could attract buyers, but the stock\u0026#8217;s movement remains tentative, with resistance around $1.60, and a figure turning into a hammer, which could indicate final dip levels.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"685\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11-1024x685.png\" alt=\"\" class=\"wp-image-636071\" style=\"width:567px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11-1024x685.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11-300x201.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11-768x514.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11-1536x1027.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133920/Captura20de20pantalla202024-11-0720a20la28s292015.29.11.png 1615w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eSNDL (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SNDL#NASDAQ\"\u003eSNDL\u003c/a\u003e): Holding Support\u003c/h3\u003e\n\u003cp\u003eSNDL is showing resilience at the $2.00 support level, recovering slightly to $2.02 with a neutral RSI at 45.90. The stock has managed to absorb some of the selling pressure, though it remains below its recent high near $2.60. This indicates that traders may be taking a wait-and-see approach for clearer signs of sustained support before fully stepping back in.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"652\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD-1024x652.png\" alt=\"\" class=\"wp-image-636070\" style=\"width:565px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD-1024x652.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD-300x191.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD-768x489.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD-1536x979.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133854/SNLD.png 1695w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eTrulieve (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e): Strong Bounce\u003c/h3\u003e\n\u003cp\u003eTrulieve, which suffered a drastic drop yesterday following Florida\u0026#8217;s failed cannabis legalization effort, is now up 6.53%, trading at $7.67. The RSI of 28.54 highlighted an oversold condition, drawing in buyers looking for value. This recovery suggests the initial selling may have been excessive.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"711\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE-1024x711.png\" alt=\"\" class=\"wp-image-636072\" style=\"width:574px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE-1024x711.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE-300x208.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE-768x533.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE-1536x1066.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07133941/TRULIEVE.png 1556w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eAdvisorShares Pure US Cannabis ETF (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOS#NYSE\"\u003eMSOS\u003c/a\u003e): ETF Stability May \u003c/h3\u003e\n\u003cp\u003eMSOS, a popular cannabis ETF, has risen by 4.83% to $5.21, rebounding from an RSI of 31.15, which flagged oversold conditions. With many cannabis stocks attempting recoveries, MSOS is holding above the $5.00 level, a critical support.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"710\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20-1024x710.png\" alt=\"\" class=\"wp-image-636074\" style=\"width:574px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20-1024x710.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20-300x208.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20-768x533.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20-1536x1065.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134013/Captura20de20pantalla202024-11-0720a20la28s292015.32.20.png 1557w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41237666/exclusive-tax-changes-could-unlock-hundreds-of-millions-in-cash-flow-for-cannabis-sector-experts\"\u003e EXCLUSIVE: Tax Changes Could Unlock \u0026#8216;Hundreds Of Millions In Cash Flow\u0026#8217; For Cannabis Sector, Experts Predict\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eIs Buying The Dip A Good Idea?\u003c/h3\u003e\n\u003cp\u003eWhile the sector is showing early signs of stabilization, the underlying risks remain. Still, most stocks look heavily oversold or reaching that point.\u003c/p\u003e\n\u003cp\u003eFundaments are relevant to understand what the outcome might look like in the mid-turn. \u003c/p\u003e\n\u003cp\u003eWith a GOP-majority Senate likely to stall cannabis reform, there's a possibility of four more years of cannabis protectionism \u0026#8211; a period marked by minimal legislative progress and regulatory insularity.\u003c/p\u003e\n\u003cp\u003eNevertheless, an argument could be made that the fundamentals of cannabis have not changed and, particularly, that the impact of rescheduling on balance sheets, due to the suppression of \u003ca href=\"https://www.benzinga.com/topic/280e\"\u003e280E burden\u003c/a\u003e, would be \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41237666/exclusive-tax-changes-could-unlock-hundreds-of-millions-in-cash-flow-for-cannabis-sector-experts\"\u003eformidable \u003c/a\u003efor the industry. \u003ca href=\"https://www.benzinga.com/topic/cannabis-rescheduling\"\u003eRescheduling\u003c/a\u003e does not require a\u003cstrong\u003e Senate majority\u003c/strong\u003e or \u003cstrong\u003epresidential involvement\u003c/strong\u003e.\u003c/p\u003e\n\u003cp\u003eThat said, stock prices for cannabis rely heavily on the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40567326/dea-delays-cannabis-rescheduling-decision-until-after-november-presidential-election\"\u003eupcoming DEA administrative hearing and ruling\u003c/a\u003e.\u003c/p\u003e\n\u003cp\u003eInvestors should weigh the potential for long-term industry growth against the immediate political headwinds.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003eTilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eDisclosure: this article is not intended to provide financial advice. Consult a professional before making investment decisions.\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41823267/cannabis-stocks-is-it-time-to-buy-the-dip-after-elections-and-legalization-setbacks","image":"https://cdn.benzinga.com/files/images/story/2024/11/07/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/07/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/07/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":774329,"name":"MSOS","description":null},{"tid":753165,"name":"SNDL","description":""},{"tid":731053,"name":"TCNNF","description":""},{"tid":723743,"name":"TLRY","description":""}],"tags":[{"tid":24159,"name":"analysis","description":""},{"tid":18656,"name":"Donald Trump","description":""},{"tid":38151,"name":"elections","description":""},{"tid":163833,"name":"top stories","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41823267\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41823267\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 41823267\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41782344,"author":"Rolando García","created":"Wed, 06 Nov 2024 12:52:08 -0500","updated":"Wed, 06 Nov 2024 18:57:55 -0500","title":"Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty","teaser":"Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.","body":"\u003cp\u003eThe cannabis market is experiencing a rough patch after \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41744722/election-day-2024-will-florida-nebraska-north-and-south-dakota-join-the-marijuana-revolution\"\u003eelection day\u003c/a\u003e, with many top U.S. and Canadian cannabis stocks under pressure following \u003cstrong\u003eDonald Trump\u003c/strong\u003e\u0026#8216;s victory, the prospect of a GOP-controlled Senate and \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003eFlorida\u0026#8217;s rejection of Amendment 3\u003c/a\u003e that would have legalized cannabis.\u003c/p\u003e\n\u003cp\u003eAs of Wednesday mid-morning, key cannabis players experienced notable drops in share prices, reflecting investor caution and panic sales as the sector\u003cstrong\u003e faces a wave of political uncertainty\u003c/strong\u003e.\u003c/p\u003e\n\u003cp\u003eFor instance, shares of cannabis leader \u003cstrong\u003eTilray Brands Inc (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e)\u003c/strong\u003e are trading at $1.53, \u003cstrong\u003edown $0.25\u003c/strong\u003e, or\u003cstrong\u003e -13.7%.\u003c/strong\u003e Tilray\u0026#8217;s chart shows a sharp decline with increased trading volume nearing 10 million shares.\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"475\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray-1024x475.png\" alt=\"\" class=\"wp-image-633330\" style=\"width:656px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray-1024x475.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray-300x139.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray-768x356.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray-1536x713.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06122623/tilray.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eHere's how other top U.S. and Canadian cannabis stocks are trading as of Wednesday mid-morning:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCuraleaf Holdings Inc \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e) shares are trading at $2.38, down $0.74.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eGreen Thumb Industries Inc (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e) \u003c/strong\u003eshares are trading at $8.78, down $1.90.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eTrulieve Cannabis Corp \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) \u003ca href=\"https://www.trulieve.com/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003c/a\u003eshares are trading at $7.27, down $5.43.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eCanopy Growth Corp (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) shares are trading at $4.35, down $1.25.\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eA look at how some of the most traded cannabis ETFs are trading:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAdvisorShares Pure US Cannabis ETF \u003c/strong\u003e(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/YOLO#NYSE\"\u003eYOLO\u003c/a\u003e) shares are trading at $5.01, down $1.87.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eETFMG Alternative Harvest ETF \u003c/strong\u003e(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MJ#NYSE\"\u003eMJ\u003c/a\u003e) shares are trading at $2.74, down $0.59.\u003c/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdvisorShares Pure Cannabis ETF (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOS#NYSE\"\u003eMSOS\u003c/a\u003e) shares are trading at $2.80, down $0.52.\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res\"\u003eFlorida\u0026#8217;s Cannabis Initiative Defeated: Trulieve CEO Kim Rivers, NFL\u0026#8217;s Ricky Williams And Others Respond\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMarket Takes A Toll On Trulieve Bet\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eTrulieve Cannabis Corp (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) stands out in this market slump, experiencing a -43% at the moment of writing. \u003c/p\u003e\n\u003cp\u003eTrulieve, which invested heavily in Florida's \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res\"\u003eAmendment 3 campaign\u003c/a\u003e \u0026#8211; over $110 million \u0026#8211; saw its shares tumble from nearly $12 to $7.27, losing $5.43.\u003c/p\u003e\n\u003cp\u003eThis drastic drop comes on the heels of both the company\u0026#8217;s \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41743807/trulieves-q3-revenue-up-slightly-year-over-year-net-loss-grows-amid-48m-in-cannabis-legalization\"\u003eQ3 earnings report\u003c/a\u003e and the failed Florida legalization measure.\u003c/p\u003e\n\u003cp\u003eTrulieve reported $284 million in revenue, a modest 3% year-over-year increase, but the substantial campaign investment weighed heavily on its financials. \u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"608\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34-1024x608.png\" alt=\"\" class=\"wp-image-633191\" style=\"width:655px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34-1536x911.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06114215/Captura-de-pantalla-2024-11-06-a-las-13.18.34.png 1820w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eThe chart for Trulieve shows a sharp drop from over $12 to the $7 range, with significant volume spikes, indicating heavy selling pressure. \u003c/p\u003e\n\u003cp\u003eHad the amendment passed, a clear win for Trulieve, the situation would probably be quite different.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41780260/canopy-growth-and-other-top-cannabis-companies-to-report-earnings-will-results-get-pot-stocks-on\"\u003eCanopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: AI-generated image\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc","image":"https://cdn.benzinga.com/files/images/story/2024/11/06/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/06/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/06/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":144213,"name":"Regulations","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":22438,"name":"CGC","description":"Canopy Growth Corp"},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":576854,"name":"MJ","description":""},{"tid":774329,"name":"MSOS","description":null},{"tid":731053,"name":"TCNNF","description":""},{"tid":723743,"name":"TLRY","description":""},{"tid":731962,"name":"YOLO","description":null}],"tags":[{"tid":24159,"name":"analysis","description":""},{"tid":752742,"name":"cannabis market","description":""},{"tid":148171,"name":"cannabis stocks","description":""},{"tid":38151,"name":"elections","description":""},{"tid":18240,"name":"markets","description":""},{"tid":163833,"name":"top stories","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41782344\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41782344\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 41782344\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41780079,"author":"Rolando García","created":"Wed, 06 Nov 2024 11:38:39 -0500","updated":"Wed, 06 Nov 2024 11:38:39 -0500","title":"Florida's Cannabis Initiative Defeated: Trulieve CEO Kim Rivers, NFL's Ricky Williams And Others Respond","teaser":"Florida's cannabis legalization bid, Amendment 3, narrowly missed the mark. Industry leaders pledge to keep pushing for future reform efforts.","body":"\u003cp\u003eFlorida\u0026#8217;s cannabis legalization initiative, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c\"\u003eAmendment 3 \u003c/a\u003e(AM3), \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003efailed to pass\u003c/a\u003e on Tuesday despite gaining a majority of the vote. The initiative achieved 55.8% support although a constitutional amendment in Florida needs to garner 60% of the vote to be adopted.\u003c/p\u003e\n\u003cp\u003eBacked by cannabis advocates and public figures like former President \u003cstrong\u003eDonald Trump\u003c/strong\u003e, the amendment faced persistent opposition from Governor \u003cstrong\u003eRon DeSantis\u003c/strong\u003e and Florida's Republican Party, among other \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775784/hemp-vs-marijuana-industry-tensions-rise-amid-rejection-of-cannabis-legalization-in-florida-the-\"\u003ecannabis prohibition\u003c/a\u003e groups.\u003c/p\u003e\n\u003cp\u003eWith a total of\u003cstrong\u003e 5,941,050 in favor\u003c/strong\u003e and \u003cstrong\u003e4,688,829 votes against\u003c/strong\u003e, the amendment was defeated.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eKim Rivers\u003c/strong\u003e, CEO of \u003cstrong\u003eTrulieve\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTCQX\"\u003eTCNNF\u003c/a\u003e) wrote in X account that she was \"Proud to have fought the fight – we left it all on the field.\" \u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter\"\u003e\u003cbr /\u003e\n\u003cdiv class=\"wp-block-embed__wrapper\"\u003e\n\u003cblockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\"\u003e\u003cp lang=\"en\" dir=\"ltr\"\u003eProud to have fought the fight \u0026#8211; we left it all on the field. Looking forward to working with the legislature on the next steps to ensure safe access to marijuana for adults in Florida, decriminalization for personal possession and home grow. A big thank you to everyone across… \u003ca href=\"https://t.co/2fFXMLvxkV\"\u003ehttps://t.co/2fFXMLvxkV\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u0026mdash; Kim Rivers (@rivers_kim) \u003ca href=\"https://twitter.com/rivers_kim/status/1853984242759541100?ref_src=twsrc%5Etfw\"\u003eNovember 6, 2024\u003c/a\u003e\u003c/p\u003e\u003c/blockquote\u003e\n\u003cscript async src=\"https://platform.twitter.com/widgets.js\" charset=\"utf-8\"\u003e\u003c/script\u003e\u003c/div\u003e\n\u003cp\u003e\u003c/p\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003e\"Looking forward to working with the legislature on the next steps to ensure safe access to marijuana for adults in Florida, decriminalization for personal possession and home grow,\" Rivers added.\u003c/p\u003e\n\u003cp\u003eTrulieve was the main economic supporter of the amendment, championing \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41656678/trump-harris-and-desantis-face-off-on-cannabis-legalization-in-florida-and-beyond\"\u003eSmart and Safe\u003c/a\u003e Florida with millions in donations.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003eFlorida Rejects Cannabis Legalization Amendment Supported By Trump, Detested By DeSantis\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eFormer Miami Dolphins running back and founder of \u003cstrong\u003eHighsman\u003c/strong\u003e, \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41642265/ricky-williams-and-wellness-experts-discuss-strategies-for-cannabis-patient-centric-care\"\u003eRicky Williams\u003c/a\u003e\u003c/strong\u003e, also expressed his disappointment, in a statement shared with Benzinga Cannabis. \u003c/p\u003e\n\u003cp\u003e\"I know what it's like to lose something over cannabis,\" he said, referencing the setbacks he faced in his career due to cannabis use. \"I lost time in my career, I lost respect from people who didn't get it. This vote not passing is frustrating, but it's just another step in the journey. The movement for cannabis reform is only growing, and we'll keep pushing until everyone's ready to catch up.\"\u003c/p\u003e\n\u003cp\u003e\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"501\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29-1024x501.png\" alt=\"\" class=\"wp-image-633027\" style=\"width:722px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29-1024x501.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29-768x376.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29-1536x751.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06103257/Captura-de-pantalla-2024-11-06-a-las-12.32.29.png 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eSource: The \u003ca href=\"https://www.washingtonpost.com/elections/results/2024/11/05/florida-amendment-3/\"\u003eWashington Post Results Website\u003c/a\u003e\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eOther Industry members shared their disappointment and expectations regarding the future.\u003c/p\u003e\n\u003cp\u003e\"While we are disappointed by the outcome, we respect the voice of the voters. Our commitment to educating the public about the benefits of cannabis legalization is stronger than ever,\u0026#8221; said \u003cstrong\u003eDavid Craig\u003c/strong\u003e, chief marketing officer of \u003cstrong\u003eIllicit Gardens\u003c/strong\u003e. \u0026#8220;We believe that responsible policies can lead to economic prosperity, improved public health, and social justice.\"\u003c/p\u003e\n\u003cp\u003eFor\u003cem\u003e \u003c/em\u003e\u003cstrong\u003eTerra Boldt\u003c/strong\u003e, vice president of sales at \u003cstrong\u003eThe Blinc Group\u003c/strong\u003e added that \u0026#8220;the failure of this amendment won't diminish the role cannabis already plays in Florida's culture and daily life.\"\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLouis Samuel\u003c/strong\u003e, CEO of \u003cstrong\u003eGolden State Canna\u003c/strong\u003e added to the litany of disappointed voices. \u0026#8220;I am greatly saddened that the people of Florida have put tradition over reason and voted this progressive measure down. One of the primary arguments against the measure was the streets smelling like cannabis, and I\u0026#8217;ve been on the streets in Florida and I have a secret folks, they are already smoking all over.\u0026#8221;\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41775784/hemp-vs-marijuana-industry-tensions-rise-amid-rejection-of-cannabis-legalization-in-florida-the-\"\u003eHemp Vs. Marijuana: Industry Tensions Rise Amid Rejection Of Cannabis Legalization In Florida, The Dakotas\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: El Planteo\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res","image":"https://cdn.benzinga.com/files/images/story/2024/11/06/Florida-Cannabis.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/06/Florida-Cannabis.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/06/Florida-Cannabis.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":29619,"name":"Legal","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":859664,"name":"Amendment 3","description":""},{"tid":875442,"name":"DeSantis","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":944380,"name":"Rivers","description":""},{"tid":514116,"name":"Trump","description":""},{"tid":41982,"name":"Williams","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41780079\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41780079\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41775784,"author":"Patricio Liddle","created":"Wed, 06 Nov 2024 09:41:30 -0500","updated":"Wed, 06 Nov 2024 09:41:31 -0500","title":"Hemp Vs. Marijuana: Industry Tensions Rise Amid Rejection Of Cannabis Legalization In Florida, The Dakotas","teaser":"Explore rising cannabis industry tensions as hemp companies clash with MSOs over market control, legalization rejections, and regulatory divides.","body":"\u003cp\u003eTensions within the U.S. cannabis industry have intensified, particularly within the \u003cstrong\u003eU.S. Cannabis Council (USCC)\u003c/strong\u003e, where conflicts between \u003ca href=\"http://benzinga.com/topic/hemp\"\u003ehemp\u003c/a\u003e companies and large marijuana operators have come to the forefront. These internal disputes are unfolding against the backdrop of recent rejections of adult use marijuana legalization in Florida, North Dakota and South Dakota.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eIndustry \"Civil War\" Over Cannabis Control\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003e\u003cstrong\u003eRobert Hoban\u003c/strong\u003e, a prominent figure in the \u003ca href=\"http://benzinga.com/cannabis\"\u003ecannabis\u003c/a\u003e sector, recently addressed what he terms the industry\u0026#8217;s \u0026#8220;civil war.\u0026#8221; In his recent \u003ca href=\"https://www.forbes.com/sites/roberthoban/2024/11/01/cannabis-civil-war-continues-as-the-us-cannabis-counsel-rejects-hemp-applicants-to-its-board/\"\u003earticle\u003c/a\u003e in Forbes, Hoban questioned the future of the market: \"Will the cannabis market be controlled by a small group of publicly-traded, multi-billion dollar vertically-integrated marijuana companies\u0026#8230; or will cannabis be produced and distributed by farmers and small businesses?\"\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHoban argues that this question underscores the high stakes in the battle between large multi-state operators (MSOs) and independent hemp producers.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003c/em\u003e\u003c/strong\u003e\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\"\u003e\u003cstrong\u003e\u003cem\u003ehere\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e\u003cem\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eThe USCC, a key cannabis industry association, recently rejected applications from several hemp companies seeking board membership. These companies, including \u003cstrong\u003eMood\u003c/strong\u003e, \u003cstrong\u003eApotheca\u003c/strong\u003e and \u003cstrong\u003eKight Law\u003c/strong\u003e, aimed to collaborate with marijuana businesses to promote unified industry policies.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026#8220;The olive branch offered by the hemp industry was forcefully rejected by the MSOs,\u0026#8221; Hoban stated. According to him, \u0026#8220;a representative of one of the largest MSOs engaged in heavy politicking\u0026#8230; to \u0026#8216;preserve the voting block.'\u0026#8221; This move, he suggests, undermines the USCC's credibility as a \"big-tent\" organization and highlights the deepening divide within the industry.\u003c/p\u003e\n\u003cp\u003e\"The MSOs don't want to risk Main Street having a chance to compete in a market with Wall Street,\" Hoban added. The conflict between corporate consolidation and the interests of smaller businesses is becoming increasingly apparent.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp Market On The Rise As Florida, Dakotas Reject Cannabis Legalization\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eMeanwhile, the market for hemp-derived THC products is booming, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40561082/delta-8-thc-exposure-is-lower-in-states-where-recreational-marijuana-is-legal-say-researchers-ba\"\u003eespecially in states where cannabis remains illegal\u003c/a\u003e. Hemp companies have capitalized on legal loopholes to sell products containing delta-8 THC and other hemp-derived cannabinoids, which are unregulated and widely available. This burgeoning market poses a competitive threat to traditional marijuana businesses, exacerbating industry tensions.\u003c/p\u003e\n\u003cp\u003eThis internal industry conflict is mirrored in recent state election results. Voters in Florida, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41764652/north-dakotans-reject-measure-to-legalize-recreational-cannabis-keeping-a-shadow-over-their-gard\"\u003eNorth Dakota\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41765421/south-dakota-rejects-measure-29-cannabis-legalization-fails-again\"\u003eSouth Dakota\u003c/a\u003e rejected measures to legalize recreational cannabis. Florida\u0026#8217;s Amendment 3, which aimed to legalize recreational cannabis, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis\"\u003ereceived 55.8% yes votes but failed to reach the 60% threshold\u003c/a\u003e required for a constitutional change. The initiative faced strong opposition from \u003cstrong\u003eGovernor Ron DeSantis\u003c/strong\u003e and the Florida GOP, who allied with hemp companies opposing the policy shift.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41764503/nebraska-says-yes-to-medical-cannabis-after-years-of-failed-legalization-attempts-heres-what-you\"\u003e\u003cstrong\u003eNebraska Says Yes To Medical Cannabis After Years Of Failed Legalization Attempts: Here\u0026#8217;s What You Need To Know\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003eHemp businesses \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726320/hemp-donations-fuel-desantis-and-florida-gops-charge-against-weed-legalization-new-findings?_bhlid=52c795541290a0dccbfdeb6fe8c2509b8ed89232\"\u003econtributed over $500,000 to DeSantis and the GOP to oppose Amendment 3\u003c/a\u003e, fearing that legalization would harm small enterprises involved in hemp cultivation and sales. Some of these donors\u0026#8217; hemp products were found to \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/04/38151776/93-of-smokable-hemp-exceeds-legal-thc-limit-government-funded-study-finds\"\u003eexceed legal THC limits\u003c/a\u003e and contain unauthorized pesticides, raising concerns about unregulated products in the market.\u003c/p\u003e\n\u003cp\u003eConversely, \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TRUL#OTC\"\u003eTRUL\u003c/a\u003e) (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), a major cannabis company, \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41589320/desantis-battles-149m-cannabis-legalization-push-in-floridas-fiercest-amendment-fight-yet\"\u003esupported the legalization effort by donating significantly to the campaign\u003c/a\u003e. This highlights the contrasting interests within the industry, with large marijuana operators pushing for legalization while some hemp businesses resist.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp And Marijuana Industry At Odds\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eThe rejection of cannabis legalization initiatives in Florida and the Dakotas underscores the complex dynamics within the cannabis industry, where hemp companies and large marijuana operators are often divided. As Hoban predicts, this may be \u0026#8220;the beginning of the end of their reign,\u0026#8221; referring to \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41755971/desantis-on-wrong-side-of-history-curaleaf-chair-says-as-governor-calls-trulieve-big-pharma-on-s\"\u003eMSOs\u0026#8217; dominance\u003c/a\u003e as he asserts their motives become more transparent.\u003c/p\u003e\n\u003cp\u003eIndustry leaders acknowledge that while these setbacks are significant, public support for cannabis reform continues to grow. The tensions between hemp and marijuana sectors reflect \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40833963/expert-calls-for-a-united-hemp-and-cannabis-front-industries-should-collaborate-and-push-for-fed\"\u003ebroader challenges in achieving unified regulations\u003c/a\u003e and market practices.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41755971/desantis-on-wrong-side-of-history-curaleaf-chair-says-as-governor-calls-trulieve-big-pharma-on-s\"\u003e\u003cstrong\u003eDeSantis \u0026#8216;On Wrong Side Of History,\u0026#8217; Curaleaf Chair Says: Governor Calls Trulieve \u0026#8216;Big Pharma On Steroids\u0026#8217;\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41775784/hemp-vs-marijuana-industry-tensions-rise-amid-rejection-of-cannabis-legalization-in-florida-the-","image":"https://cdn.benzinga.com/files/images/story/2024/11/06/Drought-Resistant-Hemp.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/06/Drought-Resistant-Hemp.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/06/Drought-Resistant-Hemp.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":26029,"name":"Government","description":""},{"tid":57,"name":"News","description":""},{"tid":144213,"name":"Regulations","description":""}],"stocks":[{"tid":731053,"name":"TCNNF","description":""},{"tid":96325,"name":"TRUL","description":"TRULITE, INC."}],"tags":[{"tid":825924,"name":"2024 election","description":""},{"tid":731964,"name":"cannabis legalization","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":912371,"name":"MOOD","description":""},{"tid":802525,"name":"Robert Hoban","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41775784\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41775784\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41775201,"author":"Javier Hasse","created":"Wed, 06 Nov 2024 09:26:36 -0500","updated":"Wed, 06 Nov 2024 11:12:09 -0500","title":"Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit","teaser":"Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.","body":"\u003cp\u003eCannabis reform faced a challenging moment in the 2024 U.S. elections, with several key state initiatives falling short and delivering a setback to advocates and industry players alike. Despite high hopes, the results painted a mixed, often sobering picture of regional attitudes toward cannabis reform. Here's a look at each state's journey, the measures they considered and what these outcomes signify for the cannabis community and the future of legalization efforts nationwide.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eFlorida\u003c/h3\u003e\n\u003cp\u003eFlorida's Amendment 3, which sought to legalize cannabis for adult use, gained 55.9% support but fell short of the required 60% threshold for constitutional amendments. \u003c/p\u003e\n\u003cp\u003eDespite support from high-profile advocates, including former President \u003cstrong\u003eDonald Trump,\u003c/strong\u003e the initiative faced consistent opposition from GOP figures like Governor \u003cstrong\u003eRon DeSantis.\u003c/strong\u003e Leading up to the election, DeSantis held conferences opposing the measure, with additional opposition funded by the state's transportation department. Although disappointed, industry leaders like \u003cstrong\u003eAnthony Coniglio\u003c/strong\u003e of \u003cstrong\u003eNewLake Capital Partners\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/NLCP#OTC\"\u003eNLCP\u003c/a\u003e) expressed optimism, noting, \"It's important to recognize the bipartisan voter support that the measure received.\"\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eNebraska\u003c/h3\u003e\n\u003cp\u003eNebraska saw a significant shift in policy with the passage of two medical cannabis measures. Initiative 437, which enacts the Nebraska Medical Cannabis Protection Act, allows patients to use cannabis to manage health conditions. Initiative 438, the Nebraska Medical Cannabis Regulation Act, establishes a commission to regulate the medical cannabis market.\u003c/p\u003e\n\u003cp\u003e\"Following the adoption of the Commission\u0026#8217;s regulations, the market may open as early as Summer 2026,\" explained \u003cstrong\u003ePaula Savchenko,\u003c/strong\u003e founding partner of \u003cstrong\u003eCannacore Group. \u003c/strong\u003eThis long-awaited result, driven by activist efforts and significant public support, signals a new era for medical cannabis in the state.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eNorth Dakota\u003c/h3\u003e\n\u003cp\u003eFor the third time, North Dakota voters declined to legalize adult-use cannabis, with 53% voting against Measure 5. Despite advocating for financial benefits and regulatory structures similar to neighboring states, proponents couldn't secure enough support. \u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCuraleaf\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e)'s CEO, \u003cstrong\u003eBoris Jordan,\u003c/strong\u003e remarked, \"Curaleaf remains committed to advocating for responsible cannabis access and education.\" North Dakota's vote reflects a conservative stance that contrasts with the broader national trend toward legalization.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eSouth Dakota\u003c/h3\u003e\n\u003cp\u003eSouth Dakota also opted against legalizing cannabis for adult use with Measure 29, which fell short in a close vote. The measure had proposed limited possession rights and cultivation for adults over 21. \u003c/p\u003e\n\u003cp\u003eLocal industry voices like \u003cstrong\u003eJohn Mueller,\u003c/strong\u003e co-founder of \u003cstrong\u003eGreenlight,\u003c/strong\u003e described the outcome as \"a missed opportunity,\" highlighting the potential economic benefits South Dakota could have reaped from a legal cannabis market. With similar measures failing in past elections, South Dakota's stance remains firmly anti-legalization, though advocates are hopeful for future progress.\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003eDallas, Texas\u003c/h3\u003e\n\u003cp\u003eIn a landmark decision, Dallas voters approved the \"Dallas Freedom Act\" to decriminalize small amounts of cannabis, setting the stage for reform in Texas. The act, which passed with 65% support, prohibits arrests for possession of up to 4 ounces of cannabis and restricts the police from using cannabis odor as probable cause. \u003c/p\u003e\n\u003cp\u003eLocal advocacy group \u003cstrong\u003eGround Game Texas\u003c/strong\u003e celebrated the victory, stating, \"This is more than a victory for marijuana decriminalization—it's a win for the people of Dallas.\" The success in Dallas reflects a growing trend in Texas cities to pursue cannabis reform, even as state-level opposition continues.\u003c/p\u003e\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCannabis Stocks Fall After 2024 Election\u003c/strong\u003e\u003c/h2\u003e\n\u003cp\u003eIn response to these election outcomes, U.S.-focused cannabis stocks and ETFs are trading down in Wednesday\u0026#8217;s pre-market session. Notably, \u003cstrong\u003eVerano Holdings Corp\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e), \u003cstrong\u003eCuraleaf Holdings Inc\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), \u003cstrong\u003eGreen Thumb Industries Inc\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e) and \u003cstrong\u003eTrulieve Cannabis Corp\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) have experienced sharp declines, along with ETFs such as the \u003cstrong\u003eAdvisorShares Pure US Cannabis ETF\u003c/strong\u003e (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOS#NYSE\"\u003eMSOS\u003c/a\u003e) and \u003cstrong\u003eAmplify Alternative Harvest\u003c/strong\u003e ETF (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MJ#NYSE\"\u003eMJ\u003c/a\u003e), most trading down by double digits.\u003c/p\u003e\n\u003cp\u003eAs cannabis legalization and decriminalization efforts advance, the varied responses across states showcase an evolving but complex landscape. With each election, states signal their readiness, or reluctance, to embrace cannabis reform, reflecting both local values and national debates.\u003c/p\u003e\n\u003cp\u003eCover image made with AI\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41775201/cannabis-reform-stumbles-in-2024-elections-a-state-by-state-breakdown-as-stocks-take-a-hit","image":"https://cdn.benzinga.com/files/images/story/2024/11/06/Screen-Shot-2024-11-06-at-11-09-48.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/06/Screen-Shot-2024-11-06-at-11-09-48.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/06/Screen-Shot-2024-11-06-at-11-09-48.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":29619,"name":"Legal","description":""},{"tid":138079,"name":"Top Stories","description":""},{"tid":24,"name":"Movers","description":""}],"stocks":[{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":576854,"name":"MJ","description":""},{"tid":774329,"name":"MSOS","description":null},{"tid":814109,"name":"NLCP","description":null},{"tid":731053,"name":"TCNNF","description":""},{"tid":797063,"name":"VRNOF","description":"Verano Holdings"}],"tags":[{"tid":731964,"name":"cannabis legalization","description":""},{"tid":612802,"name":"US Elections","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41775201\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41775201\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41763058,"author":"Benzinga Newsdesk","created":"Tue, 05 Nov 2024 20:44:03 -0500","updated":"Tue, 05 Nov 2024 20:44:03 -0500","title":"AP Reports Florida Voters Reject Cannabis Legalization; Amendment 3 Did Not Secure 60% Of Vote","teaser":"","body":"","url":"https://www.benzinga.com/markets/cannabis/24/11/41763058/ap-reports-florida-voters-reject-cannabis-legalization-amendment-3-did-not-secure-60-of-vote","image":null,"image_thumb":null,"image_large":null,"channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":16779,"name":"Politics","description":""},{"tid":2,"name":"Markets","description":""},{"tid":18467,"name":"General","description":""}],"stocks":[{"tid":809634,"name":"AAWH","description":null},{"tid":158152,"name":"ACB","description":""},{"tid":723168,"name":"ALEAF","description":"ALEAFIA HEALTH INC ORD by Aleafia Health Inc."},{"tid":738931,"name":"AUSAF","description":"Australis Capital"},{"tid":809545,"name":"AVTBF","description":null},{"tid":786348,"name":"AYRWF","description":null},{"tid":151455,"name":"BBRRF","description":""},{"tid":714096,"name":"BHHKF","description":""},{"tid":142558,"name":"BLOZF","description":""},{"tid":705821,"name":"BMMJ","description":null},{"tid":134741,"name":"CANN","description":"Advanced Cannabis Solutions"},{"tid":725159,"name":"CBDY","description":"TARGET GROUP INC by Target Group Inc."},{"tid":143947,"name":"CBMJ","description":"CANNA BRANDS, INC."},{"tid":703340,"name":"CBWTF","description":"CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp."},{"tid":22438,"name":"CGC","description":"Canopy Growth Corp"},{"tid":710555,"name":"CHOOF","description":"CHOOM HLDGS INC by Choom Hldgs Inc."},{"tid":371295,"name":"CLSH","description":""},{"tid":778344,"name":"CLVR","description":null},{"tid":753129,"name":"CNBS","description":null},{"tid":143965,"name":"CNBX","description":""},{"tid":711078,"name":"CNGGF","description":""},{"tid":731496,"name":"CNPOF","description":""},{"tid":744423,"name":"CNTMF","description":"Cansortium"},{"tid":792226,"name":"CNVCF","description":"BioHarvest Sciences"},{"tid":650230,"name":"CPHRF","description":""},{"tid":735580,"name":"CRLBF","description":""},{"tid":714301,"name":"CRON","description":""},{"tid":734995,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":658814,"name":"CURR","description":"CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp."},{"tid":778480,"name":"CVHIF","description":"Ventura Cannabis"},{"tid":121615,"name":"CVSI","description":""},{"tid":731558,"name":"CWBHF","description":""},{"tid":718244,"name":"CWWBF","description":"CANNIBIS GROWTH OPTY CORP by Cannabis Growth Opportunity Corp."},{"tid":725516,"name":"CXXIF","description":"C21 Investments Inc"},{"tid":728588,"name":"ELLXF","description":""},{"tid":736848,"name":"EMOR","description":"Emerald Organic Products"},{"tid":149946,"name":"ETST","description":""},{"tid":699317,"name":"EVIO","description":"EVIO INC by EVIO, Inc."},{"tid":740416,"name":"FFLWF","description":"Fire \u0026 Flower Holdings"},{"tid":755132,"name":"FFNTF","description":null},{"tid":663257,"name":"FFRMF","description":"FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc."},{"tid":711054,"name":"FLGC","description":null},{"tid":731883,"name":"FLOOF","description":""},{"tid":736277,"name":"FLWPF","description":"The Flowr"},{"tid":715534,"name":"FNNZF","description":"FINCANNA CAPITAL CORP by Fincanna Capital Corp."},{"tid":687429,"name":"FUAPF","description":""},{"tid":735250,"name":"GABLF","description":"GABRIELLAS KITCHEN INC by Gabriella's Kitchen Inc."},{"tid":149947,"name":"GBHPF","description":""},{"tid":11536,"name":"GENE","description":"Genetic Technologies"},{"tid":809917,"name":"GHBWF","description":null},{"tid":809918,"name":"GLASF","description":null},{"tid":741912,"name":"GNLN","description":null},{"tid":790137,"name":"GRAMF","description":null},{"tid":99330,"name":"GRNH","description":"GREENGRO TECH"},{"tid":613021,"name":"GRWG","description":""},{"tid":686995,"name":"GSRX","description":"GREEN SPIRIT INDUSTRIES by Green Spirit Industries Inc."},{"tid":724072,"name":"GTBIF","description":""},{"tid":750851,"name":"HBOSF","description":""},{"tid":91868,"name":"HEMP","description":"HEMP, INC."},{"tid":730265,"name":"HERTF","description":""},{"tid":707131,"name":"HHPHF","description":""},{"tid":709679,"name":"HMLSF","description":""},{"tid":612887,"name":"IIPR","description":""},{"tid":144250,"name":"INCR","description":"INC Research Holdings"},{"tid":719254,"name":"INLB","description":null},{"tid":693703,"name":"ISOLF","description":"ISODIOL INTERNATIONAL ORD by Isodiol International Inc."},{"tid":94170,"name":"ITHUF","description":"ITALIAN THAI DEV "},{"tid":614612,"name":"IVITF","description":""},{"tid":728459,"name":"JWCAF","description":""},{"tid":593347,"name":"KALY","description":""},{"tid":371298,"name":"KAYS","description":""},{"tid":722236,"name":"KHRNF","description":"KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp."},{"tid":674796,"name":"LBUY","description":"LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc."},{"tid":740700,"name":"LFCOF","description":"Lift"},{"tid":832476,"name":"LFLY","description":null},{"tid":836526,"name":"LIFD","description":null},{"tid":739155,"name":"LMLLF","description":""},{"tid":714581,"name":"LNLHF","description":""},{"tid":752326,"name":"LOVFF","description":"Cannara Biotech"},{"tid":731594,"name":"LRSNF","description":"Global Health Clinics"},{"tid":94977,"name":"LVRLF","description":"LIVEREEL MEDIA CO"},{"tid":728973,"name":"LXLLF","description":"LiveWell Canada"},{"tid":719417,"name":"MAPS","description":null},{"tid":711775,"name":"MGCLF","description":""},{"tid":614986,"name":"MGWFF","description":""},{"tid":576854,"name":"MJ","description":""},{"tid":150357,"name":"MJNE","description":""},{"tid":803402,"name":"MJUS","description":null},{"tid":722844,"name":"MMNFF","description":""},{"tid":743414,"name":"MPXOF","description":"MPX International"},{"tid":676688,"name":"MRMD","description":"MARIMED INC by MariMed Inc."},{"tid":9606,"name":"MXC","description":"Mexco Energy"},{"tid":728298,"name":"NDVAF","description":"INDIVA LTD by Indiva Ltd."},{"tid":740954,"name":"NOBDF","description":"North Bud Farms"},{"tid":92031,"name":"NWVCF","description":"ENWAVE CORP (CDA)"},{"tid":142418,"name":"OGI","description":""},{"tid":749099,"name":"OILFF","description":"Nextleaf Solutions"},{"tid":66274,"name":"PHOT","description":""},{"tid":150250,"name":"PKPH","description":""},{"tid":12561,"name":"PMD","description":"Psychemedicsoration"},{"tid":761714,"name":"RHNMF","description":"Rhinomed"},{"tid":161549,"name":"RMHB","description":""},{"tid":143801,"name":"RSSFF","description":""},{"tid":16259,"name":"SMG","description":"Scotts Miracle-Gro Company"},{"tid":753165,"name":"SNDL","description":""},{"tid":16276,"name":"SOL","description":"Renesola Ltd"},{"tid":733391,"name":"SOLCF","description":""},{"tid":808511,"name":"SSIC","description":null},{"tid":680652,"name":"TBPMF","description":"TETRA BIO-PHARMA INC ORD by Tetra Bio-Pharma Inc."},{"tid":731053,"name":"TCNNF","description":""},{"tid":706178,"name":"TGIFF","description":""},{"tid":756432,"name":"TLLTF","description":null},{"tid":723743,"name":"TLRY","description":""},{"tid":714097,"name":"TRSSF","description":""},{"tid":941389,"name":"TSX:RGI","description":null},{"tid":738507,"name":"TSX:SUGR","description":null},{"tid":758313,"name":"UGRO","description":null},{"tid":367997,"name":"VFF","description":""},{"tid":744818,"name":"VREOF","description":""},{"tid":728382,"name":"VVCIF","description":""},{"tid":13425,"name":"WRLD","description":"World Acceptance"},{"tid":801343,"name":"XTXXF","description":"Phyto Extractions"},{"tid":94616,"name":"XXII","description":"22ND CENT"},{"tid":744935,"name":"YCBD","description":null},{"tid":731962,"name":"YOLO","description":null},{"tid":136727,"name":"ZDPY","description":"Zoned Properties"},{"tid":711776,"name":"ZLDAF","description":""}],"tags":[],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41763058\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41763058\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_bottom = {\n id: 515,\n nid: 41763058\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_bottom.cid, bzCampaign_bottom.nid);\n }\n var bzCampaignJS_bottom = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/money-line\\/?t=moop1we6joca11bo\u0026amp;utm_source=campaignifybottomA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-bottom')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-bottom').length \u003e 0) {\n $('.bz-campaign-text-bottom')[0].innerHTML = bzCampaignJS_bottom;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-bottom script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"},{"id":41759869,"author":"Rolando García","created":"Tue, 05 Nov 2024 16:55:50 -0500","updated":"Tue, 05 Nov 2024 16:55:50 -0500","title":"Cannabis Stocks React On Election Day, SNDL Surges While Trulieve Raised The Stakes","teaser":"On Election Day, cannabis stocks had mixed results. SNDL soared with strong financials, while Trulieve's stock dropped while waiting Florida.","body":"\u003cp\u003e\u003cstrong\u003eSNDL Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/SNDL#NASDAQ\"\u003eSNDL\u003c/a\u003e) rose over 10% on \u003ca href=\"https://www.benzinga.com/topic/election-day\"\u003eElection Day\u003c/a\u003e at market close, following the release of its \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41745816/sndls-q3-revenue-slides-year-over-year-due-to-liquor-market-softening-cannabis-operations-going-\"\u003ethird-quarter earnings\u003c/a\u003e, reporting CA$236.9 million ($170.65 million) in revenue.\u003c/p\u003e\n\u003cp\u003eAlthough the company faced a slight decline in its liquor retail segment, its core cannabis operations showed strong growth. \u003c/p\u003e\n\u003cp\u003eSNDL's record gross margin, positive cash flow and cash reserves of over CA$263 million with zero debt-fueled investor confidence.\u003c/p\u003e\n\u003cp\u003eIn contrast, \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e) saw an 8% decline in its stock, attributed to both its \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41743807/trulieves-q3-revenue-up-slightly-year-over-year-net-loss-grows-amid-48m-in-cannabis-legalization\"\u003eQ3 earnings report \u003c/a\u003eand what might be the boldest move in the cannabis industry so far, since the company has made a significant investment in Florida's legalization campaign. \u003c/p\u003e\n\u003cp\u003eReporting $284 million in revenue—a 3% increase year-over-year—Trulieve demonstrated operational strength with a gross margin of 61% and adjusted EBITDA of $96 million. However, the company allocated $48 million to support the Florida legalization ballot initiative, which weighed heavily on its finances. Total investment in Florida\u0026#8217;s Amendment 3 amounts to nearly \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41405555/floridas-cannabis-amendment-record-spending-unlikely-alliances-and-criticism-from-the-catholic-c\"\u003e$90 million\u003c/a\u003e. Should voters approve recreational cannabis, Trulieve stands to benefit from its established presence, potentially reversing recent losses. However, a negative result could add strain to Trulieve's finances.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41743807/trulieves-q3-revenue-up-slightly-year-over-year-net-loss-grows-amid-48m-in-cannabis-legalization\"\u003eTrulieve\u0026#8217;s Q3 Revenue Up Slightly Year-Over-Year, Net Loss Grows Amid $48M In Cannabis Legalization Support\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCannabis Stocks On Election Day\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eWhile SNDL's resilient financials spurred a bullish reaction, Trulieve's fortunes now rest on the outcome of Florida's vote.\u003c/p\u003e\n\u003cp\u003eThe general market is a different story. \u003c/p\u003e\n\u003cp\u003eThe average daily change in cannabis stock prices in Benzinga\u0026#8217;s watchlist on Tuesday is up approximately +2.34%, indicating a generally positive sentiment in the market for cannabis stocks.\u003c/p\u003e\n\u003cp\u003eElection day underscores the heightened stakes for the cannabis sector, with investors closely watching for both state-level outcomes and federal reform, which could set the stage for a massive shift in the cannabis landscape.\u003c/p\u003e\n\u003cp\u003eIf true reform materializes, cannabis stocks could experience unprecedented growth, attracting institutional investors and stabilizing a historically volatile market. However, the complexity of the political landscape could lead investors to remain cautious until concrete legislative changes are enacted.\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41745816/sndls-q3-revenue-slides-year-over-year-due-to-liquor-market-softening-cannabis-operations-going-\"\u003eSNDL\u0026#8217;s Q3 Revenue Slides Year-Over-Year Due To Liquor Market Softening, Cannabis Operations Going Strong\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e\n","url":"https://www.benzinga.com/markets/cannabis/24/11/41759869/cannabis-stocks-react-on-election-day-sndl-surges-while-trulieve-raised-the-stakes","image":"https://cdn.benzinga.com/files/images/story/2024/11/05/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=768\u0026amp;width=1024\u0026amp;fit=crop","image_thumb":"https://cdn.benzinga.com/files/images/story/2024/11/05/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=187\u0026amp;width=250\u0026amp;fit=crop","image_large":"https://cdn.benzinga.com/files/images/story/2024/11/05/Cannabis-stocks.png?optimize=medium\u0026amp;dpr=1\u0026amp;auto=webp\u0026amp;height=1536\u0026amp;width=2048\u0026amp;fit=crop","channels":[{"tid":123430,"name":"Cannabis","description":""},{"tid":57,"name":"News","description":""},{"tid":30777,"name":"Retail Sales","description":""},{"tid":29619,"name":"Legal","description":""},{"tid":2,"name":"Markets","description":""}],"stocks":[{"tid":753165,"name":"SNDL","description":""},{"tid":731053,"name":"TCNNF","description":""}],"tags":[{"tid":144661,"name":"election day","description":""},{"tid":717114,"name":"Florida Cannabis","description":""},{"tid":823713,"name":"SNDL","description":""},{"tid":163833,"name":"top stories","description":""},{"tid":733749,"name":"Trulieve","description":""}],"campaigns":"\n var bzCampaign_top = {\n id: 560,\n nid: 41759869\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_top.cid, bzCampaign_top.nid);\n }\n var bzCampaignJS_top = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003cp\u003e\u003cstrong\u003eAccess Nic Chahine's 2 best options plays every single week starting at only $0.99.\u0026nbsp;\u003c\\/strong\u003e \u003ca href=\\\"https:\\/\\/events.benzinga.com\\/options-starter-99-intro?utm_source=campaignifytop\\\"\u003e\u003cB\u003eBuy here now\u003c\\/B\u003e\u003c\\/a\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-top')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-top').length \u003e 0) {\n $('.bz-campaign-text-top')[0].innerHTML = bzCampaignJS_top;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-top script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }\n var bzCampaign_middle = {\n id: 588,\n nid: 41759869\n };\n\n if(typeof bzCampaignStats == 'function') {\n // If/stats is enabled, fire them\n bzCampaignStats(bzCampaign_middle.cid, bzCampaign_middle.nid);\n }\n var bzCampaignJS_middle = \"\u003chr style=\\\"margin-top: 0px; margin-bottom: 15px;\\\" \\/\u003e\\r\\n\u003ch4 style=\\\"text-align: center;\\\"\u003e\u003cstrong\u003e20-Year Pro Trader Reveals His \u0026ldquo;MoneyLine\u0026rdquo; \u0026mdash; Simple Trades\u003cbr \\/\u003e\u003c\\/strong\u003e\u003c\\/h4\u003e\\r\\n\u003cp style=\\\"text-align: left; padding: 5px;\\\"\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eA simple line tells you when to buy and when to sell that\u0026rsquo;s helped Nic win 83% of his trades.\u0026nbsp;\u003cstrong\u003e\u003ca href=\\\"https:\\/\\/www.benzinga.com\\/premium\\/ideas\\/options-moneyline-2\\/?t=mo7op1we6joca11mi2\u0026amp;utm_source=campaignifymiddleA\\\"\u003eClick here for access.\u003c\\/a\u003e\u003c\\/strong\u003e\u003c\\/span\u003e\u003c\\/p\u003e\\r\\n\u003chr style=\\\"margin-top: 10px; margin-bottom: 15px;\\\" \\/\u003e\";\n if($('.bz-campaign-text-middle')) {\n // Jquery prevents scripts from being written\n if($('.bz-campaign-text-middle').length \u003e 0) {\n $('.bz-campaign-text-middle')[0].innerHTML = bzCampaignJS_middle;\n }\n\n // Rewrite and Execute any JS after loading.\n $('.bz-campaign-text-middle script').each(function() {\n var script = document.createElement('script');\n var text = $(this).text();\n text = text.replace(/[\\r\\n]/g, \" \");\n script[(script.innerText===undefined?\"textContent\":\"innerText\")] = text;\n //console.log(text);\n //console.log(script);\n document.documentElement.appendChild(script);\n });\n }"}],"partnersRelease":{"contentStock":{"AAWH":{"name":"AAWH"},"AYRWF":{"name":"AYRWF"},"CNBS":{"name":"CNBS"},"CRLBF":{"name":"CRLBF"},"CURLF":{"name":"CURLF"},"GTBIF":{"name":"GTBIF"},"JUSHF":{"name":"JUSHF"},"MJ":{"name":"MJ"},"TCNNF":{"name":"TCNNF"},"VRNOF":{"name":"VRNOF"},"YOLO":{"name":"YOLO"},"AGFY":{"name":"AGFY"},"AYWWF":{"name":"AYWWF"},"CBSTF":{"name":"CBSTF"},"CNTMF":{"name":"CNTMF"},"GHBWF":{"name":"GHBWF"},"GLASF":{"name":"GLASF"},"GRUSF":{"name":"GRUSF"},"IIPR":{"name":"IIPR"},"MSOS":{"name":"MSOS"},"TLRY":{"name":"TLRY"},"TSNDF":{"name":"TSNDF"},"VREOF":{"name":"VREOF"},"ACB":{"name":"ACB"},"ATAI":{"name":"ATAI"},"CANN":{"name":"CANN"},"CGC":{"name":"CGC"},"CMPS":{"name":"CMPS"},"CRON":{"name":"CRON"},"CVSI":{"name":"CVSI"},"CYBN":{"name":"CYBN"},"IGC":{"name":"IGC"},"RLMD":{"name":"RLMD"},"ENVB":{"name":"ENVB"},"GRWG":{"name":"GRWG"},"IMCC":{"name":"IMCC"},"MEDIF":{"name":"MEDIF"},"NLCP":{"name":"NLCP"},"SHFS":{"name":"SHFS"}},"content":{"41967893":{"id":41967893,"author":"Seeking Alpha","created":"Thu, 14 Nov 2024 08:02:26 -0400","updated":"Thu, 14 Nov 2024 08:05:16 -0400","title":"Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post","teaser":"","body":"","url":"https://seekingalpha.com/news/4289008-cannabis-stocks-gain-gaetz-picked-ag-post?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","MSOS","TCNNF","TSNDF","VRNOF","YOLO"],"tags":[]},"41982855":{"id":41982855,"author":"TipRanks","created":"Thu, 14 Nov 2024 13:30:20 -0400","updated":"Thu, 14 Nov 2024 13:59:03 -0400","title":"Rising High: Cannabis firms report quarterly earnings","teaser":"In this week\u0026#39;s \u0026#34;Rising High,\u0026#34; The Fly\u0026#39;s recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...","body":"In this week's \"Rising High,\" The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...","url":"https://www.tipranks.com/news/the-fly/rising-high-cannabis-firms-report-quarterly-earnings?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["AAWH","ACB","ATAI","AYRWF","CANN","CGC","CMPS","CRLBF","CRON","CVSI","CYBN","ENVB","GRWG","IGC","IMCC","MEDIF","NLCP","RLMD","SHFS","TCNNF","TLRY","VREOF"],"tags":[]},"42062915":{"id":42062915,"author":"TipRanks","created":"Tue, 19 Nov 2024 09:39:23 -0400","updated":"Tue, 19 Nov 2024 09:57:43 -0400","title":"Trulieve Expands with New Florida Dispensaries","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. is expanding its footprint in Florida with new medical cannabis dispen...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. is expanding its footprint in Florida with new medical cannabis dispen...","url":"https://www.tipranks.com/news/company-announcements/trulieve-expands-with-new-florida-dispensaries?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},"42117276":{"id":42117276,"author":"TipRanks","created":"Thu, 21 Nov 2024 12:05:42 -0400","updated":"Thu, 21 Nov 2024 12:27:12 -0400","title":"Rising High: Numinus Wellness to sell five Utah clinics for $3.53M","teaser":"In this week\u0026#39;s \u0026#34;Rising High,\u0026#34; The Fly\u0026#39;s recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a clinic sale, effic...","body":"In this week's \"Rising High,\" The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a clinic sale, effic...","url":"https://www.tipranks.com/news/the-fly/rising-high-numinus-wellness-to-sell-five-utah-clinics-for-3-53m?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["ACB","ATAI","CANN","CBSTF","CGC","CMPS","CRON","CVSI","CYBN","GTBIF","IGC","RLMD","TCNNF","TLRY","VREOF","VRNOF"],"tags":[]},"42127096":{"id":42127096,"author":"Seeking Alpha","created":"Thu, 21 Nov 2024 19:40:00 -0400","updated":"Thu, 21 Nov 2024 19:45:48 -0400","title":"Cause For Concern In Cannabis With A Few Rays Of Light","teaser":"","body":"","url":"https://seekingalpha.com/article/4739459-cause-for-concern-in-cannabis-with-a-few-rays-of-light?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=article","image":[],"channels":[],"stocks":["AAWH","AGFY","AYRWF","AYWWF","CBSTF","CNTMF","CRLBF","CURLF","GHBWF","GLASF","GRUSF","GTBIF","IIPR","MSOS","TCNNF","TLRY","TSNDF","VREOF","VRNOF"],"tags":[]},"42139246":{"id":42139246,"author":"TipRanks","created":"Fri, 22 Nov 2024 10:37:15 -0400","updated":"Fri, 22 Nov 2024 10:47:24 -0400","title":"Trulieve Expands with New Jacksonville Dispensary","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis is opening a new medical cannabis dispensary in Jacksonville, Florida, offer...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis is opening a new medical cannabis dispensary in Jacksonville, Florida, offer...","url":"https://www.tipranks.com/news/company-announcements/trulieve-expands-with-new-jacksonville-dispensary?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},"42140132":{"id":42140132,"author":"TipRanks","created":"Fri, 22 Nov 2024 11:07:47 -0400","updated":"Fri, 22 Nov 2024 11:17:27 -0400","title":"Trulieve Executives Show Confidence with Share Purchases","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. has announced that its executive leadership and board members have pur...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. has announced that its executive leadership and board members have pur...","url":"https://www.tipranks.com/news/company-announcements/trulieve-executives-show-confidence-with-share-purchases?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},"42143475":{"id":42143475,"author":"Seeking Alpha","created":"Fri, 22 Nov 2024 13:18:08 -0400","updated":"Fri, 22 Nov 2024 13:20:55 -0400","title":"Trulieve Cannabis announces insider share purchases by executive leadership and board members","teaser":"","body":"","url":"https://seekingalpha.com/news/4322543-trulieve-cannabis-announces-insider-share-purchases-by-executive-leadership-and-board-members?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},"42199392":{"id":42199392,"author":"Seeking Alpha","created":"Tue, 26 Nov 2024 15:55:06 -0400","updated":"Tue, 26 Nov 2024 16:02:03 -0400","title":"HHS declines to provide witnesses for DEA hearing on marijuana rescheduling","teaser":"","body":"","url":"https://seekingalpha.com/news/4336949-hh-sdeclinestoprovidewitnessesfor-de-ahearingonmarijuanarescheduling?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","TCNNF","VRNOF"],"tags":[]},"42200037":{"id":42200037,"author":"Seeking Alpha","created":"Tue, 26 Nov 2024 16:27:45 -0400","updated":"Tue, 26 Nov 2024 16:37:03 -0400","title":"Initial hearing on marijuana rescheduling set for Dec. 2","teaser":"","body":"","url":"https://seekingalpha.com/news/4337062-marijuana-rescheduling-hearing-set-dec-2?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","TCNNF","VRNOF","YOLO"],"tags":[]}},"partnerContent":{"AAWH":["41967893","41982855","42127096","42199392","42200037"],"AYRWF":["41967893","41982855","42127096","42199392","42200037"],"CNBS":["41967893","42199392","42200037"],"CRLBF":["41967893","41982855","42127096","42199392","42200037"],"CURLF":["41967893","42127096","42199392","42200037"],"GTBIF":["41967893","42117276","42127096","42199392","42200037"],"JUSHF":["41967893","42199392","42200037"],"MJ":["41967893","42199392","42200037"],"MSOS":["41967893","42127096"],"TCNNF":["41967893","41982855","42062915","42117276","42127096","42139246","42140132","42143475","42199392","42200037"],"TSNDF":["41967893","42127096"],"VRNOF":["41967893","42117276","42127096","42199392","42200037"],"YOLO":["41967893","42200037"],"ACB":["41982855","42117276"],"ATAI":["41982855","42117276"],"CANN":["41982855","42117276"],"CGC":["41982855","42117276"],"CMPS":["41982855","42117276"],"CRON":["41982855","42117276"],"CVSI":["41982855","42117276"],"CYBN":["41982855","42117276"],"ENVB":["41982855"],"GRWG":["41982855"],"IGC":["41982855","42117276"],"IMCC":["41982855"],"MEDIF":["41982855"],"NLCP":["41982855"],"RLMD":["41982855","42117276"],"SHFS":["41982855"],"TLRY":["41982855","42117276","42127096"],"VREOF":["41982855","42117276","42127096"],"CBSTF":["42117276","42127096"],"AGFY":["42127096"],"AYWWF":["42127096"],"CNTMF":["42127096"],"GHBWF":["42127096"],"GLASF":["42127096"],"GRUSF":["42127096"],"IIPR":["42127096"]},"sortedContent":[{"id":42200037,"author":"Seeking Alpha","created":"Tue, 26 Nov 2024 16:27:45 -0400","updated":"Tue, 26 Nov 2024 16:37:03 -0400","title":"Initial hearing on marijuana rescheduling set for Dec. 2","teaser":"","body":"","url":"https://seekingalpha.com/news/4337062-marijuana-rescheduling-hearing-set-dec-2?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","TCNNF","VRNOF","YOLO"],"tags":[]},{"id":42199392,"author":"Seeking Alpha","created":"Tue, 26 Nov 2024 15:55:06 -0400","updated":"Tue, 26 Nov 2024 16:02:03 -0400","title":"HHS declines to provide witnesses for DEA hearing on marijuana rescheduling","teaser":"","body":"","url":"https://seekingalpha.com/news/4336949-hh-sdeclinestoprovidewitnessesfor-de-ahearingonmarijuanarescheduling?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","TCNNF","VRNOF"],"tags":[]},{"id":42143475,"author":"Seeking Alpha","created":"Fri, 22 Nov 2024 13:18:08 -0400","updated":"Fri, 22 Nov 2024 13:20:55 -0400","title":"Trulieve Cannabis announces insider share purchases by executive leadership and board members","teaser":"","body":"","url":"https://seekingalpha.com/news/4322543-trulieve-cannabis-announces-insider-share-purchases-by-executive-leadership-and-board-members?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},{"id":42140132,"author":"TipRanks","created":"Fri, 22 Nov 2024 11:07:47 -0400","updated":"Fri, 22 Nov 2024 11:17:27 -0400","title":"Trulieve Executives Show Confidence with Share Purchases","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. has announced that its executive leadership and board members have pur...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. has announced that its executive leadership and board members have pur...","url":"https://www.tipranks.com/news/company-announcements/trulieve-executives-show-confidence-with-share-purchases?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},{"id":42139246,"author":"TipRanks","created":"Fri, 22 Nov 2024 10:37:15 -0400","updated":"Fri, 22 Nov 2024 10:47:24 -0400","title":"Trulieve Expands with New Jacksonville Dispensary","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis is opening a new medical cannabis dispensary in Jacksonville, Florida, offer...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis is opening a new medical cannabis dispensary in Jacksonville, Florida, offer...","url":"https://www.tipranks.com/news/company-announcements/trulieve-expands-with-new-jacksonville-dispensary?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},{"id":42127096,"author":"Seeking Alpha","created":"Thu, 21 Nov 2024 19:40:00 -0400","updated":"Thu, 21 Nov 2024 19:45:48 -0400","title":"Cause For Concern In Cannabis With A Few Rays Of Light","teaser":"","body":"","url":"https://seekingalpha.com/article/4739459-cause-for-concern-in-cannabis-with-a-few-rays-of-light?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=article","image":[],"channels":[],"stocks":["AAWH","AGFY","AYRWF","AYWWF","CBSTF","CNTMF","CRLBF","CURLF","GHBWF","GLASF","GRUSF","GTBIF","IIPR","MSOS","TCNNF","TLRY","TSNDF","VREOF","VRNOF"],"tags":[]},{"id":42117276,"author":"TipRanks","created":"Thu, 21 Nov 2024 12:05:42 -0400","updated":"Thu, 21 Nov 2024 12:27:12 -0400","title":"Rising High: Numinus Wellness to sell five Utah clinics for $3.53M","teaser":"In this week\u0026#39;s \u0026#34;Rising High,\u0026#34; The Fly\u0026#39;s recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a clinic sale, effic...","body":"In this week's \"Rising High,\" The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on a clinic sale, effic...","url":"https://www.tipranks.com/news/the-fly/rising-high-numinus-wellness-to-sell-five-utah-clinics-for-3-53m?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["ACB","ATAI","CANN","CBSTF","CGC","CMPS","CRON","CVSI","CYBN","GTBIF","IGC","RLMD","TCNNF","TLRY","VREOF","VRNOF"],"tags":[]},{"id":42062915,"author":"TipRanks","created":"Tue, 19 Nov 2024 09:39:23 -0400","updated":"Tue, 19 Nov 2024 09:57:43 -0400","title":"Trulieve Expands with New Florida Dispensaries","teaser":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. is expanding its footprint in Florida with new medical cannabis dispen...","body":"Trulieve Cannabis (TSE:TRUL) has released an update. Trulieve Cannabis Corp. is expanding its footprint in Florida with new medical cannabis dispen...","url":"https://www.tipranks.com/news/company-announcements/trulieve-expands-with-new-florida-dispensaries?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["TCNNF"],"tags":[]},{"id":41982855,"author":"TipRanks","created":"Thu, 14 Nov 2024 13:30:20 -0400","updated":"Thu, 14 Nov 2024 13:59:03 -0400","title":"Rising High: Cannabis firms report quarterly earnings","teaser":"In this week\u0026#39;s \u0026#34;Rising High,\u0026#34; The Fly\u0026#39;s recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...","body":"In this week's \"Rising High,\" The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...","url":"https://www.tipranks.com/news/the-fly/rising-high-cannabis-firms-report-quarterly-earnings?utm_source=benzinga.com\u0026utm_medium=referral","image":[],"channels":[],"stocks":["AAWH","ACB","ATAI","AYRWF","CANN","CGC","CMPS","CRLBF","CRON","CVSI","CYBN","ENVB","GRWG","IGC","IMCC","MEDIF","NLCP","RLMD","SHFS","TCNNF","TLRY","VREOF"],"tags":[]},{"id":41967893,"author":"Seeking Alpha","created":"Thu, 14 Nov 2024 08:02:26 -0400","updated":"Thu, 14 Nov 2024 08:05:16 -0400","title":"Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post","teaser":"","body":"","url":"https://seekingalpha.com/news/4289008-cannabis-stocks-gain-gaetz-picked-ag-post?utm_source=partner_\u0026utm_medium=referral\u0026feed_item_type=news","image":[],"channels":[],"stocks":["AAWH","AYRWF","CNBS","CRLBF","CURLF","GTBIF","JUSHF","MJ","MSOS","TCNNF","TSNDF","VRNOF","YOLO"],"tags":[]}]},"postData":null,"pressRelease":{"contentStock":{"CSE:TRUL":{"name":"CSE:TRUL"},"TCNNF":{"name":"TCNNF"},"TRUL":{"name":"TRUL"}},"content":{"41114906":{"id":41114906,"author":"PRNewswire","created":"Tue, 01 Oct 2024 08:00:00 -0400","updated":"Tue, 01 Oct 2024 08:00:09 -0400","title":"Trulieve Partners with Black Buddha Cannabis to Launch Premium Products in Arizona and Pennsylvania","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41114906/trulieve-partners-with-black-buddha-cannabis-to-launch-premium-products-in-arizona-and-pennsylvani","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF","TRUL"],"tags":[{"name":"Licensing/Marketing Agreements"},{"name":"New Products/Services"}]},"41204673":{"id":41204673,"author":"PRNewswire","created":"Mon, 07 Oct 2024 08:00:00 -0400","updated":"Mon, 07 Oct 2024 08:00:07 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Hallandale Beach, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41204673/trulieve-to-open-medical-cannabis-dispensary-in-hallandale-beach-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},"41310847":{"id":41310847,"author":"PRNewswire","created":"Mon, 14 Oct 2024 08:00:00 -0400","updated":"Mon, 14 Oct 2024 08:00:13 -0400","title":"Trulieve Cannabis Corp. to Hold Third Quarter 2024 Results Conference Call on November 5, 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41310847/trulieve-cannabis-corp-to-hold-third-quarter-2024-results-conference-call-on-november-5-2024","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Conference Call Announcements"}]},"41328881":{"id":41328881,"author":"PRNewswire","created":"Tue, 15 Oct 2024 08:00:00 -0400","updated":"Tue, 15 Oct 2024 08:00:22 -0400","title":"Trulieve to Open Florida Medical Cannabis Dispensaries in Bonita Springs and St. Augustine","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41328881/trulieve-to-open-florida-medical-cannabis-dispensaries-in-bonita-springs-and-st-augustine","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},"41400138":{"id":41400138,"author":"PRNewswire","created":"Fri, 18 Oct 2024 08:00:00 -0400","updated":"Fri, 18 Oct 2024 08:00:06 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Orlando, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41400138/trulieve-to-open-medical-cannabis-dispensary-in-orlando-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},"41542467":{"id":41542467,"author":"PRNewswire","created":"Fri, 25 Oct 2024 08:00:00 -0400","updated":"Fri, 25 Oct 2024 08:00:08 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Lake Placid, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41542467/trulieve-to-open-medical-cannabis-dispensary-in-lake-placid-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},"41739367":{"id":41739367,"author":"PRNewswire","created":"Tue, 05 Nov 2024 07:00:00 -0400","updated":"Tue, 05 Nov 2024 07:00:13 -0400","title":"Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n41739367/trulieve-reports-third-quarter-2024-results-ahead-of-florida-adult-use-vote","image":[],"channels":[{"name":"Earnings"},{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},"42060617":{"id":42060617,"author":"PRNewswire","created":"Tue, 19 Nov 2024 09:00:00 -0400","updated":"Tue, 19 Nov 2024 09:00:25 -0400","title":"Trulieve to Open Florida Medical Cannabis Dispensaries in Dania Beach and Spring Hill","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42060617/trulieve-to-open-florida-medical-cannabis-dispensaries-in-dania-beach-and-spring-hill","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},"42136075":{"id":42136075,"author":"PRNewswire","created":"Fri, 22 Nov 2024 09:00:00 -0400","updated":"Fri, 22 Nov 2024 09:00:07 -0400","title":"Trulieve Cannabis Corp. Announces Insider Share Purchases By Executive Leadership and Board Members","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42136075/trulieve-cannabis-corp-announces-insider-share-purchases-by-executive-leadership-and-board-members","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},"42136529":{"id":42136529,"author":"PRNewswire","created":"Fri, 22 Nov 2024 09:15:00 -0400","updated":"Fri, 22 Nov 2024 09:15:06 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42136529/trulieve-to-open-medical-cannabis-dispensary-in-jacksonville-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]}},"pressContent":{"CSE:TRUL":["41114906","41204673","41310847","41328881","41400138","41542467","41739367","42060617","42136075","42136529"],"TCNNF":["41114906","41204673","41310847","41328881","41400138","41542467","41739367","42060617","42136075","42136529"],"TRUL":["41114906"]},"sortedContent":[{"id":42136529,"author":"PRNewswire","created":"Fri, 22 Nov 2024 09:15:00 -0400","updated":"Fri, 22 Nov 2024 09:15:06 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42136529/trulieve-to-open-medical-cannabis-dispensary-in-jacksonville-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},{"id":42136075,"author":"PRNewswire","created":"Fri, 22 Nov 2024 09:00:00 -0400","updated":"Fri, 22 Nov 2024 09:00:07 -0400","title":"Trulieve Cannabis Corp. Announces Insider Share Purchases By Executive Leadership and Board Members","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42136075/trulieve-cannabis-corp-announces-insider-share-purchases-by-executive-leadership-and-board-members","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},{"id":42060617,"author":"PRNewswire","created":"Tue, 19 Nov 2024 09:00:00 -0400","updated":"Tue, 19 Nov 2024 09:00:25 -0400","title":"Trulieve to Open Florida Medical Cannabis Dispensaries in Dania Beach and Spring Hill","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n42060617/trulieve-to-open-florida-medical-cannabis-dispensaries-in-dania-beach-and-spring-hill","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},{"id":41739367,"author":"PRNewswire","created":"Tue, 05 Nov 2024 07:00:00 -0400","updated":"Tue, 05 Nov 2024 07:00:13 -0400","title":"Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/11/n41739367/trulieve-reports-third-quarter-2024-results-ahead-of-florida-adult-use-vote","image":[],"channels":[{"name":"Earnings"},{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},{"id":41542467,"author":"PRNewswire","created":"Fri, 25 Oct 2024 08:00:00 -0400","updated":"Fri, 25 Oct 2024 08:00:08 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Lake Placid, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41542467/trulieve-to-open-medical-cannabis-dispensary-in-lake-placid-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},{"id":41400138,"author":"PRNewswire","created":"Fri, 18 Oct 2024 08:00:00 -0400","updated":"Fri, 18 Oct 2024 08:00:06 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Orlando, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41400138/trulieve-to-open-medical-cannabis-dispensary-in-orlando-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},{"id":41328881,"author":"PRNewswire","created":"Tue, 15 Oct 2024 08:00:00 -0400","updated":"Tue, 15 Oct 2024 08:00:22 -0400","title":"Trulieve to Open Florida Medical Cannabis Dispensaries in Bonita Springs and St. Augustine","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41328881/trulieve-to-open-florida-medical-cannabis-dispensaries-in-bonita-springs-and-st-augustine","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Corporate Expansion"}]},{"id":41310847,"author":"PRNewswire","created":"Mon, 14 Oct 2024 08:00:00 -0400","updated":"Mon, 14 Oct 2024 08:00:13 -0400","title":"Trulieve Cannabis Corp. to Hold Third Quarter 2024 Results Conference Call on November 5, 2024","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41310847/trulieve-cannabis-corp-to-hold-third-quarter-2024-results-conference-call-on-november-5-2024","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[{"name":"Conference Call Announcements"}]},{"id":41204673,"author":"PRNewswire","created":"Mon, 07 Oct 2024 08:00:00 -0400","updated":"Mon, 07 Oct 2024 08:00:07 -0400","title":"Trulieve to Open Medical Cannabis Dispensary in Hallandale Beach, Florida","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41204673/trulieve-to-open-medical-cannabis-dispensary-in-hallandale-beach-florida","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF"],"tags":[]},{"id":41114906,"author":"PRNewswire","created":"Tue, 01 Oct 2024 08:00:00 -0400","updated":"Tue, 01 Oct 2024 08:00:09 -0400","title":"Trulieve Partners with Black Buddha Cannabis to Launch Premium Products in Arizona and Pennsylvania","teaser":"","body":"","url":"https://www.benzinga.com/pressreleases/24/10/n41114906/trulieve-partners-with-black-buddha-cannabis-to-launch-premium-products-in-arizona-and-pennsylvani","image":[],"channels":[{"name":"Small Cap"},{"name":"Press Releases"}],"stocks":["CSE:TRUL","TCNNF","TRUL"],"tags":[{"name":"Licensing/Marketing Agreements"},{"name":"New Products/Services"}]}]},"ratingsSummary":{"aggregateRatings":{"Buy":4,"Hold":0,"Overweight":1,"Sell":0,"Underweight":0},"consensusPriceTarget":"18.50","consensusRating":"Buy","consensusRatingValue":84.8,"highestPriceRating":{"date":"2023-03-09","firm":"Cantor Fitzgerald","price":"37.00"},"highestPriceTarget":"37.00","lowestPriceRating":{"date":"2023-08-11","firm":"Wedbush","price":"6.00"},"lowestPriceTarget":"6.00","mostRecentFirms":[{"date":"2024-08-06","name":"Needham"},{"date":"2024-05-10","name":"Roth MKM"},{"date":"2024-03-05","name":"Seaport Global"},{"date":"2023-08-11","name":"Wedbush"},{"date":"2023-03-09","name":"Cantor Fitzgerald"}],"numRatings":22,"numUniqueRatings":6,"ratings":[{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"14.50","adjusted_pt_prior":"14.50","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2024-08-06","exchange":"OTC","id":"66b261b2157a570001808e42","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"14.50","pt_prior":"14.50","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"13:47:30","updated":1722966513,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"19.00","adjusted_pt_prior":"16.00","analyst":"Roth MKM","analyst_name":"Scott Fortune","currency":"USD","cusip":"89788C104","date":"2024-05-10","exchange":"OTC","id":"663e2c827b871e0001f780d0","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"19.0000","pt_prior":"16.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"10:17:38","updated":1715350719,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"14.50","adjusted_pt_prior":"13.50","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2024-05-10","exchange":"OTC","id":"663df1137b871e0001f77079","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"14.5000","pt_prior":"13.50","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"06:04:03","updated":1715335483,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"16.00","adjusted_pt_prior":"12.00","analyst":"Seaport Global","analyst_name":"Sonny Randhawa","currency":"USD","cusip":"89788C104","date":"2024-03-05","exchange":"OTC","id":"65e75404534d300001343610","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"16","pt_prior":"12.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"12:19:00","updated":1709659173,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"13.50","adjusted_pt_prior":"6.50","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2024-03-01","exchange":"OTC","id":"65e1ab10dc025900010ada9c","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"13.5000","pt_prior":"6.50","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"05:16:48","updated":1709288340,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"6.50","adjusted_pt_prior":"9.00","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2023-11-09","exchange":"OTC","id":"654d64021e70180001da40ff","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"6.50","pt_prior":"9.00","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"17:58:10","updated":1699570720,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"6.00","adjusted_pt_prior":"8.00","analyst":"Wedbush","analyst_name":"Gerald Pascarelli","currency":"USD","cusip":"89788C104","date":"2023-08-11","exchange":"OTC","id":"64d6495eb721680001b252be","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"6.0000","pt_prior":"8.0000","rating_current":"Outperform","rating_prior":"Outperform","ticker":"TCNNF","time":"10:44:46","updated":1691765113,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"9.00","adjusted_pt_prior":"10.00","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2023-08-10","exchange":"OTC","id":"64d4a1e03cc4810001d99b97","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"9.0000","pt_prior":"10.00","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"04:37:52","updated":1691656693,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"10.00","adjusted_pt_prior":"12.00","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2023-05-10","exchange":"OTC","id":"645bda7692e96700016a7191","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"10.0000","pt_prior":"12.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"13:55:02","updated":1683741370,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"12.00","adjusted_pt_prior":"14.25","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2023-03-09","exchange":"OTC","id":"6409a779b3cca4000180b4eb","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"12.0000","pt_prior":"14.2500","rating_current":"Buy","rating_prior":"","ticker":"TCNNF","time":"04:31:37","updated":1678354325,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"37.00","adjusted_pt_prior":"41.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2023-03-09","exchange":"OTC","id":"6409a746b3cca4000180b4d7","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"37.0000","pt_prior":"41.0000","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"04:30:46","updated":1678354274,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"41.00","adjusted_pt_prior":"51.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2023-03-06","exchange":"OTC","id":"6405b49ea5409a00018d5779","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"41.0000","pt_prior":"51.0000","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"04:38:38","updated":1678095582,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Initiates Coverage On","action_pt":"Announces","adjusted_pt_current":"18.00","adjusted_pt_prior":"","analyst":"Wedbush","analyst_name":"Gerald Pascarelli","currency":"USD","cusip":"89788C104","date":"2022-12-02","exchange":"OTC","id":"6389e1ae9f15fd0001ba5203","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"18.0000","pt_prior":"","rating_current":"Outperform","rating_prior":"","ticker":"TCNNF","time":"06:29:50","updated":1669980627,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"51.00","adjusted_pt_prior":"54.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2022-11-10","exchange":"OTC","id":"636cd9b138196600014a50f7","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"51.0000","pt_prior":"54.0000","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"06:00:01","updated":1668078040,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"54.00","adjusted_pt_prior":"57.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2022-08-11","exchange":"OTC","id":"62f4c8757f112200012f8cf8","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"54.0000","pt_prior":"57.00","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"05:14:29","updated":1660209321,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Initiates Coverage On","action_pt":"Announces","adjusted_pt_current":"23.00","adjusted_pt_prior":"","analyst":"Seaport Global","analyst_name":"Sonny Randhawa","currency":"USD","cusip":"89788C104","date":"2022-07-22","exchange":"OTC","id":"62da94a680322300019ef4cc","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"23.00","pt_prior":"","rating_current":"Buy","rating_prior":"","ticker":"TCNNF","time":"08:14:30","updated":1658492107,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"57.00","adjusted_pt_prior":"59.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2022-05-13","exchange":"OTC","id":"627e2c7b6660cf00010f1370","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"57.00","pt_prior":"59.00","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"06:01:31","updated":1652436143,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"47.00","adjusted_pt_prior":"50.00","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2022-03-31","exchange":"OTC","id":"62456d3a10f69f0001234fd9","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"47.00","pt_prior":"50.00","rating_current":"Buy","rating_prior":"","ticker":"TCNNF","time":"04:58:34","updated":1648717150,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"60.00","adjusted_pt_prior":"72.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2022-03-29","exchange":"OTC","id":"6242cac465a64100016e64b9","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"60.00","pt_prior":"72.00","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"05:00:52","updated":1648544492,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"50.00","adjusted_pt_prior":"54.00","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2022-02-18","exchange":"OTC","id":"620f7a9e4a807800011ac4b9","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"50.00","pt_prior":"54.00","rating_current":"Buy","rating_prior":"","ticker":"TCNNF","time":"05:53:18","updated":1645181643,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Initiates Coverage On","action_pt":"","adjusted_pt_current":"","adjusted_pt_prior":"","analyst":"Wolfe Research","analyst_name":"Greg Badishkanian","currency":"USD","cusip":"89788C104","date":"2022-01-07","exchange":"OTC","id":"61d82baf5ad724000184edb8","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"","pt_prior":"","rating_current":"Outperform","rating_prior":"","ticker":"TCNNF","time":"07:01:51","updated":1641556952,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"72.00","adjusted_pt_prior":"73.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2021-12-06","exchange":"OTC","id":"61adf4b26284470001989f52","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"72.00","pt_prior":"73.00","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"06:32:02","updated":1638790393,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"}],"uniqueRatingsFromLastThreeYears":[{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"6.00","adjusted_pt_prior":"8.00","analyst":"Wedbush","analyst_name":"Gerald Pascarelli","currency":"USD","cusip":"89788C104","date":"2023-08-11","exchange":"OTC","id":"64d6495eb721680001b252be","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"6.0000","pt_prior":"8.0000","rating_current":"Outperform","rating_prior":"Outperform","ticker":"TCNNF","time":"10:44:46","updated":1691765113,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Reiterates","action_pt":"Maintains","adjusted_pt_current":"14.50","adjusted_pt_prior":"14.50","analyst":"Needham","analyst_name":"Matt McGinley","currency":"USD","cusip":"89788C104","date":"2024-08-06","exchange":"OTC","id":"66b261b2157a570001808e42","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"14.50","pt_prior":"14.50","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"13:47:30","updated":1722966513,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"16.00","adjusted_pt_prior":"12.00","analyst":"Seaport Global","analyst_name":"Sonny Randhawa","currency":"USD","cusip":"89788C104","date":"2024-03-05","exchange":"OTC","id":"65e75404534d300001343610","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"16","pt_prior":"12.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"12:19:00","updated":1709659173,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Raises","adjusted_pt_current":"19.00","adjusted_pt_prior":"16.00","analyst":"Roth MKM","analyst_name":"Scott Fortune","currency":"USD","cusip":"89788C104","date":"2024-05-10","exchange":"OTC","id":"663e2c827b871e0001f780d0","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"19.0000","pt_prior":"16.0000","rating_current":"Buy","rating_prior":"Buy","ticker":"TCNNF","time":"10:17:38","updated":1715350719,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"},{"action_company":"Maintains","action_pt":"Lowers","adjusted_pt_current":"37.00","adjusted_pt_prior":"41.00","analyst":"Cantor Fitzgerald","analyst_name":"Pablo Zuanic","currency":"USD","cusip":"89788C104","date":"2023-03-09","exchange":"OTC","id":"6409a746b3cca4000180b4d7","importance":0,"isin":"CA89788C1041","name":"Trulieve Cannabis","notes":"","pt_current":"37.0000","pt_prior":"41.0000","rating_current":"Overweight","rating_prior":"","ticker":"TCNNF","time":"04:30:46","updated":1678354274,"url":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_calendar":"https://www.benzinga.com/quote/TCNNF/analyst-ratings","url_news":"https://www.benzinga.com/stock-articles/TCNNF/analyst-ratings"}]},"recentNewsQuery":{"excludeAutomated":true,"limit":3,"tickers":"TCNNF","type":["story","benzinga_reach","marketbeat"]},"splitsData":[],"sponsoredPosts":[],"technicals":{"rsi":0}},"showGovLink":false,"symbol":"TCNNF","sidebar":{"id":59458,"title":"Cryptocurrency /Money Sidebar","type":"sidebar","dynamic":false,"blocks":[{"blockName":"acf/sidebar-related-posts","attrs":{"name":"acf/sidebar-related-posts","data":{"title":"Learn About Cryptocurrency","related_posts":[95574,105115,296872,296517],"style":"money"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","posts":[{"id":95574,"slug":"what-is-ethereum","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2021/01/12102515/0bo235rhqec-768x512.jpg","published_at":"2024-03-21T09:26:57.000000Z","url":"/money/what-is-ethereum/","title":"What is Ethereum?","seotitle":"","author":{"name":"Anna Yen","gravatar":"//secure.gravatar.com/avatar/51dfafb02597374d0cd8da0cdc86a3b9?d=mm"},"date":"March 21st, 2024","description":"Learn about this leading blockchain platform that supports decentralized applications and smart contracts."},{"id":105115,"slug":"how-to-earn-interest-on-ethereum","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2021/03/29142306/0bo235rhqec-1-768x512.jpg","published_at":"2021-03-29T14:36:35.000000Z","url":"/money/how-to-earn-interest-on-ethereum/","title":"How to Earn Interest on Ethereum","seotitle":"","author":{"name":"Ryan McNamara","gravatar":"//secure.gravatar.com/avatar/8acd10f73d8a83ef13da39a2cbe047da?d=mm"},"date":"March 29th, 2021","description":"Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps."},{"id":296872,"slug":"best-cryptocurrencies-to-invest-in-for-november-2024","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/11/10181630/best-crypto-to-invest-768x512.jpg","published_at":"2024-11-25T13:26:48.000000Z","url":"/money/best-cryptocurrencies-to-invest-in-for-november-2024/","title":"10 Best Cryptocurrencies to Invest in for November 2024","seotitle":"10 Best Cryptocurrencies to Invest In for November 2024","author":{"name":"Caden Pok","gravatar":"//secure.gravatar.com/avatar/be39fe5efbca3e3f0b9133317520c725?d=mm"},"date":"November 25th, 2024","description":"Discover the 10 best cryptocurrencies to invest in for November 2024. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!"},{"id":296517,"slug":"best-altcoins","type":"post","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/10/30173251/best-altcoins-768x512.jpg","published_at":"2024-10-31T08:38:09.000000Z","url":"/money/best-altcoins/","title":"10 Best Altcoins in November 2024","seotitle":"Top 10 Best Altcoins • Benzinga Crypto","author":{"name":"Ishan Jain","gravatar":"//secure.gravatar.com/avatar/744edc395b489bbe265452a916cf7659?d=mm"},"date":"October 31st, 2024","description":"Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin."}]},{"blockName":"acf/news-feed","attrs":{"name":"acf/news-feed","data":{"primary_header":false,"header_see_more_text":"","header_see_more_link":"","title":"Top Cryptocurrency News","description_visible":true,"thumbnail_hidden":false,"see_all_text":null,"see_all_link":null,"feed_type":"parsely","topics":[],"channels":[],"news_custom_urls":"","news_primary_channel":"","posts_limit":null,"news":null,"style":"rated","load_more":null,"show_newsletter_block":false,"hide_tickers":false,"newsletter_title":null,"newsletter_form_id":null,"newsletter_description":null,"newsletter_style":null,"newsletter_utm_label":null,"newsletter_show_position":null,"news_feed_mode":"default","excluded_authors":""},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","top_posts":[{"id":42232028,"author":"Aniket Verma","created":"Thu, 28 Nov 2024 08:00:00 -0400","updated":"Thu, 28 Nov 2024 20:35:34 -0400","title":"Remember James Howells Who Lost His Hard Drive With 8,000 Bitcoins Now Worth $760M? His Ex-Girlfriend Reveals It Was She Who Threw It Away (CORRECTED)","teaser":"Editor’s Note: A quote initially attributed to James Howells has been corrected to reflect its proper source, Halfina Eddy-Evans.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42232028/remember-james-howells-who-lost-his-hard-drive-with-8000-bitcoins-now-worth-760m-his-ex-girlfriend-reveals-it-was-she-who-threw-it-away","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/28/Bitcoin-hard-drive.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/28/Bitcoin-hard-drive.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/28/Bitcoin-hard-drive.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Markets"}],"stocks":[{"name":"$BTC"}],"tags":[{"name":"Bitcoin"},{"name":"Hard Drive"},{"name":"James Howells"},{"name":"Landfill"},{"name":"Missed Profits"}]},{"id":42250465,"author":"Murtuza Merchant","created":"Fri, 29 Nov 2024 15:46:20 -0400","updated":"Fri, 29 Nov 2024 15:46:21 -0400","title":"Dogecoin Price Up 6.5%: What Is Going On?","teaser":"Dogecoin\u0026#39;s (CRYPTO: DOGE) rally back above 40 cents has captured the attention of traders, with many expressing optimism about a potential rally to new highs.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42250465/dogecoin-price-up-65-what-is-going-on","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/29/Dogecoin-Doge-Cryptocurrency-Means-Of-Pa.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/29/Dogecoin-Doge-Cryptocurrency-Means-Of-Pa.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/29/Dogecoin-Doge-Cryptocurrency-Means-Of-Pa.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Top Stories"}],"stocks":[{"name":"$DOGE"}],"tags":[{"name":"crypto regulation"},{"name":"Digital Assets"},{"name":"Dogecoin ETF"}]},{"id":42225289,"author":"Chris Katje","created":"Wed, 27 Nov 2024 17:36:06 -0400","updated":"Wed, 27 Nov 2024 17:36:07 -0400","title":"Here's How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs","teaser":"The cryptocurrency XRP Token (CRYPTO: XRP) from Ripple has soared in price over the last week, with optimism coming from an XRP exchange-traded fund and news that Ripple will invest in a newly rebranded ","body":"","url":"https://www.benzinga.com/24/11/42225289/heres-how-much-100-invested-in-xrp-token-today-will-be-worth-if-crypto-returns-to-all-time-highs","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/27/xrdDAE9HpS4rJc10093-j5149136682099195582.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/27/xrdDAE9HpS4rJc10093-j5149136682099195582.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/27/xrdDAE9HpS4rJc10093-j5149136682099195582.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"Education"},{"name":"Top Stories"}],"stocks":[{"name":"$XRP"}],"tags":[{"name":"Bitwise"},{"name":"Brad Garlinghouse"},{"name":"Here's how much $100"},{"name":"Hunter Horsley"},{"name":"ICYMI"},{"name":"if you invested"},{"name":"ripple"},{"name":"Ripple Labs"},{"name":"SEC"},{"name":"WisdomTree"}]},{"id":42252369,"author":"Ivan Crnogatić","created":"Fri, 29 Nov 2024 19:16:18 -0400","updated":"Fri, 29 Nov 2024 19:16:19 -0400","title":"Bitcoin, Ethereum, Dogecoin Climb, But Ripple Rockets: Analyst Calls It 'An Insane Period'","teaser":"Cryptocurrency markets are closing Friday strong, with Bitcoin’s performance paving the way for altcoin gains.","body":"","url":"https://www.benzinga.com/markets/cryptocurrency/24/11/42252369/bitcoin-ethereum-dogecoin-climb-but-ripple-rockets-analyst-calls-it-an-insane-period","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/29/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/29/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/29/Cryptocurrency-Photo-by-SvetlanaParnikov.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"News"},{"name":"Top Stories"}],"stocks":[{"name":"$ALGO"},{"name":"$BTC"},{"name":"$DOGE"},{"name":"$ETH"},{"name":"$HBAR"},{"name":"$SHIB"},{"name":"$SOL"},{"name":"$XRP"}],"tags":[{"name":"Expert Ideas"},{"name":"Stories That Matter"}]},{"id":42246620,"author":"Ivan Crnogatić","created":"Fri, 29 Nov 2024 12:07:11 -0400","updated":"Fri, 29 Nov 2024 12:07:12 -0400","title":"XRP Price Soars 20% In 24 Hours: Why Is XRP Up?","teaser":"XRP (CRYPTO: XRP) is up 20% over the past 24 hours, riding high on bullish sentiment around altcoins.","body":"","url":"https://www.benzinga.com/etfs/specialty-etfs/24/11/42246620/xrp-price-soars-20-in-24-hours-why-is-xrp-up","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/29/Ripple-XRP.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/29/Ripple-XRP.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/29/Ripple-XRP.jpeg"}],"channels":[{"name":"Cryptocurrency"},{"name":"Specialty ETFs"},{"name":"ETFs"}],"stocks":[{"name":"$ADA"},{"name":"$ALGO"},{"name":"$XRP"}],"tags":[{"name":"altcoins"},{"name":"Brad Garlinghouse"},{"name":"Brandon Hong"},{"name":"DonAlt"},{"name":"XRP ETF"}]}]},{"blockName":"acf/page-sidebar-placement","attrs":{"name":"acf/page-sidebar-placement","data":{"widget":{"ID":94647,"post_author":"353","post_date":"2020-12-28 11:04:28","post_date_gmt":"2020-12-28 16:04:28","post_content":"\u003c!-- wp:acf/newsletter-subscription-box {\"name\":\"acf/newsletter-subscription-box\",\"data\":{\"title\":\"Future Finance Newsletter\",\"_title\":\"field_title\",\"form_id\":\"6d120c76-8a53-4729-9627-e36a737e2a30\",\"_form_id\":\"field_form_id\",\"style\":\"default\",\"_style\":\"field_style\",\"mobile_only\":\"0\",\"_mobile_only\":\"field_mobile_only\",\"description\":\"\\u003cul\\u003e\\r\\n \\t\\u003cli\\u003eInsider Interviews\\u003c/li\\u003e\\r\\n \\t\\u003cli\\u003eNews \\u0026amp; Show Highlights\\u003c/li\\u003e\\r\\n \\t\\u003cli\\u003eCompletely FREE\\u003c/li\\u003e\\r\\n\\u003c/ul\\u003e\",\"_description\":\"field_description\",\"redirect_url\":\"\",\"_redirect_url\":\"redirect_url\",\"utm_label\":\"Sign Up\",\"_utm_label\":\"field_utm_label\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e","post_title":"Future Finance Newsletter","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"crypto-newsletter-sign-up","to_ping":"","pinged":"","post_modified":"2024-06-11 03:10:07","post_modified_gmt":"2024-06-11 07:10:07","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=94647","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":""}]}},"__N_SSP":true},"page":"/quotev2/[ticker]","query":{"ticker":"TCNNF"},"buildId":"ai_akWtpvOvhV1YpY4JBy","isFallback":false,"isExperimentalCompile":false,"gssp":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10